BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 022347
(298 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 136 bits (343), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 92/233 (39%), Positives = 134/233 (57%), Gaps = 16/233 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL-VSLRPNKLDLHVAL 82
F+REV +M R++H N+V F+GA + P + IVTE L SL + L S +LD L
Sbjct: 81 FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 83 NFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQK-SLKLADFGLARXXXXXXXXXXX 139
+ A D+A+ M+ LH I+HRDLK NLL+ D+K ++K+ DFGL+R
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLV--DKKYTVKVCDFGLSRLKASXFLXSKX 198
Query: 140 XXXY-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
WMAPE+ LR + N K DVYSFG++LWEL T + P+ ++ Q A
Sbjct: 199 AAGTPEWMAPEV-----LRD---EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 250
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251
FK R +P +++P +A I++ CW +P RPSF+ I+ +L + + PP
Sbjct: 251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 135 bits (341), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 88/233 (37%), Positives = 131/233 (56%), Gaps = 16/233 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL-VSLRPNKLDLHVAL 82
F+REV +M R++H N+V F+GA + P + IVTE L SL + L S +LD L
Sbjct: 81 FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 83 NFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQK-SLKLADFGLARXXXXXXXXXXX 139
+ A D+A+ M+ LH I+HR+LK NLL+ D+K ++K+ DFGL+R
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 140 XXXY-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
WMAPE+ LR + N K DVYSFG++LWEL T + P+ ++ Q A
Sbjct: 199 AAGTPEWMAPEV-----LRD---EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 250
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251
FK R +P +++P +A I++ CW +P RPSF+ I+ +L + + PP
Sbjct: 251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 123 bits (308), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 76/229 (33%), Positives = 110/229 (48%), Gaps = 23/229 (10%)
Query: 27 REVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E + + +KH N++ G C K+P + +V E G L + L R + + +N+A
Sbjct: 55 QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWA 111
Query: 86 LDIARAMDCLHANGI---IHRDLKPDNLLLTP-------DQKSLKLADFGLARXXXXXXX 135
+ IAR M+ LH I IHRDLK N+L+ K LK+ DFGLAR
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
Y WMAPE+ +G DV+S+G++LWELLT +PF G+ L
Sbjct: 172 MSAAGA-YAWMAPEVIRASMFSKGS--------DVWSYGVLLWELLTGEVPFRGIDGLAV 222
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
AY A +P A +++ CW DP+ RPSF+ I+ L
Sbjct: 223 AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 120 bits (300), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 76/229 (33%), Positives = 118/229 (51%), Gaps = 22/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--- 81
FI E+ +SRV H N+VK GAC +P+ +V E G SL L P L + A
Sbjct: 49 FIVELRQLSRVNHPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEP--LPYYTAAHA 105
Query: 82 LNFALDIARAMDCLHA---NGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
+++ L ++ + LH+ +IHRDLKP NLLL LK+ DFG A
Sbjct: 106 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK 165
Query: 139 XXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE--GMSNLQAA 196
WMAPE++ E +Y+ K DV+S+GI+LWE++T R PF+ G +
Sbjct: 166 GSAA--WMAPEVF--------EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 215
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ A RP L +++ + ++ CW +DP+ RPS +I++++ +
Sbjct: 216 W-AVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 263
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 120 bits (300), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 76/229 (33%), Positives = 118/229 (51%), Gaps = 22/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--- 81
FI E+ +SRV H N+VK GAC +P+ +V E G SL L P L + A
Sbjct: 48 FIVELRQLSRVNHPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEP--LPYYTAAHA 104
Query: 82 LNFALDIARAMDCLHA---NGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
+++ L ++ + LH+ +IHRDLKP NLLL LK+ DFG A
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK 164
Query: 139 XXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE--GMSNLQAA 196
WMAPE++ E +Y+ K DV+S+GI+LWE++T R PF+ G +
Sbjct: 165 GSAA--WMAPEVF--------EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ A RP L +++ + ++ CW +DP+ RPS +I++++ +
Sbjct: 215 W-AVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 110 bits (274), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C +P IVTE +P +L YL ++ V L
Sbjct: 74 EFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLL 133
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 134 YMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHVVKVADFGLSRLMTGDTYTAHAGAK 192
Query: 143 Y--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAY 197
+ +W APE Y+T ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 193 FPIKWTAPESLAYNTFSI----------KSDVWAFGVLLWEIATYGMSPYPGI-DLSQVY 241
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
K R PE P + ++++CW P RPSF++
Sbjct: 242 DLLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAE 280
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 109 bits (272), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 75/241 (31%), Positives = 118/241 (48%), Gaps = 20/241 (8%)
Query: 12 GSTSDERALLEG--RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLV 69
G + E ++E F REV +MS + H N+VK G +P +V E +P L L+
Sbjct: 55 GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRLL 113
Query: 70 SLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTP-DQKS---LKLAD 123
+ + + V L LDIA ++ + I+HRDL+ N+ L D+ + K+AD
Sbjct: 114 D-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172
Query: 124 FGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
FGL++ ++WMAPE E++ Y K D YSF ++L+ +LT
Sbjct: 173 FGLSQQSVHSVSGLLGN--FQWMAPETIGA------EEESYTEKADTYSFAMILYTILTG 224
Query: 184 RLPFEGMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
PF+ S + + + RP +PED P L +++ CW DP RP FS I++ L
Sbjct: 225 EGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
Query: 242 N 242
+
Sbjct: 285 S 285
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 108 bits (271), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 67 FKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDI 125
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---XXXXXXXXXXX 141
A AR MD LHA IIHRDLK +N+ L D ++K+ DFGLA
Sbjct: 126 ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
WMAPE+ +R + Y+ + DVY+FGIVL+EL+T +LP+ ++N
Sbjct: 185 SILWMAPEV-----IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239
Query: 202 KHARPGLPEDISPDLAFIVQSC 223
+ + +SPDL+ + +C
Sbjct: 240 RGS-------LSPDLSKVRSNC 254
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 108 bits (270), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 55 FKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDI 113
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---XXXXXXXXXXX 141
A AR MD LHA IIHRDLK +N+ L D ++K+ DFGLA
Sbjct: 114 ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATVKSRWSGSHQFEQLSG 172
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
WMAPE+ +R + Y+ + DVY+FGIVL+EL+T +LP+ ++N
Sbjct: 173 SILWMAPEV-----IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 227
Query: 202 KHARPGLPEDISPDLAFIVQSC 223
+ + +SPDL+ + +C
Sbjct: 228 RGS-------LSPDLSKVRSNC 242
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 108 bits (269), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 67 FKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDI 125
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---XXXXXXXXXXX 141
A AR MD LHA IIHRDLK +N+ L D ++K+ DFGLA
Sbjct: 126 ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
WMAPE+ +R + Y+ + DVY+FGIVL+EL+T +LP+ ++N
Sbjct: 185 SILWMAPEV-----IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239
Query: 202 KHARPGLPEDISPDLAFIVQSC 223
+ + +SPDL+ + +C
Sbjct: 240 RGS-------LSPDLSKVRSNC 254
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 107 bits (268), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 74/237 (31%), Positives = 112/237 (47%), Gaps = 17/237 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M ++HD LVK + I+TE + SL +L S +K L ++F
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 289
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
+ IA M + IHRDL+ N+L++ K+ADFGLAR +
Sbjct: 290 SAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE + + T+ K DV+SFGI+L E++T R+P+ GMSN + A
Sbjct: 349 IKWTAPEAINFGSFTI----------KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
+ P PE+ +L I+ CW P RP+F I +L+ F +P
Sbjct: 399 ERGYRMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQXEEIP 454
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 107 bits (267), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 74/241 (30%), Positives = 117/241 (48%), Gaps = 20/241 (8%)
Query: 12 GSTSDERALLEG--RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLV 69
G + E ++E F REV +MS + H N+VK G +P +V E +P L L+
Sbjct: 55 GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRLL 113
Query: 70 SLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTP-DQKS---LKLAD 123
+ + + V L LDIA ++ + I+HRDL+ N+ L D+ + K+AD
Sbjct: 114 D-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172
Query: 124 FGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
FG ++ ++WMAPE E++ Y K D YSF ++L+ +LT
Sbjct: 173 FGTSQQSVHSVSGLLGN--FQWMAPETIGA------EEESYTEKADTYSFAMILYTILTG 224
Query: 184 RLPFEGMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
PF+ S + + + RP +PED P L +++ CW DP RP FS I++ L
Sbjct: 225 EGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
Query: 242 N 242
+
Sbjct: 285 S 285
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 107 bits (267), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 114/234 (48%), Gaps = 19/234 (8%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLR 72
T E A+ E FI E +M ++ H LV+ G C + + +VTE + L YL + R
Sbjct: 39 TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR 98
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX 132
L LD+ M L +IHRDL N L+ +Q +K++DFG+ R
Sbjct: 99 -GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD 156
Query: 133 XXXXXXXXXXY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 189
+ +W +PE++S Y++K DV+SFG+++WE+ + ++P+E
Sbjct: 157 DQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
Query: 190 MSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
SN + + F+ +P L S + I+ CW E P RP+FS+++R L
Sbjct: 209 RSNSEVVEDISTGFRLYKPRLA---STHVYQIMNHCWRERPEDRPAFSRLLRQL 259
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 107 bits (267), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 68 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 127
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 128 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAK 186
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 187 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 237
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 238 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 275
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 107 bits (266), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 60 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 179 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 229
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 230 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 69/218 (31%), Positives = 112/218 (51%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 60 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTXTAHAGAK 178
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 179 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 229
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 230 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 60 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 179 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 229
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 230 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 59 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 118
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 178 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 228
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 57 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 116
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAK 175
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 176 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 226
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 227 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 57 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 116
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAK 175
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 176 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 226
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 227 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 56 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 115
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 116 YMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAPAGAK 174
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 175 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 225
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 226 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL ++ V L
Sbjct: 55 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 174 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 224
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 57 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 116
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAPAGAK 175
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 176 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 226
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 227 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 78 FKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDI 136
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX---XXXXXXXXX 141
A A+ MD LHA IIHRDLK +N+ L D ++K+ DFGLA
Sbjct: 137 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSG 195
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAA 200
WMAPE+ +R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N Q +
Sbjct: 196 SILWMAPEV-----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 250
Query: 201 FKHARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P L + + + ++ C + + RP F QI+
Sbjct: 251 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 291
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL ++ V L
Sbjct: 60 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 119
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 179 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 229
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 230 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 15/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL--MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F+ E ++M++++H NLV+ LG + + IVTE + SL YL S + L L
Sbjct: 61 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 120
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
F+LD+ AM+ L N +HRDL N+L++ D + K++DFGL +
Sbjct: 121 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPV- 178
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 201
+W APE LR+ K ++ K DV+SFGI+LWE+ + R+P+ + L+
Sbjct: 179 -KWTAPE-----ALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVE 228
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
K + P+ P + ++++CW D +RPSF Q+ L
Sbjct: 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 79 FKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDI 137
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX---XXXXXXXXX 141
A A+ MD LHA IIHRDLK +N+ L D ++K+ DFGLA
Sbjct: 138 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSG 196
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAA 200
WMAPE+ +R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N Q +
Sbjct: 197 SILWMAPEV-----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 251
Query: 201 FKHARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P L + + + ++ C + + RP F QI+
Sbjct: 252 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 292
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 74/241 (30%), Positives = 117/241 (48%), Gaps = 20/241 (8%)
Query: 12 GSTSDERALLEG--RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLV 69
G + E ++E F REV +MS + H N+VK G +P +V E +P L L+
Sbjct: 55 GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRLL 113
Query: 70 SLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTP-DQKS---LKLAD 123
+ + + V L LDIA ++ + I+HRDL+ N+ L D+ + K+AD
Sbjct: 114 D-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172
Query: 124 FGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
F L++ ++WMAPE E++ Y K D YSF ++L+ +LT
Sbjct: 173 FSLSQQSVHSVSGLLGN--FQWMAPETIGA------EEESYTEKADTYSFAMILYTILTG 224
Query: 184 RLPFEGMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
PF+ S + + + RP +PED P L +++ CW DP RP FS I++ L
Sbjct: 225 EGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
Query: 242 N 242
+
Sbjct: 285 S 285
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 79 FKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDI 137
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX---XXXXXXXXX 141
A A+ MD LHA IIHRDLK +N+ L D ++K+ DFGLA
Sbjct: 138 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSG 196
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAA 200
WMAPE+ +R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N Q +
Sbjct: 197 SILWMAPEV-----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 251
Query: 201 FKHARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P L + + + ++ C + + RP F QI+
Sbjct: 252 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 292
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 70/236 (29%), Positives = 114/236 (48%), Gaps = 19/236 (8%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLR 72
T E A+ E FI E +M ++ H LV+ G C + + +V E + L YL + R
Sbjct: 38 TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR 97
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX 132
L LD+ M L +IHRDL N L+ +Q +K++DFG+ R
Sbjct: 98 -GLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD 155
Query: 133 XXXXXXXXXXY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 189
+ +W +PE++S Y++K DV+SFG+++WE+ + ++P+E
Sbjct: 156 DQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYEN 207
Query: 190 MSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243
SN + + F+ +P L S + I+ CW E P RP+FS+++R L A
Sbjct: 208 RSNSEVVEDISTGFRLYKPRLA---STHVYQIMNHCWKERPEDRPAFSRLLRQLAA 260
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 55 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 114
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 174 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 224
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL ++ V L
Sbjct: 55 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 174 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 224
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 55 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 114
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 174 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 224
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 71 FKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDI 129
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX---XXXXXXXXX 141
A A+ MD LHA IIHRDLK +N+ L D ++K+ DFGLA
Sbjct: 130 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSG 188
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAA 200
WMAPE+ +R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N Q +
Sbjct: 189 SILWMAPEV-----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 243
Query: 201 FKHARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P L + + + ++ C + + RP F QI+
Sbjct: 244 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 284
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 56 FKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDI 114
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX---XXXXXXXXXX 141
A A+ MD LHA IIHRDLK +N+ L D ++K+ DFGLA
Sbjct: 115 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSG 173
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAA 200
WMAPE+ +R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N Q +
Sbjct: 174 SILWMAPEV-----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 228
Query: 201 FKHARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P L + + + ++ C + + RP F QI+
Sbjct: 229 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 269
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 51 FKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDI 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX---XXXXXXXXXX 141
A A+ MD LHA IIHRDLK +N+ L D ++K+ DFGLA
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAA 200
WMAPE+ +R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N Q +
Sbjct: 169 SILWMAPEV-----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
Query: 201 FKHARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P L + + + ++ C + + RP F QI+
Sbjct: 224 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 53 FKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDI 111
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX---XXXXXXXXXX 141
A A+ MD LHA IIHRDLK +N+ L D ++K+ DFGLA
Sbjct: 112 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSG 170
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAA 200
WMAPE+ +R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N Q +
Sbjct: 171 SILWMAPEV-----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 225
Query: 201 FKHARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P L + + + ++ C + + RP F QI+
Sbjct: 226 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 266
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 106 bits (264), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 15/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL--MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F+ E ++M++++H NLV+ LG + + IVTE + SL YL S + L L
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
F+LD+ AM+ L N +HRDL N+L++ D + K++DFGL +
Sbjct: 106 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPV- 163
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 201
+W APE LR+ K ++ K DV+SFGI+LWE+ + R+P+ + L+
Sbjct: 164 -KWTAPE-----ALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVE 213
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
K + P+ P + ++++CW D +RPSF Q+ L
Sbjct: 214 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 254
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 106 bits (264), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 56 FKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDI 114
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX---XXXXXXXXXX 141
A A+ MD LHA IIHRDLK +N+ L D ++K+ DFGLA
Sbjct: 115 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSG 173
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAA 200
WMAPE+ +R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N Q +
Sbjct: 174 SILWMAPEV-----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 228
Query: 201 FKHARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P L + + + ++ C + + RP F QI+
Sbjct: 229 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 269
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 106 bits (264), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 51 FKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDI 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX---XXXXXXXXXX 141
A A+ MD LHA IIHRDLK +N+ L D ++K+ DFGLA
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAA 200
WMAPE+ +R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N Q +
Sbjct: 169 SILWMAPEV-----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
Query: 201 FKHARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P L + + + ++ C + + RP F QI+
Sbjct: 224 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 51 FKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDI 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX---XXXXXXXXXX 141
A A+ MD LHA IIHRDLK +N+ L D ++K+ DFGLA
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAA 200
WMAPE+ +R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N Q +
Sbjct: 169 SILWMAPEV-----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
Query: 201 FKHARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P L + + + ++ C + + RP F QI+
Sbjct: 224 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 73/225 (32%), Positives = 110/225 (48%), Gaps = 17/225 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M ++HD LVK + I+TE + SL +L S +K L ++F
Sbjct: 57 FLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 116
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
+ IA M + IHRDL+ N+L++ K+ADFGLAR +
Sbjct: 117 SAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFP 175
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE + + T+ K DV+SFGI+L E++T R+P+ GMSN + A
Sbjct: 176 IKWTAPEAINFGSFTI----------KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 225
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
+ P PE+ +L I+ CW P RP+F I +L+ F
Sbjct: 226 ERGYRMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 269
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 18/220 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 259 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 318
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHR+L N L+ + +K+ADFGL+R
Sbjct: 319 YMATQISSAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAK 377
Query: 143 Y--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAY 197
+ +W APE Y+ ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 378 FPIKWTAPESLAYNKFSI----------KSDVWAFGVLLWEIATYGMSPYPGI-DLSQVY 426
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 427 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 466
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 71/232 (30%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS----L 71
E ++ E F +E M ++ H LVKF G C K+ + IVTE + L YL S L
Sbjct: 42 EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGL 101
Query: 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX 131
P++L L D+ M L ++ IHRDL N L+ D +K++DFG+ R
Sbjct: 102 EPSQL-----LEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVL 155
Query: 132 XXXXXXXXXXXY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 188
+ +W APE++ Y++K DV++FGI++WE+ + ++P++
Sbjct: 156 DDQYVSSVGTKFPVKWSAPEVFHYFK--------YSSKSDVWAFGILMWEVFSLGKMPYD 207
Query: 189 GMSNLQAAYAAAFKH--ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+N + + H RP L D + I+ SCW E P RP+F Q++
Sbjct: 208 LYTNSEVVLKVSQGHRLYRPHLASDT---IYQIMYSCWHELPEKRPTFQQLL 256
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 18/220 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 301 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 360
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHR+L N L+ + +K+ADFGL+R
Sbjct: 361 YMATQISSAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAK 419
Query: 143 Y--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAY 197
+ +W APE Y+ ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 420 FPIKWTAPESLAYNKFSI----------KSDVWAFGVLLWEIATYGMSPYPGI-DLSQVY 468
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 469 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 508
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 69/218 (31%), Positives = 110/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL ++ V L
Sbjct: 53 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 112
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTXTAHAGAK 171
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ Q Y
Sbjct: 172 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYEL 222
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 223 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 105 bits (261), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 72/228 (31%), Positives = 115/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 63 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 122
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHRDL+ N+L++ D S K+ADFGLAR +
Sbjct: 123 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFP 181
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY-- 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 182 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 231
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 232 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 276
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 105 bits (261), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 19/234 (8%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLR 72
T E A+ E FI E +M ++ H LV+ G C + + +V E + L YL + R
Sbjct: 38 TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR 97
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX 132
L LD+ M L +IHRDL N L+ +Q +K++DFG+ R
Sbjct: 98 -GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD 155
Query: 133 XXXXXXXXXXY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 189
+ +W +PE++S Y++K DV+SFG+++WE+ + ++P+E
Sbjct: 156 DQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYEN 207
Query: 190 MSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
SN + + F+ +P L S + I+ CW E P RP+FS+++R L
Sbjct: 208 RSNSEVVEDISTGFRLYKPRLA---STHVYQIMNHCWKERPEDRPAFSRLLRQL 258
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 105 bits (261), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 72/228 (31%), Positives = 115/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 61 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 120
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHRDL+ N+L++ D S K+ADFGLAR +
Sbjct: 121 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFP 179
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY-- 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 180 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 229
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 230 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 274
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 105 bits (261), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 72/228 (31%), Positives = 115/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHRDL+ N+L++ D S K+ADFGLAR +
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDAEXTAREGAKFP 173
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY-- 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 174 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 224 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 105 bits (261), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 19/234 (8%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLR 72
T E A+ E FI E +M ++ H LV+ G C + + +V E + L YL + R
Sbjct: 36 TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR 95
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX 132
L LD+ M L +IHRDL N L+ +Q +K++DFG+ R
Sbjct: 96 -GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD 153
Query: 133 XXXXXXXXXXY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 189
+ +W +PE++S Y++K DV+SFG+++WE+ + ++P+E
Sbjct: 154 DQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205
Query: 190 MSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
SN + + F+ +P L S + I+ CW E P RP+FS+++R L
Sbjct: 206 RSNSEVVEDISTGFRLYKPRLA---STHVYQIMNHCWKERPEDRPAFSRLLRQL 256
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 105 bits (261), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+ E + +L YL +++ V L
Sbjct: 56 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLL 115
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 116 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTXTAHAGAK 174
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 175 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 225
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 226 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 105 bits (261), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 72/228 (31%), Positives = 115/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 64 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 123
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHRDL+ N+L++ D S K+ADFGLAR +
Sbjct: 124 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFP 182
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY-- 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 183 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 232
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 233 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 277
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 105 bits (261), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL ++ V L
Sbjct: 53 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 112
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTFTAHAGAK 171
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ Q Y
Sbjct: 172 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYEL 222
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 223 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 105 bits (261), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 68/220 (30%), Positives = 111/220 (50%), Gaps = 18/220 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL ++ V L
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 321
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHR+L N L+ + +K+ADFGL+R
Sbjct: 322 YMATQISSAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAK 380
Query: 143 Y--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAY 197
+ +W APE Y+ ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 381 FPIKWTAPESLAYNKFSI----------KSDVWAFGVLLWEIATYGMSPYPGI-DLSQVY 429
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 430 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 105 bits (261), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 19/234 (8%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLR 72
T E A+ E FI E +M ++ H LV+ G C + + +V E + L YL + R
Sbjct: 41 TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR 100
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX 132
L LD+ M L +IHRDL N L+ +Q +K++DFG+ R
Sbjct: 101 -GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD 158
Query: 133 XXXXXXXXXXY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 189
+ +W +PE++S Y++K DV+SFG+++WE+ + ++P+E
Sbjct: 159 DQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210
Query: 190 MSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
SN + + F+ +P L S + I+ CW E P RP+FS+++R L
Sbjct: 211 RSNSEVVEDISTGFRLYKPRLA---STHVYQIMNHCWRERPEDRPAFSRLLRQL 261
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 105 bits (261), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 71/228 (31%), Positives = 114/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 65 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 124
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHRDL+ N+L++ D S K+ADFGLAR +
Sbjct: 125 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFP 183
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY-- 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 184 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 233
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 234 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 278
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 104 bits (260), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 73/223 (32%), Positives = 109/223 (48%), Gaps = 23/223 (10%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M ++HD LVK + I+TE + SL +L S +K L ++F
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 283
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ IA M + IHRDL+ N+L++ K+ADFGLAR +
Sbjct: 284 SAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVGAKFPI--------K 334
Query: 145 WMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 201
W APE + + T+ K DV+SFGI+L E++T R+P+ GMSN + A
Sbjct: 335 WTAPEAINFGSFTI----------KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 384
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
+ P PE+ +L I+ CW P RP+F I +L+ F
Sbjct: 385 GYRMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 426
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 104 bits (260), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 71/228 (31%), Positives = 114/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 61 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 120
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHRDL+ N+L++ D S K+ADFGLAR +
Sbjct: 121 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFP 179
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY-- 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 180 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 229
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 230 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 274
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 104 bits (260), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 72/228 (31%), Positives = 115/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHRDL+ N+L++ D S K+ADFGLAR +
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY-- 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 174 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 224 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 104 bits (260), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 71/228 (31%), Positives = 114/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 60 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 119
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHRDL+ N+L++ D S K+ADFGLAR +
Sbjct: 120 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFP 178
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY-- 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 179 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 228
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 229 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 273
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 104 bits (260), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 71/228 (31%), Positives = 114/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 50 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHRDL+ N+L++ D S K+ADFGLAR +
Sbjct: 110 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFP 168
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAA--Y 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 169 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 218
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 219 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 263
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 104 bits (260), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+ E + +L YL ++ V L
Sbjct: 55 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 174 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 224
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 104 bits (260), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 114/221 (51%), Gaps = 15/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL--MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F+ E ++M++++H NLV+ LG + + IVTE + SL YL S + L L
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 292
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
F+LD+ AM+ L N +HRDL N+L++ D + K++DFGL +
Sbjct: 293 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPV- 350
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 201
+W APE LR+ K ++ K DV+SFGI+LWE+ + R+P+ + L+
Sbjct: 351 -KWTAPE-----ALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVE 400
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
K + P+ P + ++++CW D RP+F Q+ L
Sbjct: 401 KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 104 bits (260), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 67/218 (30%), Positives = 110/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+ E + +L YL +++ V L
Sbjct: 60 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 179 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 229
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 230 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 104 bits (259), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+ E + +L YL ++ V L
Sbjct: 55 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 174 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 224
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 104 bits (259), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 72/228 (31%), Positives = 115/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 56 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 115
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHRDL+ N+L++ D S K+ADFGLAR +
Sbjct: 116 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFP 174
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY-- 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 175 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 224
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 225 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 269
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 104 bits (259), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 114/221 (51%), Gaps = 15/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL--MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F+ E ++M++++H NLV+ LG + + IVTE + SL YL S + L L
Sbjct: 52 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 111
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
F+LD+ AM+ L N +HRDL N+L++ D + K++DFGL +
Sbjct: 112 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPV- 169
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 201
+W APE LR+ ++ K DV+SFGI+LWE+ + R+P+ + L+
Sbjct: 170 -KWTAPE-----ALREAA---FSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVE 219
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
K + P+ P + ++++CW D +RPSF Q+ L
Sbjct: 220 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 260
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 104 bits (259), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 72/228 (31%), Positives = 115/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 57 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 116
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHRDL+ N+L++ D S K+ADFGLAR +
Sbjct: 117 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFP 175
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY-- 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 176 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 225
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 226 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 270
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 104 bits (259), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 68/234 (29%), Positives = 113/234 (48%), Gaps = 19/234 (8%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLR 72
T E ++ E FI E +M ++ H LV+ G C + + +V E + L YL + R
Sbjct: 58 TIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR 117
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX 132
L LD+ M L +IHRDL N L+ +Q +K++DFG+ R
Sbjct: 118 -GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD 175
Query: 133 XXXXXXXXXXY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 189
+ +W +PE++S Y++K DV+SFG+++WE+ + ++P+E
Sbjct: 176 DQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYEN 227
Query: 190 MSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
SN + + F+ +P L S + I+ CW E P RP+FS+++R L
Sbjct: 228 RSNSEVVEDISTGFRLYKPRLA---STHVYQIMNHCWKERPEDRPAFSRLLRQL 278
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 104 bits (259), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 71/228 (31%), Positives = 114/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHRDL+ N+L++ D S K+ADFGLAR +
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY-- 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 174 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 224 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 104 bits (259), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 72/228 (31%), Positives = 115/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHRDL+ N+L++ D S K+ADFGLAR +
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAA--Y 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 174 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 224 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 70/228 (30%), Positives = 114/228 (50%), Gaps = 21/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ L+
Sbjct: 51 FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + IHR+L+ N+L++ D S K+ADFGLAR +
Sbjct: 111 AAQIAEGMAFIEERNYIHRNLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFP 169
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAA--Y 197
+W APE Y T T+ K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 170 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 219
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 220 ERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 264
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 102 bits (255), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+ E + +L YL ++ V L
Sbjct: 53 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLL 112
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTXTAHAGAK 171
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA 199
+ +W APE + ++ K DV++FG++LWE+ T + P+ G+ Q Y
Sbjct: 172 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYEL 222
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R PE + ++++CW +P+ RPSF++I
Sbjct: 223 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 102 bits (253), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 74/231 (32%), Positives = 115/231 (49%), Gaps = 20/231 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDL 78
L+ +F++E ++ + H N+V+ +G C K P+ IV EL+ G +L + +L +
Sbjct: 155 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRT-EGARLRV 212
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
L D A M+ L + IHRDL N L+T ++ LK++DFG++R
Sbjct: 213 KTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVXAAS 271
Query: 139 X---XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 194
+W APE L G Y+++ DV+SFGI+LWE + P+ +SN Q
Sbjct: 272 GGLRQVPVKWTAPE-----ALNYG---RYSSESDVWSFGILLWETFSLGASPYPNLSN-Q 322
Query: 195 AAYAAAFKHARPGLPEDISPDLAF-IVQSCWVEDPNLRPSFSQIIRMLNAF 244
K R PE + PD F +++ CW +P RPSFS I + L +
Sbjct: 323 QTREFVEKGGRLPCPE-LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 102 bits (253), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 77/240 (32%), Positives = 120/240 (50%), Gaps = 34/240 (14%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
I E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP L+
Sbjct: 80 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLQARRPPGLEFSFN 138
Query: 82 --------------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLA
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLA 197
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ + Y ++ DV+SFG++LWE+ T
Sbjct: 198 RDIHHIDXXKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTL 248
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 249 GGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 102 bits (253), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 73/231 (31%), Positives = 114/231 (49%), Gaps = 20/231 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDL 78
L+ +F++E ++ + H N+V+ +G C K P+ IV EL+ G +L + +L +
Sbjct: 155 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRT-EGARLRV 212
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
L D A M+ L + IHRDL N L+T ++ LK++DFG++R
Sbjct: 213 KTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVYAAS 271
Query: 139 X---XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 194
+W APE L G Y+++ DV+SFGI+LWE + P+ +SN Q
Sbjct: 272 GGLRQVPVKWTAPE-----ALNYG---RYSSESDVWSFGILLWETFSLGASPYPNLSN-Q 322
Query: 195 AAYAAAFKHARPGLPEDISPDLAF-IVQSCWVEDPNLRPSFSQIIRMLNAF 244
K R PE + PD F +++ CW +P RPSFS I + L +
Sbjct: 323 QTREFVEKGGRLPCPE-LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 102 bits (253), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 75/240 (31%), Positives = 118/240 (49%), Gaps = 34/240 (14%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
I E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP L+
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLQARRPPGLEYSYN 179
Query: 82 --------------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLA
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLA 238
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ + Y ++ DV+SFG++LWE+ T
Sbjct: 239 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTL 289
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 290 GGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 102 bits (253), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 75/243 (30%), Positives = 119/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
I E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP L+
Sbjct: 80 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLQARRPPGLEYSYN 138
Query: 82 --------------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLA
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLA 197
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ + Y ++ DV+SFG++LWE+ T
Sbjct: 198 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTL 248
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 249 GGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 243 AFL 245
+
Sbjct: 308 RIV 310
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 102 bits (253), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 75/243 (30%), Positives = 119/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
I E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP L+
Sbjct: 69 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLQARRPPGLEYSYN 127
Query: 82 --------------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLA
Sbjct: 128 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLA 186
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ + Y ++ DV+SFG++LWE+ T
Sbjct: 187 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTL 237
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 238 GGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 296
Query: 243 AFL 245
+
Sbjct: 297 RIV 299
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 101 bits (252), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 23/226 (10%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK 75
E ++ E FI E +M + H+ LV+ G C K + I+TE + L YL +R ++
Sbjct: 38 EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HR 96
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
L D+ AM+ L + +HRDL N L+ DQ +K++DFGL+R
Sbjct: 97 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY 155
Query: 136 XXXXXXXY--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190
+ RW PE +YS +++K D+++FG+++WE+ + ++P+E
Sbjct: 156 TSSVGSKFPVRWSPPEVLMYSK----------FSSKSDIWAFGVLMWEIYSLGKMPYERF 205
Query: 191 SNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
+N + A A + RP L S + I+ SCW E + RP+F
Sbjct: 206 TNSETAEHIAQGLRLYRPHLA---SEKVYTIMYSCWHEKADERPTF 248
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 101 bits (252), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 75/243 (30%), Positives = 119/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
I E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP L+
Sbjct: 73 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLQARRPPGLEYSYN 131
Query: 82 --------------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLA
Sbjct: 132 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLA 190
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ + Y ++ DV+SFG++LWE+ T
Sbjct: 191 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTL 241
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 242 GGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 300
Query: 243 AFL 245
+
Sbjct: 301 RIV 303
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 101 bits (252), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 23/226 (10%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK 75
E ++ E FI E +M + H+ LV+ G C K + I+TE + L YL +R ++
Sbjct: 58 EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HR 116
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
L D+ AM+ L + +HRDL N L+ DQ +K++DFGL+R
Sbjct: 117 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEE 175
Query: 136 XXXXXXXY--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190
+ RW PE +YS +++K D+++FG+++WE+ + ++P+E
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSK----------FSSKSDIWAFGVLMWEIYSLGKMPYERF 225
Query: 191 SNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
+N + A A + RP L S + I+ SCW E + RP+F
Sbjct: 226 TNSETAEHIAQGLRLYRPHLA---SEKVYTIMYSCWHEKADERPTF 268
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 101 bits (252), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 75/243 (30%), Positives = 119/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
I E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP L+
Sbjct: 72 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLQARRPPGLEYSYN 130
Query: 82 --------------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLA
Sbjct: 131 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLA 189
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ + Y ++ DV+SFG++LWE+ T
Sbjct: 190 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTL 240
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 241 GGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 299
Query: 243 AFL 245
+
Sbjct: 300 RIV 302
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 101 bits (252), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 23/226 (10%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK 75
E ++ E FI E +M + H+ LV+ G C K + I+TE + L YL +R ++
Sbjct: 49 EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HR 107
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
L D+ AM+ L + +HRDL N L+ DQ +K++DFGL+R
Sbjct: 108 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY 166
Query: 136 XXXXXXXY--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190
+ RW PE +YS +++K D+++FG+++WE+ + ++P+E
Sbjct: 167 TSSVGSKFPVRWSPPEVLMYSK----------FSSKSDIWAFGVLMWEIYSLGKMPYERF 216
Query: 191 SNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
+N + A A + RP L S + I+ SCW E + RP+F
Sbjct: 217 TNSETAEHIAQGLRLYRPHLA---SEKVYTIMYSCWHEKADERPTF 259
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 101 bits (252), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 23/226 (10%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK 75
E ++ E FI E +M + H+ LV+ G C K + I+TE + L YL +R ++
Sbjct: 42 EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HR 100
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
L D+ AM+ L + +HRDL N L+ DQ +K++DFGL+R
Sbjct: 101 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY 159
Query: 136 XXXXXXXY--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190
+ RW PE +YS +++K D+++FG+++WE+ + ++P+E
Sbjct: 160 TSSVGSKFPVRWSPPEVLMYSK----------FSSKSDIWAFGVLMWEIYSLGKMPYERF 209
Query: 191 SNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
+N + A A + RP L S + I+ SCW E + RP+F
Sbjct: 210 TNSETAEHIAQGLRLYRPHLA---SEKVYTIMYSCWHEKADERPTF 252
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 101 bits (252), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 23/226 (10%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK 75
E ++ E FI E +M + H+ LV+ G C K + I+TE + L YL +R ++
Sbjct: 58 EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HR 116
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
L D+ AM+ L + +HRDL N L+ DQ +K++DFGL+R
Sbjct: 117 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY 175
Query: 136 XXXXXXXY--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190
+ RW PE +YS +++K D+++FG+++WE+ + ++P+E
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSK----------FSSKSDIWAFGVLMWEIYSLGKMPYERF 225
Query: 191 SNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
+N + A A + RP L S + I+ SCW E + RP+F
Sbjct: 226 TNSETAEHIAQGLRLYRPHLA---SEKVYTIMYSCWHEKADERPTF 268
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 101 bits (252), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 23/226 (10%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK 75
E ++ E FI E +M + H+ LV+ G C K + I+TE + L YL +R ++
Sbjct: 43 EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HR 101
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
L D+ AM+ L + +HRDL N L+ DQ +K++DFGL+R
Sbjct: 102 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY 160
Query: 136 XXXXXXXY--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190
+ RW PE +YS +++K D+++FG+++WE+ + ++P+E
Sbjct: 161 TSSRGSKFPVRWSPPEVLMYSK----------FSSKSDIWAFGVLMWEIYSLGKMPYERF 210
Query: 191 SNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
+N + A A + RP L S + I+ SCW E + RP+F
Sbjct: 211 TNSETAEHIAQGLRLYRPHLA---SEKVYTIMYSCWHEKADERPTF 253
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 101 bits (252), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 70/242 (28%), Positives = 119/242 (49%), Gaps = 27/242 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK 75
E ++ E FI E +M + H+ LV+ G C K + I+TE + L YL +R ++
Sbjct: 43 EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HR 101
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
L D+ AM+ L + +HRDL N L+ DQ +K++DFGL+R
Sbjct: 102 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY 160
Query: 136 XXXXXXXY--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190
+ RW PE +YS +++K D+++FG+++WE+ + ++P+E
Sbjct: 161 TSSVGSKFPVRWSPPEVLMYSK----------FSSKSDIWAFGVLMWEIYSLGKMPYERF 210
Query: 191 SNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF----SQIIRMLNAF 244
+N + A A + RP L S + I+ SCW E + RP+F S I+ +++
Sbjct: 211 TNSETAEHIAQGLRLYRPHLA---SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEN 267
Query: 245 LF 246
L+
Sbjct: 268 LY 269
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 101 bits (251), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 75/243 (30%), Positives = 119/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRP-------- 73
I E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP
Sbjct: 65 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLQARRPPGLEYCYN 123
Query: 74 ------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+L ++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLA
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLA 182
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ + Y ++ DV+SFG++LWE+ T
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTL 233
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 234 GGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 243 AFL 245
+
Sbjct: 293 RIV 295
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 101 bits (251), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 72/231 (31%), Positives = 108/231 (46%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E +M ++KHD LV+ + + IVTE + SL +L L L ++
Sbjct: 51 FLEEAQIMKKLKHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDM 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A +A M + IHRDL+ N+L+ + K+ADFGLAR +
Sbjct: 111 AAQVAAGMAYIERMNYIHRDLRSANILVG-NGLICKIADFGLARLIEDNEXTARQGAKFP 169
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL+T R+P+ GM+N +
Sbjct: 170 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 219
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P P+D L ++ CW +DP RP+F + L + P
Sbjct: 220 ERGYRMP-CPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEP 269
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 100 bits (250), Expect = 7e-22, Method: Compositional matrix adjust.
Identities = 75/240 (31%), Positives = 118/240 (49%), Gaps = 34/240 (14%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRP-------- 73
I E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP
Sbjct: 80 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLQARRPPGLEYCYN 138
Query: 74 ------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+L ++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLA
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLA 197
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ + Y ++ DV+SFG++LWE+ T
Sbjct: 198 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTL 248
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 249 GGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 69/231 (29%), Positives = 114/231 (49%), Gaps = 14/231 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F EV ++ + +H N++ F+G + IVT+ G SL K+L ++ K + ++
Sbjct: 79 FRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHL-HVQETKFQMFQLIDI 137
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX--- 141
A A+ MD LHA IIHRD+K +N+ L + ++K+ DFGLA
Sbjct: 138 ARQTAQGMDYLHAKNIIHRDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSGSQQVEQPTG 196
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAA 200
WMAPE+ +R + ++ + DVYS+GIVL+EL+T LP+ ++N Q +
Sbjct: 197 SVLWMAPEV-----IRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG 251
Query: 201 FKHARPGLP---EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
+A P L ++ + +V C + RP F QI+ + +L
Sbjct: 252 RGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 73/243 (30%), Positives = 118/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKG-NLREYLRARRPPGMEYSYD 145
Query: 82 LN--------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+N +AR M+ L + IHRDL N+L+T + +K+ADFGLA
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 204
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 255
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 256 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 243 AFL 245
L
Sbjct: 315 RIL 317
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 73/243 (30%), Positives = 118/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYD 191
Query: 82 LN--------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+N +AR M+ L + IHRDL N+L+T + +K+ADFGLA
Sbjct: 192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 250
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 251 RDINNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 301
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 302 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360
Query: 243 AFL 245
L
Sbjct: 361 RIL 363
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 73/243 (30%), Positives = 118/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 74 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYD 132
Query: 82 LN--------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+N +AR M+ L + IHRDL N+L+T + +K+ADFGLA
Sbjct: 133 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVT-ENNVMKIADFGLA 191
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 192 RDINNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 242
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 243 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 301
Query: 243 AFL 245
L
Sbjct: 302 RIL 304
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 73/243 (30%), Positives = 118/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 76 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYD 134
Query: 82 LN--------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+N +AR M+ L + IHRDL N+L+T + +K+ADFGLA
Sbjct: 135 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 193
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 194 RDINNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 244
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 245 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 303
Query: 243 AFL 245
L
Sbjct: 304 RIL 306
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 73/243 (30%), Positives = 118/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYD 145
Query: 82 LN--------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+N +AR M+ L + IHRDL N+L+T + +K+ADFGLA
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 204
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 255
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 256 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 243 AFL 245
L
Sbjct: 315 RIL 317
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 73/243 (30%), Positives = 118/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 79 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYD 137
Query: 82 LN--------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+N +AR M+ L + IHRDL N+L+T + +K+ADFGLA
Sbjct: 138 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 196
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 197 RDINNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 247
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 248 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 306
Query: 243 AFL 245
L
Sbjct: 307 RIL 309
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 73/243 (30%), Positives = 118/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 87 LVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYD 145
Query: 82 LN--------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+N +AR M+ L + IHRDL N+L+T + +K+ADFGLA
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 204
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 255
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 256 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 243 AFL 245
L
Sbjct: 315 RIL 317
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 73/243 (30%), Positives = 118/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 87 LVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYD 145
Query: 82 LN--------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+N +AR M+ L + IHRDL N+L+T + +K+ADFGLA
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 204
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 255
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 256 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 243 AFL 245
L
Sbjct: 315 RIL 317
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 75/243 (30%), Positives = 120/243 (49%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYD 145
Query: 82 LN--------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+N +AR M+ L + IHRDL N+L+T + +K+ADFGLA
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 204
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 205 RDINNIDXXKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 255
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 256 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 243 AFL 245
L
Sbjct: 315 RIL 317
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 75/243 (30%), Positives = 120/243 (49%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEXSYD 145
Query: 82 LN--------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+N +AR M+ L + IHRDL N+L+T + +K+ADFGLA
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 204
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 205 RDINNIDXXKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 255
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 256 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 243 AFL 245
L
Sbjct: 315 RIL 317
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 99.8 bits (247), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 73/243 (30%), Positives = 118/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKG-NLREYLRARRPPGMEYSYD 145
Query: 82 LN--------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+N +AR M+ L + IHRDL N+L+T + +K+ADFGLA
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 204
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 255
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 256 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 243 AFL 245
L
Sbjct: 315 RIL 317
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 99.8 bits (247), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 73/243 (30%), Positives = 118/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYD 145
Query: 82 LN--------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+N +AR M+ L + IHRDL N+L+T + +K+ADFGLA
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 204
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 205 RDINNIDYYKNTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 255
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 256 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 243 AFL 245
L
Sbjct: 315 RIL 317
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 74/243 (30%), Positives = 118/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
I E+ MM + KH N++ LGAC PL VIV G +LR+YL + P L+
Sbjct: 80 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLQAREPPGLEYSYN 138
Query: 82 --------------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLA
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLA 197
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ + Y ++ DV+SFG++LWE+ T
Sbjct: 198 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTL 248
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 249 GGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 243 AFL 245
+
Sbjct: 308 RIV 310
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 99.0 bits (245), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 72/243 (29%), Positives = 118/243 (48%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYD 145
Query: 82 LN--------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+N +AR M+ L + IHRDL N+L+T + +++ADFGLA
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMRIADFGLA 204
Query: 128 RXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 255
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 256 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 243 AFL 245
L
Sbjct: 315 RIL 317
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 99.0 bits (245), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 74/231 (32%), Positives = 105/231 (45%), Gaps = 19/231 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
FIREVN M + H NL++ G P M +VTEL P SL L + + L L +
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 126
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX----XXXXXXXXXXX 140
A+ +A M L + IHRDL NLLL + +K+ DFGL R
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHXVMQEHRK 185
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+ W APE T T +++ D + FG+ LWE+ T + P+ G++ Q +
Sbjct: 186 VPFAWCAPESLKTRT--------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ R PED D+ ++ CW P RP+F L FL +P
Sbjct: 238 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA----LRDFLLEAQP 284
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 99.0 bits (245), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 73/231 (31%), Positives = 104/231 (45%), Gaps = 19/231 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
FIREVN M + H NL++ G P M +VTEL P SL L + + L L +
Sbjct: 62 FIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 120
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX----XXXXXXXXXXX 140
A+ +A M L + IHRDL NLLL + +K+ DFGL R
Sbjct: 121 AVQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+ W APE T T +++ D + FG+ LWE+ T + P+ G++ Q +
Sbjct: 180 VPFAWCAPESLKTRT--------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 231
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ R PED D+ ++ CW P RP+F L FL +P
Sbjct: 232 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV----ALRDFLLEAQP 278
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 99.0 bits (245), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 73/231 (31%), Positives = 104/231 (45%), Gaps = 19/231 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
FIREVN M + H NL++ G P M +VTEL P SL L + + L L +
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 126
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX----XXXXXXXXXX 140
A+ +A M L + IHRDL NLLL + +K+ DFGL R
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+ W APE T T +++ D + FG+ LWE+ T + P+ G++ Q +
Sbjct: 186 VPFAWCAPESLKTRT--------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ R PED D+ ++ CW P RP+F L FL +P
Sbjct: 238 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA----LRDFLLEAQP 284
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 74/231 (32%), Positives = 105/231 (45%), Gaps = 19/231 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
FIREVN M + H NL++ G P M +VTEL P SL L + + L L +
Sbjct: 58 FIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 116
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX----XXXXXXXXXX 140
A+ +A M L + IHRDL NLLL + +K+ DFGL R
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHXVMQEHRK 175
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+ W APE T T +++ D + FG+ LWE+ T + P+ G++ Q +
Sbjct: 176 VPFAWCAPESLKTRT--------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ R PED D+ ++ CW P RP+F L FL +P
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA----LRDFLLEAQP 274
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
FIREVN M + H NL++ G P M +VTEL P SL L + + L L +
Sbjct: 62 FIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 120
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX----XXXXXXXXXX 140
A+ +A M L + IHRDL NLLL + +K+ DFGL R
Sbjct: 121 AVQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+ W APE T T +++ D + FG+ LWE+ T + P+ G++ Q +
Sbjct: 180 VPFAWCAPESLKTRT--------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 231
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
+ R PED D+ ++ CW P RP+F
Sbjct: 232 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 266
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 73/231 (31%), Positives = 104/231 (45%), Gaps = 19/231 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
FIREVN M + H NL++ G P M +VTEL P SL L + + L L +
Sbjct: 58 FIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 116
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX----XXXXXXXXXX 140
A+ +A M L + IHRDL NLLL + +K+ DFGL R
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+ W APE T T +++ D + FG+ LWE+ T + P+ G++ Q +
Sbjct: 176 VPFAWCAPESLKTRT--------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ R PED D+ ++ CW P RP+F L FL +P
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA----LRDFLLEAQP 274
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
FIREVN M + H NL++ G P M +VTEL P SL L + + L L +
Sbjct: 58 FIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 116
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX----XXXXXXXXXX 140
A+ +A M L + IHRDL NLLL + +K+ DFGL R
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+ W APE T T +++ D + FG+ LWE+ T + P+ G++ Q +
Sbjct: 176 VPFAWCAPESLKTRT--------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
+ R PED D+ ++ CW P RP+F
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 262
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 120/244 (49%), Gaps = 33/244 (13%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69
T +E A + R F+ E ++M ++V+ LG P +VI+ EL+ L+ YL
Sbjct: 84 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLR 142
Query: 70 SLRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
SLRP + L + A +IA M L+AN +HRDL N ++ D ++K+
Sbjct: 143 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKI 201
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
DFG+ R RWM+PE +L+ G Y+ DV+SFG+VLW
Sbjct: 202 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGVFTTYS---DVWSFGVVLW 253
Query: 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSF 234
E+ T P++G+SN Q GL + D PD+ F +++ CW +P +RPSF
Sbjct: 254 EIATLAEQPYQGLSNEQVLRFVM----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 309
Query: 235 SQII 238
+II
Sbjct: 310 LEII 313
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 123/244 (50%), Gaps = 33/244 (13%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69
T +E A + R F+ E ++M ++V+ LG P +VI+ EL+ L+ YL
Sbjct: 56 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLR 114
Query: 70 SLRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
SLRP + L + A +IA M L+AN +HRDL N ++ D ++K+
Sbjct: 115 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKI 173
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
DFG+ R RWM+PE +L+ G Y+ DV+SFG+VLW
Sbjct: 174 GDFGMTRDIXETDXXRKGGKGLLPVRWMSPE-----SLKDGVFTTYS---DVWSFGVVLW 225
Query: 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSF 234
E+ T P++G+SN Q GL + D PD+ F +++ CW +P +RPSF
Sbjct: 226 EIATLAEQPYQGLSNEQVLRFVM----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 281
Query: 235 SQII 238
+II
Sbjct: 282 LEII 285
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 120/244 (49%), Gaps = 33/244 (13%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69
T +E A + R F+ E ++M ++V+ LG P +VI+ EL+ L+ YL
Sbjct: 56 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLR 114
Query: 70 SLRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
SLRP + L + A +IA M L+AN +HRDL N ++ D ++K+
Sbjct: 115 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKI 173
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
DFG+ R RWM+PE +L+ G Y+ DV+SFG+VLW
Sbjct: 174 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGVFTTYS---DVWSFGVVLW 225
Query: 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSF 234
E+ T P++G+SN Q GL + D PD+ F +++ CW +P +RPSF
Sbjct: 226 EIATLAEQPYQGLSNEQVLRFVM----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 281
Query: 235 SQII 238
+II
Sbjct: 282 LEII 285
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 120/244 (49%), Gaps = 33/244 (13%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69
T +E A + R F+ E ++M ++V+ LG P +VI+ EL+ L+ YL
Sbjct: 53 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLR 111
Query: 70 SLRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
SLRP + L + A +IA M L+AN +HRDL N ++ D ++K+
Sbjct: 112 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKI 170
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
DFG+ R RWM+PE +L+ G Y+ DV+SFG+VLW
Sbjct: 171 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGVFTTYS---DVWSFGVVLW 222
Query: 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSF 234
E+ T P++G+SN Q GL + D PD+ F +++ CW +P +RPSF
Sbjct: 223 EIATLAEQPYQGLSNEQVLRFVM----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 278
Query: 235 SQII 238
+II
Sbjct: 279 LEII 282
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 17/238 (7%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS 70
+ TSD + +F++E M + H ++VK +G + + I+ EL LR +L
Sbjct: 75 KNCTSDS---VREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL-Q 130
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+R LDL + +A ++ A+ L + +HRD+ N+L++ + +KL DFGL+R
Sbjct: 131 VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYM 189
Query: 131 XXXXXXXXXXXX--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PF 187
+WMAPE ++ R+ + + DV+ FG+ +WE+L + + PF
Sbjct: 190 EDSTYYKASKGKLPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMHGVKPF 241
Query: 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+G+ N R +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 242 QGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 298
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 18/226 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F+ E N+M ++HD LV+ K+ + I+TE + SL +L S K+ L ++
Sbjct: 54 FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLID 113
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
F+ IA M + IHRDL+ N+L++ + K+ADFGLAR +
Sbjct: 114 FSAQIAEGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKF 172
Query: 144 --RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 198
+W APE + T+ K +V+SFGI+L+E++T ++P+ G +N A
Sbjct: 173 PIKWTAPEAINFGCFTI----------KSNVWSFGILLYEIVTYGKIPYPGRTNADVMSA 222
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
+ + P + E+ +L I++ CW E RP+F + +L+ F
Sbjct: 223 LSQGYRMPRM-ENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDF 267
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 17/238 (7%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS 70
+ TSD + +F++E M + H ++VK +G + + I+ EL LR +L
Sbjct: 50 KNCTSDS---VREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL-Q 105
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+R LDL + +A ++ A+ L + +HRD+ N+L++ + +KL DFGL+R
Sbjct: 106 VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYM 164
Query: 131 XXXXXXXXXXXX--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PF 187
+WMAPE ++ R+ + + DV+ FG+ +WE+L + + PF
Sbjct: 165 EDSTYYKASKGKLPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMHGVKPF 216
Query: 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+G+ N R +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 217 QGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 273
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 18/226 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F+ E N+M ++HD LV+ ++ + I+TE + SL +L S K+ L ++
Sbjct: 55 FLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID 114
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
F+ IA M + IHRDL+ N+L++ + K+ADFGLAR +
Sbjct: 115 FSAQIAEGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKF 173
Query: 144 --RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 198
+W APE + T+ K DV+SFGI+L+E++T ++P+ G +N A
Sbjct: 174 PIKWTAPEAINFGCFTI----------KSDVWSFGILLYEIVTYGKIPYPGRTNADVMTA 223
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
+ + P + E+ +L I++ CW E RP+F + +L+ F
Sbjct: 224 LSQGYRMPRV-ENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDF 268
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 120/244 (49%), Gaps = 33/244 (13%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69
T +E A + R F+ E ++M ++V+ LG P +VI+ EL+ L+ YL
Sbjct: 55 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLR 113
Query: 70 SLRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
SLRP + L + A +IA M L+AN +HRDL N ++ D ++K+
Sbjct: 114 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKI 172
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
DFG+ R RWM+PE +L+ G Y+ DV+SFG+VLW
Sbjct: 173 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGVFTTYS---DVWSFGVVLW 224
Query: 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSF 234
E+ T P++G+SN Q GL + D PD+ F +++ CW +P +RPSF
Sbjct: 225 EIATLAEQPYQGLSNEQVLRFVM----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 280
Query: 235 SQII 238
+II
Sbjct: 281 LEII 284
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 120/244 (49%), Gaps = 33/244 (13%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69
T +E A + R F+ E ++M ++V+ LG P +VI+ EL+ L+ YL
Sbjct: 49 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLR 107
Query: 70 SLRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
SLRP + L + A +IA M L+AN +HRDL N ++ D ++K+
Sbjct: 108 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKI 166
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
DFG+ R RWM+PE +L+ G Y+ DV+SFG+VLW
Sbjct: 167 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGVFTTYS---DVWSFGVVLW 218
Query: 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSF 234
E+ T P++G+SN Q GL + D PD+ F +++ CW +P +RPSF
Sbjct: 219 EIATLAEQPYQGLSNEQVLRFVM----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 274
Query: 235 SQII 238
+II
Sbjct: 275 LEII 278
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 17/238 (7%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS 70
+ TSD + +F++E M + H ++VK +G + + I+ EL LR +L
Sbjct: 52 KNCTSDS---VREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL-Q 107
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+R LDL + +A ++ A+ L + +HRD+ N+L++ + +KL DFGL+R
Sbjct: 108 VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYM 166
Query: 131 XXXXXXXXXXXX--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PF 187
+WMAPE ++ R+ + + DV+ FG+ +WE+L + + PF
Sbjct: 167 EDSTYYKASKGKLPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMHGVKPF 218
Query: 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+G+ N R +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 219 QGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 120/244 (49%), Gaps = 33/244 (13%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69
T +E A + R F+ E ++M ++V+ LG P +VI+ EL+ L+ YL
Sbjct: 55 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLR 113
Query: 70 SLRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
SLRP + L + A +IA M L+AN +HRDL N ++ D ++K+
Sbjct: 114 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKI 172
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
DFG+ R RWM+PE +L+ G Y+ DV+SFG+VLW
Sbjct: 173 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGVFTTYS---DVWSFGVVLW 224
Query: 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSF 234
E+ T P++G+SN Q GL + D PD+ F +++ CW +P +RPSF
Sbjct: 225 EIATLAEQPYQGLSNEQVLRFVM----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 280
Query: 235 SQII 238
+II
Sbjct: 281 LEII 284
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 120/244 (49%), Gaps = 33/244 (13%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69
T +E A + R F+ E ++M ++V+ LG P +VI+ EL+ L+ YL
Sbjct: 52 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLR 110
Query: 70 SLRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
SLRP + L + A +IA M L+AN +HRDL N ++ D ++K+
Sbjct: 111 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKI 169
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
DFG+ R RWM+PE +L+ G Y+ DV+SFG+VLW
Sbjct: 170 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGVFTTYS---DVWSFGVVLW 221
Query: 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSF 234
E+ T P++G+SN Q GL + D PD+ F +++ CW +P +RPSF
Sbjct: 222 EIATLAEQPYQGLSNEQVLRFVM----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 277
Query: 235 SQII 238
+II
Sbjct: 278 LEII 281
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 69/231 (29%), Positives = 106/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 60 FLQEAQVMKKIRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 179 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P PE L ++ CW +DP RP+F + L + + P
Sbjct: 229 ERGYRMPCPPE-CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 17/238 (7%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS 70
+ TSD + +F++E M + H ++VK +G + + I+ EL LR +L
Sbjct: 47 KNCTSDS---VREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL-Q 102
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+R LDL + +A ++ A+ L + +HRD+ N+L++ + +KL DFGL+R
Sbjct: 103 VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYM 161
Query: 131 XXXXXXXXXXXX--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PF 187
+WMAPE ++ R+ + + DV+ FG+ +WE+L + + PF
Sbjct: 162 EDSTYYKASKGKLPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMHGVKPF 213
Query: 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+G+ N R +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 214 QGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 17/238 (7%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS 70
+ TSD + +F++E M + H ++VK +G + + I+ EL LR +L
Sbjct: 47 KNCTSDS---VREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL-Q 102
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+R LDL + +A ++ A+ L + +HRD+ N+L++ + +KL DFGL+R
Sbjct: 103 VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYM 161
Query: 131 XXXXXXXXXXXX--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PF 187
+WMAPE ++ R+ + + DV+ FG+ +WE+L + + PF
Sbjct: 162 EDSTYYKASKGKLPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMHGVKPF 213
Query: 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+G+ N R +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 214 QGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 17/238 (7%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS 70
+ TSD + +F++E M + H ++VK +G + + I+ EL LR +L
Sbjct: 44 KNCTSDS---VREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL-Q 99
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+R LDL + +A ++ A+ L + +HRD+ N+L++ + +KL DFGL+R
Sbjct: 100 VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYM 158
Query: 131 XXXXXXXXXXXX--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PF 187
+WMAPE ++ R+ + + DV+ FG+ +WE+L + + PF
Sbjct: 159 EDSTYYKASKGKLPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMHGVKPF 210
Query: 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+G+ N R +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 211 QGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 17/238 (7%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS 70
+ TSD + +F++E M + H ++VK +G + + I+ EL LR +L
Sbjct: 49 KNCTSDS---VREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL-Q 104
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+R LDL + +A ++ A+ L + +HRD+ N+L++ + +KL DFGL+R
Sbjct: 105 VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYM 163
Query: 131 XXXXXXXXXXXX--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PF 187
+WMAPE ++ R+ + + DV+ FG+ +WE+L + + PF
Sbjct: 164 EDSTYYKASKGKLPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMHGVKPF 215
Query: 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+G+ N R +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 216 QGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 272
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 120/244 (49%), Gaps = 33/244 (13%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69
T +E A + R F+ E ++M ++V+ LG P +VI+ EL+ L+ YL
Sbjct: 62 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLR 120
Query: 70 SLRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
SLRP + L + A +IA M L+AN +HRDL N ++ D ++K+
Sbjct: 121 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKI 179
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
DFG+ R RWM+PE +L+ G Y+ DV+SFG+VLW
Sbjct: 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGVFTTYS---DVWSFGVVLW 231
Query: 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSF 234
E+ T P++G+SN Q GL + D PD+ F +++ CW +P +RPSF
Sbjct: 232 EIATLAEQPYQGLSNEQVLRFVM----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 287
Query: 235 SQII 238
+II
Sbjct: 288 LEII 291
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 120/244 (49%), Gaps = 33/244 (13%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69
T +E A + R F+ E ++M ++V+ LG P +VI+ EL+ L+ YL
Sbjct: 62 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLR 120
Query: 70 SLRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
SLRP + L + A +IA M L+AN +HRDL N ++ D ++K+
Sbjct: 121 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKI 179
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
DFG+ R RWM+PE +L+ G Y+ DV+SFG+VLW
Sbjct: 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGVFTTYS---DVWSFGVVLW 231
Query: 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSF 234
E+ T P++G+SN Q GL + D PD+ F +++ CW +P +RPSF
Sbjct: 232 EIATLAEQPYQGLSNEQVLRFVM----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 287
Query: 235 SQII 238
+II
Sbjct: 288 LEII 291
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 17/238 (7%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS 70
+ TSD + +F++E M + H ++VK +G + + I+ EL LR +L
Sbjct: 47 KNCTSDS---VREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL-Q 102
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+R LDL + +A ++ A+ L + +HRD+ N+L++ + +KL DFGL+R
Sbjct: 103 VRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYM 161
Query: 131 XXXXXXXXXXXX--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PF 187
+WMAPE ++ R+ + + DV+ FG+ +WE+L + + PF
Sbjct: 162 EDSTXXKASKGKLPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMHGVKPF 213
Query: 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+G+ N R +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 214 QGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 95.9 bits (237), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 17/238 (7%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS 70
+ TSD + +F++E M + H ++VK +G + + I+ EL LR +L
Sbjct: 427 KNCTSDS---VREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL-Q 482
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+R LDL + +A ++ A+ L + +HRD+ N+L++ + +KL DFGL+R
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYM 541
Query: 131 XXXXXXXXXXXX--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PF 187
+WMAPE ++ R+ + + DV+ FG+ +WE+L + + PF
Sbjct: 542 EDSTYYKASKGKLPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMHGVKPF 593
Query: 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+G+ N R +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 594 QGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 369 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 428 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P P + L ++ CW ++P RP+F + L + + P
Sbjct: 478 ERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 95.5 bits (236), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 60 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 179 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P P + L ++ CW +DP RP+F + L + + P
Sbjct: 229 ERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 95.5 bits (236), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 80/262 (30%), Positives = 125/262 (47%), Gaps = 37/262 (14%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS 70
T +E A L R F+ E ++M ++V+ LG K ++V EL+ L+ YL S
Sbjct: 54 TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
Query: 71 LRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
LRP + L + A +IA M L+A +HRDL N ++ D ++K+
Sbjct: 114 LRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIG 172
Query: 123 DFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
DFG+ R RWMAPE +L+ G + D++SFG+VLWE
Sbjct: 173 DFGMTRDIXETDXXRKGGKGLLPVRWMAPE-----SLKDGV---FTTSSDMWSFGVVLWE 224
Query: 180 LLT-NRLPFEGMSNLQA---AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
+ + P++G+SN Q + PE ++ +++ CW +PN+RP+F
Sbjct: 225 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTD----LMRMCWQFNPNMRPTFL 280
Query: 236 QIIRMLNAFLFTLRPPSPSVPE 257
+I+ +L L PS PE
Sbjct: 281 EIVNLLKDDL------HPSFPE 296
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 95.5 bits (236), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 69/231 (29%), Positives = 106/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 49 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 109 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 167
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 168 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 217
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P PE L ++ CW +DP RP+F + L + + P
Sbjct: 218 ERGYRMPCPPE-CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 267
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 95.1 bits (235), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 69/231 (29%), Positives = 106/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 51 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 111 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 169
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 170 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 219
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P PE L ++ CW +DP RP+F + L + + P
Sbjct: 220 ERGYRMPCPPE-CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 269
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 95.1 bits (235), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 115/238 (48%), Gaps = 17/238 (7%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS 70
+ TSD + +F++E M + H ++VK +G + + I+ EL LR +L
Sbjct: 47 KNCTSDS---VREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL-Q 102
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+R LDL + +A ++ A+ L + +HRD+ N+L++ +KL DFGL+R
Sbjct: 103 VRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATD-CVKLGDFGLSRYM 161
Query: 131 XXXXXXXXXXXX--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PF 187
+WMAPE ++ R+ + + DV+ FG+ +WE+L + + PF
Sbjct: 162 EDSTYYKASKGKLPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMHGVKPF 213
Query: 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+G+ N R +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 214 QGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 95.1 bits (235), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 345 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P PE L ++ CW ++P RP+F + L + + P
Sbjct: 395 ERGYRMPCPPE-CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 95.1 bits (235), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 227 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 286
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGL R +
Sbjct: 287 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLGRLIEDNEYTARQGAKFP 345
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 346 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 395
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P PE L ++ CW +DP RP+F + L + + P
Sbjct: 396 ERGYRMPCPPE-CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 445
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 95.1 bits (235), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 115/238 (48%), Gaps = 17/238 (7%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS 70
+ TSD + +F++E M + H ++VK +G + + I+ EL LR +L
Sbjct: 427 KNCTSDS---VREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL-Q 482
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+R LDL + +A ++ A+ L + +HRD+ N+L++ +KL DFGL+R
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATD-CVKLGDFGLSRYM 541
Query: 131 XXXXXXXXXXXX--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PF 187
+WMAPE ++ R+ + + DV+ FG+ +WE+L + + PF
Sbjct: 542 EDSTYYKASKGKLPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMHGVKPF 593
Query: 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+G+ N R +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 594 QGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 95.1 bits (235), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 345 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P PE L ++ CW ++P RP+F + L + + P
Sbjct: 395 ERGYRMPCPPE-CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 94.4 bits (233), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 122/244 (50%), Gaps = 33/244 (13%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69
T +E A + R F+ E ++M ++V+ LG P +VI+ EL+ L+ YL
Sbjct: 47 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLR 105
Query: 70 SLRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
SLRP + L + A +IA M L+AN +HRDL N ++ D ++K+
Sbjct: 106 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKI 164
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
DFG+ R RWM+PE +L+ G Y+ DV+SFG+VLW
Sbjct: 165 GDFGMTRDIXETDXXRKGGKGLLPVRWMSPE-----SLKDGVFTTYS---DVWSFGVVLW 216
Query: 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSF 234
E+ T P++G+SN Q GL + D PD+ +++ CW +P +RPSF
Sbjct: 217 EIATLAEQPYQGLSNEQVLRFVM----EGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSF 272
Query: 235 SQII 238
+II
Sbjct: 273 LEII 276
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 94.4 bits (233), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 60 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL N+L+ + K+ADFGLAR +
Sbjct: 120 AAQIASGMAYVERMNYVHRDLAAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 179 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P P + L ++ CW +DP RP+F + L + + P
Sbjct: 229 ERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 94.4 bits (233), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 50 FLQEAQVMKKLRHEKLVQLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 110 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEXTARQGAKFP 168
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 169 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 218
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P PE L ++ CW ++P RP+F + L + + P
Sbjct: 219 ERGYRMPCPPE-CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 268
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 94.0 bits (232), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 76/262 (29%), Positives = 121/262 (46%), Gaps = 37/262 (14%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS 70
T +E A L R F+ E ++M ++V+ LG K ++V EL+ L+ YL S
Sbjct: 53 TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 112
Query: 71 LRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
LRP + L + A +IA M L+A +HRDL N ++ D ++K+
Sbjct: 113 LRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIG 171
Query: 123 DFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
DFG+ R RWMAPE +L+ G + D++SFG+VLWE
Sbjct: 172 DFGMTRDIYETDYYRKGGKGLLPVRWMAPE-----SLKDGV---FTTSSDMWSFGVVLWE 223
Query: 180 LLT-NRLPFEGMSNLQA---AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
+ + P++G+SN Q + PE ++ +++ CW +P +RP+F
Sbjct: 224 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTD----LMRMCWQFNPKMRPTFL 279
Query: 236 QIIRMLNAFLFTLRPPSPSVPE 257
+I+ +L L PS PE
Sbjct: 280 EIVNLLKDDL------HPSFPE 295
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 94.0 bits (232), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 76/262 (29%), Positives = 122/262 (46%), Gaps = 37/262 (14%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS 70
T +E A L R F+ E ++M ++V+ LG K ++V EL+ L+ YL S
Sbjct: 55 TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 114
Query: 71 LRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
LRP + L + A +IA M L+A +HR+L N ++ D ++K+
Sbjct: 115 LRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHD-FTVKIG 173
Query: 123 DFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
DFG+ R RWMAPE +L+ G + D++SFG+VLWE
Sbjct: 174 DFGMTRDIYETDYYRKGGKGLLPVRWMAPE-----SLKDGV---FTTSSDMWSFGVVLWE 225
Query: 180 LLT-NRLPFEGMSNLQA---AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
+ + P++G+SN Q + PE ++ +++ CW +PN+RP+F
Sbjct: 226 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTD----LMRMCWQFNPNMRPTFL 281
Query: 236 QIIRMLNAFLFTLRPPSPSVPE 257
+I+ +L L PS PE
Sbjct: 282 EIVNLLKDDL------HPSFPE 297
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 94.0 bits (232), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + L +L L L ++
Sbjct: 60 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDM 119
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 179 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P PE L ++ CW +DP RP+F + L + + P
Sbjct: 229 ERGYRMPCPPE-CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 94.0 bits (232), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 53 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 112
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 113 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 171
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 172 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 221
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P PE L ++ CW ++P RP+F + L + + P
Sbjct: 222 ERGYRMPCPPE-CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 271
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 77/262 (29%), Positives = 119/262 (45%), Gaps = 39/262 (14%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKD-PLMVIVTELLP 60
K MKE ++ D F E+ ++ ++ H N++ LGAC+ + + E P
Sbjct: 58 KRMKEYASKDDHRD--------FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109
Query: 61 GMSLRKYLVSLRPNKLDLHVA--------------LNFALDIARAMDCLHANGIIHRDLK 106
+L +L R + D A L+FA D+AR MD L IHRDL
Sbjct: 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 169
Query: 107 PDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHY 164
N+L+ + + K+ADFGL+R RWMA E YS Y
Sbjct: 170 ARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV----------Y 218
Query: 165 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 223
DV+S+G++LWE+++ P+ GM+ + Y + R P + ++ +++ C
Sbjct: 219 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQC 277
Query: 224 WVEDPNLRPSFSQIIRMLNAFL 245
W E P RPSF+QI+ LN L
Sbjct: 278 WREKPYERPSFAQILVSLNRML 299
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 77/262 (29%), Positives = 119/262 (45%), Gaps = 39/262 (14%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKD-PLMVIVTELLP 60
K MKE ++ D F E+ ++ ++ H N++ LGAC+ + + E P
Sbjct: 48 KRMKEYASKDDHRD--------FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 99
Query: 61 GMSLRKYLVSLRPNKLDLHVA--------------LNFALDIARAMDCLHANGIIHRDLK 106
+L +L R + D A L+FA D+AR MD L IHRDL
Sbjct: 100 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 159
Query: 107 PDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHY 164
N+L+ + + K+ADFGL+R RWMA E YS Y
Sbjct: 160 ARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV----------Y 208
Query: 165 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 223
DV+S+G++LWE+++ P+ GM+ + Y + R P + ++ +++ C
Sbjct: 209 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQC 267
Query: 224 WVEDPNLRPSFSQIIRMLNAFL 245
W E P RPSF+QI+ LN L
Sbjct: 268 WREKPYERPSFAQILVSLNRML 289
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IV E + SL +L L L ++
Sbjct: 60 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 179 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P P + L ++ CW +DP RP+F + L + + P
Sbjct: 229 ERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 76/262 (29%), Positives = 122/262 (46%), Gaps = 37/262 (14%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS 70
T +E A L R F+ E ++M ++V+ LG K ++V EL+ L+ YL S
Sbjct: 54 TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
Query: 71 LRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
LRP + L + A +IA M L+A +HR+L N ++ D ++K+
Sbjct: 114 LRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHD-FTVKIG 172
Query: 123 DFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
DFG+ R RWMAPE +L+ G + D++SFG+VLWE
Sbjct: 173 DFGMTRDIYETDYYRKGGKGLLPVRWMAPE-----SLKDGV---FTTSSDMWSFGVVLWE 224
Query: 180 LLT-NRLPFEGMSNLQA---AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
+ + P++G+SN Q + PE ++ +++ CW +PN+RP+F
Sbjct: 225 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTD----LMRMCWQFNPNMRPTFL 280
Query: 236 QIIRMLNAFLFTLRPPSPSVPE 257
+I+ +L L PS PE
Sbjct: 281 EIVNLLKDDL------HPSFPE 296
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 79/262 (30%), Positives = 124/262 (47%), Gaps = 37/262 (14%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS 70
T +E A L R F+ E ++M ++V+ LG K ++V EL+ L+ YL S
Sbjct: 51 TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 110
Query: 71 LRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
LRP + L + A +IA M L+A +HRDL N ++ D ++K+
Sbjct: 111 LRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIG 169
Query: 123 DFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
DFG+ R RWMAPE +L+ G + D++SFG+VLWE
Sbjct: 170 DFGMTRDIXETDXXRKGGKGLLPVRWMAPE-----SLKDGV---FTTSSDMWSFGVVLWE 221
Query: 180 LLT-NRLPFEGMSNLQA---AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
+ + P++G+SN Q + PE ++ +++ CW +P +RP+F
Sbjct: 222 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTD----LMRMCWQFNPKMRPTFL 277
Query: 236 QIIRMLNAFLFTLRPPSPSVPE 257
+I+ +L L PS PE
Sbjct: 278 EIVNLLKDDL------HPSFPE 293
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 76/262 (29%), Positives = 121/262 (46%), Gaps = 37/262 (14%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS 70
T +E A L R F+ E ++M ++V+ LG K ++V EL+ L+ YL S
Sbjct: 54 TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
Query: 71 LRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
LRP + L + A +IA M L+A +HRDL N ++ D ++K+
Sbjct: 114 LRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIG 172
Query: 123 DFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
DFG+ R RWMAPE +L+ G + D++SFG+VLWE
Sbjct: 173 DFGMTRDIYETAYYRKGGKGLLPVRWMAPE-----SLKDGV---FTTSSDMWSFGVVLWE 224
Query: 180 LLT-NRLPFEGMSNLQA---AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
+ + P++G+SN Q + PE ++ +++ CW +P +RP+F
Sbjct: 225 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTD----LMRMCWQFNPKMRPTFL 280
Query: 236 QIIRMLNAFLFTLRPPSPSVPE 257
+I+ +L L PS PE
Sbjct: 281 EIVNLLKDDL------HPSFPE 296
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IV E + SL +L L L ++
Sbjct: 60 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEXTARQGAKFP 178
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 179 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P P + L ++ CW +DP RP+F + L + + P
Sbjct: 229 ERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 93.2 bits (230), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IV E + SL +L L L ++
Sbjct: 60 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 179 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P P + L ++ CW +DP RP+F + L + + P
Sbjct: 229 ERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 93.2 bits (230), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 79/262 (30%), Positives = 124/262 (47%), Gaps = 37/262 (14%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS 70
T +E A L R F+ E ++M ++V+ LG K ++V EL+ L+ YL S
Sbjct: 54 TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
Query: 71 LRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
LRP + L + A +IA M L+A +HRDL N ++ D ++K+
Sbjct: 114 LRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIG 172
Query: 123 DFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
DFG+ R RWMAPE +L+ G + D++SFG+VLWE
Sbjct: 173 DFGMTRDIXETDXXRKGGKGLLPVRWMAPE-----SLKDGV---FTTSSDMWSFGVVLWE 224
Query: 180 LLT-NRLPFEGMSNLQA---AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
+ + P++G+SN Q + PE ++ +++ CW +P +RP+F
Sbjct: 225 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTD----LMRMCWQFNPKMRPTFL 280
Query: 236 QIIRMLNAFLFTLRPPSPSVPE 257
+I+ +L L PS PE
Sbjct: 281 EIVNLLKDDL------HPSFPE 296
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 93.2 bits (230), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 78/244 (31%), Positives = 118/244 (48%), Gaps = 33/244 (13%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69
T +E A + R F+ E ++M ++V+ LG P +VI+ EL+ L+ YL
Sbjct: 49 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLR 107
Query: 70 SLRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
SLRP + L + A +IA M L+AN +HRDL N + D ++K+
Sbjct: 108 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAED-FTVKI 166
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
DFG+ R RWM+PE +L+ G Y+ DV+SFG+VLW
Sbjct: 167 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGVFTTYS---DVWSFGVVLW 218
Query: 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSF 234
E+ T P++G+SN Q GL + D PD+ +++ CW +P +RPSF
Sbjct: 219 EIATLAEQPYQGLSNEQVLRFVM----EGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSF 274
Query: 235 SQII 238
+II
Sbjct: 275 LEII 278
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 81/261 (31%), Positives = 125/261 (47%), Gaps = 41/261 (15%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK--DPLMVIVTELL 59
K ++L + +DE+ L + E+ +MS + +H+N+V LGAC P++VI
Sbjct: 70 KVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 125
Query: 60 PGMSL----RKYLVSL-----RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 110
G L RK L RP L+L L+F+ +A+ M L + IHRD+ N+
Sbjct: 126 YGDLLNFLRRKAEADLDKEDGRP--LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 183
Query: 111 LLTPDQKSLKLADFGLARXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNN 166
LLT + K+ DFGLAR +WMAPE ++ V Y
Sbjct: 184 LLTNGHVA-KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV---------YTV 233
Query: 167 KVDVYSFGIVLWELLTNRL-PFEGM---SNLQAAYAAAFKHARPGL-PEDISPDLAFIVQ 221
+ DV+S+GI+LWE+ + L P+ G+ S ++ A+P P++I I+Q
Sbjct: 234 QSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYS----IMQ 289
Query: 222 SCWVEDPNLRPSFSQIIRMLN 242
+CW +P RP+F QI L
Sbjct: 290 ACWALEPTHRPTFQQICSFLQ 310
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 81/261 (31%), Positives = 125/261 (47%), Gaps = 41/261 (15%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK--DPLMVIVTELL 59
K ++L + +DE+ L + E+ +MS + +H+N+V LGAC P++VI
Sbjct: 78 KVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 60 PGMSL----RKYLVSL-----RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 110
G L RK L RP L+L L+F+ +A+ M L + IHRD+ N+
Sbjct: 134 YGDLLNFLRRKAEADLDKEDGRP--LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 191
Query: 111 LLTPDQKSLKLADFGLARXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNN 166
LLT + K+ DFGLAR +WMAPE ++ V Y
Sbjct: 192 LLTNGHVA-KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV---------YTV 241
Query: 167 KVDVYSFGIVLWELLTNRL-PFEGM---SNLQAAYAAAFKHARPGL-PEDISPDLAFIVQ 221
+ DV+S+GI+LWE+ + L P+ G+ S ++ A+P P++I I+Q
Sbjct: 242 QSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYS----IMQ 297
Query: 222 SCWVEDPNLRPSFSQIIRMLN 242
+CW +P RP+F QI L
Sbjct: 298 ACWALEPTHRPTFQQICSFLQ 318
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 76/262 (29%), Positives = 121/262 (46%), Gaps = 37/262 (14%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS 70
T +E A L R F+ E ++M ++V+ LG K ++V EL+ L+ YL S
Sbjct: 54 TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
Query: 71 LRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
LRP + L + A +IA M L+A +HRDL N ++ D ++K+
Sbjct: 114 LRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIG 172
Query: 123 DFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
DFG+ R RWMAPE +L+ G + D++SFG+VLWE
Sbjct: 173 DFGMTRDIYETDYYRKGGKGLLPVRWMAPE-----SLKDGV---FTTSSDMWSFGVVLWE 224
Query: 180 LLT-NRLPFEGMSNLQA---AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
+ + P++G+SN Q + PE ++ +++ CW +P +RP+F
Sbjct: 225 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTD----LMRMCWQFNPKMRPTFL 280
Query: 236 QIIRMLNAFLFTLRPPSPSVPE 257
+I+ +L L PS PE
Sbjct: 281 EIVNLLKDDL------HPSFPE 296
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 78/259 (30%), Positives = 126/259 (48%), Gaps = 36/259 (13%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDP---LMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC P LMVIV E
Sbjct: 63 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 116
Query: 62 MSLRKYLVSLR----PNK------LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+L YL S R P K L L + ++ +A+ M+ L + IHRDL N+L
Sbjct: 117 GNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNIL 176
Query: 112 LTPDQKSLKLADFGLARXXXX---XXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKHYNNK 167
L+ ++ +K+ DFGLAR +WMAPE ++ V Y +
Sbjct: 177 LS-EKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV---------YTIQ 226
Query: 168 VDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVE 226
DV+SFG++LWE+ + P+ G+ + + R P+ +P++ + CW
Sbjct: 227 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 286
Query: 227 DPNLRPSFSQIIRMLNAFL 245
+P+ RP+FS+++ L L
Sbjct: 287 EPSQRPTFSELVEHLGNLL 305
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 75/263 (28%), Positives = 127/263 (48%), Gaps = 40/263 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDPL--MVIVTELLPGM 62
++L G+T S+ RAL+ E+ ++ + H N+V LGAC P ++++TE
Sbjct: 54 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 63 SLRKYLVSLR----PNK----------LDLHVALNFALDIARAMDCLHANGIIHRDLKPD 108
+L YL S R P K L L + ++ +A+ M+ L + IHRDL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 168
Query: 109 NLLLTPDQKSLKLADFGLARXXXX---XXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKHY 164
N+LL+ ++ +K+ DFGLAR +WMAPE ++ V Y
Sbjct: 169 NILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV---------Y 218
Query: 165 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQS 222
+ DV+SFG++LWE+ + P+ G+ + + K R P+ +P++ +
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 277
Query: 223 CWVEDPNLRPSFSQIIRMLNAFL 245
CW +P+ RP+FS+++ L L
Sbjct: 278 CWHGEPSQRPTFSELVEHLGNLL 300
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 77/263 (29%), Positives = 129/263 (49%), Gaps = 40/263 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDPL--MVIVTELLPGM 62
++L G+T S+ RAL+ E+ ++ + H N+V LGAC P ++++TE
Sbjct: 54 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 63 SLRKYLVSLR----PNK----------LDLHVALNFALDIARAMDCLHANGIIHRDLKPD 108
+L YL S R P K L L + ++ +A+ M+ L + IHRDL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 168
Query: 109 NLLLTPDQKSLKLADFGLARXXXX---XXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKHY 164
N+LL+ ++ +K+ DFGLAR +WMAPE ++ V Y
Sbjct: 169 NILLS-EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRV---------Y 218
Query: 165 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQS 222
+ DV+SFG++LWE+ + P+ G+ + + K R P+ +P++ +
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 277
Query: 223 CWVEDPNLRPSFSQIIRMLNAFL 245
CW +P+ RP+FS+++ L L
Sbjct: 278 CWHGEPSQRPTFSELVEHLGNLL 300
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 75/263 (28%), Positives = 127/263 (48%), Gaps = 40/263 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDPL--MVIVTELLPGM 62
++L G+T S+ RAL+ E+ ++ + H N+V LGAC P ++++TE
Sbjct: 54 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 63 SLRKYLVSLR----PNK----------LDLHVALNFALDIARAMDCLHANGIIHRDLKPD 108
+L YL S R P K L L + ++ +A+ M+ L + IHRDL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 168
Query: 109 NLLLTPDQKSLKLADFGLARXXXX---XXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKHY 164
N+LL+ ++ +K+ DFGLAR +WMAPE ++ V Y
Sbjct: 169 NILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV---------Y 218
Query: 165 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQS 222
+ DV+SFG++LWE+ + P+ G+ + + K R P+ +P++ +
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 277
Query: 223 CWVEDPNLRPSFSQIIRMLNAFL 245
CW +P+ RP+FS+++ L L
Sbjct: 278 CWHGEPSQRPTFSELVEHLGNLL 300
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 80/259 (30%), Positives = 127/259 (49%), Gaps = 36/259 (13%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDP---LMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC P LMVIV E
Sbjct: 63 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 116
Query: 62 MSLRKYLVSLR----PNK------LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+L YL S R P K L L + ++ +A+ M+ L + IHRDL N+L
Sbjct: 117 GNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNIL 176
Query: 112 LTPDQKSLKLADFGLARXXXX---XXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV 168
L+ ++ +K+ DFGLAR +WMAPE T+ R Y +
Sbjct: 177 LS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE---TIFDRV-----YTIQS 227
Query: 169 DVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVE 226
DV+SFG++LWE+ + P+ G+ + + K R P+ +P++ + CW
Sbjct: 228 DVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 286
Query: 227 DPNLRPSFSQIIRMLNAFL 245
+P+ RP+FS+++ L L
Sbjct: 287 EPSQRPTFSELVEHLGNLL 305
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IV E + SL +L L L ++
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDM 285
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 345 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P PE L ++ CW ++P RP+F + L + + P
Sbjct: 395 ERGYRMPCPPE-CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 57 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDM 116
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
+ IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 117 SAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 175
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 176 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 225
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P PE L ++ CW ++P RP+F + L + + P
Sbjct: 226 ERGYRMPCPPE-CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 275
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 81/262 (30%), Positives = 129/262 (49%), Gaps = 40/262 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDP---LMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC P LMVIV E
Sbjct: 65 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 118
Query: 62 MSLRKYLVSLR----PNK--------LDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 109
+L YL S R P K L L + ++ +A+ M+ L + IHRDL N
Sbjct: 119 GNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARN 178
Query: 110 LLLTPDQKSLKLADFGLARXXXX---XXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKHYN 165
+LL+ ++ +K+ DFGLAR +WMAPE ++ V Y
Sbjct: 179 ILLS-EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRV---------YT 228
Query: 166 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSC 223
+ DV+SFG++LWE+ + P+ G+ + + K R P+ +P++ + C
Sbjct: 229 IQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 287
Query: 224 WVEDPNLRPSFSQIIRMLNAFL 245
W +P+ RP+FS+++ L L
Sbjct: 288 WHGEPSQRPTFSELVEHLGNLL 309
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 81/264 (30%), Positives = 129/264 (48%), Gaps = 42/264 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDP---LMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC P LMVIV E
Sbjct: 54 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 107
Query: 62 MSLRKYLVSLR----PNK----------LDLHVALNFALDIARAMDCLHANGIIHRDLKP 107
+L YL S R P K L L + ++ +A+ M+ L + IHRDL
Sbjct: 108 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 167
Query: 108 DNLLLTPDQKSLKLADFGLARXXXX---XXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKH 163
N+LL+ ++ +K+ DFGLAR +WMAPE ++ V
Sbjct: 168 RNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRV--------- 217
Query: 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQ 221
Y + DV+SFG++LWE+ + P+ G+ + + K R P+ +P++ +
Sbjct: 218 YTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 276
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFL 245
CW +P+ RP+FS+++ L L
Sbjct: 277 DCWHGEPSQRPTFSELVEHLGNLL 300
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 79/264 (29%), Positives = 127/264 (48%), Gaps = 42/264 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDP---LMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC P LMVIV E
Sbjct: 100 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 153
Query: 62 MSLRKYLVSLR----PNK----------LDLHVALNFALDIARAMDCLHANGIIHRDLKP 107
+L YL S R P K L L + ++ +A+ M+ L + IHRDL
Sbjct: 154 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 213
Query: 108 DNLLLTPDQKSLKLADFGLARXXXX---XXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKH 163
N+LL+ ++ +K+ DFGLAR +WMAPE ++ V
Sbjct: 214 RNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--------- 263
Query: 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQ 221
Y + DV+SFG++LWE+ + P+ G+ + + K R P+ +P++ +
Sbjct: 264 YTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 322
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFL 245
CW +P+ RP+FS+++ L L
Sbjct: 323 DCWHGEPSQRPTFSELVEHLGNLL 346
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 57 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDM 116
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
+ IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 117 SAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEWTARQGAKFP 175
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 176 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 225
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P PE L ++ CW ++P RP+F + L + + P
Sbjct: 226 ERGYRMPCPPE-CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 275
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 81/270 (30%), Positives = 119/270 (44%), Gaps = 48/270 (17%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMS 63
++L + S ER L + E+ MM+++ H+N+V LGAC P+ +I G
Sbjct: 81 KMLKEKADSSEREAL----MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG-D 135
Query: 64 LRKYLVSLRP---------------------NKLDLHVALNFALDIARAMDCLHANGIIH 102
L YL S R N L L FA +A+ M+ L +H
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 195
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQG 159
RDL N+L+T K +K+ DFGLAR +WMAPE +L +G
Sbjct: 196 RDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE-----SLFEG 249
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRL-PFEGM---SNLQAAYAAAFKHARPGLPEDISPD 215
Y K DV+S+GI+LWE+ + + P+ G+ +N FK +P + +
Sbjct: 250 ---IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA---TEE 303
Query: 216 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ I+QSCW D RPSF + L L
Sbjct: 304 IYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 81/263 (30%), Positives = 129/263 (49%), Gaps = 41/263 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDP---LMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC P LMVIV E
Sbjct: 64 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 117
Query: 62 MSLRKYLVSLR----PNK---------LDLHVALNFALDIARAMDCLHANGIIHRDLKPD 108
+L YL S R P K L L + ++ +A+ M+ L + IHRDL
Sbjct: 118 GNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177
Query: 109 NLLLTPDQKSLKLADFGLARXXXX---XXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKHY 164
N+LL+ ++ +K+ DFGLAR +WMAPE ++ V Y
Sbjct: 178 NILLS-EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRV---------Y 227
Query: 165 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQS 222
+ DV+SFG++LWE+ + P+ G+ + + K R P+ +P++ +
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 286
Query: 223 CWVEDPNLRPSFSQIIRMLNAFL 245
CW +P+ RP+FS+++ L L
Sbjct: 287 CWHGEPSQRPTFSELVEHLGNLL 309
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 79/264 (29%), Positives = 127/264 (48%), Gaps = 42/264 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDP---LMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC P LMVIV E
Sbjct: 65 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 118
Query: 62 MSLRKYLVSLR----PNK----------LDLHVALNFALDIARAMDCLHANGIIHRDLKP 107
+L YL S R P K L L + ++ +A+ M+ L + IHRDL
Sbjct: 119 GNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 178
Query: 108 DNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKH 163
N+LL+ ++ +K+ DFGLAR +WMAPE ++ V
Sbjct: 179 RNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--------- 228
Query: 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQ 221
Y + DV+SFG++LWE+ + P+ G+ + + K R P+ +P++ +
Sbjct: 229 YTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 287
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFL 245
CW +P+ RP+FS+++ L L
Sbjct: 288 DCWHGEPSQRPTFSELVEHLGNLL 311
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 66/236 (27%), Positives = 119/236 (50%), Gaps = 21/236 (8%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
++LN T+ +A +E F+ E +M+ + H +LV+ LG C P + +VT+L+P L +
Sbjct: 73 KILN--ETTGPKANVE--FMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLE 128
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFG 125
Y+ + N + + LN+ + IA+ M L ++HRDL N+L+ +P+ +K+ DFG
Sbjct: 129 YVHEHKDN-IGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFG 185
Query: 126 LARXXXXXXXXXXX---XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
LAR +WMA E + + ++ DV+S+G+ +WEL+T
Sbjct: 186 LARLLEGDEKEYNADGGKMPIKWMALECIHY--------RKFTHQSDVWSYGVTIWELMT 237
Query: 183 -NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
P++G+ + K R P + D+ ++ CW+ D + RP F ++
Sbjct: 238 FGGKPYDGIPTREIPDLLE-KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 292
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 91.7 bits (226), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 76/262 (29%), Positives = 119/262 (45%), Gaps = 39/262 (14%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKD-PLMVIVTELLP 60
K MKE ++ D F E+ ++ ++ H N++ LGAC+ + + E P
Sbjct: 55 KRMKEYASKDDHRD--------FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 106
Query: 61 GMSLRKYLVSLRPNKLDLHVA--------------LNFALDIARAMDCLHANGIIHRDLK 106
+L +L R + D A L+FA D+AR MD L IHR+L
Sbjct: 107 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLA 166
Query: 107 PDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHY 164
N+L+ + + K+ADFGL+R RWMA E YS Y
Sbjct: 167 ARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV----------Y 215
Query: 165 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 223
DV+S+G++LWE+++ P+ GM+ + Y + R P + ++ +++ C
Sbjct: 216 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQC 274
Query: 224 WVEDPNLRPSFSQIIRMLNAFL 245
W E P RPSF+QI+ LN L
Sbjct: 275 WREKPYERPSFAQILVSLNRML 296
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 91.7 bits (226), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 81/264 (30%), Positives = 129/264 (48%), Gaps = 42/264 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDP---LMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC P LMVIV E
Sbjct: 63 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 116
Query: 62 MSLRKYLVSLR----PNK----------LDLHVALNFALDIARAMDCLHANGIIHRDLKP 107
+L YL S R P K L L + ++ +A+ M+ L + IHRDL
Sbjct: 117 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176
Query: 108 DNLLLTPDQKSLKLADFGLARXXXX---XXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKH 163
N+LL+ ++ +K+ DFGLAR +WMAPE ++ V
Sbjct: 177 RNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRV--------- 226
Query: 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQ 221
Y + DV+SFG++LWE+ + P+ G+ + + K R P+ +P++ +
Sbjct: 227 YTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 285
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFL 245
CW +P+ RP+FS+++ L L
Sbjct: 286 DCWHGEPSQRPTFSELVEHLGNLL 309
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 91.7 bits (226), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/248 (28%), Positives = 111/248 (44%), Gaps = 26/248 (10%)
Query: 15 SDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYL 68
S +R + E F+ E M H N+++ LG C + P +++ + L YL
Sbjct: 75 SSQREIEE--FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL 132
Query: 69 VSLR----PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 124
+ R P + L L F +DIA M+ L +HRDL N +L D ++ +ADF
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADF 191
Query: 125 GLARXXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
GL++ +W+A E + + Y +K DV++FG+ +WE+
Sbjct: 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLA--------DRVYTSKSDVWAFGVTMWEIA 243
Query: 182 TNRL-PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
T + P+ G+ N Y R PED +L I+ SCW DP RP+FS +
Sbjct: 244 TRGMTPYPGVQN-HEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302
Query: 241 LNAFLFTL 248
L L +L
Sbjct: 303 LEKLLESL 310
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 91.7 bits (226), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 80/264 (30%), Positives = 128/264 (48%), Gaps = 42/264 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDP---LMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC P LMVIV E
Sbjct: 63 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 116
Query: 62 MSLRKYLVSLR----PNK----------LDLHVALNFALDIARAMDCLHANGIIHRDLKP 107
+L YL S R P K L L + ++ +A+ M+ L + IHRDL
Sbjct: 117 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176
Query: 108 DNLLLTPDQKSLKLADFGLARXXXX---XXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKH 163
N+LL+ ++ +K+ DFGLAR +WMAPE ++ V
Sbjct: 177 RNILLS-EKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRV--------- 226
Query: 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQ 221
Y + DV+SFG++LWE+ + P+ G+ + + K R P+ +P++ +
Sbjct: 227 YTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 285
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFL 245
CW +P+ RP+FS+++ L L
Sbjct: 286 DCWHGEPSQRPTFSELVEHLGNLL 309
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 91.7 bits (226), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 79/265 (29%), Positives = 124/265 (46%), Gaps = 45/265 (16%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK--DPLMVIVTELL 59
K ++L + +DE+ L + E+ +MS + +H+N+V LGAC P++VI TE
Sbjct: 78 KVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHGGPVLVI-TEYC 132
Query: 60 PGMSLRKYLVSLRPNKLDLHVA--------------LNFALDIARAMDCLHANGIIHRDL 105
L +L RP L+ L+F+ +A+ M L + IHRD+
Sbjct: 133 CYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDV 192
Query: 106 KPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEK 161
N+LLT + K+ DFGLAR +WMAPE ++ V
Sbjct: 193 AARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV------- 244
Query: 162 KHYNNKVDVYSFGIVLWELLTNRL-PFEGM---SNLQAAYAAAFKHARPGL-PEDISPDL 216
Y + DV+S+GI+LWE+ + L P+ G+ S ++ A+P P++I
Sbjct: 245 --YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYS-- 300
Query: 217 AFIVQSCWVEDPNLRPSFSQIIRML 241
I+Q+CW +P RP+F QI L
Sbjct: 301 --IMQACWALEPTHRPTFQQICSFL 323
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 79/264 (29%), Positives = 127/264 (48%), Gaps = 42/264 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDP---LMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC P LMVIV E
Sbjct: 63 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 116
Query: 62 MSLRKYLVSLR----PNK----------LDLHVALNFALDIARAMDCLHANGIIHRDLKP 107
+L YL S R P K L L + ++ +A+ M+ L + IHRDL
Sbjct: 117 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176
Query: 108 DNLLLTPDQKSLKLADFGLARXXXX---XXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKH 163
N+LL+ ++ +K+ DFGLAR +WMAPE ++ V
Sbjct: 177 RNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--------- 226
Query: 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQ 221
Y + DV+SFG++LWE+ + P+ G+ + + K R P+ +P++ +
Sbjct: 227 YTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 285
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFL 245
CW +P+ RP+FS+++ L L
Sbjct: 286 DCWHGEPSQRPTFSELVEHLGNLL 309
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IV E + L +L L L ++
Sbjct: 60 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDM 119
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR +
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 179 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P PE L ++ CW +DP RP+F + L + + P
Sbjct: 229 ERGYRMPCPPE-CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 91.3 bits (225), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 17/219 (7%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F+ E +M+ + H +LV+ LG C P + +VT+L+P L +Y+ + N + + LN
Sbjct: 63 EFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDN-IGSQLLLN 121
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARXXXXXXXXXXX--- 139
+ + IA+ M L ++HRDL N+L+ +P+ +K+ DFGLAR
Sbjct: 122 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGG 179
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 198
+WMA E + + ++ DV+S+G+ +WEL+T P++G+ +
Sbjct: 180 KMPIKWMALECIHY--------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL 231
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K R P + D+ ++ CW+ D + RP F ++
Sbjct: 232 LE-KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 269
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 90.1 bits (222), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 78/263 (29%), Positives = 124/263 (47%), Gaps = 41/263 (15%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK--DPLMVIVTELL 59
K ++L + +DE+ L + E+ +MS + +H+N+V LGAC P++VI
Sbjct: 78 KVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 60 PGMSL----RKYLV-------SLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 108
G L RK V ++ + L L+F+ +A+ M L + IHRD+
Sbjct: 134 YGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAAR 193
Query: 109 NLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHY 164
N+LLT + K+ DFGLAR +WMAPE ++ V Y
Sbjct: 194 NVLLTNGHVA-KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV---------Y 243
Query: 165 NNKVDVYSFGIVLWELLTNRL-PFEGM---SNLQAAYAAAFKHARPGL-PEDISPDLAFI 219
+ DV+S+GI+LWE+ + L P+ G+ S ++ A+P P++I I
Sbjct: 244 TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYS----I 299
Query: 220 VQSCWVEDPNLRPSFSQIIRMLN 242
+Q+CW +P RP+F QI L
Sbjct: 300 MQACWALEPTHRPTFQQICSFLQ 322
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 90.1 bits (222), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 80/272 (29%), Positives = 125/272 (45%), Gaps = 50/272 (18%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK--DPLMVIVTELL 59
K ++L + +DE+ L + E+ +MS + +H+N+V LGAC P++VI
Sbjct: 63 KVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 118
Query: 60 PGMSL----RKYLVSLRPN----------------KLDLHVALNFALDIARAMDCLHANG 99
G L RK L P+ L+L L+F+ +A+ M L +
Sbjct: 119 YGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN 178
Query: 100 IIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX---YRWMAPE-LYSTVT 155
IHRD+ N+LLT + K+ DFGLAR +WMAPE ++ V
Sbjct: 179 CIHRDVAARNVLLTNGHVA-KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV- 236
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGM---SNLQAAYAAAFKHARPGL-PE 210
Y + DV+S+GI+LWE+ + L P+ G+ S ++ A+P P+
Sbjct: 237 --------YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPK 288
Query: 211 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
+I I+Q+CW +P RP+F QI L
Sbjct: 289 NIYS----IMQACWALEPTHRPTFQQICSFLQ 316
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 90.1 bits (222), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 58/189 (30%), Positives = 94/189 (49%), Gaps = 18/189 (9%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
RF REV+ S++ H N+V + + D +V E + G +L +Y+ S P L + A+
Sbjct: 57 RFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAI 114
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX- 141
NF I + H I+HRD+KP N+L+ + K+LK+ DFG+A+
Sbjct: 115 NFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVL 173
Query: 142 -XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
++ +PE Q + + + D+YS GIVL+E+L PF G + A + A
Sbjct: 174 GTVQYFSPE--------QAKGEATDECTDIYSIGIVLYEMLVGEPPFNG----ETAVSIA 221
Query: 201 FKHARPGLP 209
KH + +P
Sbjct: 222 IKHIQDSVP 230
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 79/270 (29%), Positives = 124/270 (45%), Gaps = 55/270 (20%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK--DPLMVI----- 54
K ++L + +DE+ L + E+ +MS + +H+N+V LGAC P++VI
Sbjct: 78 KVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 55 -------------VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101
V E P ++ S R DL L+F+ +A+ M L + I
Sbjct: 134 YGDLLNFLRRKSRVLETDPAFAIANSTASTR----DL---LHFSSQVAQGMAFLASKNCI 186
Query: 102 HRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLR 157
HRD+ N+LLT + K+ DFGLAR +WMAPE ++ V
Sbjct: 187 HRDVAARNVLLTNGHVA-KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV--- 242
Query: 158 QGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGM---SNLQAAYAAAFKHARPGL-PEDI 212
Y + DV+S+GI+LWE+ + L P+ G+ S ++ A+P P++I
Sbjct: 243 ------YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNI 296
Query: 213 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
I+Q+CW +P RP+F QI L
Sbjct: 297 YS----IMQACWALEPTHRPTFQQICSFLQ 322
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 89.0 bits (219), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 78/249 (31%), Positives = 113/249 (45%), Gaps = 45/249 (18%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F++EV +M ++H N++KF+G KD + +TE + G +LR + S+ ++ ++
Sbjct: 54 FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVS 112
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
FA DIA M LH+ IIHRDL N L+ + K++ +ADFGLAR
Sbjct: 113 FAKDIASGMAYLHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 144 R---------------WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+ WMAPE+ + + Y+ KVDV+SFGIVL E++
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMING--------RSYDEKVDVFSFGIVLCEII------- 216
Query: 189 GMSNLQAAY---AAAFKHARPGL-----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
G N Y F G P + P I C DP RPSF +
Sbjct: 217 GRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVK---- 272
Query: 241 LNAFLFTLR 249
L +L TLR
Sbjct: 273 LEHWLETLR 281
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 88.2 bits (217), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 17/223 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F E + H N++ LGAC+ P ++T +P SL L +D A
Sbjct: 54 FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA 113
Query: 82 LNFALDIARAMDCLHA-NGIIHRD-LKPDNLLLTPDQKS-LKLADFGLARXXXXXXXXXX 138
+ FALD+AR M LH +I R L ++++ D + + +AD +
Sbjct: 114 VKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA 173
Query: 139 XXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
W+APE L++ + D++SF ++LWEL+T +PF +SN++
Sbjct: 174 ------WVAPE-----ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK 222
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
A + RP +P ISP ++ +++ C EDP RP F I+ +L
Sbjct: 223 VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 87.4 bits (215), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 65/225 (28%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 32 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 91
+ + H ++V+ LG C + +VT+ LP SL ++ R L + LN+ + IA+
Sbjct: 69 IGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKG 127
Query: 92 MDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARXX---XXXXXXXXXXXXYRWMA 147
M L +G++HR+L N+LL +P Q +++ADFG+A +WMA
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 148 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 206
E ++ G+ Y ++ DV+S+G+ +WEL+T P+ G+ L K R
Sbjct: 186 LE-----SIHFGK---YTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKGERL 236
Query: 207 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251
P+ + D+ ++ CW+ D N+RP+F + + N F R P
Sbjct: 237 AQPQICTIDVYMVMVKCWMIDENIRPTFKE---LANEFTRMARDP 278
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 65/225 (28%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 32 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 91
+ + H ++V+ LG C + +VT+ LP SL ++ R L + LN+ + IA+
Sbjct: 87 IGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKG 145
Query: 92 MDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARXX---XXXXXXXXXXXXYRWMA 147
M L +G++HR+L N+LL +P Q +++ADFG+A +WMA
Sbjct: 146 MYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203
Query: 148 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 206
E ++ G+ Y ++ DV+S+G+ +WEL+T P+ G+ L K R
Sbjct: 204 LE-----SIHFGK---YTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKGERL 254
Query: 207 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251
P+ + D+ ++ CW+ D N+RP+F + + N F R P
Sbjct: 255 AQPQICTIDVYMVMVKCWMIDENIRPTFKE---LANEFTRMARDP 296
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 10/209 (4%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVS-LRPNKLDLHVALNF 84
E+ + +KH N+V++LG+ ++ + I E +PG SL L S P K + +
Sbjct: 68 EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXY 143
I + LH N I+HRD+K DN+L+ LK++DFG + R
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 187
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-YAAAFK 202
++MAPE+ + +G + Y D++S G + E+ T + PF + QAA +
Sbjct: 188 QYMAPEI-----IDKG-PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF 241
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
P +PE +S + + C+ DP+ R
Sbjct: 242 KVHPEIPESMSAEAKAFILKCFEPDPDKR 270
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 86.7 bits (213), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 10/209 (4%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVS-LRPNKLDLHVALNF 84
E+ + +KH N+V++LG+ ++ + I E +PG SL L S P K + +
Sbjct: 54 EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 113
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXY 143
I + LH N I+HRD+K DN+L+ LK++DFG + R
Sbjct: 114 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 173
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-YAAAFK 202
++MAPE+ + +G + Y D++S G + E+ T + PF + QAA +
Sbjct: 174 QYMAPEI-----IDKGPRG-YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF 227
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
P +PE +S + + C+ DP+ R
Sbjct: 228 KVHPEIPESMSAEAKAFILKCFEPDPDKR 256
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 73/238 (30%), Positives = 114/238 (47%), Gaps = 29/238 (12%)
Query: 28 EVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
EV +M +H+N+V+ + D L V V E L G +L + R N+ +
Sbjct: 71 EVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQIAAV---C 126
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXXXYR 144
L + +A+ LHA G+IHRD+K D++LLT D + +KL+DFG A+
Sbjct: 127 LAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPY 185
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPEL S + Y +VD++S GI++ E++ P+ L+ A K
Sbjct: 186 WMAPELISRLP--------YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMI 232
Query: 205 RPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
R LP +SP L + V DP R + +++++ + FL PP+ VP
Sbjct: 233 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPPASIVP 288
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN
Sbjct: 66 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 124
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 125 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 184 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 234
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I++ CW+ D + RP F ++I
Sbjct: 235 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 273
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 15/218 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN+
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNW 122
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXXX 141
+ IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 200
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 182 PIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL 232
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I++ CW+ D + RP F ++I
Sbjct: 233 EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 270
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 15/218 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN+
Sbjct: 74 ILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNW 132
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXXX 141
+ IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 133 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKV 191
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 200
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 192 PIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL 242
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I++ CW+ D + RP F ++I
Sbjct: 243 EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 280
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 73/238 (30%), Positives = 114/238 (47%), Gaps = 29/238 (12%)
Query: 28 EVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
EV +M +H+N+V+ + D L V V E L G +L + R N+ +
Sbjct: 78 EVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQIAAV---C 133
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXXXYR 144
L + +A+ LHA G+IHRD+K D++LLT D + +KL+DFG A+
Sbjct: 134 LAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPY 192
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPEL S + Y +VD++S GI++ E++ P+ L+ A K
Sbjct: 193 WMAPELISRLP--------YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMI 239
Query: 205 RPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
R LP +SP L + V DP R + +++++ + FL PP+ VP
Sbjct: 240 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPPASIVP 295
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 73/238 (30%), Positives = 114/238 (47%), Gaps = 29/238 (12%)
Query: 28 EVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
EV +M +H+N+V+ + D L V V E L G +L + R N+ +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQIAAV---C 122
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXXXYR 144
L + +A+ LHA G+IHRD+K D++LLT D + +KL+DFG A+
Sbjct: 123 LAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPY 181
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPEL S + Y +VD++S GI++ E++ P+ L+ A K
Sbjct: 182 WMAPELISRLP--------YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMI 228
Query: 205 RPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
R LP +SP L + V DP R + +++++ + FL PP+ VP
Sbjct: 229 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPPASIVP 284
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 73/238 (30%), Positives = 114/238 (47%), Gaps = 29/238 (12%)
Query: 28 EVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
EV +M +H+N+V+ + D L V V E L G +L + R N+ +
Sbjct: 121 EVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQIAAV---C 176
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXXXYR 144
L + +A+ LHA G+IHRD+K D++LLT D + +KL+DFG A+
Sbjct: 177 LAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPY 235
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPEL S + Y +VD++S GI++ E++ P+ L+ A K
Sbjct: 236 WMAPELISRLP--------YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMI 282
Query: 205 RPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
R LP +SP L + V DP R + +++++ + FL PP+ VP
Sbjct: 283 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPPASIVP 338
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 85.5 bits (210), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 14/222 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+F+ E +M + H ++VK +G ++ I+ EL P L YL N L + +
Sbjct: 71 KFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVL 129
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX- 142
++L I +AM L + +HRD+ N+L+ + +KL DFGL+R
Sbjct: 130 YSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKASVTRL 188
Query: 143 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 200
+WM+PE ++ R+ + DV+ F + +WE+L+ + PF + N +
Sbjct: 189 PIKWMSPE---SINFRR-----FTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVL 239
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
K R P+ P L ++ CW DP+ RP F++++ L+
Sbjct: 240 EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 281
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 85.5 bits (210), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 73/238 (30%), Positives = 114/238 (47%), Gaps = 29/238 (12%)
Query: 28 EVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
EV +M +H+N+V+ + D L V V E L G +L + R N+ +
Sbjct: 76 EVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQIAAV---C 131
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXXXYR 144
L + +A+ LHA G+IHRD+K D++LLT D + +KL+DFG A+
Sbjct: 132 LAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPY 190
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPEL S + Y +VD++S GI++ E++ P+ L+ A K
Sbjct: 191 WMAPELISRLP--------YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMI 237
Query: 205 RPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
R LP +SP L + V DP R + +++++ + FL PP+ VP
Sbjct: 238 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPPASIVP 293
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 85.5 bits (210), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-- 81
F+ E ++M + H N+++ G K ++IVTE + SL +L R + V
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQL 149
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXX 137
+ IA M L G +HRDL N+L+ + K++DFGLAR
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLARVLEDDPEAAYTTR 208
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW +PE + + + + DV+S+GIVLWE+++ P+ MSN Q
Sbjct: 209 GGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 85.5 bits (210), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 14/222 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+F+ E +M + H ++VK +G ++ I+ EL P L YL N L + +
Sbjct: 59 KFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVL 117
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX- 142
++L I +AM L + +HRD+ N+L+ + +KL DFGL+R
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 143 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 200
+WM+PE ++ R+ + DV+ F + +WE+L+ + PF + N +
Sbjct: 177 PIKWMSPE---SINFRR-----FTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVL 227
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
K R P+ P L ++ CW DP+ RP F++++ L+
Sbjct: 228 EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 72/238 (30%), Positives = 115/238 (48%), Gaps = 29/238 (12%)
Query: 28 EVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
EV +M +H+N+V+ + D L V++ E L G +L + R N+ +
Sbjct: 198 EVVIMRDYQHENVVEMYNSYLVGDELWVVM-EFLEGGALTDIVTHTRMNEEQIAA---VC 253
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXXXYR 144
L + +A+ LHA G+IHRD+K D++LLT D + +KL+DFG A+
Sbjct: 254 LAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPY 312
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPEL S + Y +VD++S GI++ E++ P+ L+ A K
Sbjct: 313 WMAPELISRLP--------YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMI 359
Query: 205 RPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
R LP +SP L + V DP R + +++++ + FL PP+ VP
Sbjct: 360 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPPASIVP 415
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 14/222 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+F+ E +M + H ++VK +G ++ I+ EL P L YL N L + +
Sbjct: 55 KFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVL 113
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX- 142
++L I +AM L + +HRD+ N+L+ + +KL DFGL+R
Sbjct: 114 YSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKASVTRL 172
Query: 143 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 200
+WM+PE ++ R+ + DV+ F + +WE+L+ + PF + N +
Sbjct: 173 PIKWMSPE---SINFRR-----FTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVL 223
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
K R P+ P L ++ CW DP+ RP F++++ L+
Sbjct: 224 EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 265
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 21/230 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S++ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 81 FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+AR
Sbjct: 141 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 200
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 201 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 252
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 253 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 18/222 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
++GR RE++ + ++H +++K K +I+ G L Y+V + +K+
Sbjct: 56 MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQE 113
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
A F I A++ H + I+HRDLKP+NLLL + ++K+ADFGL+
Sbjct: 114 ARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSC 172
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
+ APE+ S K + +VDV+S G++L+ +L RLPF+ S
Sbjct: 173 GSPNYAAPEVISG-------KLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVL 220
Query: 201 FKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
FK+ G LP+ +SP A +++ + +P R S +I++
Sbjct: 221 FKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 18/222 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
++GR RE++ + ++H +++K K +I+ G L Y+V + +K+
Sbjct: 57 MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQE 114
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
A F I A++ H + I+HRDLKP+NLLL + ++K+ADFGL+
Sbjct: 115 ARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSC 173
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
+ APE+ S K + +VDV+S G++L+ +L RLPF+ S
Sbjct: 174 GSPNYAAPEVISG-------KLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVL 221
Query: 201 FKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
FK+ G LP+ +SP A +++ + +P R S +I++
Sbjct: 222 FKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 263
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S++ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 95 FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+AR
Sbjct: 155 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 214
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 215 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 266
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 267 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN
Sbjct: 70 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 128
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 129 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 188 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 238
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN
Sbjct: 70 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 128
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 129 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 188 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 238
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 18/222 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
++GR RE++ + ++H +++K K +I+ G L Y+V + +K+
Sbjct: 51 MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQE 108
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
A F I A++ H + I+HRDLKP+NLLL + ++K+ADFGL+
Sbjct: 109 ARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSC 167
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
+ APE+ S K + +VDV+S G++L+ +L RLPF+ S
Sbjct: 168 GSPNYAAPEVISG-------KLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVL 215
Query: 201 FKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
FK+ G LP+ +SP A +++ + +P R S +I++
Sbjct: 216 FKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 257
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN
Sbjct: 88 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 146
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 147 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 205
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 206 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 256
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 257 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 295
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN
Sbjct: 69 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 127
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 128 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 186
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 187 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 237
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 238 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 276
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN
Sbjct: 66 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 124
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 125 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 184 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 234
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN+
Sbjct: 98 ILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNW 156
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXXX 141
+ IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 157 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 200
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 216 PIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL 266
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 267 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 304
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN
Sbjct: 63 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 121
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 181 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 231
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S+ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 95 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+AR
Sbjct: 155 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 214
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 215 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 266
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 267 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 18/222 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
++GR RE++ + ++H +++K K +I+ G L Y+V + +K+
Sbjct: 47 MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQE 104
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
A F I A++ H + I+HRDLKP+NLLL + ++K+ADFGL+
Sbjct: 105 ARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSC 163
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
+ APE+ S K + +VDV+S G++L+ +L RLPF+ S
Sbjct: 164 GSPNYAAPEVISG-------KLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVL 211
Query: 201 FKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
FK+ G LP+ +SP A +++ + +P R S +I++
Sbjct: 212 FKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 253
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 84.7 bits (208), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN
Sbjct: 65 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 123
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 124 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 183 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 233
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 84.7 bits (208), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 68/252 (26%), Positives = 109/252 (43%), Gaps = 39/252 (15%)
Query: 27 REVNMMSRVKHDNLVKFLGA-----------------CKDPLMVIVTELLPGMSLRKYLV 69
REV ++++ H N+V + G K + I E +L +++
Sbjct: 53 REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112
Query: 70 SLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
R KLD +AL I + +D +H+ +I+RDLKP N+ L D K +K+ DFGL
Sbjct: 113 KRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV-DTKQVKIGDFGLVTS 171
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
R+M+PE S+ + Y +VD+Y+ G++L ELL
Sbjct: 172 LKNDGKRXRSKGTLRYMSPEQISS--------QDYGKEVDLYALGLILAELLH------- 216
Query: 190 MSNLQAAYAAAFKHARPGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
+ + + F R G+ DI ++Q + P RP+ S+I+R L T+
Sbjct: 217 VCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL-----TV 271
Query: 249 RPPSPSVPESDT 260
SP E T
Sbjct: 272 WKKSPEKNERHT 283
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 84.7 bits (208), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN
Sbjct: 63 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 121
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 181 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 231
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 84.7 bits (208), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-- 81
F+ E ++M + H N+++ G K ++IVTE + SL +L R + V
Sbjct: 64 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQL 120
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXX 137
+ IA M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 121 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVLEDDPEAAYTTR 179
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW +PE + + + + DV+S+GIVLWE+++ P+ MSN Q
Sbjct: 180 GGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 230
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 231 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 84.7 bits (208), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S+ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 107 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 166
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+AR
Sbjct: 167 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 226
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 227 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 278
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 279 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 84.7 bits (208), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN
Sbjct: 66 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 124
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 125 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 184 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 234
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 84.7 bits (208), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN
Sbjct: 57 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 115
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 116 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 175 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 225
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 264
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 84.7 bits (208), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-- 81
F+ E ++M + H N+++ G K ++IVTE + SL +L R + V
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQL 149
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXX 137
+ IA M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 150 VGMLRGIASGMKYLSDMGFVHRDLAARNILINSNL-VCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW +PE + + + + DV+S+GIVLWE+++ P+ MSN Q
Sbjct: 209 GGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 84.7 bits (208), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S+ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+AR
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 241 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 293 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 84.7 bits (208), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S+ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 81 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+AR
Sbjct: 141 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 200
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 201 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 252
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 253 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 84.7 bits (208), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S+ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 98 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 157
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+AR
Sbjct: 158 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 217
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 218 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 269
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 270 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 84.7 bits (208), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN
Sbjct: 63 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDN-IGSQYLLN 121
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 181 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 231
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 84.7 bits (208), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S+ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 87 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 146
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+AR
Sbjct: 147 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 206
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 207 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 258
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 259 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 84.7 bits (208), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-- 81
F+ E ++M + H N+++ G K ++IVTE + SL +L R + V
Sbjct: 64 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL---RKHDAQFTVIQL 120
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXX 137
+ IA M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 121 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVLEDDPEAAYTTR 179
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW +PE + + + + DV+S+GIVLWE+++ P+ MSN Q
Sbjct: 180 GGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 230
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 231 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 84.7 bits (208), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S+ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 95 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+AR
Sbjct: 155 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 214
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 215 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 266
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 267 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 84.7 bits (208), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S+ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+AR
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 200 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 252 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 84.7 bits (208), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-- 81
F+ E ++M + H N+++ G K ++IVTE + SL +L R + V
Sbjct: 81 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQL 137
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXX 137
+ IA M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 138 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVLEDDPEAAYTTR 196
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW +PE + + + + DV+S+GIVLWE+++ P+ MSN Q
Sbjct: 197 GGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 247
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 248 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 296
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 84.7 bits (208), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S+ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 97 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 156
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+AR
Sbjct: 157 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 216
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 217 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 268
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 269 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-- 81
F+ E ++M + H N+++ G K ++IVTE + SL +L R + V
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQL 149
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXX 137
+ IA M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW +PE + + + + DV+S+GIVLWE+++ P+ MSN Q
Sbjct: 209 GGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-- 81
F+ E ++M + H N+++ G K ++IVTE + SL +L R + V
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQL 149
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXX 137
+ IA M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW +PE + + + + DV+S+GIVLWE+++ P+ MSN Q
Sbjct: 209 GGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-- 81
F+ E ++M + H N+++ G K ++IVTE + SL +L R + V
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQL 149
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXX 137
+ IA M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW +PE + + + + DV+S+GIVLWE+++ P+ MSN Q
Sbjct: 209 GGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-- 81
F+ E ++M + H N+++ G K ++IVTE + SL +L R + V
Sbjct: 91 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQL 147
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXX 137
+ IA M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 148 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVLEDDPEAAYTTR 206
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW +PE + + + + DV+S+GIVLWE+++ P+ MSN Q
Sbjct: 207 GGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 257
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 258 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 306
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-- 81
F+ E ++M + H N+++ G K ++IVTE + SL +L R + V
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL---RKHDAQFTVIQL 149
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXX 137
+ IA M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 150 VGMLRGIASGMKYLSDMGAVHRDLAARNILINSNL-VCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW +PE + + + + DV+S+GIVLWE+++ P+ MSN Q
Sbjct: 209 GGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-- 81
F+ E ++M + H N+++ G K ++IVTE + SL +L R + V
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQL 149
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXX 137
+ IA M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW +PE + + + + DV+S+GIVLWE+++ P+ MSN Q
Sbjct: 209 GGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-- 81
F+ E ++M + H N+++ G K ++IVTE + SL +L R + V
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQL 149
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXX 137
+ IA M L G +HRDL N+L+ + K++DFGL R
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW +PE + + + + DV+S+GIVLWE+++ P+ MSN Q
Sbjct: 209 GGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 21/229 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-- 81
F+ E ++M + H N+++ G K ++IVTE + SL +L R + V
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL---RKHDAQFTVIQL 149
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXX 137
+ IA M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW +PE + + + + DV+S+GIVLWE+++ P+ MSN Q
Sbjct: 209 GGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S+ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+AR
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 200 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 252 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S+ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 72 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 131
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+AR
Sbjct: 132 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 191
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 192 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 243
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 244 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 27/248 (10%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-----MVIVTELLPG 61
E+ +R T ER RF E + ++H N+V+F + + + +V+VTEL
Sbjct: 58 ELQDRKLTKSERQ----RFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTS 113
Query: 62 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSL 119
+L+ YL + K+ V ++ I + + LH IIHRDLK DN+ +T S+
Sbjct: 114 GTLKTYLKRFKVXKI--KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV 171
Query: 120 KLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
K+ D GLA + APE Y ++ Y+ VDVY+FG E
Sbjct: 172 KIGDLGLATLKRASFAKAVIGTP-EFXAPEXY---------EEKYDESVDVYAFGXCXLE 221
Query: 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS-PDLAFIVQSCWVEDPNLRPSFSQII 238
T+ P+ N Y +P + ++ P++ I++ C ++ + R S I
Sbjct: 222 XATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS---IK 278
Query: 239 RMLNAFLF 246
+LN F
Sbjct: 279 DLLNHAFF 286
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 84.0 bits (206), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN
Sbjct: 60 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 118
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 119 WCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 178 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 228
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 229 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 267
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 30/223 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDL 78
RF RE + + H +V + PL IV E + G++LR + + P +
Sbjct: 58 RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTP 115
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
A+ D +A++ H NGIIHRD+KP N+L++ ++K+ DFG+AR
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNSVX 174
Query: 139 XXXXY----RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
++++PE Q + + DVYS G VL+E+LT PF G S +
Sbjct: 175 QTAAVIGTAQYLSPE--------QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226
Query: 195 AAYAAAFKHAR--PGLP----EDISPDLAFIVQSCWVEDPNLR 231
AY +H R P P E +S DL +V ++P R
Sbjct: 227 VAY----QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN+
Sbjct: 66 ILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNW 124
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXXX 141
+ IA+ M+ L ++HRDL N+L+ Q +K+ DFG A+
Sbjct: 125 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 200
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 184 PIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL 234
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I++ CW+ D + RP F ++I
Sbjct: 235 EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 272
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 30/223 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDL 78
RF RE + + H +V + PL IV E + G++LR + + P +
Sbjct: 58 RFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTP 115
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
A+ D +A++ H NGIIHRD+KP N++++ ++K+ DFG+AR
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVT 174
Query: 139 XXXXY----RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
++++PE Q + + DVYS G VL+E+LT PF G S +
Sbjct: 175 QTAAVIGTAQYLSPE--------QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226
Query: 195 AAYAAAFKHAR--PGLP----EDISPDLAFIVQSCWVEDPNLR 231
AY +H R P P E +S DL +V ++P R
Sbjct: 227 VAY----QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/253 (26%), Positives = 119/253 (47%), Gaps = 39/253 (15%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLR----------- 72
+ E N++ +V H +++K GAC +D ++++ E SLR +L R
Sbjct: 73 LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 73 ---------PNKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
P++ L + ++FA I++ M L ++HRDL N+L+ +K +K+
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRK-MKI 191
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
+DFGL+R +WMA E L+ + Y + DV+SFG++L
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI---------YTTQSDVWSFGVLL 242
Query: 178 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
WE++T P+ G+ + H R P++ S ++ ++ CW ++P+ RP F+
Sbjct: 243 WEIVTLGGNPYPGIPPERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 237 IIRMLNAFLFTLR 249
I + L + R
Sbjct: 302 ISKDLEKMMVKRR 314
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 60/247 (24%), Positives = 118/247 (47%), Gaps = 20/247 (8%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+VL +G+ E+A E +RE +M ++ + +V+ +G C+ +++V E+ G L K
Sbjct: 43 KVLKQGT---EKADTE-EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHK 98
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+LV R ++ + ++ M L +HRDL N+LL ++ K++DFGL
Sbjct: 99 FLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGL 156
Query: 127 ARXXXXXXXXXXXXXX----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
++ +W APE + R+ ++++ DV+S+G+ +WE L+
Sbjct: 157 SKALGADDSYYTARSAGKWPLKWYAPE---CINFRK-----FSSRSDVWSYGVTMWEALS 208
Query: 183 -NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
+ P++ M + A + R P + P+L ++ CW+ RP F + + +
Sbjct: 209 YGQKPYKKMKGPEVM-AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267
Query: 242 NAFLFTL 248
A ++L
Sbjct: 268 RACYYSL 274
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 37 HDNLVKFLGACK--DPLMVIVTELLPG---MSLRKYLVSLRPNKLDLHV----------- 80
H N+V LGAC P +VI G LR+ S +K +
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 81 -ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX 139
L+F+ +A+ M L + IHRDL N+LLT + + K+ DFGLAR
Sbjct: 162 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSNYVVK 220
Query: 140 XXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 194
+WMAPE +++ V Y + DV+S+GI LWEL + P+ GM
Sbjct: 221 GNARLPVKWMAPESIFNCV---------YTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 271
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
Y + R PE ++ I+++CW DP RP+F QI++++
Sbjct: 272 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 318
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 63/230 (27%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP-----NKLDL 78
F+ E ++S+ H N+V+ +G L I+ EL+ G L+ +L RP + L +
Sbjct: 81 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLARXXXXXXXX 136
L+ A DIA L N IHRD+ N LLT + K+ DFG+A+
Sbjct: 141 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYY 200
Query: 137 XXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
+WM PE + + + +K D +SFG++LWE+ + +P+ SN
Sbjct: 201 RKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 252
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
Q R P++ + I+ CW P RP+F+ I+ +
Sbjct: 253 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 37 HDNLVKFLGACK--DPLMVIVTELLPG---MSLRKYLVSLRPNKLDLHV----------- 80
H N+V LGAC P +VI G LR+ S +K +
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 81 -ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX 139
L+F+ +A+ M L + IHRDL N+LLT + + K+ DFGLAR
Sbjct: 169 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARHIKNDSNYVVK 227
Query: 140 XXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 194
+WMAPE +++ V Y + DV+S+GI LWEL + P+ GM
Sbjct: 228 GNARLPVKWMAPESIFNCV---------YTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 278
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
Y + R PE ++ I+++CW DP RP+F QI++++
Sbjct: 279 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 111/241 (46%), Gaps = 33/241 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-------- 74
F RE +++ ++H+++VKF G C DPL ++V E + L K+L + P+
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 75 ------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
+L L L+ A IA M L + +HRDL N L+ + +K+ DFG++R
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSR 181
Query: 129 XXXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 184
RWM PE ++ R+ + + DV+SFG++LWE+ T +
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPE---SIMYRK-----FTTESDVWSFGVILWEIFTYGK 233
Query: 185 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF-IVQSCWVEDPNLRPSFSQIIRMLNA 243
P+ +SN + R + P + ++ CW +P R + +I ++L+A
Sbjct: 234 QPWFQLSNTEV--IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHA 291
Query: 244 F 244
Sbjct: 292 L 292
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 30/223 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDL 78
RF RE + + H +V + PL IV E + G++LR + + P +
Sbjct: 58 RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTP 115
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
A+ D +A++ H NGIIHRD+KP N++++ ++K+ DFG+AR
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVT 174
Query: 139 XXXXY----RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
++++PE Q + + DVYS G VL+E+LT PF G S +
Sbjct: 175 QTAAVIGTAQYLSPE--------QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226
Query: 195 AAYAAAFKHAR--PGLP----EDISPDLAFIVQSCWVEDPNLR 231
AY +H R P P E +S DL +V ++P R
Sbjct: 227 VAY----QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 37 HDNLVKFLGACK--DPLMVIVTELLPG---MSLRKYLVSLRPNKLDLHV----------- 80
H N+V LGAC P +VI G LR+ S +K +
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 81 -ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX 139
L+F+ +A+ M L + IHRDL N+LLT + + K+ DFGLAR
Sbjct: 164 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSNYVVK 222
Query: 140 XXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 194
+WMAPE +++ V Y + DV+S+GI LWEL + P+ GM
Sbjct: 223 GNARLPVKWMAPESIFNCV---------YTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 273
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
Y + R PE ++ I+++CW DP RP+F QI++++
Sbjct: 274 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 320
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 37 HDNLVKFLGACK--DPLMVIVTELLPG---MSLRKYLVSLRPNKLDLHV----------- 80
H N+V LGAC P +VI G LR+ S +K +
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 81 -ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX 139
L+F+ +A+ M L + IHRDL N+LLT + + K+ DFGLAR
Sbjct: 169 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSNYVVK 227
Query: 140 XXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 194
+WMAPE +++ V Y + DV+S+GI LWEL + P+ GM
Sbjct: 228 GNARLPVKWMAPESIFNCV---------YTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 278
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
Y + R PE ++ I+++CW DP RP+F QI++++
Sbjct: 279 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 30/223 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDL 78
RF RE + + H +V + PL IV E + G++LR + + P +
Sbjct: 58 RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTP 115
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
A+ D +A++ H NGIIHRD+KP N++++ ++K+ DFG+AR
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVT 174
Query: 139 XXXXY----RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
++++PE Q + + DVYS G VL+E+LT PF G S +
Sbjct: 175 QTAAVIGTAQYLSPE--------QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226
Query: 195 AAYAAAFKHAR--PGLP----EDISPDLAFIVQSCWVEDPNLR 231
AY +H R P P E +S DL +V ++P R
Sbjct: 227 VAY----QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 37 HDNLVKFLGACK--DPLMVIVTELLPG---MSLRKYLVSLRPNKLDLHV----------- 80
H N+V LGAC P +VI G LR+ S +K +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 81 -ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX 139
L+F+ +A+ M L + IHRDL N+LLT + + K+ DFGLAR
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSNYVVK 204
Query: 140 XXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 194
+WMAPE +++ V Y + DV+S+GI LWEL + P+ GM
Sbjct: 205 GNARLPVKWMAPESIFNCV---------YTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
Y + R PE ++ I+++CW DP RP+F QI++++
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 48 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 107
K + I E +L +++ R KLD +AL I + +D +H+ +IHRDLKP
Sbjct: 105 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKP 164
Query: 108 DNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNK 167
N+ L D K +K+ DFGL R+M+PE S+ + Y +
Sbjct: 165 SNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS--------QDYGKE 215
Query: 168 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI-SPDLAFIVQSCWVE 226
VD+Y+ G++L ELL + + + F R G+ DI ++Q +
Sbjct: 216 VDLYALGLILAELLH-------VCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSK 268
Query: 227 DPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDT 260
P RP+ S+I+R L T+ SP E T
Sbjct: 269 KPEDRPNTSEILRTL-----TVWKKSPEKNERHT 297
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 82.4 bits (202), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++ +L+P L Y+ + N + LN
Sbjct: 65 EILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLN 123
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 124 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 183 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 233
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 82.4 bits (202), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/253 (26%), Positives = 119/253 (47%), Gaps = 39/253 (15%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLR----------- 72
+ E N++ +V H +++K GAC +D ++++ E SLR +L R
Sbjct: 73 LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 73 ---------PNKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
P++ L + ++FA I++ M L ++HRDL N+L+ +K +K+
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK-MKI 191
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
+DFGL+R +WMA E L+ + Y + DV+SFG++L
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI---------YTTQSDVWSFGVLL 242
Query: 178 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
WE++T P+ G+ + H R P++ S ++ ++ CW ++P+ RP F+
Sbjct: 243 WEIVTLGGNPYPGIPPERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 237 IIRMLNAFLFTLR 249
I + L + R
Sbjct: 302 ISKDLEKMMVKRR 314
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 82.4 bits (202), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++ +L+P L Y+ + N + LN
Sbjct: 70 EILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLN 128
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 129 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 188 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 238
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++ +L+P L Y+ + N + LN
Sbjct: 67 EILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLN 125
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 126 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 184
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 185 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 235
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 236 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++ +L+P L Y+ + N + LN
Sbjct: 64 EILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLN 122
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 123 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 182 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 232
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 233 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/253 (25%), Positives = 118/253 (46%), Gaps = 39/253 (15%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLR----------- 72
+ E N++ +V H +++K GAC +D ++++ E SLR +L R
Sbjct: 73 LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 73 ---------PNKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
P++ L + ++FA I++ M L ++HRDL N+L+ +K +K+
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK-MKI 191
Query: 122 ADFGLARXXXXXXXXXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
+DFGL+R +WMA E L+ + Y + DV+SFG++L
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI---------YTTQSDVWSFGVLL 242
Query: 178 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
WE++T P+ G+ + H R P++ S ++ ++ CW ++P+ RP F+
Sbjct: 243 WEIVTLGGNPYPGIPPERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 237 IIRMLNAFLFTLR 249
I + L + R
Sbjct: 302 ISKDLEKMMVKRR 314
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++ +L+P L Y+ + N + LN
Sbjct: 63 EILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLN 121
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 181 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 231
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++ +L+P L Y+ + N + LN
Sbjct: 66 EILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLN 124
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 125 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 184 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 234
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 25/223 (11%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNF 84
E+ ++ + H N++K +D M IV E G L + +VS R L
Sbjct: 70 EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLL--TPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
+ A+ H+ ++H+DLKP+N+L T +K+ DFGLA
Sbjct: 130 MKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGT 189
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+MAPE++ K+ K D++S G+V++ LLT LPF G S + A +K
Sbjct: 190 ALYMAPEVF---------KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK 240
Query: 203 ------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
RP ++P +++ +DP RPS +Q++
Sbjct: 241 EPNYAVECRP-----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 15/218 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN+
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNW 122
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXXX 141
+ IA+ M+ L ++HRDL N+L+ Q +K+ DFG A+
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAEGGKV 181
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 200
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 182 PIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL 232
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 233 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 15/218 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+ E +M+ V + ++ + LG C + ++T+L+P L Y+ + N + LN+
Sbjct: 71 ILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNW 129
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXXX 141
+ IA+ M+ L ++HRDL N+L+ Q +K+ DFG A+
Sbjct: 130 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAEGGKV 188
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 200
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 189 PIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL 239
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 240 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 59/247 (23%), Positives = 118/247 (47%), Gaps = 20/247 (8%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+VL +G+ E+A E +RE +M ++ + +V+ +G C+ +++V E+ G L K
Sbjct: 369 KVLKQGT---EKADTE-EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHK 424
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+LV R ++ + ++ M L +HR+L N+LL ++ K++DFGL
Sbjct: 425 FLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-NRHYAKISDFGL 482
Query: 127 ARXXXXXXXXXXXXXX----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
++ +W APE + R+ ++++ DV+S+G+ +WE L+
Sbjct: 483 SKALGADDSYYTARSAGKWPLKWYAPE---CINFRK-----FSSRSDVWSYGVTMWEALS 534
Query: 183 -NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
+ P++ M + A + R P + P+L ++ CW+ RP F + + +
Sbjct: 535 YGQKPYKKMKGPEVM-AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593
Query: 242 NAFLFTL 248
A ++L
Sbjct: 594 RACYYSL 600
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E +M+ V + ++ + LG C + ++ +L+P L Y+ + N + LN
Sbjct: 64 EILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDN-IGSQYLLN 122
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ + IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+
Sbjct: 123 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 182 VPIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 232
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 233 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 73/240 (30%), Positives = 108/240 (45%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 76 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 130
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXXXX 133
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 131 VKDL---IGFGLQVAKGMKYLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 185
Query: 134 XXXXXXXXX-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 186 EXXSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 237
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 238 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 297
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 69 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 123
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXXXX 133
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 124 VKDL---IGFGLQVAKGMKYLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 178
Query: 134 XXXXXXXXX-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 179 EYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 230
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 231 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 290
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 49/169 (28%), Positives = 85/169 (50%), Gaps = 15/169 (8%)
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
++++ +AR M+ L + IHRDL N+LL+ + +K+ DFGLAR
Sbjct: 202 ISYSFQVARGMEFLSSRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKGD 260
Query: 142 X---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
+WMAPE ++ + Y+ K DV+S+G++LWE+ + P+ G+ +
Sbjct: 261 TRLPLKWMAPESIFDKI---------YSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDF 311
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ + R PE +P++ I+ CW DP RP F++++ L L
Sbjct: 312 CSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDLL 360
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 30/223 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDL 78
RF RE + + H +V + PL IV E + G++LR + + P +
Sbjct: 75 RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTP 132
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
A+ D +A++ H NGIIHRD+KP N++++ ++K+ DFG+AR
Sbjct: 133 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVT 191
Query: 139 XXXXY----RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
++++PE Q + + DVYS G VL+E+LT PF G S +
Sbjct: 192 QTAAVIGTAQYLSPE--------QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 243
Query: 195 AAYAAAFKHAR--PGLP----EDISPDLAFIVQSCWVEDPNLR 231
AY +H R P P E +S DL +V ++P R
Sbjct: 244 VAY----QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 282
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 82.0 bits (201), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 72/255 (28%), Positives = 115/255 (45%), Gaps = 45/255 (17%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+E++++ + H++++K+ G C+D + +V E +P SLR YL + + L L
Sbjct: 82 QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLL 138
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
FA I M LHA IHRDL N+LL D + +K+ DFGLA+ Y
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVKIGDFGLAK------AVPEGHEXY 191
Query: 144 R----------WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR--------- 184
R W APE E K Y DV+SFG+ L+ELLT+
Sbjct: 192 RVREDGDSPVFWYAPECLK-------EYKFYYAS-DVWSFGVTLYELLTHCDSSQSPPTK 243
Query: 185 -LPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
L G++ Q + G P+ ++ ++++CW + + RP+F +I
Sbjct: 244 FLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
Query: 240 MLNAFLFTLRPPSPS 254
+L + +PS
Sbjct: 304 ILKTVHEKYQGQAPS 318
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 82.0 bits (201), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 74 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 128
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXXXX 133
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 129 VKDL---IGFGLQVAKGMKYLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 183
Query: 134 XXXXXXXXX-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 184 EYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 235
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 236 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 82.0 bits (201), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 77 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 131
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXXXX 133
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 132 VKDL---IGFGLQVAKGMKYLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 186
Query: 134 XXXXXXXXX-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 187 EYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 238
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 239 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 298
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 82.0 bits (201), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 95 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 149
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXXXX 133
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 150 VKDL---IGFGLQVAKGMKYLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 204
Query: 134 XXXXXXXXX-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 205 EYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 256
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 257 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 316
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 82.0 bits (201), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 96 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 150
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXXXX 133
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 151 VKDL---IGFGLQVAKGMKYLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 205
Query: 134 XXXXXXXXX-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 206 EYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 257
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 258 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 317
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 82.0 bits (201), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 77 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 131
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXXXX 133
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 132 VKDL---IGFGLQVAKGMKYLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 186
Query: 134 XXXXXXXXX-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 187 EYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 238
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 239 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 298
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 72/255 (28%), Positives = 112/255 (43%), Gaps = 45/255 (17%)
Query: 19 ALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKL- 76
A ++ F RE +M+ + N+VK LG C M ++ E + L ++L S+ P+ +
Sbjct: 91 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 150
Query: 77 -----DLHV----------------ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 115
DL L A +A M L +HRDL N L+ +
Sbjct: 151 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-E 209
Query: 116 QKSLKLADFGLARXXXXXXXXXXX---XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172
+K+ADFGL+R RWM PE S R Y + DV++
Sbjct: 210 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE--SIFYNR------YTTESDVWA 261
Query: 173 FGIVLWELLTNRL-PFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVED 227
+G+VLWE+ + L P+ GM++ + Y + R G PE+ +L +++ CW +
Sbjct: 262 YGVVLWEIFSYGLQPYYGMAHEEVIY-----YVRDGNILACPENCPLELYNLMRLCWSKL 316
Query: 228 PNLRPSFSQIIRMLN 242
P RPSF I R+L
Sbjct: 317 PADRPSFCSIHRILQ 331
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 190
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXX-- 131
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 191 VKDL---IGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 245
Query: 132 ---XXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 246 EFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 297
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 298 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 76 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 130
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXXXX 133
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 131 VKDL---IGFGLQVAKGMKYLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 185
Query: 134 XXXXXXXXX-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 186 EYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 237
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 238 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 297
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 75 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 129
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXXXX 133
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 130 VKDL---IGFGLQVAKGMKYLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 184
Query: 134 XXXXXXXXX-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 185 EYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 236
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 237 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 296
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 72 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 126
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXXXX 133
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 127 VKDL---IGFGLQVAKGMKYLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 181
Query: 134 XXXXXXXXX-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 182 EYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 233
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 234 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 81.6 bits (200), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 77 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 131
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXX-- 131
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 132 VKDL---IGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 186
Query: 132 ---XXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 187 EFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 238
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 239 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 298
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 81.6 bits (200), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 26/232 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLR---- 72
F+RE M H ++ K +G + P+ +++ + L +L++ R
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX 132
P L L + F +DIA M+ L + IHRDL N +L D ++ +ADFGL+R
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVCVADFGLSRKIYS 189
Query: 133 XXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 188
+W+A E + Y DV++FG+ +WE++T + P+
Sbjct: 190 GDYYRQGCASKLPVKWLALESLA--------DNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
G+ N + Y R P + ++ ++ CW DP RPSF+ +RM
Sbjct: 242 GIENAE-IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFT-CLRM 291
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 81.6 bits (200), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 23/232 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNK--LDLHVA 81
F REV + +H+N+V F+GAC P + I+T L G +L Y V +R K LD++
Sbjct: 76 FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL--YSV-VRDAKIVLDVNKT 132
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL---ARXXXXXXXXXX 138
A +I + M LHA GI+H+DLK N+ D + + DFGL +
Sbjct: 133 RQIAQEIVKGMGYLHAKGILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDK 190
Query: 139 XXXXYRW---MAPELYSTVTLRQGEKK-HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
W +APE+ ++ E K ++ DV++ G + +EL PF+ Q
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK----TQ 246
Query: 195 AAYAAAFKHA---RPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
A A ++ +P L + + +++ I+ CW + RP+F++++ ML
Sbjct: 247 PAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 77 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 131
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXX-- 131
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 132 VKDL---IGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 186
Query: 132 ---XXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 187 EFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 238
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 239 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 298
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 78 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 132
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXX-- 131
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 133 VKDL---IGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 187
Query: 132 ---XXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 188 EFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 239
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 240 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 299
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 75 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 129
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXX-- 131
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 130 VKDL---IGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 184
Query: 132 ---XXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 185 EFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 236
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 237 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 296
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 78 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 132
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXX-- 131
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 133 VKDL---IGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMLDK 187
Query: 132 ---XXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 188 EFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 239
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 240 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 299
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGM---SLRKYL--VSLRPN 74
+F+ E +M H N++ LG C PL+V LP M LR ++ + P
Sbjct: 82 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV-----LPYMKHGDLRNFIRNETHNPT 136
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXX-- 131
DL + F L +A+ M L + +HRDL N +L D+K ++K+ADFGLAR
Sbjct: 137 VKDL---IGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDK 191
Query: 132 ---XXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+WMA E T + + K DV+SFG++LWEL+T P
Sbjct: 192 EFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPY 243
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
N + R PE L ++ CW +RPSFS+++ ++A T
Sbjct: 244 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 303
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 81.3 bits (199), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F+ E ++M + H N+++ G + L +IVTE + SL +L + + + +
Sbjct: 97 FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVG 155
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXXXX 139
+ M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAXTTTGG 214
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 198
RW APE + T +++ DV+SFG+V+WE+L P+ M+N +
Sbjct: 215 KIPIRWTAPEAIAFRT--------FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS 266
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ P P L ++ CW +D RP FSQI+ +L+A +
Sbjct: 267 VEEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 81.3 bits (199), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 17/227 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F+ E ++M + H N+++ G + L +IVTE + SL +L + + + +
Sbjct: 97 FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVG 155
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXXXX 139
+ M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGG 214
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 198
RW APE + T +++ DV+SFG+V+WE+L P+ M+N +
Sbjct: 215 KIPIRWTAPEAIAFRT--------FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS 266
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ P P L ++ CW +D RP FSQI+ +L+A +
Sbjct: 267 VEEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 81.3 bits (199), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 32/235 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR+YL + ++D
Sbjct: 61 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHK-ERIDHIKL 119
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 120 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 179 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 230
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
N + F + R P+ ++ I+ CW + N RPSF +
Sbjct: 231 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 81.3 bits (199), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 15/218 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+ E +M+ V + ++ + LG C + ++ +L+P L Y+ + N + LN+
Sbjct: 66 ILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLNW 124
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXXX 141
+ IA+ M+ L ++HRDL N+L+ Q +K+ DFG A+
Sbjct: 125 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 200
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 184 PIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL 234
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I++ CW+ D + RP F ++I
Sbjct: 235 EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 272
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 80.9 bits (198), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDL 78
RF RE + + H +V + PL IV E + G++LR + + P +
Sbjct: 58 RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTP 115
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
A+ D +A++ H NGIIHRD+KP N++++ ++K+ DFG+AR
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVT 174
Query: 139 XXXXY----RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
++++PE Q + + DVYS G VL+E+LT PF G S
Sbjct: 175 QTAAVIGTAQYLSPE--------QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDS 226
Query: 195 AAYAAAFKHAR--PGLP----EDISPDLAFIVQSCWVEDPNLR 231
AY +H R P P E +S DL +V ++P R
Sbjct: 227 VAY----QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 80.9 bits (198), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 17/227 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F+ E ++M + H N++ G K ++IVTE + SL +L + + +
Sbjct: 70 FLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL-KKNDGQFTVIQLVG 128
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXXXX 139
I+ M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 129 MLRGISAGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVLEDDPEAAYTTRGG 187
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 198
RW APE + R+ + + DV+S+GIV+WE+++ P+ M+N A
Sbjct: 188 KIPIRWTAPE---AIAFRK-----FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKA 239
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ P P D L ++ CW ++ N RP F +I+ ML+ +
Sbjct: 240 VEEGYRLPS-PMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLI 285
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 80.9 bits (198), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 21/245 (8%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLR 65
+ L G T +R F+ E +M + H N+++ G K M+I+TE + +L
Sbjct: 79 KTLKAGYTEKQRV----DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALD 134
Query: 66 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
K+L + + + + IA M L +HRDL N+L+ + K++DFG
Sbjct: 135 KFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFG 192
Query: 126 LARXXX----XXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
L+R RW APE S + + + DV+SFGIV+WE++
Sbjct: 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVM 244
Query: 182 T-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
T P+ +SN + A P P D + ++ CW ++ RP F+ I+ +
Sbjct: 245 TYGERPYWELSNHEVMKAINDGFRLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303
Query: 241 LNAFL 245
L+ +
Sbjct: 304 LDKLI 308
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 80.9 bits (198), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
L+ + E N+M ++ + +V+ +G C+ ++V E+ L KYL R K D ++
Sbjct: 414 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK-DKNI 472
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
+ ++ M L + +HRDL N+LL Q K++DFGL++
Sbjct: 473 -IELVHQVSMGMKYLEESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQ 530
Query: 141 XX----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 195
+W APE + +++K DV+SFG+++WE + + P+ GM +
Sbjct: 531 THGKWPVKWYAPECINYYK--------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 582
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI-IRMLNAF 244
A K R G P ++ ++ CW D RP F+ + +R+ N +
Sbjct: 583 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 631
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 60/229 (26%), Positives = 105/229 (45%), Gaps = 19/229 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F+ E ++M + +H N+++ G + + ++I+TE + +L +L L + + +
Sbjct: 64 FLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL-RLNDGQFTVIQLVG 122
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX- 142
IA M L +HRDL N+L+ + K++DFGL+R
Sbjct: 123 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSL 181
Query: 143 -----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
RW APE + R+ + + D +S+GIV+WE+++ P+ MSN Q
Sbjct: 182 GGKIPIRWTAPE---AIAFRK-----FTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDV 232
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F Q++ L+ +
Sbjct: 233 INAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 281
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
L+ + E N+M ++ + +V+ +G C+ ++V E+ L KYL R K D ++
Sbjct: 413 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK-DKNI 471
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
+ ++ M L + +HRDL N+LL Q K++DFGL++
Sbjct: 472 -IELVHQVSMGMKYLEESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQ 529
Query: 141 XX----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 195
+W APE + +++K DV+SFG+++WE + + P+ GM +
Sbjct: 530 THGKWPVKWYAPECINYYK--------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 581
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI-IRMLNAF 244
A K R G P ++ ++ CW D RP F+ + +R+ N +
Sbjct: 582 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 80.9 bits (198), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 31/240 (12%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+E+ ++ + H+N+VK+ G C + + ++ E LP SL++YL + NK++L L
Sbjct: 72 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLK 130
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+A+ I + MD L + +HRDL N+L+ + + +K+ DFGL +
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEXXTVKDDR 189
Query: 144 R----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR----------LPFEG 189
W APE L Q + + DV+SFG+ L ELLT L G
Sbjct: 190 DSPVFWYAPE-----CLMQSK---FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
Query: 190 MSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ Q + G P + ++ +++ CW P+ R SF +I A L
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 80.5 bits (197), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 69/225 (30%), Positives = 102/225 (45%), Gaps = 25/225 (11%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLR-----PNKLDLH 79
F+RE +M + H N++ +G P + LLP M L +R P DL
Sbjct: 69 FLREGLLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL- 126
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX 139
++F L +AR M+ L +HRDL N +L + ++K+ADFGLAR
Sbjct: 127 --ISFGLQVARGMEYLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQ 183
Query: 140 XXXY-----RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNL 193
+ +W A E S T R + K DV+SFG++LWELLT P+ +
Sbjct: 184 QHRHARLPVKWTALE--SLQTYR------FTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235
Query: 194 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ A P PE L ++Q CW DP +RP+F ++
Sbjct: 236 DLTHFLAQGRRLPQ-PEYCPDSLYQVMQQCWEADPAVRPTFRVLV 279
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 31/240 (12%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+E+ ++ + H+N+VK+ G C + + ++ E LP SL++YL + NK++L L
Sbjct: 60 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLK 118
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+A+ I + MD L + +HRDL N+L+ + + +K+ DFGL +
Sbjct: 119 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEXXTVKDDR 177
Query: 144 R----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR----------LPFEG 189
W APE L Q + + DV+SFG+ L ELLT L G
Sbjct: 178 DSPVFWYAPE-----CLMQSK---FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 229
Query: 190 MSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ Q + G P + ++ +++ CW P+ R SF +I A L
Sbjct: 230 PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 289
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 147
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 148 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 206
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 207 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 258
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
N + F + R P+ ++ I+ CW + N RPSF
Sbjct: 259 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 310
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 72/238 (30%), Positives = 109/238 (45%), Gaps = 29/238 (12%)
Query: 28 EVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
EV +M HDN+V + D L V V E L G +L + R N+ +
Sbjct: 92 EVVIMRDYHHDNVVDMYSSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQI---ATVC 147
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXXXYR 144
L + RA+ LH G+IHRD+K D++LLT D + +KL+DFG A+
Sbjct: 148 LSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKXLVGTPY 206
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPE+ S + Y +VD++S GI++ E++ P+ LQ A +
Sbjct: 207 WMAPEVISRLP--------YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AMRRI 253
Query: 205 RPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
R LP +S L + V +P+ R + +++ + FL PPS VP
Sbjct: 254 RDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQELLG--HPFLKLAGPPSCIVP 309
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 64/247 (25%), Positives = 111/247 (44%), Gaps = 23/247 (9%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLR 65
+ L G T +R F+ E ++M + +H N+++ G + + ++I+TE + +L
Sbjct: 48 KTLKGGYTERQRR----EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALD 103
Query: 66 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
+L L + + + IA M L +HRDL N+L+ + K++DFG
Sbjct: 104 SFL-RLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNL-VCKVSDFG 161
Query: 126 LARXXXXXXXXXXXXXX------YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
L+R RW APE + R+ + + D +S+GIV+WE
Sbjct: 162 LSRFLEENSSDPTYTSSLGGKIPIRWTAPE---AIAFRK-----FTSASDAWSYGIVMWE 213
Query: 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+++ P+ MSN Q A + R P D L ++ CW +D N RP F Q++
Sbjct: 214 VMSFGERPYWDMSN-QDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVV 272
Query: 239 RMLNAFL 245
L+ +
Sbjct: 273 SALDKMI 279
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 68/244 (27%), Positives = 108/244 (44%), Gaps = 45/244 (18%)
Query: 27 REVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
RE+ ++ + H+++VK+ G C+D + +V E +P SLR YL + + L L
Sbjct: 60 REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR---HCVGLAQLLL 116
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
FA I M LHA IHR L N+LL D + +K+ DFGLA+ Y
Sbjct: 117 FAQQICEGMAYLHAQHYIHRALAARNVLLDND-RLVKIGDFGLAK------AVPEGHEYY 169
Query: 144 R----------WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----NRLPFEG 189
R W APE K +Y + DV+SFG+ L+ELLT N+ P
Sbjct: 170 RVREDGDSPVFWYAPECLKEC------KFYYAS--DVWSFGVTLYELLTYCDSNQSPHTK 221
Query: 190 MSNLQAAYAAAF----------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ L + R P+ ++ ++++CW + + RP+F ++
Sbjct: 222 FTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVP 281
Query: 240 MLNA 243
+L
Sbjct: 282 ILQT 285
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 11/220 (5%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F E + H N++ LGAC+ P ++T P SL L +D A
Sbjct: 54 FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQA 113
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
+ FALD AR LH L P + L + +S+ + + AR
Sbjct: 114 VKFALDXARGXAFLHT----LEPLIPRHAL---NSRSVXIDEDXTARISXADVKFSFQSP 166
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
R AP + L++ + D +SF ++LWEL+T +PF +SN + A
Sbjct: 167 G-RXYAPAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVAL 225
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
+ RP +P ISP ++ + + C EDP RP F I+ +L
Sbjct: 226 EGLRPTIPPGISPHVSKLXKICXNEDPAKRPKFDXIVPIL 265
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 56/185 (30%), Positives = 89/185 (48%), Gaps = 12/185 (6%)
Query: 15 SDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRP 73
SD+ +++ +RE+ ++ +++H+NLV L CK +V E + L + L P
Sbjct: 61 SDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDD--LELFP 118
Query: 74 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXX 133
N LD V + I + H++ IIHRD+KP+N+L++ +KL DFG AR
Sbjct: 119 NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAP 177
Query: 134 XXXXXXXXXYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
RW APEL G+ K Y VDV++ G ++ E+ F G S+
Sbjct: 178 GEVYDDEVATRWYRAPELLV------GDVK-YGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230
Query: 193 LQAAY 197
+ Y
Sbjct: 231 IDQLY 235
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/235 (28%), Positives = 104/235 (44%), Gaps = 32/235 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 61 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQA-HAERIDHIKL 119
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 120 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 179 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 230
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
N + F + R P+ ++ I+ CW + N RPSF +
Sbjct: 231 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 61 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 119
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 120 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 179 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 230
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
N + F + R P+ ++ I+ CW + N RPSF
Sbjct: 231 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 282
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 65 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 123
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 124 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 182
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 183 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 234
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
N + F + R P+ ++ I+ CW + N RPSF
Sbjct: 235 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 286
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 56/218 (25%), Positives = 104/218 (47%), Gaps = 15/218 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+ E +M+ V + ++ + LG C + ++ +L+P L Y+ + N + LN+
Sbjct: 66 ILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLNW 124
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXXX 141
+ IA+ M+ L ++HRDL N+L+ Q +K+ DFG A+
Sbjct: 125 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 200
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 184 PIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL 234
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 235 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/235 (28%), Positives = 104/235 (44%), Gaps = 32/235 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 64 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 122
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 123 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 181
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 182 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 233
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
N + F + R P+ ++ I+ CW + N RPSF +
Sbjct: 234 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 288
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 76 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 134
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 135 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 193
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 194 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 245
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
N + F + R P+ ++ I+ CW + N RPSF
Sbjct: 246 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 297
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 116
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 175
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 176 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
N + F + R P+ ++ I+ CW + N RPSF
Sbjct: 228 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 279
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
L+ + E N+M ++ + +V+ +G C+ ++V E+ L KYL R K D ++
Sbjct: 49 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK-DKNI 107
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
+ ++ M L + +HRDL N+LL Q K++DFGL++
Sbjct: 108 -IELVHQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQ 165
Query: 141 XX----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 195
+W APE + +++K DV+SFG+++WE + + P+ GM +
Sbjct: 166 THGKWPVKWYAPECINYYK--------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 217
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI-IRMLNAF 244
A K R G P ++ ++ CW D RP F+ + +R+ N +
Sbjct: 218 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 266
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 63 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 121
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 122 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 180
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 181 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 232
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
N + F + R P+ ++ I+ CW + N RPSF
Sbjct: 233 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 284
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
L+ + E N+M ++ + +V+ +G C+ ++V E+ L KYL R K D ++
Sbjct: 71 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK-DKNI 129
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
+ ++ M L + +HRDL N+LL Q K++DFGL++
Sbjct: 130 -IELVHQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQ 187
Query: 141 XX----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 195
+W APE + +++K DV+SFG+++WE + + P+ GM +
Sbjct: 188 THGKWPVKWYAPECINYYK--------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI-IRMLNAF 244
A K R G P ++ ++ CW D RP F+ + +R+ N +
Sbjct: 240 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 288
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
L+ + E N+M ++ + +V+ +G C+ ++V E+ L KYL R K D ++
Sbjct: 71 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK-DKNI 129
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
+ ++ M L + +HRDL N+LL Q K++DFGL++
Sbjct: 130 -IELVHQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQ 187
Query: 141 XX----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 195
+W APE + +++K DV+SFG+++WE + + P+ GM +
Sbjct: 188 THGKWPVKWYAPECINYYK--------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI-IRMLNAF 244
A K R G P ++ ++ CW D RP F+ + +R+ N +
Sbjct: 240 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 288
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 68/244 (27%), Positives = 108/244 (44%), Gaps = 45/244 (18%)
Query: 27 REVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
RE+ ++ + H+++VK+ G C+D + +V E +P SLR YL + + L L
Sbjct: 59 REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR---HCVGLAQLLL 115
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
FA I M LHA IHR L N+LL D + +K+ DFGLA+ Y
Sbjct: 116 FAQQICEGMAYLHAQHYIHRALAARNVLLDND-RLVKIGDFGLAK------AVPEGHEYY 168
Query: 144 R----------WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----NRLPFEG 189
R W APE K +Y + DV+SFG+ L+ELLT N+ P
Sbjct: 169 RVREDGDSPVFWYAPECLKEC------KFYYAS--DVWSFGVTLYELLTYCDSNQSPHTK 220
Query: 190 MSNLQAAYAAAF----------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ L + R P+ ++ ++++CW + + RP+F ++
Sbjct: 221 FTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVP 280
Query: 240 MLNA 243
+L
Sbjct: 281 ILQT 284
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
L+ + E N+M ++ + +V+ +G C+ ++V E+ L KYL R K D ++
Sbjct: 69 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK-DKNI 127
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
+ ++ M L + +HRDL N+LL Q K++DFGL++
Sbjct: 128 -IELVHQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQ 185
Query: 141 XX----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 195
+W APE + +++K DV+SFG+++WE + + P+ GM +
Sbjct: 186 THGKWPVKWYAPECINYYK--------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 237
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI-IRMLNAF 244
A K R G P ++ ++ CW D RP F+ + +R+ N +
Sbjct: 238 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 286
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 56 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 114
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 115 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 173
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 174 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 225
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
N + F + R P+ ++ I+ CW + N RPSF
Sbjct: 226 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 277
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 56/218 (25%), Positives = 104/218 (47%), Gaps = 15/218 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+ E +M+ V + ++ + LG C + ++ +L+P L Y+ + N + LN+
Sbjct: 68 ILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLNW 126
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---XXXXXXXXXXXXX 141
+ IA+ M+ L ++HRDL N+L+ Q +K+ DFG A+
Sbjct: 127 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAEGGKV 185
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 200
+WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + +
Sbjct: 186 PIKWMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL 236
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 237 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
L+ + E N+M ++ + +V+ +G C+ ++V E+ L KYL R K D ++
Sbjct: 55 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK-DKNI 113
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
+ ++ M L + +HRDL N+LL Q K++DFGL++
Sbjct: 114 -IELVHQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQ 171
Query: 141 XX----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 195
+W APE + +++K DV+SFG+++WE + + P+ GM +
Sbjct: 172 THGKWPVKWYAPECINYYK--------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 223
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI-IRMLNAF 244
A K R G P ++ ++ CW D RP F+ + +R+ N +
Sbjct: 224 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 272
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 18/230 (7%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
L+ + E N+M ++ + +V+ +G C+ ++V E+ L KYL R K D ++
Sbjct: 55 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK-DKNI 113
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
+ ++ M L + +HRDL N+LL Q K++DFGL++
Sbjct: 114 -IELVHQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENXYKAQ 171
Query: 141 XX----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 195
+W APE + +++K DV+SFG+++WE + + P+ GM +
Sbjct: 172 THGKWPVKWYAPECINYYK--------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 223
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI-IRMLNAF 244
A K R G P ++ ++ CW D RP F+ + +R+ N +
Sbjct: 224 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 272
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
L+ + E N+M ++ + +V+ +G C+ ++V E+ L KYL R K D ++
Sbjct: 51 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK-DKNI 109
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
+ ++ M L + +HRDL N+LL Q K++DFGL++
Sbjct: 110 -IELVHQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQ 167
Query: 141 XX----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 195
+W APE + +++K DV+SFG+++WE + + P+ GM +
Sbjct: 168 THGKWPVKWYAPECINYYK--------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI-IRMLNAF 244
A K R G P ++ ++ CW D RP F+ + +R+ N +
Sbjct: 220 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 57 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 115
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 116 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 174
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 175 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 226
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
N + F + R P+ ++ I+ CW + N RPSF
Sbjct: 227 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 278
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
L+ + E N+M ++ + +V+ +G C+ ++V E+ L KYL R K D ++
Sbjct: 61 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK-DKNI 119
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
+ ++ M L + +HRDL N+LL Q K++DFGL++
Sbjct: 120 -IELVHQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQ 177
Query: 141 XX----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 195
+W APE + +++K DV+SFG+++WE + + P+ GM +
Sbjct: 178 THGKWPVKWYAPECINYYK--------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI-IRMLNAF 244
A K R G P ++ ++ CW D RP F+ + +R+ N +
Sbjct: 230 T-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 76 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 134
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 135 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 193
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 194 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 245
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
N + F + R P+ ++ I+ CW + N RPSF
Sbjct: 246 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 297
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 116
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 175
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 176 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
N + F + R P+ ++ I+ CW + N RPSF
Sbjct: 228 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 279
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 66/235 (28%), Positives = 104/235 (44%), Gaps = 32/235 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 62 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 120
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 121 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKE 179
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 180 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 231
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
N + F + R P+ ++ I+ CW + N RPSF +
Sbjct: 232 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 286
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 68/249 (27%), Positives = 108/249 (43%), Gaps = 27/249 (10%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLR 65
+ L G T +R F+ E ++M + H N++ G K ++I+TE + SL
Sbjct: 67 KTLKSGYTEKQRR----DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 122
Query: 66 KYLVSLRPNKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
+L R N V + IA M L +HRDL N+L+ + K++D
Sbjct: 123 SFL---RQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSD 178
Query: 124 FGLARXXXXXXXXXXXXXX------YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
FGL+R RW APE + + + + DV+S+GIV+
Sbjct: 179 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI--------QYRKFTSASDVWSYGIVM 230
Query: 178 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
WE+++ P+ M+N Q A + R P D L ++ CW +D N RP F Q
Sbjct: 231 WEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 289
Query: 237 IIRMLNAFL 245
I+ L+ +
Sbjct: 290 IVNTLDKMI 298
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 32/232 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 116
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL +
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 176 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
N + F + R P+ ++ I+ CW + N RPSF
Sbjct: 228 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 279
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 32/240 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVS------------ 70
F RE +++ ++H ++V+F G C + PL+++ + G L ++L S
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG-DLNRFLRSHGPDAKLLAGGE 148
Query: 71 -LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ P L L L A +A M L +HRDL N L+ +K+ DFG++R
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRD 207
Query: 130 XXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 185
RWM PE ++ R+ + + DV+SFG+VLWE+ T +
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPE---SILYRK-----FTTESDVWSFGVVLWEIFTYGKQ 259
Query: 186 PFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
P+ +SN +A R P P++ I++ CW +P R S + L A
Sbjct: 260 PWYQLSNTEA--IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 65/223 (29%), Positives = 109/223 (48%), Gaps = 15/223 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ REV +M + H N+VK + + + ++ E G + YLV+ ++ A
Sbjct: 57 KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA--HGRMKEKEAR 114
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
+ I A+ H I+HRDLK +NLLL D ++K+ADFG +
Sbjct: 115 SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDTFCGS 173
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+ APEL+ QG KK+ +VDV+S G++L+ L++ LPF+G NL+ +
Sbjct: 174 PPYAAPELF------QG-KKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLR 225
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII--RMLNA 243
+ +P +S D +++ V +P R + QI+ R +NA
Sbjct: 226 -GKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 267
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 13/217 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ REV +M + H N+VK + + + +V E G + YLV+ ++ A
Sbjct: 59 KLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA--HGRMKEKEAR 116
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
I A+ H I+HRDLK +NLLL D ++K+ADFG +
Sbjct: 117 AKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGS 175
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+ APEL+ QG KK+ +VDV+S G++L+ L++ LPF+G NL+ +
Sbjct: 176 PPYAAPELF------QG-KKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLR 227
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ +P +S D +++ + +P+ R + QI++
Sbjct: 228 -GKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK 263
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 13/217 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ REV +M + H N+VK + + + +V E G + YLV+ ++ A
Sbjct: 59 KLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA--HGRMKEKEAR 116
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
I A+ H I+HRDLK +NLLL D ++K+ADFG +
Sbjct: 117 AKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGS 175
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+ APEL+ QG KK+ +VDV+S G++L+ L++ LPF+G NL+ +
Sbjct: 176 PPYAAPELF------QG-KKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLR 227
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ +P +S D +++ + +P+ R + QI++
Sbjct: 228 -GKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK 263
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 13/217 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ REV +M + H N+VK + + + +V E G + YLV+ ++ A
Sbjct: 59 KLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA--HGRMKEKEAR 116
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
I A+ H I+HRDLK +NLLL D ++K+ADFG +
Sbjct: 117 AKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGS 175
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+ APEL+ QG KK+ +VDV+S G++L+ L++ LPF+G NL+ +
Sbjct: 176 PPYAAPELF------QG-KKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLR 227
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ +P +S D +++ + +P+ R + QI++
Sbjct: 228 -GKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK 263
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 13/217 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ REV +M + H N+VK + + + +V E G + YLV+ ++ A
Sbjct: 59 KLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA--HGRMKEKEAR 116
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
I A+ H I+HRDLK +NLLL D ++K+ADFG +
Sbjct: 117 AKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDEFCGS 175
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+ APEL+ QG KK+ +VDV+S G++L+ L++ LPF+G NL+ +
Sbjct: 176 PPYAAPELF------QG-KKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLR 227
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ +P +S D +++ + +P+ R + QI++
Sbjct: 228 -GKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK 263
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 13/217 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ REV +M + H N+VK + + + +V E G + YLV+ ++ A
Sbjct: 59 KLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA--HGRMKEKEAR 116
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
I A+ H I+HRDLK +NLLL D ++K+ADFG +
Sbjct: 117 AKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDAFCGA 175
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+ APEL+ QG KK+ +VDV+S G++L+ L++ LPF+G NL+ +
Sbjct: 176 PPYAAPELF------QG-KKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLR 227
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ +P +S D +++ + +P+ R + QI++
Sbjct: 228 -GKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK 263
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 72/237 (30%), Positives = 112/237 (47%), Gaps = 21/237 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
I E+ +M K+ N+V +L + D L V++ E L G SL + ++ +
Sbjct: 65 IINEILVMRENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVC 123
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXX 141
L +A++ LH+N +IHRD+K DN+LL D S+KL DFG A+
Sbjct: 124 RECL---QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSXMVG 179
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
WMAPE+ + +K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 180 TPYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA- 230
Query: 202 KHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
+ P L PE +S + C D R S ++I+ + FL +P S P
Sbjct: 231 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQ--HQFLKIAKPLSSLTP 285
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 32/240 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVS------------ 70
F RE +++ ++H ++V+F G C + PL+++ + G L ++L S
Sbjct: 67 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG-DLNRFLRSHGPDAKLLAGGE 125
Query: 71 -LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ P L L L A +A M L +HRDL N L+ +K+ DFG++R
Sbjct: 126 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRD 184
Query: 130 XXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 185
RWM PE ++ R+ + + DV+SFG+VLWE+ T +
Sbjct: 185 IYSTDYYRVGGRTMLPIRWMPPE---SILYRK-----FTTESDVWSFGVVLWEIFTYGKQ 236
Query: 186 PFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
P+ +SN +A R P P++ I++ CW +P R S + L A
Sbjct: 237 PWYQLSNTEA--IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 294
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 32/240 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVS------------ 70
F RE +++ ++H ++V+F G C + PL+++ + G L ++L S
Sbjct: 61 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG-DLNRFLRSHGPDAKLLAGGE 119
Query: 71 -LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ P L L L A +A M L +HRDL N L+ +K+ DFG++R
Sbjct: 120 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRD 178
Query: 130 XXXXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 185
RWM PE ++ R+ + + DV+SFG+VLWE+ T +
Sbjct: 179 IYSTDYYRVGGRTMLPIRWMPPE---SILYRK-----FTTESDVWSFGVVLWEIFTYGKQ 230
Query: 186 PFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
P+ +SN +A R P P++ I++ CW +P R S + L A
Sbjct: 231 PWYQLSNTEA--IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 288
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/223 (29%), Positives = 109/223 (48%), Gaps = 15/223 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ REV +M + H N+VK + + + ++ E G + YLV+ ++ A
Sbjct: 60 KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA--HGRMKEKEAR 117
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
+ I A+ H I+HRDLK +NLLL D ++K+ADFG +
Sbjct: 118 SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDAFCGA 176
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+ APEL+ QG KK+ +VDV+S G++L+ L++ LPF+G NL+ +
Sbjct: 177 PPYAAPELF------QG-KKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLR 228
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII--RMLNA 243
+ +P +S D +++ V +P R + QI+ R +NA
Sbjct: 229 -GKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 45/244 (18%)
Query: 27 REVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+E++++ + H++++K+ G C+D + +V E +P SLR YL + + L L
Sbjct: 65 QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPR---HSIGLAQLLL 121
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
FA I M LHA IHR+L N+LL D + +K+ DFGLA+ Y
Sbjct: 122 FAQQICEGMAYLHAQHYIHRNLAARNVLLDND-RLVKIGDFGLAK------AVPEGHEYY 174
Query: 144 R----------WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR--------- 184
R W APE E K Y DV+SFG+ L+ELLT+
Sbjct: 175 RVREDGDSPVFWYAPECLK-------EYKFYYAS-DVWSFGVTLYELLTHCDSSQSPPTK 226
Query: 185 -LPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
L G++ Q + G P+ ++ ++++CW + + RP+F +I
Sbjct: 227 FLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIP 286
Query: 240 MLNA 243
+L
Sbjct: 287 ILKT 290
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P + K L L +K
Sbjct: 52 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL--SK 109
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 110 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 167
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 168 RTTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 218
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 219 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 78.2 bits (191), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 32/232 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + ++ E LP SLR YL + ++D
Sbjct: 59 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKL 117
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L + I + M+ L IHR+L N+L+ ++ +K+ DFGL +
Sbjct: 118 LQYTSQICKGMEYLGTKRYIHRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKE 176
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----NRLPFEGM-- 190
W APE + + ++ DV+SFG+VL+EL T P E M
Sbjct: 177 PGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 228
Query: 191 -SNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
N + F + R P+ ++ I+ CW + N RPSF
Sbjct: 229 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 280
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 78.2 bits (191), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P + K L L +K
Sbjct: 52 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL--SK 109
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 110 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 167
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 168 RXXLXGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 218
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 219 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 77.8 bits (190), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 71/237 (29%), Positives = 112/237 (47%), Gaps = 21/237 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
I E+ +M K+ N+V +L + D L V++ E L G SL + ++ +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVC 122
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXX 141
L +A++ LH+N +IHRD+K DN+LL D S+KL DFG A+
Sbjct: 123 RECL---QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSXMVG 178
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
WMAPE+ + +K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 179 TPYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA- 229
Query: 202 KHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
+ P L PE +S + C D R S ++++ + FL +P S P
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HQFLKIAKPLSSLTP 284
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 77.8 bits (190), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 21/237 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
I E+ +M K+ N+V +L + D L V++ E L G SL + ++ +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVC 122
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXX 141
L +A++ LH+N +IHRD+K DN+LL D S+KL DFG A+
Sbjct: 123 RECL---QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
WMAPE+ + +K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 179 TPYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA- 229
Query: 202 KHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
+ P L PE +S + C D R S ++++ + FL +P S P
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIAKPLSSLTP 284
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E+ ++S+ + K+ G+ KD + I+ E L G S L L P LD
Sbjct: 54 QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATIL 110
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXYR 144
+I + +D LH+ IHRD+K N+LL+ + +KLADFG+A +
Sbjct: 111 REILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 169
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPE+ ++ Y++K D++S GI EL P + ++ + K+
Sbjct: 170 WMAPEVI--------KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNN 220
Query: 205 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P L + S L V++C ++P+ RP+ ++++
Sbjct: 221 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 255
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E+ ++S+ + K+ G+ KD + I+ E L G S L L P LD
Sbjct: 74 QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATIL 130
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXYR 144
+I + +D LH+ IHRD+K N+LL+ + +KLADFG+A +
Sbjct: 131 REILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 189
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPE+ ++ Y++K D++S GI EL P + ++ + K+
Sbjct: 190 WMAPEVI--------KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNN 240
Query: 205 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P L + S L V++C ++P+ RP+ ++++
Sbjct: 241 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 275
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 63/270 (23%), Positives = 122/270 (45%), Gaps = 21/270 (7%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPG 61
++ +V+N+ S ++ +REV ++ ++ H N++K +D IV EL G
Sbjct: 49 EYAVKVINKASAKNKDT---STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 62 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SL 119
L ++ + + H A + + +H + I+HRDLKP+N+LL +K +
Sbjct: 106 GELFDEII--KRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI 163
Query: 120 KLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
K+ DFGL+ ++APE+ + Y+ K DV+S G++L+
Sbjct: 164 KIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL---------RGTYDEKCDVWSAGVILYI 214
Query: 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQI 237
LL+ PF G + LP+ IS D +++ P+LR + +Q
Sbjct: 215 LLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
Query: 238 IRMLNAFLFTLRPPSPSVPESDTNEAAATS 267
+ + ++ +P++ + + E+A T+
Sbjct: 275 LE--HPWIQKYSSETPTISDLPSLESAMTN 302
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 48 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 105
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 106 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-CHAPSSR 163
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 164 RTTLSGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 214
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 215 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 77.4 bits (189), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 21/237 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
I E+ +M K+ N+V +L + D L V++ E L G SL + ++ +
Sbjct: 65 IINEILVMRENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVC 123
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXX 141
L +A++ LH+N +IHR++K DN+LL D S+KL DFG A+
Sbjct: 124 RECL---QALEFLHSNQVIHRNIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVG 179
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
WMAPE+ + +K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 180 TPYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA- 230
Query: 202 KHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
+ P L PE +S + C D R S ++I+ + FL +P S P
Sbjct: 231 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQ--HQFLKIAKPLSSLTP 285
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 77.4 bits (189), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 21/237 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
I E+ +M K+ N+V +L + D L V++ E L G SL + ++ +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVC 122
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXX 141
L +A++ LH+N +IHRD+K DN+LL D S+KL DFG A+
Sbjct: 123 RECL---QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSEMVG 178
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
WMAPE+ + +K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 179 TPYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA- 229
Query: 202 KHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
+ P L PE +S + C D R S ++++ + FL +P S P
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIAKPLSSLTP 284
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 77.4 bits (189), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 25/231 (10%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA---CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F+ E ++M + H N++ G CK P+M+I TE + SL +L R N V
Sbjct: 77 FLSEASIMGQFDHPNIIHLEGVVTKCK-PVMII-TEYMENGSLDAFL---RKNDGRFTVI 131
Query: 82 --LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXX 135
+ I M L +HRDL N+L+ + K++DFG++R
Sbjct: 132 QLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNL-VCKVSDFGMSRVLEDDPEAAYT 190
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 194
RW APE + + + + DV+S+GIV+WE+++ P+ MSN Q
Sbjct: 191 TRGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-Q 241
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW ++ + RP F QI+ ML+ +
Sbjct: 242 DVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 292
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 77.4 bits (189), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 25/231 (10%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA---CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F+ E ++M + H N++ G CK P+M+I TE + SL +L R N V
Sbjct: 62 FLSEASIMGQFDHPNIIHLEGVVTKCK-PVMII-TEYMENGSLDAFL---RKNDGRFTVI 116
Query: 82 --LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXX 135
+ I M L +HRDL N+L+ + K++DFG++R
Sbjct: 117 QLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNL-VCKVSDFGMSRVLEDDPEAAYT 175
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 194
RW APE + + + + DV+S+GIV+WE+++ P+ MSN Q
Sbjct: 176 TRGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-Q 226
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW ++ + RP F QI+ ML+ +
Sbjct: 227 DVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 277
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 77.4 bits (189), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E+ ++S+ + K+ G+ KD + I+ E L G S L L P LD
Sbjct: 69 QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATIL 125
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXYR 144
+I + +D LH+ IHRD+K N+LL+ + +KLADFG+A +
Sbjct: 126 REILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPF 184
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPE+ ++ Y++K D++S GI EL P + ++ + K+
Sbjct: 185 WMAPEVI--------KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNN 235
Query: 205 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P L + S L V++C ++P+ RP+ ++++
Sbjct: 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 77.4 bits (189), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E+ ++S+ + K+ G+ KD + I+ E L G S L L P LD
Sbjct: 54 QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATIL 110
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXYR 144
+I + +D LH+ IHRD+K N+LL+ + +KLADFG+A +
Sbjct: 111 REILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPF 169
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPE+ ++ Y++K D++S GI EL P + ++ + K+
Sbjct: 170 WMAPEVI--------KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNN 220
Query: 205 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P L + S L V++C ++P+ RP+ ++++
Sbjct: 221 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 255
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 77.4 bits (189), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 13/174 (7%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 73 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 130
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 131 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 188
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
++ PE+ E + ++ KVD++S G++ +E L + PFE
Sbjct: 189 RTTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 77.4 bits (189), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 22/221 (9%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
R RE++ + ++H +++K P +++ G L Y+V + ++
Sbjct: 55 RVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKK--RMTEDEGRR 112
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
F I A++ H + I+HRDLKP+NLLL D ++K+ADFGL+
Sbjct: 113 FFQQIICAIEYCHRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSP 171
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAF 201
+ APE+ + K + +VDV+S GIVL+ +L RLPF E + NL F
Sbjct: 172 NYAAPEVING-------KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------F 217
Query: 202 KHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
K +P+ +SP +++ V DP R + +I R
Sbjct: 218 KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 77.4 bits (189), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 67/244 (27%), Positives = 110/244 (45%), Gaps = 45/244 (18%)
Query: 27 REVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+E++++ + H++++K+ G C+D + +V E +P SLR YL + + L L
Sbjct: 65 QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPR---HSIGLAQLLL 121
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
FA I M LH+ IHR+L N+LL D + +K+ DFGLA+ Y
Sbjct: 122 FAQQICEGMAYLHSQHYIHRNLAARNVLLDND-RLVKIGDFGLAK------AVPEGHEYY 174
Query: 144 R----------WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR--------- 184
R W APE E K Y DV+SFG+ L+ELLT+
Sbjct: 175 RVREDGDSPVFWYAPECLK-------EYKFYYAS-DVWSFGVTLYELLTHCDSSQSPPTK 226
Query: 185 -LPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
L G++ Q + G P+ ++ ++++CW + + RP+F +I
Sbjct: 227 FLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIP 286
Query: 240 MLNA 243
+L
Sbjct: 287 ILKT 290
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 77.4 bits (189), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 13/217 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ REV +M + H N+VK + + + +V E G + YLV+ K +
Sbjct: 52 KLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMK-EKEARA 110
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
F I A+ H I+HRDLK +NLLL D ++K+ADFG +
Sbjct: 111 KFR-QIVSAVQYCHQKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGS 168
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+ APEL+ QG KK+ +VDV+S G++L+ L++ LPF+G NL+ +
Sbjct: 169 PPYAAPELF------QG-KKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLR 220
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ +P +S D +++ + +P+ R + QI++
Sbjct: 221 -GKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK 256
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 64 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 121
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 122 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 179
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 180 RTTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 230
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 231 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 272
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 50 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 107
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 108 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 165
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 166 RTTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 216
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 217 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 25/231 (10%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA---CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F+ E ++M + H N++ G CK P+M+I TE + SL +L R N V
Sbjct: 56 FLSEASIMGQFDHPNIIHLEGVVTKCK-PVMII-TEYMENGSLDAFL---RKNDGRFTVI 110
Query: 82 --LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXX 135
+ I M L +HRDL N+L+ + K++DFG++R
Sbjct: 111 QLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNL-VCKVSDFGMSRVLEDDPEAAYT 169
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 194
RW APE + + + + DV+S+GIV+WE+++ P+ MSN Q
Sbjct: 170 TRGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-Q 220
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW ++ + RP F QI+ ML+ +
Sbjct: 221 DVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 271
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 104
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 105 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 162
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 163 RTTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 213
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 214 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 52 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 109
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 110 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 167
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 168 RTTLCGTLDYLPPEXI--------EGRXHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 218
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 219 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVL 260
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 52 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 109
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 110 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 167
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 168 RTTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 218
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 219 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L M L+K++ + + L + ++
Sbjct: 53 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSY 111
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP+NLL+ + ++KLADFGLAR
Sbjct: 112 LFQLLQGLAFCHSHRVLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 171 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 222
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 223 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 249
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E+ ++S+ + K+ G+ K + I+ E L G S L LR D
Sbjct: 70 QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSA---LDLLRAGPFDEFQIATML 126
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXYR 144
+I + +D LH+ IHRD+K N+LL+ +Q +KLADFG+A +
Sbjct: 127 KEILKGLDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 185
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPE+ ++ Y++K D++S GI EL P M ++ + K+
Sbjct: 186 WMAPEVI--------QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNN 236
Query: 205 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P L D + + +C +DP+ RP+ ++++
Sbjct: 237 PPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLK 271
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 51 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 108
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 109 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 166
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 167 RTTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 217
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 218 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 259
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 115/238 (48%), Gaps = 20/238 (8%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMS 63
+KE+ +S ER E R REV +++ +KH N+V++ + ++ + IV + G
Sbjct: 54 IKEINISRMSSKERE--ESR--REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGD 109
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
L K + + + L++ + I A+ +H I+HRD+K N+ LT D +++L D
Sbjct: 110 LFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGD 168
Query: 124 FGLARXXXXXXXXXXXXXXY-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
FG+AR +++PE+ E K YNNK D+++ G VL+EL T
Sbjct: 169 FGIARVLNSTVELARACIGTPYYLSPEI--------CENKPYNNKSDIWALGCVLYELCT 220
Query: 183 NRLPFEG--MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ FE M NL + + P + S DL +V + +P RPS + I+
Sbjct: 221 LKHAFEAGSMKNLVLKIISG---SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L M L+K++ + + L + ++
Sbjct: 51 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSY 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP+NLL+ + ++KLADFGLAR
Sbjct: 110 LFQLLQGLAFCHSHRVLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 168
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 169 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 220
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 221 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 247
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 50 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 107
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 108 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 165
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 166 RAALCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 216
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 217 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 46 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 103
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 104 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 161
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 162 RTTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 212
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 213 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 254
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 104
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 105 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 162
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 163 RTELCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 213
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 214 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 63/250 (25%), Positives = 113/250 (45%), Gaps = 18/250 (7%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 104
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 105 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 162
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 163 RTDLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 213
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSV 255
Y P+ ++ ++ +P+ RP ++ L T PS
Sbjct: 214 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV---LEHPWITANSSKPSN 269
Query: 256 PESDTNEAAA 265
++ + AAA
Sbjct: 270 CQNKESAAAA 279
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 76.6 bits (187), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 50 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 107
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 108 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 165
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 166 RTTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 216
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 217 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 76.6 bits (187), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 52 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 109
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 110 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 167
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 168 RTDLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 218
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 219 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 76.6 bits (187), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 44 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 101
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 102 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 159
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 160 RTTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 210
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 211 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 252
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 76.6 bits (187), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 104
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 105 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 162
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 163 RAALCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 213
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 214 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 49 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 106
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 107 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 164
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 165 RXXLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 215
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 216 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 257
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/223 (25%), Positives = 105/223 (47%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 104
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 105 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 162
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 163 RTXLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 213
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 214 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 52/182 (28%), Positives = 90/182 (49%), Gaps = 14/182 (7%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 73 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 130
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 131 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 188
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 189 RDDLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 239
Query: 196 AY 197
Y
Sbjct: 240 TY 241
>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
pdb|4EUT|B Chain B, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
Length = 396
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 11/171 (6%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+RE ++ ++ H N+VK ++ V++ E P SL Y V P+
Sbjct: 55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL--YTVLEEPSNAYGLPES 112
Query: 83 NFAL---DIARAMDCLHANGIIHRDLKPDNLL--LTPDQKSL-KLADFGLARXXXXXXXX 136
F + D+ M+ L NGI+HR++KP N++ + D +S+ KL DFG AR
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 137 XXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++ P++Y LR+ +K Y VD++S G+ + T LPF
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 104
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 105 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 162
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 163 RTDLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 213
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 214 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 67/249 (26%), Positives = 107/249 (42%), Gaps = 27/249 (10%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLR 65
+ L G T +R F+ E ++M + H N++ G K ++I+TE + SL
Sbjct: 41 KTLKSGYTEKQRR----DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 96
Query: 66 KYLVSLRPNKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
+L R N V + IA M L +HR L N+L+ + K++D
Sbjct: 97 SFL---RQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNL-VCKVSD 152
Query: 124 FGLARXXXXXXXXXXXXXX------YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
FGL+R RW APE + + + + DV+S+GIV+
Sbjct: 153 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI--------QYRKFTSASDVWSYGIVM 204
Query: 178 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
WE+++ P+ M+N Q A + R P D L ++ CW +D N RP F Q
Sbjct: 205 WEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 263
Query: 237 IIRMLNAFL 245
I+ L+ +
Sbjct: 264 IVNTLDKMI 272
>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
pdb|4EUU|B Chain B, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
Length = 319
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 11/171 (6%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+RE ++ ++ H N+VK ++ V++ E P SL Y V P+
Sbjct: 55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL--YTVLEEPSNAYGLPES 112
Query: 83 NFAL---DIARAMDCLHANGIIHRDLKPDNLL--LTPDQKSL-KLADFGLARXXXXXXXX 136
F + D+ M+ L NGI+HR++KP N++ + D +S+ KL DFG AR
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 137 XXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++ P++Y LR+ +K Y VD++S G+ + T LPF
Sbjct: 173 VXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 48 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 105
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 106 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 163
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 164 RDTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 214
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 215 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 48 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 105
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 106 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 163
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 164 RTDLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 214
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 215 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 17/219 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+ E +M+ V + + LG C + +VT+L+P L ++ R +L LN+
Sbjct: 66 ILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENR-GRLGSQDLLNW 124
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAR---XXXXXXXXXXXX 140
+ IA+ M L ++HRDL N+L+ +P+ +K+ DFGLAR
Sbjct: 125 CMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEYHADGGK 182
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA L ++ + ++ DV+S+G+ +WEL+T P++G+ +
Sbjct: 183 VPIKWMA--------LESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 234
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K R P + D+ I+ CW+ D RP F +++
Sbjct: 235 E-KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 272
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 17/176 (9%)
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX--- 132
L L + ++ +A+ M+ L + IHRDL N+LL+ ++ +K+ DFGLAR
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 246
Query: 133 XXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190
+WMAPE ++ V Y + DV+SFG++LWE+ + P+ G+
Sbjct: 247 YVRKGDARLPLKWMAPETIFDRV---------YTIQSDVWSFGVLLWEIFSLGASPYPGV 297
Query: 191 SNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ + K R P+ +P++ + CW +P+ RP+FS+++ L L
Sbjct: 298 -KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 352
Score = 30.4 bits (67), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 27/71 (38%), Positives = 38/71 (53%), Gaps = 11/71 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKD---PLMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC PLMVIV E
Sbjct: 56 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 109
Query: 62 MSLRKYLVSLR 72
+L YL S R
Sbjct: 110 GNLSTYLRSKR 120
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKL--SK 104
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 105 FDEQRTATYITELANALSYCHSKKVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 162
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 163 RAALCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQD 213
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 214 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 17/176 (9%)
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
L L + ++ +A+ M+ L + IHRDL N+LL+ ++ +K+ DFGLAR
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 255
Query: 136 XXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190
+WMAPE ++ V Y + DV+SFG++LWE+ + P+ G+
Sbjct: 256 YVRKGDARLPLKWMAPETIFDRV---------YTIQSDVWSFGVLLWEIFSLGASPYPGV 306
Query: 191 SNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ + K R P+ +P++ + CW +P+ RP+FS+++ L L
Sbjct: 307 -KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 361
Score = 30.4 bits (67), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 27/71 (38%), Positives = 38/71 (53%), Gaps = 11/71 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKD---PLMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC PLMVIV E
Sbjct: 65 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 118
Query: 62 MSLRKYLVSLR 72
+L YL S R
Sbjct: 119 GNLSTYLRSKR 129
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 17/176 (9%)
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX--- 132
L L + ++ +A+ M+ L + IHRDL N+LL+ ++ +K+ DFGLAR
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 248
Query: 133 XXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190
+WMAPE ++ V Y + DV+SFG++LWE+ + P+ G+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRV---------YTIQSDVWSFGVLLWEIFSLGASPYPGV 299
Query: 191 SNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ + K R P+ +P++ + CW +P+ RP+FS+++ L L
Sbjct: 300 -KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354
Score = 30.4 bits (67), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 27/71 (38%), Positives = 38/71 (53%), Gaps = 11/71 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKD---PLMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC PLMVIV E
Sbjct: 58 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 111
Query: 62 MSLRKYLVSLR 72
+L YL S R
Sbjct: 112 GNLSTYLRSKR 122
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 17/176 (9%)
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
L L + ++ +A+ M+ L + IHRDL N+LL+ ++ +K+ DFGLAR
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 253
Query: 136 XXXXXXX---YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190
+WMAPE ++ V Y + DV+SFG++LWE+ + P+ G+
Sbjct: 254 YVRKGDARLPLKWMAPETIFDRV---------YTIQSDVWSFGVLLWEIFSLGASPYPGV 304
Query: 191 SNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ + K R P+ +P++ + CW +P+ RP+FS+++ L L
Sbjct: 305 -KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 359
Score = 30.4 bits (67), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 27/71 (38%), Positives = 38/71 (53%), Gaps = 11/71 (15%)
Query: 7 EVLNRGST-SDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKD---PLMVIVTELLPG 61
++L G+T S+ RAL+ E+ ++ + H N+V LGAC PLMVIV E
Sbjct: 63 KMLKEGATHSEHRALMS-----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKF 116
Query: 62 MSLRKYLVSLR 72
+L YL S R
Sbjct: 117 GNLSTYLRSKR 127
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 47 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 104
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 105 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 162
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 163 RXXLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 213
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 214 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 65/247 (26%), Positives = 112/247 (45%), Gaps = 34/247 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-------- 74
F RE +++ ++H+++VKF G C DPL ++V E + L K+L + P+
Sbjct: 62 FHREAELLTNLQHEHIVKFYGVCVEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 120
Query: 75 ---KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX 131
+L L+ A IA M L + +HRDL N L+ + +K+ DFG++R
Sbjct: 121 PPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG-ENLLVKIGDFGMSRDVY 179
Query: 132 XXXXXXXXXXX---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 187
RWM PE ++ R+ + + DV+S G+VLWE+ T + P+
Sbjct: 180 STDYYRVGGHTMLPIRWMPPE---SIMYRK-----FTTESDVWSLGVVLWEIFTYGKQPW 231
Query: 188 EGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
+SN + R P ++ ++ CW +P++R + I+ ++ L
Sbjct: 232 YQLSNNEV--IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKN----IKGIHTLLQ 285
Query: 247 TLRPPSP 253
L SP
Sbjct: 286 NLAKASP 292
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 50 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 107
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 108 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 165
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 166 RDDLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 216
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 217 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 53/193 (27%), Positives = 91/193 (47%), Gaps = 17/193 (8%)
Query: 6 KEVLNRGSTSDERALLEG---RFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPG 61
K ++G SD+ +E E++++ + H N++K +D +VTE G
Sbjct: 71 KSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEG 130
Query: 62 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SL 119
L + +++ +K D A N I + LH + I+HRD+KP+N+LL ++
Sbjct: 131 GELFEQIIN--RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188
Query: 120 KLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
K+ DFGL+ ++APE+ KK YN K DV+S G++++
Sbjct: 189 KIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL---------KKKYNEKCDVWSCGVIMYI 239
Query: 180 LLTNRLPFEGMSN 192
LL PF G ++
Sbjct: 240 LLCGYPPFGGQND 252
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 50 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 107
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG +
Sbjct: 108 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSR 165
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 166 RXXLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 216
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 217 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 19/228 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F+ E ++M + H N+V G P+M+++ E + +L +L + + +
Sbjct: 91 FLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVI-EFMENGALDAFLRK-HDGQFTVIQLV 148
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX----XXXXXXX 138
IA M L G +HRDL N+L+ + K++DFGL+R
Sbjct: 149 GMLRGIAAGMRYLADMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVIEDDPEAVYTTTG 207
Query: 139 XXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 197
RW APE + + + + DV+S+GIV+WE+++ P+ MSN
Sbjct: 208 GKIPVRWTAPEAI--------QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK 259
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + P P D L ++ CW ++ RP F QI+ +L+ +
Sbjct: 260 AIEEGYRLPA-PMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMI 306
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 59/241 (24%), Positives = 108/241 (44%), Gaps = 19/241 (7%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPG 61
++ +V+N+ S ++ +REV ++ ++ H N++K +D IV EL G
Sbjct: 49 EYAVKVINKASAKNKDT---STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 62 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SL 119
L ++ + + H A + + +H + I+HRDLKP+N+LL +K +
Sbjct: 106 GELFDEII--KRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI 163
Query: 120 KLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
K+ DFGL+ ++APE+ + Y+ K DV+S G++L+
Sbjct: 164 KIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL---------RGTYDEKCDVWSAGVILYI 214
Query: 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQI 237
LL+ PF G + LP+ IS D +++ P+LR + +Q
Sbjct: 215 LLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
Query: 238 I 238
+
Sbjct: 275 L 275
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 13/217 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ REV +M + H N+VK + + + +V E G + YLV+ ++ A
Sbjct: 60 KLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA--HGRMKEKEAR 117
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
I A+ H I+HRDLK +NLLL D ++K+ADFG +
Sbjct: 118 AKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDM-NIKIADFGFSNEFTVGNKLDTFCGS 176
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+ APEL+ QG KK+ +VDV+S G++L+ L++ LPF+G NL+ +
Sbjct: 177 PPYAAPELF------QG-KKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLR 228
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ +P +S D +++ V +P R S QI++
Sbjct: 229 -GKYRIPFYMSTDCENLLKKLLVLNPIKRGSLEQIMK 264
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 59/241 (24%), Positives = 108/241 (44%), Gaps = 19/241 (7%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPG 61
++ +V+N+ S ++ +REV ++ ++ H N++K +D IV EL G
Sbjct: 49 EYAVKVINKASAKNKDT---STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 62 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SL 119
L ++ + + H A + + +H + I+HRDLKP+N+LL +K +
Sbjct: 106 GELFDEII--KRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI 163
Query: 120 KLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
K+ DFGL+ ++APE+ + Y+ K DV+S G++L+
Sbjct: 164 KIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL---------RGTYDEKCDVWSAGVILYI 214
Query: 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQI 237
LL+ PF G + LP+ IS D +++ P+LR + +Q
Sbjct: 215 LLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
Query: 238 I 238
+
Sbjct: 275 L 275
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 55/223 (24%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 49 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 106
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+A+FG +
Sbjct: 107 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIANFGWS-VHAPSSR 164
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 165 RTTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 215
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 216 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 257
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 75.1 bits (183), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 55/223 (24%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L +K
Sbjct: 50 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK 107
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + ++A A+ H+ +IHRD+KP+NLLL LK+A+FG +
Sbjct: 108 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIANFGWS-VHAPSSR 165
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E + ++ KVD++S G++ +E L + PFE + Q
Sbjct: 166 RTTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQE 216
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y P+ ++ ++ +P+ RP +++
Sbjct: 217 TY-KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 50/179 (27%), Positives = 90/179 (50%), Gaps = 13/179 (7%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLR 72
T E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L
Sbjct: 48 TQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL- 106
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX 132
++ D + ++A A+ H+ +IHRD+KP+NLLL + + LK+ADFG +
Sbjct: 107 -SRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGE-LKIADFGWS-VHAP 163
Query: 133 XXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 191
++ PE+ E + ++ KVD++S G++ +E L PFE +
Sbjct: 164 SSRRTTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 85/172 (49%), Gaps = 13/172 (7%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYL----VSLRPNKLDLHV 80
IRE+++M +KH+N+V+ + + +V E + L+KY+ V P L+L++
Sbjct: 51 IREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNL 109
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
F + + + H N I+HRDLKP NLL+ + LKL DFGLAR
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
W Y + G + Y+ +D++S G +L E++T + F G ++
Sbjct: 169 VVTLW-----YRAPDVLMGSRT-YSTSIDIWSCGCILAEMITGKPLFPGTND 214
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 28 EVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNF 84
E+++ + H ++V F G +D + +V EL R+ L+ L R L A +
Sbjct: 71 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL----CRRRSLLELHKRRKALTEPEARYY 126
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXY 143
I LH N +IHRDLK NL L D + +K+ DFGLA +
Sbjct: 127 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKTLCGTP 185
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
++APE+ S KK ++ +VDV+S G +++ LL + PFE S L+ Y K+
Sbjct: 186 NYIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN 236
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247
+P+ I+P A ++Q DP RP+ ++ +LN FT
Sbjct: 237 EY-SIPKHINPVAASLIQKMLQTDPTARPTINE---LLNDEFFT 276
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 28 EVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNF 84
E+++ + H ++V F G +D + +V EL R+ L+ L R L A +
Sbjct: 67 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL----CRRRSLLELHKRRKALTEPEARYY 122
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXY 143
I LH N +IHRDLK NL L D + +K+ DFGLA +
Sbjct: 123 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
++APE+ S KK ++ +VDV+S G +++ LL + PFE S L+ Y K+
Sbjct: 182 NYIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN 232
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247
+P+ I+P A ++Q DP RP+ ++ +LN FT
Sbjct: 233 EY-SIPKHINPVAASLIQKMLQTDPTARPTINE---LLNDEFFT 272
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 74.7 bits (182), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 28 EVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNF 84
E+++ + H ++V F G +D + +V EL R+ L+ L R L A +
Sbjct: 67 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL----CRRRSLLELHKRRKALTEPEARYY 122
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXY 143
I LH N +IHRDLK NL L D + +K+ DFGLA +
Sbjct: 123 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
++APE+ S KK ++ +VDV+S G +++ LL + PFE S L+ Y K+
Sbjct: 182 NYIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN 232
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247
+P+ I+P A ++Q DP RP+ ++ +LN FT
Sbjct: 233 EY-SIPKHINPVAASLIQKMLQTDPTARPTINE---LLNDEFFT 272
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 74.7 bits (182), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 28 EVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNF 84
E+++ + H ++V F G +D + +V EL R+ L+ L R L A +
Sbjct: 65 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL----CRRRSLLELHKRRKALTEPEARYY 120
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXY 143
I LH N +IHRDLK NL L D + +K+ DFGLA +
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
++APE+ S KK ++ +VDV+S G +++ LL + PFE S L+ Y K
Sbjct: 180 NYIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETY-LRIKK 229
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247
+P+ I+P A ++Q DP RP+ ++ +LN FT
Sbjct: 230 NEYSIPKHINPVAASLIQKMLQTDPTARPTINE---LLNDEFFT 270
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 28 EVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNF 84
E+++ + H ++V F G +D + +V EL R+ L+ L R L A +
Sbjct: 91 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL----CRRRSLLELHKRRKALTEPEARYY 146
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXY 143
I LH N +IHRDLK NL L D + +K+ DFGLA +
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTP 205
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
++APE+ S KK ++ +VDV+S G +++ LL + PFE S L+ Y K+
Sbjct: 206 NYIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN 256
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247
+P+ I+P A ++Q DP RP+ ++ +LN FT
Sbjct: 257 EY-SIPKHINPVAASLIQKMLQTDPTARPTINE---LLNDEFFT 296
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 28 EVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNF 84
E+++ + H ++V F G +D + +V EL R+ L+ L R L A +
Sbjct: 89 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL----CRRRSLLELHKRRKALTEPEARYY 144
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXY 143
I LH N +IHRDLK NL L D + +K+ DFGLA +
Sbjct: 145 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTP 203
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
++APE+ S KK ++ +VDV+S G +++ LL + PFE S L+ Y K+
Sbjct: 204 NYIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN 254
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247
+P+ I+P A ++Q DP RP+ ++ +LN FT
Sbjct: 255 EY-SIPKHINPVAASLIQKMLQTDPTARPTINE---LLNDEFFT 294
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 50/179 (27%), Positives = 90/179 (50%), Gaps = 13/179 (7%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLR 72
T E+A +E + REV + S ++H N+++ G D V ++ E P ++ + L L
Sbjct: 48 TQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL- 106
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX 132
++ D + ++A A+ H+ +IHRD+KP+NLLL + + LK+ADFG +
Sbjct: 107 -SRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGE-LKIADFGWS-VHAP 163
Query: 133 XXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 191
++ PE+ E + ++ KVD++S G++ +E L PFE +
Sbjct: 164 SSRRDTLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 74.3 bits (181), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 47/146 (32%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX-XXYRW 145
++A A+D LH+ GII+RDLKP+N+LL ++ +KL DFGL++ +
Sbjct: 135 ELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 193
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 205
MAPE V R+G + D +SFG++++E+LT LPF+G + A+
Sbjct: 194 MAPE----VVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQGKDRKET--MTMILKAK 243
Query: 206 PGLPEDISPDLAFIVQSCWVEDPNLR 231
G+P+ +SP+ +++ + +P R
Sbjct: 244 LGMPQFLSPEAQSLLRMLFKRNPANR 269
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 74.3 bits (181), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 13/217 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ REV + + H N+VK + + + +V E G + YLV+ K +
Sbjct: 59 KLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXK-EKEARA 117
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
F I A+ H I+HRDLK +NLLL D ++K+ADFG +
Sbjct: 118 KFR-QIVSAVQYCHQKFIVHRDLKAENLLLDADX-NIKIADFGFSNEFTFGNKLDAFCGA 175
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+ APEL+ QG KK+ +VDV+S G++L+ L++ LPF+G NL+ +
Sbjct: 176 PPYAAPELF------QG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-NLKELRERVLR 227
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ +P S D +++ + +P+ R + QI +
Sbjct: 228 -GKYRIPFYXSTDCENLLKKFLILNPSKRGTLEQIXK 263
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 74.3 bits (181), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 47/146 (32%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX-XXYRW 145
++A A+D LH+ GII+RDLKP+N+LL ++ +KL DFGL++ +
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 205
MAPE V R+G + D +SFG++++E+LT LPF+G + A+
Sbjct: 193 MAPE----VVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQGKDRKET--MTMILKAK 242
Query: 206 PGLPEDISPDLAFIVQSCWVEDPNLR 231
G+P+ +SP+ +++ + +P R
Sbjct: 243 LGMPQFLSPEAQSLLRMLFKRNPANR 268
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 74.3 bits (181), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 47/146 (32%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX-XXYRW 145
++A A+D LH+ GII+RDLKP+N+LL ++ +KL DFGL++ +
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 205
MAPE V R+G + D +SFG++++E+LT LPF+G + A+
Sbjct: 193 MAPE----VVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQGKDRKET--MTMILKAK 242
Query: 206 PGLPEDISPDLAFIVQSCWVEDPNLR 231
G+P+ +SP+ +++ + +P R
Sbjct: 243 LGMPQFLSPEAQSLLRMLFKRNPANR 268
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 74.3 bits (181), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 109 LFQLLQGLSFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTL 167
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 168 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 219
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 220 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 246
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 74.3 bits (181), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 52 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP+NLL+ + ++KLADFGLAR
Sbjct: 111 LFQLLQGLAFCHSHRVLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 169
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 170 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 221
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 222 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 248
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 73.9 bits (180), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L M L+ ++ + + L + ++
Sbjct: 52 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSY 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 111 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 169
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 170 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 221
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 222 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 248
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 73.9 bits (180), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 51 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP+NLL+ + ++KLADFGLAR
Sbjct: 110 LFQLLQGLAFCHSHRVLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 168
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 169 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 220
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 221 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 247
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 73.9 bits (180), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L M L+ ++ + + L + ++
Sbjct: 53 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSY 111
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 112 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 171 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 222
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 223 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 249
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 57 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 115
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 116 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTL 174
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 175 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 226
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 227 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 253
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 26 IREVNMMSRVK---HDNLVKFLGAC------KDPLMVIVTELLPGMSLRKYLVSLRPNKL 76
+REV ++ R++ H N+V+ + C ++ + +V E + LR YL P L
Sbjct: 51 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGL 109
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXX 136
+ R +D LHAN I+HRDLKP+N+L+T ++KLADFGLAR
Sbjct: 110 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL 168
Query: 137 XXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
+ APE+ T Y VD++S G + E+ + F G S
Sbjct: 169 APVVVTLWYRAPEVLLQST--------YATPVDMWSVGCIFAEMFRRKPLFCGNSE 216
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 4 FMKEVLNRGSTSDERALLEGRFI--REVNMMSRVKHDNLVKFL------GACKDPLMV-I 54
+ ++ + G + +L+G+ RE+ +M ++ H N+V+ G KD + + +
Sbjct: 37 YQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96
Query: 55 VTELLPGMSLR--KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
V + +P R ++ + ++V L + + R++ +H+ GI HRD+KP NLLL
Sbjct: 97 VLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLL 155
Query: 113 TPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172
PD LKL DFG A+ + APEL T Y + +DV+S
Sbjct: 156 DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT-------DYTSSIDVWS 208
Query: 173 FGIVLWELLTNRLPFEGMSNL 193
G VL ELL + F G S +
Sbjct: 209 AGCVLAELLLGQPIFPGDSGV 229
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 26 IREVNMMSRVK---HDNLVKFLGAC------KDPLMVIVTELLPGMSLRKYLVSLRPNKL 76
+REV ++ R++ H N+V+ + C ++ + +V E + LR YL P L
Sbjct: 59 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGL 117
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXX 136
+ R +D LHAN I+HRDLKP+N+L+T ++KLADFGLAR
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL 176
Query: 137 XXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
+ APE+ T Y VD++S G + E+ + F G S
Sbjct: 177 TPVVVTLWYRAPEVLLQST--------YATPVDMWSVGCIFAEMFRRKPLFCGNSE 224
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTL 167
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 168 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 219
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 220 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 246
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 49 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 107
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTL 166
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 167 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 218
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 219 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 245
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTL 167
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 168 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 219
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 220 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 246
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 49 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 107
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTL 166
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 167 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 218
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 219 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 245
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 57 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 115
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 116 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTL 174
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 175 WYRAPEILLG-------XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 226
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 227 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 253
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 54 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 112
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 113 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 171
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 172 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 223
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 224 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 250
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTL 167
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 168 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 219
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 220 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 246
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 49 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 107
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTL 166
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 167 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 218
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 219 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 245
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 52 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 111 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 169
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 170 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 221
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 222 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 248
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 51 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 110 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTL 168
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 169 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 220
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 221 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 247
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 33/239 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMS---LRKYLVSLRPNK--- 75
++E+ MS+ H N+V + + KD L +V +LL G S + K++V+ +K
Sbjct: 59 ELLKEIQAMSQCHHPNIVSYYTSFVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGV 117
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
LD ++ ++ LH NG IHRD+K N+LL D S+++ADFG++
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGD 176
Query: 136 XXXXXXXYR------WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
WMAPE+ V + Y+ K D++SFGI EL T P+
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVMEQV-------RGYDFKADIWSFGITAIELATGAAPYHK 229
Query: 190 MSNLQAAYAAAFKHARPGLPEDI---------SPDLAFIVQSCWVEDPNLRPSFSQIIR 239
++ ++ P L + ++ C +DP RP+ ++++R
Sbjct: 230 YPPMK-VLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 53 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 111
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 112 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 171 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 222
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 223 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 249
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 52 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 111 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 169
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 170 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 221
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 222 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 248
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTL 167
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 168 WYRAPEILLG-------XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 219
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 220 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 246
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 54 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 112
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 113 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTL 171
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 172 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 223
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 224 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 250
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E+ ++S+ + ++ G+ K + I+ E L G S L L+P L+
Sbjct: 66 QEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATIL 122
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXYR 144
+I + +D LH+ IHRD+K N+LL+ +Q +KLADFG+A +
Sbjct: 123 REILKGLDYLHSERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNXFVGTPF 181
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPE+ ++ Y+ K D++S GI EL P + ++ + K++
Sbjct: 182 WMAPEVI--------KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNS 232
Query: 205 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P L S V++C +DP RP+ ++++
Sbjct: 233 PPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLK 267
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 35/246 (14%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGAC-KD-PLMVIVTELLPGMSLRKYLVSLRPNK--- 75
L F E + +R++H N+V LG KD PL +I + G L ++LV P+
Sbjct: 72 LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHG-DLHEFLVMRSPHSDVG 130
Query: 76 -----------LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 124
L+ ++ IA M+ L ++ ++H+DL N+L+ D+ ++K++D
Sbjct: 131 STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY-DKLNVKISDL 189
Query: 125 GLARXXXXXXXXXXXXXX---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
GL R RWMAPE +Y ++ D++S+G+VLWE
Sbjct: 190 GLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDS----------DIWSYGVVLWE 239
Query: 180 LLTNRL-PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ + L P+ G SN + P P+D + ++ CW E P+ RP F I
Sbjct: 240 VFSYGLQPYCGYSNQDVVEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIH 298
Query: 239 RMLNAF 244
L A+
Sbjct: 299 SRLRAW 304
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 53 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 111
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 112 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 171 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 222
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 223 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 249
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 35/246 (14%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGAC-KD-PLMVIVTELLPGMSLRKYLVSLRPNK--- 75
L F E + +R++H N+V LG KD PL +I + G L ++LV P+
Sbjct: 55 LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHG-DLHEFLVMRSPHSDVG 113
Query: 76 -----------LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 124
L+ ++ IA M+ L ++ ++H+DL N+L+ D+ ++K++D
Sbjct: 114 STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY-DKLNVKISDL 172
Query: 125 GLARXXXXXXXXXXXXXX---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
GL R RWMAPE +Y ++ D++S+G+VLWE
Sbjct: 173 GLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDS----------DIWSYGVVLWE 222
Query: 180 LLTNRL-PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ + L P+ G SN + P P+D + ++ CW E P+ RP F I
Sbjct: 223 VFSYGLQPYCGYSNQDVVEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIH 281
Query: 239 RMLNAF 244
L A+
Sbjct: 282 SRLRAW 287
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 51 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 110 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 168
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 169 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 220
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 221 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 247
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 73.2 bits (178), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 26 IREVNMMSRVK---HDNLVKFLGAC------KDPLMVIVTELLPGMSLRKYLVSLRPNKL 76
+REV ++ R++ H N+V+ + C ++ + +V E + LR YL P L
Sbjct: 51 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGL 109
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXX 136
+ R +D LHAN I+HRDLKP+N+L+T ++KLADFGLAR
Sbjct: 110 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL 168
Query: 137 XXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
+ APE+ T Y VD++S G + E+ + F G S
Sbjct: 169 FPVVVTLWYRAPEVLLQST--------YATPVDMWSVGCIFAEMFRRKPLFCGNSE 216
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 73.2 bits (178), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 26 IREVNMMSRVK---HDNLVKFLGAC------KDPLMVIVTELLPGMSLRKYLVSLRPNKL 76
+REV ++ R++ H N+V+ + C ++ + +V E + LR YL P L
Sbjct: 51 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGL 109
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXX 136
+ R +D LHAN I+HRDLKP+N+L+T ++KLADFGLAR
Sbjct: 110 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL 168
Query: 137 XXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
+ APE+ T Y VD++S G + E+ + F G S
Sbjct: 169 DPVVVTLWYRAPEVLLQST--------YATPVDMWSVGCIFAEMFRRKPLFCGNSE 216
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 167
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 168 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 219
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 220 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 246
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 167
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 168 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 219
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 220 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 246
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 167
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 168 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 219
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 220 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 246
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 49 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 107
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 166
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 167 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 218
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 219 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 245
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 51 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 110 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 168
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 169 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 220
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 221 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 247
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 167
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 168 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 219
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 220 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 246
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 33/239 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMS---LRKYLVSLRPNK--- 75
++E+ MS+ H N+V + + KD L +V +LL G S + K++V+ +K
Sbjct: 54 ELLKEIQAMSQCHHPNIVSYYTSFVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGV 112
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
LD ++ ++ LH NG IHRD+K N+LL D S+++ADFG++
Sbjct: 113 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGD 171
Query: 136 XXXXXXXYR------WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
WMAPE+ V + Y+ K D++SFGI EL T P+
Sbjct: 172 ITRNKVRKTFVGTPCWMAPEVMEQV-------RGYDFKADIWSFGITAIELATGAAPYHK 224
Query: 190 MSNLQAAYAAAFKHARPGLPEDI---------SPDLAFIVQSCWVEDPNLRPSFSQIIR 239
++ ++ P L + ++ C +DP RP+ ++++R
Sbjct: 225 YPPMK-VLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 282
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + L + ++
Sbjct: 49 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 107
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 166
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 167 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 218
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 219 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 245
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNAM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 69 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 117
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 118 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSE-LKILDFGLAR 175
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 176 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 226
Query: 189 GMSNL 193
G ++
Sbjct: 227 GTDHI 231
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKXQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 73 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 121
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 122 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSE-LKILDFGLAR 179
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 180 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 230
Query: 189 GMSNL 193
G ++
Sbjct: 231 GTDHI 235
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 13/208 (6%)
Query: 40 LVKFLGAC-KDPLMVIVTELLPGM--SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96
+V+F GA ++ I EL+ KY+ S+ + + + L +A++ L
Sbjct: 83 IVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 97 AN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVT 155
N IIHRD+KP N+LL ++KL DFG++ +MAPE
Sbjct: 143 ENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 201
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP----ED 211
RQG Y+ + DV+S GI L+EL T R P+ +++ K P L +
Sbjct: 202 SRQG----YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257
Query: 212 ISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
SP V C +D + RP + ++++
Sbjct: 258 FSPSFINFVNLCLTKDESKRPKYKELLK 285
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 4 FMKEVLNRGSTSDERALLEGRFI--REVNMMSRVKHDNLVKFL------GACKDPLMV-I 54
+ ++ + G + +L+G+ RE+ +M ++ H N+V+ G KD + + +
Sbjct: 37 YQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96
Query: 55 VTELLPGMSLR--KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
V + +P R ++ + ++V L + + R++ +H+ GI HRD+KP NLLL
Sbjct: 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLL 155
Query: 113 TPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172
PD LKL DFG A+ + APEL T Y + +DV+S
Sbjct: 156 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT-------DYTSSIDVWS 208
Query: 173 FGIVLWELLTNRLPFEGMSNL 193
G VL ELL + F G S +
Sbjct: 209 AGCVLAELLLGQPIFPGDSGV 229
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 78 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 126
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 127 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXE-LKILDFGLAR 184
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 185 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 235
Query: 189 GMSNL 193
G ++
Sbjct: 236 GTDHI 240
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 72 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 120
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 121 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXE-LKILDFGLAR 178
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 179 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 229
Query: 189 GMSNL 193
G ++
Sbjct: 230 GTDHI 234
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 72 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 120
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 121 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXE-LKILDFGLAR 178
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 179 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 229
Query: 189 GMSNL 193
G ++
Sbjct: 230 GTDHI 234
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 89 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 148
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 149 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 207
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 208 AKQLVRGEPNVSYICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 260
Query: 187 FEGMSNL 193
F G S +
Sbjct: 261 FPGDSGV 267
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 85 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 144
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 145 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 204 AKQLVRGEPNVSYICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 256
Query: 187 FEGMSNL 193
F G S +
Sbjct: 257 FPGDSGV 263
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKF------LGACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 79 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 138
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 139 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 197
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 198 AKQLVRGEPNVSYICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 250
Query: 187 FEGMSNL 193
F G S +
Sbjct: 251 FPGDSGV 257
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 4 FMKEVLNRGSTSDERALLEGRFI--REVNMMSRVKHDNLVKFL------GACKDPLMV-I 54
+ ++ + G + +L+G+ RE+ +M ++ H N+V+ G KD + + +
Sbjct: 37 YQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96
Query: 55 VTELLPGMSLR--KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
V + +P R ++ + ++V L + + R++ +H+ GI HRD+KP NLLL
Sbjct: 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLL 155
Query: 113 TPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172
PD LKL DFG A+ + APEL T Y + +DV+S
Sbjct: 156 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT-------DYTSSIDVWS 208
Query: 173 FGIVLWELLTNRLPFEGMSNL 193
G VL ELL + F G S +
Sbjct: 209 AGCVLAELLLGQPIFPGDSGV 229
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 85 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 144
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 145 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 204 AKQLVRGEPNVSXICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 256
Query: 187 FEGMSNL 193
F G S +
Sbjct: 257 FPGDSGV 263
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 87 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 146
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 147 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 205
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 206 AKQLVRGEPNVSYICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 258
Query: 187 FEGMSNL 193
F G S +
Sbjct: 259 FPGDSGV 265
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKF------LGACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 130 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 189
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 190 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 248
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 249 AKQLVRGEPNVSYICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 301
Query: 187 FEGMSNL 193
F G S +
Sbjct: 302 FPGDSGV 308
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 122
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 123 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 180
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 181 HTADEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 231
Query: 189 GMSNL 193
G ++
Sbjct: 232 GTDHI 236
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 54/179 (30%), Positives = 81/179 (45%), Gaps = 28/179 (15%)
Query: 24 RFIREVNMMSRVKHDNLVK-------FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKL 76
R+ E+ +M ++ H N+V + L ++ E G LRKYL N+
Sbjct: 58 RWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-----NQF 112
Query: 77 DLHVAL------NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL--KLADFGLAR 128
+ L DI+ A+ LH N IIHRDLKP+N++L P + L K+ D G A+
Sbjct: 113 ENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+++APEL E+K Y VD +SFG + +E +T PF
Sbjct: 173 ELDQGELCTEFVGTLQYLAPELL--------EQKKYTVTVDYWSFGTLAFECITGFRPF 223
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 111/238 (46%), Gaps = 29/238 (12%)
Query: 28 EVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
EV +M +H N+V+ + + L V++ E L G +L + +R N+ +
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELWVLM-EFLQGGALTDIVSQVRLNEEQIATVCEAV 150
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXXXYR 144
L +A+ LHA G+IHRD+K D++LLT D + +KL+DFG A+
Sbjct: 151 L---QALAYLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKXLVGTPY 206
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPE+ S + Y +VD++S GI++ E++ P+ S +Q A K
Sbjct: 207 WMAPEVIS--------RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----AMKRL 253
Query: 205 RPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
R P +SP L ++ V DP R + +++ + FL P VP
Sbjct: 254 RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD--HPFLLQTGLPECLVP 309
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 122
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 123 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 180
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 181 HTADEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 231
Query: 189 GMSNL 193
G ++
Sbjct: 232 GTDHI 236
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 54/179 (30%), Positives = 81/179 (45%), Gaps = 28/179 (15%)
Query: 24 RFIREVNMMSRVKHDNLVK-------FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKL 76
R+ E+ +M ++ H N+V + L ++ E G LRKYL N+
Sbjct: 59 RWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-----NQF 113
Query: 77 DLHVAL------NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL--KLADFGLAR 128
+ L DI+ A+ LH N IIHRDLKP+N++L P + L K+ D G A+
Sbjct: 114 ENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+++APEL E+K Y VD +SFG + +E +T PF
Sbjct: 174 ELDQGELCTEFVGTLQYLAPELL--------EQKKYTVTVDYWSFGTLAFECITGFRPF 224
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 122
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 123 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 180
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 181 HTADEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 231
Query: 189 GMSNL 193
G ++
Sbjct: 232 GTDHI 236
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKXQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 68/261 (26%), Positives = 118/261 (45%), Gaps = 29/261 (11%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+I E+ +++ H +VK LGA D + I+ E PG ++ ++ L + + +
Sbjct: 55 YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV- 113
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXXX 142
+ A++ LH+ IIHRDLK N+L+T + ++LADFG+ A+
Sbjct: 114 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTL-EGDIRLADFGVSAKNLKTLQKRDSFIGT 172
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE+ T++ Y+ K D++S GI L E+ P ++ ++ A K
Sbjct: 173 PYWMAPEVVMCETMKDTP---YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-K 228
Query: 203 HARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDT 260
P L P S + ++ ++P RPS +Q++ P V
Sbjct: 229 SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE------------HPFV----- 271
Query: 261 NEAAATSNGAMTEFSARARGK 281
++ TSN A+ E A A+ +
Sbjct: 272 --SSITSNKALRELVAEAKAE 290
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 56 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 115
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 116 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 174
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 175 AKQLVRGEPNVSYICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 227
Query: 187 FEGMSNL 193
F G S +
Sbjct: 228 FPGDSGV 234
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 79 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 127
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 128 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 185
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 186 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 236
Query: 189 GMSNL 193
G ++
Sbjct: 237 GTDHI 241
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 69 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 117
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 118 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 175
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 176 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 226
Query: 189 GMSNL 193
G ++
Sbjct: 227 GTDHI 231
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 58/167 (34%), Positives = 85/167 (50%), Gaps = 15/167 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK-LDL 78
L+ +F +E+ +M++ +H+NLV+ LG D + +V +P SL L L L
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---XXXXX 135
H+ A A ++ LH N IHRD+K N+LL + + K++DFGLAR
Sbjct: 133 HMRCKIAQGAANGINFLHENHHIHRDIKSANILL-DEAFTAKISDFGLARASEKFAQTVM 191
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
+MAPE LR GE K D+YSFG+VL E++T
Sbjct: 192 XSRIVGTTAYMAPE-----ALR-GE---ITPKSDIYSFGVVLLEIIT 229
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 53/172 (30%), Positives = 80/172 (46%), Gaps = 19/172 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLG------ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLD 77
R RE+ ++ +KH+N++ L + +D V + L G L + S + D
Sbjct: 73 RTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALS--D 130
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXX 137
HV + R + +H+ GIIHRDLKP N+ + D + L++ DFGLAR
Sbjct: 131 EHVQF-LVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSE-LRILDFGLARQADEEMTGY 188
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
YR APE+ HYN VD++S G ++ ELL + F G
Sbjct: 189 VATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLQGKALFPG 231
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 68/261 (26%), Positives = 118/261 (45%), Gaps = 29/261 (11%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+I E+ +++ H +VK LGA D + I+ E PG ++ ++ L + + +
Sbjct: 63 YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV- 121
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXXXX 142
+ A++ LH+ IIHRDLK N+L+T + ++LADFG+ A+
Sbjct: 122 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTL-EGDIRLADFGVSAKNLKTLQKRDSFIGT 180
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE+ T++ Y+ K D++S GI L E+ P ++ ++ A K
Sbjct: 181 PYWMAPEVVMCETMKDTP---YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-K 236
Query: 203 HARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDT 260
P L P S + ++ ++P RPS +Q++ P V
Sbjct: 237 SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE------------HPFV----- 279
Query: 261 NEAAATSNGAMTEFSARARGK 281
++ TSN A+ E A A+ +
Sbjct: 280 --SSITSNKALRELVAEAKAE 298
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 72 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 120
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 121 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 178
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 179 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 229
Query: 189 GMSNL 193
G ++
Sbjct: 230 GTDHI 234
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 66 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 114
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 115 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 172
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 173 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 223
Query: 189 GMSNL 193
G ++
Sbjct: 224 GTDHI 228
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 63 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 122
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 123 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 181
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 182 AKQLVRGEPNVSXICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 234
Query: 187 FEGMSNL 193
F G S +
Sbjct: 235 FPGDSGV 241
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 77 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 125
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 126 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 183
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 184 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 234
Query: 189 GMSNL 193
G ++
Sbjct: 235 GTDHI 239
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 79 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 127
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 128 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 185
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 186 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 236
Query: 189 GMSNL 193
G ++
Sbjct: 237 GTDHI 241
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 69 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 117
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 118 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 175
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 176 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 226
Query: 189 GMSNL 193
G ++
Sbjct: 227 GTDHI 231
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 79 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 127
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 128 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 185
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 186 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 236
Query: 189 GMSNL 193
G ++
Sbjct: 237 GTDHI 241
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 78 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 126
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 127 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 184
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 185 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 235
Query: 189 GMSNL 193
G ++
Sbjct: 236 GTDHI 240
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 96 RTYRELRLLKHMKHENVIGLLDV-----------FTPATSLEEFNDVYLVTHLMGADLNN 144
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 145 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 202
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 203 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNMTVDIWSVGCIMAELLTGRTLFP 253
Query: 189 GMSNL 193
G ++
Sbjct: 254 GTDHI 258
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 69 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 117
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 118 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 175
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 176 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 226
Query: 189 GMSNL 193
G ++
Sbjct: 227 GTDHI 231
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 82/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGL R
Sbjct: 116 IVKSQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSE-LKILDFGLCR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 122
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 123 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 180
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 181 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 231
Query: 189 GMSNL 193
G ++
Sbjct: 232 GTDHI 236
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 73 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 121
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 122 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 179
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 180 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 230
Query: 189 GMSNL 193
G ++
Sbjct: 231 GTDHI 235
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 60/185 (32%), Positives = 84/185 (45%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 90 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 138
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 139 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 196
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 197 HTDDEMXGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 247
Query: 189 GMSNL 193
G ++
Sbjct: 248 GTDHI 252
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 4 FMKEVLNRGSTSDERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IV 55
F +++ + ++ L + RF RE+ +M VKH N+V G KD + + +V
Sbjct: 57 FQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116
Query: 56 TELLPGMSLR--KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 113
E +P R ++ L+ L + L + + R++ +H+ GI HRD+KP NLLL
Sbjct: 117 LEYVPETVYRASRHYAKLKQTMPMLLIKL-YMYQLLRSLAYIHSIGICHRDIKPQNLLLD 175
Query: 114 PDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173
P LKL DFG A+ + APEL T +Y +D++S
Sbjct: 176 PPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGAT-------NYTTNIDIWST 228
Query: 174 GIVLWELLTNRLPFEGMSNL 193
G V+ EL+ + F G S +
Sbjct: 229 GCVMAELMQGQPLFPGESGI 248
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 90 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 138
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 139 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 196
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 197 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 247
Query: 189 GMSNL 193
G ++
Sbjct: 248 GTDHI 252
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 73 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 121
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 122 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 179
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 180 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 230
Query: 189 GMSNL 193
G ++
Sbjct: 231 GTDHI 235
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 87 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 135
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 136 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 193
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 194 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 244
Query: 189 GMSNL 193
G ++
Sbjct: 245 GTDHI 249
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 86 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 134
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 135 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 192
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 193 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 243
Query: 189 GMSNL 193
G ++
Sbjct: 244 GTDHI 248
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 64 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 123
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 124 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 182
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 183 AKQLVRGEPNVSYICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 235
Query: 187 FEGMSNL 193
F G S +
Sbjct: 236 FPGDSGV 242
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 72 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 120
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 121 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 178
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 179 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 229
Query: 189 GMSNL 193
G ++
Sbjct: 230 GTDHI 234
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 59 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 118
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 119 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 177
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 178 AKQLVRGEPNVSXICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 230
Query: 187 FEGMSNL 193
F G S +
Sbjct: 231 FPGDSGV 237
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 86 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 134
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 135 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 192
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 193 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 243
Query: 189 GMSNL 193
G ++
Sbjct: 244 GTDHI 248
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+ ++ + + L + ++
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSY 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP+NLL+ + ++KLADFGLAR
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 167
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 168 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 219
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 220 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 246
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 87 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 135
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 136 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 193
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 194 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 244
Query: 189 GMSNL 193
G ++
Sbjct: 245 GTDHI 249
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/167 (34%), Positives = 85/167 (50%), Gaps = 15/167 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK-LDL 78
L+ +F +E+ +M++ +H+NLV+ LG D + +V +P SL L L L
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
H+ A A ++ LH N IHRD+K N+LL + + K++DFGLAR
Sbjct: 133 HMRCKIAQGAANGINFLHENHHIHRDIKSANILL-DEAFTAKISDFGLARASEKFAQTVM 191
Query: 139 X---XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
+MAPE LR GE K D+YSFG+VL E++T
Sbjct: 192 XXRIVGTTAYMAPE-----ALR-GE---ITPKSDIYSFGVVLLEIIT 229
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 70 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 129
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 130 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 188
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 189 AKQLVRGEPNVSXICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 241
Query: 187 FEGMSNL 193
F G S +
Sbjct: 242 FPGDSGV 248
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMAGFVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 73 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 121
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 122 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 179
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 180 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 230
Query: 189 GMSNL 193
G ++
Sbjct: 231 GTDHI 235
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 63 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 122
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 123 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 181
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 182 AKQLVRGEPNVSXICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 234
Query: 187 FEGMSNL 193
F G S +
Sbjct: 235 FPGDSGV 241
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMAGFVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 60/185 (32%), Positives = 84/185 (45%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGXVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 55 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 114
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 115 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 173
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 174 AKQLVRGEPNVSXICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 226
Query: 187 FEGMSNL 193
F G S +
Sbjct: 227 FPGDSGV 233
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 65 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 113
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 114 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 171
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 172 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 222
Query: 189 GMSNL 193
G ++
Sbjct: 223 GTDHI 227
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/185 (32%), Positives = 85/185 (45%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 87 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 135
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 136 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 193
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 194 HTDDEMXGXVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 244
Query: 189 GMSNL 193
G ++
Sbjct: 245 GTDHI 249
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 51 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 110
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 111 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 170 AKQLVRGEPNVSXICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 222
Query: 187 FEGMSNL 193
F G S +
Sbjct: 223 FPGDSGV 229
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 111
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 112 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 169
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 170 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 220
Query: 189 GMSNL 193
G ++
Sbjct: 221 GTDHI 225
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 111
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 112 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 169
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 170 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 220
Query: 189 GMSNL 193
G ++
Sbjct: 221 GTDHI 225
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 64 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 112
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 113 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 170
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 171 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 221
Query: 189 GMSNL 193
G ++
Sbjct: 222 GTDHI 226
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 51 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 110
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 111 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 222
Query: 187 FEGMSNL 193
F G S +
Sbjct: 223 FPGDSGV 229
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 51 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 110
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 111 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 170 AKQLVRGEPNVSXICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 222
Query: 187 FEGMSNL 193
F G S +
Sbjct: 223 FPGDSGV 229
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 52 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 111
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 112 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 170
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 171 AKQLVRGEPNVSXICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 223
Query: 187 FEGMSNL 193
F G S +
Sbjct: 224 FPGDSGV 230
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 45/146 (30%), Positives = 81/146 (55%), Gaps = 12/146 (8%)
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX-XXYRW 145
++A +D LH+ GII+RDLKP+N+LL ++ +KL DFGL++ +
Sbjct: 138 ELALGLDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEY 196
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 205
MAPE V RQG +++ D +S+G++++E+LT LPF+G + A+
Sbjct: 197 MAPE----VVNRQG----HSHSADWWSYGVLMFEMLTGSLPFQGKDRKET--MTLILKAK 246
Query: 206 PGLPEDISPDLAFIVQSCWVEDPNLR 231
G+P+ +S + ++++ + +P R
Sbjct: 247 LGMPQFLSTEAQSLLRALFKRNPANR 272
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 22/231 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F +MMS++ H +LV G C ++V E + SL YL + N +++ L
Sbjct: 59 FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLE 117
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKS-----LKLADFGLARXXXXXXXX 136
A +A AM L N +IH ++ N+LL D+K+ +KL+D G++
Sbjct: 118 VAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---ITVLPK 174
Query: 137 XXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 196
W+ PE K+ N D +SFG LWE+ + + +S L +
Sbjct: 175 DILQERIPWVPPECIEN-------PKNLNLATDKWSFGTTLWEICSGG--DKPLSALDSQ 225
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247
F R LP + +LA ++ +C +P+ RPSF IIR LN+ LFT
Sbjct: 226 RKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS-LFT 275
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 64 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 112
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 113 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 170
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 171 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 221
Query: 189 GMSNL 193
G ++
Sbjct: 222 GTDHI 226
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 68/251 (27%), Positives = 121/251 (48%), Gaps = 21/251 (8%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMS 63
+K++ G S+E+ I+EV + +++H N +++ G ++ +V E G +
Sbjct: 84 IKKMSYSGKQSNEKW---QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 140
Query: 64 LRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
V +P ++++ + AL + + LH++ +IHRD+K N+LL+ + +KL
Sbjct: 141 SDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLG 196
Query: 123 DFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
DFG A WMAPE+ + + +G+ Y+ KVDV+S GI EL
Sbjct: 197 DFGSASIMAPANXFVGTPY---WMAPEV--ILAMDEGQ---YDGKVDVWSLGITCIELAE 248
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
+ P M+ + A Y A ++ P L S V SC + P RP+ +++
Sbjct: 249 RKPPLFNMNAMSALYHIA-QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK-- 305
Query: 242 NAFLFTLRPPS 252
+ F+ RPP+
Sbjct: 306 HRFVLRERPPT 316
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 58/167 (34%), Positives = 85/167 (50%), Gaps = 15/167 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK-LDL 78
L+ +F +E+ +M++ +H+NLV+ LG D + +V +P SL L L L
Sbjct: 67 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
H+ A A ++ LH N IHRD+K N+LL + + K++DFGLAR
Sbjct: 127 HMRCKIAQGAANGINFLHENHHIHRDIKSANILL-DEAFTAKISDFGLARASEKFAQXVM 185
Query: 139 ---XXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
+MAPE LR GE K D+YSFG+VL E++T
Sbjct: 186 XXRIVGTTAYMAPE-----ALR-GE---ITPKSDIYSFGVVLLEIIT 223
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSL-RP-NKLDLHVA 81
++ E+++++ H N+VK L A + + I+ E G ++ ++ L RP + + V
Sbjct: 81 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 140
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXX 140
LD A++ LH N IIHRDLK N+L T D +KLADFG+ A+
Sbjct: 141 CKQTLD---ALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFI 196
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
WMAPE+ V + + Y+ K DV+S GI L E+ P ++ ++ A
Sbjct: 197 GTPYWMAPEV---VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253
Query: 201 FKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
K P L P S + ++ C ++ + R + SQ+++
Sbjct: 254 -KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+ ++ + + L + ++
Sbjct: 53 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSY 111
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 112 LFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 171 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRT 222
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 223 L--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 249
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 26 IREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
IRE++++ + H N+VK L ++ L ++ + L+K++ + + L + +
Sbjct: 53 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHV--DQDLKKFMDASALTGIPLPLIKS 110
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ + + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 111 YLFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 144 RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 170 LWYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFR 221
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 222 TL--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 249
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 22/231 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F +MMS++ H +LV G C ++V E + SL YL + N +++ L
Sbjct: 59 FFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLE 117
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKS-----LKLADFGLARXXXXXXXX 136
A +A AM L N +IH ++ N+LL D+K+ +KL+D G++
Sbjct: 118 VAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---ITVLPK 174
Query: 137 XXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 196
W+ PE K+ N D +SFG LWE+ + + +S L +
Sbjct: 175 DILQERIPWVPPECIEN-------PKNLNLATDKWSFGTTLWEICSGG--DKPLSALDSQ 225
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247
F R LP + +LA ++ +C +P+ RPSF IIR LN+ LFT
Sbjct: 226 RKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS-LFT 275
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 68/251 (27%), Positives = 121/251 (48%), Gaps = 21/251 (8%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMS 63
+K++ G S+E+ I+EV + +++H N +++ G ++ +V E G +
Sbjct: 45 IKKMSYSGKQSNEKW---QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101
Query: 64 LRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
V +P ++++ + AL + + LH++ +IHRD+K N+LL+ + +KL
Sbjct: 102 SDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLG 157
Query: 123 DFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
DFG A WMAPE+ + + +G+ Y+ KVDV+S GI EL
Sbjct: 158 DFGSASIMAPANXFVGTPY---WMAPEV--ILAMDEGQ---YDGKVDVWSLGITCIELAE 209
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
+ P M+ + A Y A ++ P L S V SC + P RP+ +++
Sbjct: 210 RKPPLFNMNAMSALYHIA-QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK-- 266
Query: 242 NAFLFTLRPPS 252
+ F+ RPP+
Sbjct: 267 HRFVLRERPPT 277
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 71.2 bits (173), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 111
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 112 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 169
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 170 HTDDEMAGFVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 220
Query: 189 GMSNL 193
G ++
Sbjct: 221 GTDHI 225
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 71.2 bits (173), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 14/158 (8%)
Query: 31 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 89
M+S V H +++ G +D + ++ + + G L L + + VA +A ++
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVC 116
Query: 90 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPE 149
A++ LH+ II+RDLKP+N+LL + +K+ DFG A+ Y +APE
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVTYXLCGTPDY--IAPE 173
Query: 150 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ ST K YN +D +SFGI+++E+L PF
Sbjct: 174 VVST--------KPYNKSIDWWSFGILIYEMLAGYTPF 203
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 71.2 bits (173), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSL-RP-NKLDLHVA 81
++ E+++++ H N+VK L A + + I+ E G ++ ++ L RP + + V
Sbjct: 81 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 140
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXX 140
LD A++ LH N IIHRDLK N+L T D +KLADFG+ A+
Sbjct: 141 CKQTLD---ALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRXIQRRDSFI 196
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
WMAPE+ V + + Y+ K DV+S GI L E+ P ++ ++ A
Sbjct: 197 GTPYWMAPEV---VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253
Query: 201 FKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
K P L P S + ++ C ++ + R + SQ+++
Sbjct: 254 -KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 71.2 bits (173), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 68/278 (24%), Positives = 131/278 (47%), Gaps = 28/278 (10%)
Query: 27 REVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNF 84
RE + +++H N+V+ + ++ +V +L+ G L + +V+ ++ D A +
Sbjct: 77 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHC 133
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXXXX 142
I ++ H+NGI+HR+LKP+NLLL K ++KLADFGLA
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 193
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAY-AA 199
+++PE+ +K Y+ VD+++ G++L+ LL PF E L A A
Sbjct: 194 PGYLSPEVL--------KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 245
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESD 259
A+ + P + ++P+ ++ S +P R + Q +++ ++ + ++ D
Sbjct: 246 AYDYPSPEW-DTVTPEAKSLIDSMLTVNPKKRITADQALKV--PWICNRERVASAIHRQD 302
Query: 260 TNEAAATSNGAMTEFSARARGKFAFLRQLFTAKRTKNL 297
T + + +F+AR + K A L + + NL
Sbjct: 303 TVD-------CLKKFNARRKLKGAILTTMIATRNLSNL 333
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 71.2 bits (173), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 18/187 (9%)
Query: 17 ERALLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLR--K 66
++ L + RF RE+ +M ++ H N+V+ G KD + + +V + +P R +
Sbjct: 51 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVAR 110
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + ++V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG
Sbjct: 111 HYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ + APEL T Y + +DV+S G VL ELL +
Sbjct: 170 AKQLVRGEPNVSXICSRYYRAPELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 222
Query: 187 FEGMSNL 193
F G S +
Sbjct: 223 FPGDSGV 229
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 71.2 bits (173), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSL-RP-NKLDLHVA 81
++ E+++++ H N+VK L A + + I+ E G ++ ++ L RP + + V
Sbjct: 81 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 140
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-ARXXXXXXXXXXXX 140
LD A++ LH N IIHRDLK N+L T D +KLADFG+ A+
Sbjct: 141 CKQTLD---ALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRXIQRRDXFI 196
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
WMAPE+ V + + Y+ K DV+S GI L E+ P ++ ++ A
Sbjct: 197 GTPYWMAPEV---VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253
Query: 201 FKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
K P L P S + ++ C ++ + R + SQ+++
Sbjct: 254 -KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 71.2 bits (173), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVAL 82
I+E++++ ++ H N++K+ + +D + IV EL L + + + K +
Sbjct: 80 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
+ + + A++ +H+ ++HRD+KP N+ +T +KL D GL R
Sbjct: 140 KYFVQLCSALEHMHSRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTA------ 192
Query: 143 YRWMAPELYSTVTLRQGEKKH---YNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYA 198
A L T E+ H YN K D++S G +L+E+ + PF G NL +
Sbjct: 193 ----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248
Query: 199 AAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQI 237
+ P LP D S +L +V C DP RP + +
Sbjct: 249 KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 71.2 bits (173), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 111
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 112 IVKCAKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 169
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 170 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 220
Query: 189 GMSNL 193
G ++
Sbjct: 221 GTDHI 225
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 70.9 bits (172), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ D+GLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDYGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 70.9 bits (172), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 55/189 (29%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+ V E L G L ++ S +K DL A +A +I + LH+ GI++RDLK DN+L
Sbjct: 94 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 151
Query: 112 LTPDQKSLKLADFGLARXXXXXXXXXXXXXXY-RWMAPELYSTVTLRQGEKKHYNNKVDV 170
L D +K+ADFG+ + ++APE+ G+K YN+ VD
Sbjct: 152 LDKD-GHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILL------GQK--YNHSVDW 202
Query: 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 230
+SFG++L+E+L + PF G + ++ + P P + + ++ +V +P
Sbjct: 203 WSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVKLFVREPEK 260
Query: 231 RPSFSQIIR 239
R IR
Sbjct: 261 RLGVRGDIR 269
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 70.9 bits (172), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 55/176 (31%), Positives = 81/176 (46%), Gaps = 22/176 (12%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM------VIVTELLPGMSLRKYLVSLRPNKLD 77
R +RE+ ++ R +H+N++ + P + +VT L+ G L K L + L
Sbjct: 87 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL---KTQHLS 142
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXX 137
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 143 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHT 201
Query: 138 XXXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
Y RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 202 GFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 250
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 70.9 bits (172), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 21/184 (11%)
Query: 13 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVS- 70
STS LLE EV ++ + H N++K +D +V E G L ++
Sbjct: 76 STSSNSKLLE-----EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR 130
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLAR 128
++ N++D V + L + LH + I+HRDLKP+NLLL +K +K+ DFGL+
Sbjct: 131 MKFNEVDAAVIIKQVL---SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
++APE+ +K Y+ K DV+S G++L+ LL PF
Sbjct: 188 VFENQKKMKERLGTAYYIAPEVL---------RKKYDEKCDVWSIGVILFILLAGYPPFG 238
Query: 189 GMSN 192
G ++
Sbjct: 239 GQTD 242
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 70.9 bits (172), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+ V E L G L ++ S +K DL A +A +I + LH+ GI++RDLK DN+L
Sbjct: 93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 150
Query: 112 LTPDQKSLKLADFGLARXXXXXXXXXXXXXXY-RWMAPELYSTVTLRQGEKKHYNNKVDV 170
L D +K+ADFG+ + ++APE+ G+K YN+ VD
Sbjct: 151 LDKD-GHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILL------GQK--YNHSVDW 201
Query: 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 230
+SFG++L+E+L + PF G + ++ + P P + + ++ +V +P
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVKLFVREPEK 259
Query: 231 RPSFSQIIR 239
R IR
Sbjct: 260 RLGVRGDIR 268
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 53/172 (30%), Positives = 80/172 (46%), Gaps = 19/172 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLG------ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLD 77
R RE+ ++ +KH+N++ L + +D V + L G L +V + D
Sbjct: 73 RTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNN-IVKCQALS-D 130
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXX 137
HV + R + +H+ GIIHRDLKP N+ + D + L++ DFGLAR
Sbjct: 131 EHVQF-LVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSE-LRILDFGLARQADEEMTGY 188
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
YR APE+ HYN VD++S G ++ ELL + F G
Sbjct: 189 VATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLQGKALFPG 231
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ + D +VK+ G P + +V E LP LR +L R +LD
Sbjct: 59 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRL 117
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L ++ I + M+ L + +HRDL N+L+ + +K+ADFGLA+
Sbjct: 118 LLYSSQICKGMEYLGSRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVRE 176
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-------RLPFEGM 190
+ W APE S ++ + DV+SFG+VL+EL T F M
Sbjct: 177 PGQSPIFWYAPESLSDNI--------FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 228
Query: 191 SNLQAAYAAAFKH-----------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ A + A P P ++ +++ CW P RPSFS +
Sbjct: 229 MGCERDVPALCRLLELLEEGQRLPAPPACPAEVHE----LMKLCWAPSPQDRPSFSALGP 284
Query: 240 MLN 242
L+
Sbjct: 285 QLD 287
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 39/243 (16%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ + D +VK+ G P + +V E LP LR +L R +LD
Sbjct: 55 FQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHR-ARLDASRL 113
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L ++ I + M+ L + +HRDL N+L+ + +K+ADFGLA+
Sbjct: 114 LLYSSQICKGMEYLGSRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDXXVVRE 172
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-------RLPFEGM 190
+ W APE S ++ + DV+SFG+VL+EL T F M
Sbjct: 173 PGQSPIFWYAPESLSDNI--------FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 224
Query: 191 SNLQAAYAAAFKH-----------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ A + A P P ++ +++ CW P RPSFS +
Sbjct: 225 MGCERDVPALCRLLELLEEGQRLPAPPACPAEVHE----LMKLCWAPSPQDRPSFSALGP 280
Query: 240 MLN 242
L+
Sbjct: 281 QLD 283
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ + D +VK+ G P + +V E LP LR +L R +LD
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRL 129
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L ++ I + M+ L + +HRDL N+L+ + +K+ADFGLA+
Sbjct: 130 LLYSSQICKGMEYLGSRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-------RLPFEGM 190
+ W APE S ++ + DV+SFG+VL+EL T F M
Sbjct: 189 PGQSPIFWYAPESLSDNI--------FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 240
Query: 191 SNLQAAYAAAFKH-----------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ A + A P P ++ +++ CW P RPSFS +
Sbjct: 241 MGCERDVPALSRLLELLEEGQRLPAPPACPAEVHE----LMKLCWAPSPQDRPSFSALGP 296
Query: 240 MLN 242
L+
Sbjct: 297 QLD 299
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 18/170 (10%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVS-LRPNKLDLHVAL 82
+REV ++ ++ H N++K +D +V E+ G L ++S R +++D A
Sbjct: 96 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AA 152
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXX 140
+ + +H N I+HRDLKP+NLLL K ++++ DFGL+
Sbjct: 153 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 212
Query: 141 XXYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
++APE L+ T Y+ K DV+S G++L+ LL+ PF G
Sbjct: 213 GTAYYIAPEVLHGT----------YDEKCDVWSTGVILYILLSGCPPFNG 252
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 18/170 (10%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVS-LRPNKLDLHVAL 82
+REV ++ ++ H N++K +D +V E+ G L ++S R +++D A
Sbjct: 97 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AA 153
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXX 140
+ + +H N I+HRDLKP+NLLL K ++++ DFGL+
Sbjct: 154 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 213
Query: 141 XXYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
++APE L+ T Y+ K DV+S G++L+ LL+ PF G
Sbjct: 214 GTAYYIAPEVLHGT----------YDEKCDVWSTGVILYILLSGCPPFNG 253
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 10/168 (5%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+V + + + +V E + L+K L + D + + +
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKI-Y 124
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ R + H + I+HRDLKP NLL+ D +LKLADFGLAR
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
W Y + G KK Y+ VD++S G + E++T + F G+++
Sbjct: 184 W-----YRAPDVLMGSKK-YSTSVDIWSIGCIFAEMITGKPLFPGVTD 225
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 10/168 (5%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+V + + + +V E + L+K L + D + + +
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKI-Y 124
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ R + H + I+HRDLKP NLL+ D +LKLADFGLAR
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
W Y + G KK Y+ VD++S G + E++T + F G+++
Sbjct: 184 W-----YRAPDVLMGSKK-YSTSVDIWSIGCIFAEMITGKPLFPGVTD 225
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 23/180 (12%)
Query: 15 SDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSL-R 72
+D+ +LL REV ++ ++ H N++K +D +V E+ G L ++S R
Sbjct: 74 TDKESLL-----REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 128
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXX 130
+++D A + + +H N I+HRDLKP+NLLL K ++++ DFGL+
Sbjct: 129 FSEVD---AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 185
Query: 131 XXXXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
++APE L+ T Y+ K DV+S G++L+ LL+ PF G
Sbjct: 186 EASKKMKDKIGTAYYIAPEVLHGT----------YDEKCDVWSTGVILYILLSGCPPFNG 235
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/172 (30%), Positives = 79/172 (45%), Gaps = 19/172 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLG------ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLD 77
R RE+ ++ +KH+N++ L + +D V + L G L + + D
Sbjct: 65 RTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALS--D 122
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXX 137
HV + R + +H+ GIIHRDLKP N+ + D + L++ DFGLAR
Sbjct: 123 EHVQF-LVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQADEEMTGY 180
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
YR APE+ HYN VD++S G ++ ELL + F G
Sbjct: 181 VATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLQGKALFPG 223
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 18/221 (8%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYL---VSLRPNKLDLHVAL 82
+E+ +M ++H LV + +D M +V +LL G LR +L V + + L
Sbjct: 64 KELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL---- 119
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
F ++ A+D L IIHRD+KPDN+LL + + + DF +A
Sbjct: 120 -FICELVMALDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMAGT 177
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA-AYAAAF 201
+MAPE++S+ R+G Y+ VD +S G+ +ELL R P+ S+ + F
Sbjct: 178 KPYMAPEMFSS---RKGAG--YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
+ P S ++ +++ +P+ R FSQ+ + N
Sbjct: 233 ETTVVTYPSAWSQEMVSLLKKLLEPNPDQR--FSQLSDVQN 271
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 55/186 (29%), Positives = 81/186 (43%), Gaps = 20/186 (10%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSL 71
E R +RE+ ++ R +H+N++ + P + V + + L L K L
Sbjct: 64 EHQTYXQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL--- 120
Query: 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX 131
+ L F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVAD 179
Query: 132 XXXXXXXXXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y RW APE+ K Y +D++S G +L E+L+NR F
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIF 232
Query: 188 EGMSNL 193
G L
Sbjct: 233 PGKHYL 238
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 26 IREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
IRE++++ + H N+VK L ++ L ++ + L+ ++ + + L + +
Sbjct: 49 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHV--HQDLKTFMDASALTGIPLPLIKS 106
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ + + + H++ ++HRDLKP NLL+ + ++KLADFGLAR
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 144 RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
W APE+ K+Y+ VD++S G + E++T R F G S + + F+
Sbjct: 166 LWYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFR 217
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G P++ +V P+ +PSF + R
Sbjct: 218 TL--GTPDE-------VVWPGVTSMPDYKPSFPKWAR 245
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 82/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ FGLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILGFGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 31/239 (12%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ + D +VK+ G P + +V E LP LR +L R +LD
Sbjct: 58 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRL 116
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
L ++ I + M+ L + +HRDL N+L+ + +K+ADFGLA+
Sbjct: 117 LLYSSQICKGMEYLGSRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVRE 175
Query: 142 XYR----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----------NRLPF 187
+ W APE S ++ + DV+SFG+VL+EL T L
Sbjct: 176 PGQSPIFWYAPESLSDNI--------FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 227
Query: 188 EGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
G A + + G P ++ +++ CW P RPSFS + L+
Sbjct: 228 MGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 286
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 18/170 (10%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVS-LRPNKLDLHVAL 82
+REV ++ ++ H N++K +D +V E+ G L ++S R +++D A
Sbjct: 73 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AA 129
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXX 140
+ + +H N I+HRDLKP+NLLL K ++++ DFGL+
Sbjct: 130 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 189
Query: 141 XXYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
++APE L+ T Y+ K DV+S G++L+ LL+ PF G
Sbjct: 190 GTAYYIAPEVLHGT----------YDEKCDVWSTGVILYILLSGCPPFNG 229
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 20/179 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 127
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTG 186
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
Y RW APE+ K Y +D++S G +L E+L+NR F G L
Sbjct: 187 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 67 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 123
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTG 182
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
Y RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 183 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 230
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 67 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 123
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTG 182
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
Y RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 183 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 230
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 82/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ D GLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDAGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 67 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 123
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTXDLKIXDFGLARVADPDHDHTG 182
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
Y RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 183 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 230
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 15/222 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSL-RP-NKLDLHVA 81
++ E+++++ H N+VK L A + + I+ E G ++ ++ L RP + + V
Sbjct: 54 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 113
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
LD A++ LH N IIHRDLK N+L T D +KLADFG++
Sbjct: 114 CKQTLD---ALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTXIQRRDSF 169
Query: 142 XYR--WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
WMAPE+ V + + Y+ K DV+S GI L E+ P ++ ++
Sbjct: 170 IGTPYWMAPEV---VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 226
Query: 200 AFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A K P L P S + ++ C ++ + R + SQ+++
Sbjct: 227 A-KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 267
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 82/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ D GLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDGGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 82/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DF LAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFYLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 20/179 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 72 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 128
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 129 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 187
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
Y RW APE+ K Y +D++S G +L E+L+NR F G L
Sbjct: 188 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 239
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 20/179 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 73 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 129
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 130 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 188
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
Y RW APE+ K Y +D++S G +L E+L+NR F G L
Sbjct: 189 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 240
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 20/179 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 64 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 120
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 121 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 179
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
Y RW APE+ K Y +D++S G +L E+L+NR F G L
Sbjct: 180 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 231
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 20/179 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 127
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 186
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
Y RW APE+ K Y +D++S G +L E+L+NR F G L
Sbjct: 187 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 69 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 125
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 126 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 184
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
Y RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 185 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 232
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 20/179 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 127
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 186
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
Y RW APE+ K Y +D++S G +L E+L+NR F G L
Sbjct: 187 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 65 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 121
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 122 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 180
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
Y RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 181 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 228
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 62/240 (25%), Positives = 107/240 (44%), Gaps = 23/240 (9%)
Query: 3 KFMKEVLNRGSTSDERAL-LEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLP 60
K ++LNR R+L + G+ RE+ + +H +++K P +V E +
Sbjct: 38 KVAVKILNRQKI---RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 120
G L Y+ + +++ A I A+D H + ++HRDLKP+N+LL + K
Sbjct: 95 GGELFDYIC--KHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNA-K 151
Query: 121 LADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
+ADFGL+ + APE+ S + + +VD++S G++L+ L
Sbjct: 152 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSCGVILYAL 204
Query: 181 LTNRLPFEGMSNLQAAYAAAFKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
L LPF+ FK R G +PE ++ +A ++ DP R + I
Sbjct: 205 LCGTLPFD-----DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDI 259
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXX 139
A F + + LH N +IHRDLK NL L D +K+ DFGLA +
Sbjct: 144 ARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKTL 202
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
++APE+ KK ++ +VD++S G +L+ LL + PFE S L+ Y
Sbjct: 203 CGTPNYIAPEVLC--------KKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIR 253
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K+ +P I+P + +++ DP LRPS ++++
Sbjct: 254 IKKNEY-SVPRHINPVASALIRRMLHADPTLRPSVAELL 291
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 65 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 121
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 122 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 180
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
Y RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 181 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 228
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 87 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 143
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 144 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 202
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
Y RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 203 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 250
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 75 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 131
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 132 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTG 190
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
Y RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 191 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 238
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 67 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 123
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTG 182
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
Y RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 183 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 230
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 67 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 123
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 182
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
Y RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 183 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 230
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 82/185 (44%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 115
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ D GLAR
Sbjct: 116 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDRGLAR 173
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
YR APE+ HYN VD++S G ++ ELLT R F
Sbjct: 174 HTDDEMTGYVATRWYR--APEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 224
Query: 189 GMSNL 193
G ++
Sbjct: 225 GTDHI 229
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXX 139
A F + + LH N +IHRDLK NL L D +K+ DFGLA +
Sbjct: 144 ARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKXL 202
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
++APE+ KK ++ +VD++S G +L+ LL + PFE S L+ Y
Sbjct: 203 CGTPNYIAPEVLC--------KKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIR 253
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K+ +P I+P + +++ DP LRPS ++++
Sbjct: 254 IKKNEY-SVPRHINPVASALIRRMLHADPTLRPSVAELL 291
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 17/235 (7%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHD-NLVKFLGA-------CKDPLMVIVTELLPGMSLR 65
T DE E +E+NM+ + H N+ + GA D + +V E S+
Sbjct: 60 TGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115
Query: 66 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
+ + + N L +I R + LH + +IHRD+K N+LLT + +KL DFG
Sbjct: 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFG 174
Query: 126 L-ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
+ A+ WMAPE+ + + Y+ K D++S GI E+
Sbjct: 175 VSAQLDRTVGRRNTFIGTPYWMAPEV---IACDENPDATYDFKSDLWSLGITAIEMAEGA 231
Query: 185 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P M ++A + A + S ++SC V++ + RP+ Q+++
Sbjct: 232 PPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXX 139
A F + + LH N +IHRDLK NL L D +K+ DFGLA +
Sbjct: 128 ARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDL 186
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
++APE+ KK ++ +VD++S G +L+ LL + PFE S L+ Y
Sbjct: 187 CGTPNYIAPEVLC--------KKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIR 237
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K+ +P I+P + +++ DP LRPS ++++
Sbjct: 238 IKKNEY-SVPRHINPVASALIRRMLHADPTLRPSVAELL 275
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 62/240 (25%), Positives = 107/240 (44%), Gaps = 23/240 (9%)
Query: 3 KFMKEVLNRGSTSDERAL-LEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLP 60
K ++LNR R+L + G+ RE+ + +H +++K P +V E +
Sbjct: 38 KVAVKILNRQKI---RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 120
G L Y+ + +++ A I A+D H + ++HRDLKP+N+LL + K
Sbjct: 95 GGELFDYIC--KHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNA-K 151
Query: 121 LADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
+ADFGL+ + APE+ S + + +VD++S G++L+ L
Sbjct: 152 IADFGLSNMMSDGEFLRDSCGSPNYAAPEVISG-------RLYAGPEVDIWSCGVILYAL 204
Query: 181 LTNRLPFEGMSNLQAAYAAAFKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
L LPF+ FK R G +PE ++ +A ++ DP R + I
Sbjct: 205 LCGTLPFD-----DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDI 259
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 20/179 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KCQHLSN 127
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 186
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
Y RW APE+ K Y +D++S G +L E+L+NR F G L
Sbjct: 187 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXX 139
A F + + LH N +IHRDLK NL L D +K+ DFGLA +
Sbjct: 144 ARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDL 202
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
++APE+ KK ++ +VD++S G +L+ LL + PFE S L+ Y
Sbjct: 203 CGTPNYIAPEVLC--------KKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIR 253
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
K+ +P I+P + +++ DP LRPS ++++
Sbjct: 254 IKKNEY-SVPRHINPVASALIRRMLHADPTLRPSVAELL 291
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 67.8 bits (164), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 15/192 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVAL 82
F E ++M+ +V+ A +D + +V E +PG L + + P K A
Sbjct: 122 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKW----AK 177
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG--LARXXXXXXXXXXXX 140
+ ++ A+D +H+ G+IHRD+KPDN+LL LKLADFG +
Sbjct: 178 FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK-HGHLKLADFGTCMKMDETGMVHCDTAV 236
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
+++PE+ + QG +Y + D +S G+ L+E+L PF S L Y+
Sbjct: 237 GTPDYISPEVLKS----QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-LVGTYSKI 291
Query: 201 FKHARP-GLPED 211
H PED
Sbjct: 292 MDHKNSLCFPED 303
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 53/183 (28%), Positives = 82/183 (44%), Gaps = 34/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLV-SLRPNKLDL 78
R RE+ ++ ++H+N++ L P SLR YLV L
Sbjct: 69 RAYRELLLLKHMQHENVIGLLDV-----------FTPASSLRNFYDFYLVMPFMQTDLQK 117
Query: 79 HVALNFA--------LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ L F+ + + + +H+ G++HRDLKP NL + D + LK+ DFGLAR
Sbjct: 118 IMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHA 176
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
YR APE+ + HYN VD++S G ++ E+LT + F+G
Sbjct: 177 DAEMTGYVVTRWYR--APEVILSWM-------HYNQTVDIWSVGCIMAEMLTGKTLFKGK 227
Query: 191 SNL 193
L
Sbjct: 228 DYL 230
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 18/170 (10%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVS-LRPNKLDLHVAL 82
+REV ++ ++ H N+ K +D +V E+ G L ++S R +++D A
Sbjct: 73 LLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AA 129
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXX 140
+ + H N I+HRDLKP+NLLL K ++++ DFGL+
Sbjct: 130 RIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI 189
Query: 141 XXYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
++APE L+ T Y+ K DV+S G++L+ LL+ PF G
Sbjct: 190 GTAYYIAPEVLHGT----------YDEKCDVWSTGVILYILLSGCPPFNG 229
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87
E+ ++ ++ H ++K IV EL+ G L +V + +L +
Sbjct: 64 EIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQ 121
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRW 145
+ A+ LH NGIIHRDLKP+N+LL+ ++ +K+ DFG ++ +
Sbjct: 122 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 181
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE---GMSNLQAAYAAAFK 202
+APE+ +V YN VD +S G++L+ L+ PF +L+ +
Sbjct: 182 LAPEVLVSVG-----TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 236
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ P + ++S +V+ V DP R + + +R
Sbjct: 237 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 273
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87
E+ ++ ++ H ++K IV EL+ G L +V + +L +
Sbjct: 65 EIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQ 122
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRW 145
+ A+ LH NGIIHRDLKP+N+LL+ ++ +K+ DFG ++ +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE---GMSNLQAAYAAAFK 202
+APE+ +V YN VD +S G++L+ L+ PF +L+ +
Sbjct: 183 LAPEVLVSVG-----TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ P + ++S +V+ V DP R + + +R
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 67.4 bits (163), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87
E+ ++ ++ H ++K IV EL+ G L +V + +L +
Sbjct: 65 EIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQ 122
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRW 145
+ A+ LH NGIIHRDLKP+N+LL+ ++ +K+ DFG ++ +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE---GMSNLQAAYAAAFK 202
+APE+ +V YN VD +S G++L+ L+ PF +L+ +
Sbjct: 183 LAPEVLVSVG-----TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ P + ++S +V+ V DP R + + +R
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 67.4 bits (163), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87
E+ ++ ++ H ++K IV EL+ G L +V + +L +
Sbjct: 71 EIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQ 128
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRW 145
+ A+ LH NGIIHRDLKP+N+LL+ ++ +K+ DFG ++ +
Sbjct: 129 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 188
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE---GMSNLQAAYAAAFK 202
+APE+ +V YN VD +S G++L+ L+ PF +L+ +
Sbjct: 189 LAPEVLVSVG-----TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 243
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ P + ++S +V+ V DP R + + +R
Sbjct: 244 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 280
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 67.4 bits (163), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87
E+ ++ ++ H ++K IV EL+ G L +V + +L +
Sbjct: 204 EIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQ 261
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRW 145
+ A+ LH NGIIHRDLKP+N+LL+ ++ +K+ DFG ++ +
Sbjct: 262 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 321
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE---GMSNLQAAYAAAFK 202
+APE+ +V YN VD +S G++L+ L+ PF +L+ +
Sbjct: 322 LAPEVLVSVG-----TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 376
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ P + ++S +V+ V DP R + + +R
Sbjct: 377 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 413
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 67.4 bits (163), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87
E+ ++ ++ H ++K IV EL+ G L +V + +L +
Sbjct: 65 EIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQ 122
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRW 145
+ A+ LH NGIIHRDLKP+N+LL+ ++ +K+ DFG ++ +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE---GMSNLQAAYAAAFK 202
+APE+ +V YN VD +S G++L+ L+ PF +L+ +
Sbjct: 183 LAPEVLVSVG-----TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ P + ++S +V+ V DP R + + +R
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 67.4 bits (163), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 55/164 (33%), Positives = 81/164 (49%), Gaps = 9/164 (5%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK-LDL 78
L+ +F +E+ + ++ +H+NLV+ LG D + +V P SL L L L
Sbjct: 64 LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
H A A ++ LH N IHRD+K N+LL + + K++DFGLAR
Sbjct: 124 HXRCKIAQGAANGINFLHENHHIHRDIKSANILL-DEAFTAKISDFGLARASEKFAQXVX 182
Query: 139 XXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
R + Y +GE K D+YSFG+VL E++T
Sbjct: 183 XS---RIVGTTAYXAPEALRGE---ITPKSDIYSFGVVLLEIIT 220
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 67.4 bits (163), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 58/221 (26%), Positives = 109/221 (49%), Gaps = 19/221 (8%)
Query: 27 REVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNF 84
RE + +++H N+V+ + ++ +V +L+ G L + +V+ ++ D A +
Sbjct: 54 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHC 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXXXX 142
I ++ H+NGI+HR+LKP+NLLL K ++KLADFGLA
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAY-AA 199
+++PE+ +K Y+ VD+++ G++L+ LL PF E L A A
Sbjct: 171 PGYLSPEVL--------KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 222
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
A+ + P + ++P+ ++ S +P R + Q +++
Sbjct: 223 AYDYPSPEW-DTVTPEAKSLIDSMLTVNPKKRITADQALKV 262
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 67.4 bits (163), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 58/221 (26%), Positives = 109/221 (49%), Gaps = 19/221 (8%)
Query: 27 REVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNF 84
RE + +++H N+V+ + ++ +V +L+ G L + +V+ ++ D A +
Sbjct: 53 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHC 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXXXX 142
I ++ H+NGI+HR+LKP+NLLL K ++KLADFGLA
Sbjct: 110 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 169
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAY-AA 199
+++PE+ +K Y+ VD+++ G++L+ LL PF E L A A
Sbjct: 170 PGYLSPEVL--------KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 221
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
A+ + P + ++P+ ++ S +P R + Q +++
Sbjct: 222 AYDYPSPEW-DTVTPEAKSLIDSMLTVNPKKRITADQALKV 261
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 67.4 bits (163), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87
E+ ++ ++ H ++K IV EL+ G L +V + +L +
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQ 247
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRW 145
+ A+ LH NGIIHRDLKP+N+LL+ ++ +K+ DFG ++ +
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 307
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE---GMSNLQAAYAAAFK 202
+APE+ +V YN VD +S G++L+ L+ PF +L+ +
Sbjct: 308 LAPEVLVSVG-----TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ P + ++S +V+ V DP R + + +R
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 58/221 (26%), Positives = 109/221 (49%), Gaps = 19/221 (8%)
Query: 27 REVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNF 84
RE + +++H N+V+ + ++ +V +L+ G L + +V+ ++ D A +
Sbjct: 54 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHC 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXXXX 142
I ++ H+NGI+HR+LKP+NLLL K ++KLADFGLA
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAY-AA 199
+++PE+ +K Y+ VD+++ G++L+ LL PF E L A A
Sbjct: 171 PGYLSPEVL--------KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 222
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
A+ + P + ++P+ ++ S +P R + Q +++
Sbjct: 223 AYDYPSPEW-DTVTPEAKSLIDSMLTVNPKKRITADQALKV 262
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 61/251 (24%), Positives = 113/251 (45%), Gaps = 22/251 (8%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLD 77
E +E+ ++ R++H N+++ + K + +++ + GM ++ L S+ +
Sbjct: 50 EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKRFP 107
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---XXXX 134
+ A + + ++ LH+ GI+H+D+KP NLLLT +LK++ G+A
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADD 166
Query: 135 XXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
+ PE+ + + G KVD++S G+ L+ + T PFEG N+
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSG------FKVDIWSAGVTLYNITTGLYPFEG-DNIY 219
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP---P 251
+ K + +P D P L+ +++ +P R S Q IR + F P P
Sbjct: 220 KLFENIGKGSY-AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQ-IRQHSWFRKKHPPAEAP 277
Query: 252 SPSVPESDTNE 262
P P DT +
Sbjct: 278 VPIPPSPDTKD 288
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 16/175 (9%)
Query: 18 RALLEGRFIR-EVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
+ ++ + +R E+ ++ R+ H N++K + P + +V EL+ G L +V
Sbjct: 87 KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV--EKGY 144
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQKSLKLADFGLARXXXX 132
A + I A+ LH NGI+HRDLKP+NLL PD LK+ADFGL++
Sbjct: 145 YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA-PLKIADFGLSKIVEH 203
Query: 133 XXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ APE+ Y +VD++S GI+ + LL PF
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCA--------YGPEVDMWSVGIITYILLCGFEPF 250
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 34/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY-----LVSLRPNKLDL 78
R RE+ ++ ++H+N++ L P SLR + ++ L
Sbjct: 87 RAYRELLLLKHMQHENVIGLLDV-----------FTPASSLRNFYDFYLVMPFMQTDLQK 135
Query: 79 HVALNFA--------LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ + F+ + + + +H+ G++HRDLKP NL + D + LK+ DFGLAR
Sbjct: 136 IMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHA 194
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
YR APE+ + HYN VD++S G ++ E+LT + F+G
Sbjct: 195 DAEMTGYVVTRWYR--APEVILSWM-------HYNQTVDIWSVGCIMAEMLTGKTLFKGK 245
Query: 191 SNL 193
L
Sbjct: 246 DYL 248
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 13/164 (7%)
Query: 28 EVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
E N++ VKH +V + A + + ++ E L G L ++ R A +
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLA 128
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX-XXXYRW 145
+I+ A+ LH GII+RDLKP+N++L Q +KL DFGL + +
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
MAPE + +R G +N VD +S G +++++LT PF G
Sbjct: 188 MAPE----ILMRSG----HNRAVDWWSLGALMYDMLTGAPPFTG 223
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 10/167 (5%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IREV+++ +KH N+V + + +V E L L++YL N +++H F
Sbjct: 48 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC-GNIINMHNVKLF 105
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
+ R + H ++HRDLKP NLL+ ++ LKLADFGLAR
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTL 164
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 191
W P + L + Y+ ++D++ G + +E+ T R F G +
Sbjct: 165 WYRP---PDILLGSTD---YSTQIDMWGVGCIFYEMATGRPLFPGST 205
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 52/170 (30%), Positives = 86/170 (50%), Gaps = 16/170 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH---VAL 82
RE ++ +KH ++V+ L D ++ +V E + G L +V R + ++ VA
Sbjct: 75 REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVAS 133
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLA-RXXXXXXXXXXX 139
++ I A+ H N IIHRD+KP+N+LL + S +KL DFG+A +
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR 193
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+MAPE+ +++ Y VDV+ G++L+ LL+ LPF G
Sbjct: 194 VGTPHFMAPEVV--------KREPYGKPVDVWGCGVILFILLSGCLPFYG 235
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 19/225 (8%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR-PNKLDLH 79
E E+ ++ ++KH+N+V + P + +V +L+ G L +V + D
Sbjct: 64 ESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS 123
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLL-LTPDQKS-LKLADFGLARXXXXXXXXX 137
+ LD A+ LH GI+HRDLKP+NLL + D++S + ++DFGL++
Sbjct: 124 TLIRQVLD---AVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMS 180
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNL-Q 194
++APE+ + +K Y+ VD +S G++ + LL PF E S L +
Sbjct: 181 TACGTPGYVAPEVLA--------QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFE 232
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A ++ P +DIS +++ +DPN R + Q R
Sbjct: 233 QILKAEYEFDSP-YWDDISDSAKDFIRNLMEKDPNKRYTCEQAAR 276
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 13/164 (7%)
Query: 28 EVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
E N++ VKH +V + A + + ++ E L G L ++ R A +
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLA 128
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX-XXXYRW 145
+I+ A+ LH GII+RDLKP+N++L Q +KL DFGL + +
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEY 187
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
MAPE + +R G +N VD +S G +++++LT PF G
Sbjct: 188 MAPE----ILMRSG----HNRAVDWWSLGALMYDMLTGAPPFTG 223
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ +H+N++ + P + V + + L L K L + L
Sbjct: 69 RTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 125
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 126 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTSDLKICDFGLARVADPDHDHTG 184
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
Y RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 185 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 232
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 17/219 (7%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSL-RPNKLDLHVA 81
R E+ + ++H ++ + + + +V E PG L Y++S R ++ + V
Sbjct: 54 RIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVV 113
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--XXXXXXXXXXX 139
I A+ +H+ G HRDLKP+NLL K LKL DFGL
Sbjct: 114 FR---QIVSAVAYVHSQGYAHRDLKPENLLFDEYHK-LKLIDFGLCAKPKGNKDYHLQTC 169
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
+ APEL QG K + ++ DV+S GI+L+ L+ LPF+ N+ A Y
Sbjct: 170 CGSLAYAAPELI------QG-KSYLGSEADVWSMGILLYVLMCGFLPFDD-DNVMALYKK 221
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ + +P+ +SP ++Q DP R S ++
Sbjct: 222 IMR-GKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLL 259
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 15/192 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR-PNKLDLHVAL 82
F E ++M+ +V+ A +D + +V E +PG L + + P K A
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW----AR 176
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG--LARXXXXXXXXXXXX 140
+ ++ A+D +H+ G IHRD+KPDN+LL LKLADFG +
Sbjct: 177 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
+++PE+ + QG +Y + D +S G+ L+E+L PF S L Y+
Sbjct: 236 GTPDYISPEVLKS----QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKI 290
Query: 201 FKHARP-GLPED 211
H P+D
Sbjct: 291 MNHKNSLTFPDD 302
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 15/192 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR-PNKLDLHVAL 82
F E ++M+ +V+ A +D + +V E +PG L + + P K A
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW----AR 171
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG--LARXXXXXXXXXXXX 140
+ ++ A+D +H+ G IHRD+KPDN+LL LKLADFG +
Sbjct: 172 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
+++PE+ + QG +Y + D +S G+ L+E+L PF S L Y+
Sbjct: 231 GTPDYISPEVLKS----QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKI 285
Query: 201 FKHARP-GLPED 211
H P+D
Sbjct: 286 MNHKNSLTFPDD 297
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 26/280 (9%)
Query: 3 KFMKEVLNRGSTSDERAL-LEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLP 60
K ++LNR R+L + G+ RE+ + +H +++K P + +V E +
Sbjct: 43 KVAVKILNRQKI---RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVS 99
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 120
G L Y+ + +LD + I +D H + ++HRDLKP+N+LL + K
Sbjct: 100 GGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNA-K 156
Query: 121 LADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
+ADFGL+ + APE+ S + + +VD++S G++L+ L
Sbjct: 157 IADFGLSNMMSDGEFLRXSCGSPNYAAPEVISG-------RLYAGPEVDIWSSGVILYAL 209
Query: 181 LTNRLPFEGMSNLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
L LPF+ FK G+ P+ ++P + +++ DP R +
Sbjct: 210 LCGTLPFD-----DDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKD- 263
Query: 238 IRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTEFSAR 277
IR F L P PE + + + A+ E +
Sbjct: 264 IREHEWFKQDL--PKYLFPEDPSYSSTMIDDEALKEVCEK 301
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 15/192 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR-PNKLDLHVAL 82
F E ++M+ +V+ A +D + +V E +PG L + + P K A
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW----AR 176
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG--LARXXXXXXXXXXXX 140
+ ++ A+D +H+ G IHRD+KPDN+LL LKLADFG +
Sbjct: 177 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
+++PE+ + QG +Y + D +S G+ L+E+L PF S L Y+
Sbjct: 236 GTPDYISPEVLKS----QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKI 290
Query: 201 FKHARP-GLPED 211
H P+D
Sbjct: 291 MNHKNSLTFPDD 302
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 65.9 bits (159), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 21/184 (11%)
Query: 13 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSL-RKYLVS 70
+TS+ ALL+ EV ++ ++ H N++K +D +V E+ G L + ++
Sbjct: 61 TTSNSGALLD-----EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILR 115
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLAR 128
+ +++D V + L LH + I+HRDLKP+NLLL + +K+ DFGL+
Sbjct: 116 QKFSEVDAAVIMKQVLS---GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA 172
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
++APE+ +K Y+ K DV+S G++L+ LL PF
Sbjct: 173 HFEVGGKMKERLGTAYYIAPEVL---------RKKYDEKCDVWSCGVILYILLCGYPPFG 223
Query: 189 GMSN 192
G ++
Sbjct: 224 GQTD 227
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 80/183 (43%), Gaps = 33/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
R +RE+ ++ KHDN++ A KD I+ +P + V L + DLH ++
Sbjct: 100 RTLRELKILKHFKHDNII----AIKD----ILRPTVPYGEFKSVYVVLDLMESDLHQIIH 151
Query: 84 ------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX 131
F + R + +H+ +IHRDLKP NLL+ + LK+ DFG+AR
Sbjct: 152 SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLC 210
Query: 132 XXXXX----XXXXXXYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
RW APEL ++ Y +D++S G + E+L R
Sbjct: 211 TSPAEHQYFMTEYVATRWYRAPELMLSL-------HEYTQAIDLWSVGCIFGEMLARRQL 263
Query: 187 FEG 189
F G
Sbjct: 264 FPG 266
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ +H+N++ + P + V + + L L K L + L
Sbjct: 69 RTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 125
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 126 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 184
Query: 139 XXXXY---RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
Y RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 185 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 232
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
H + +I A++ LH GII+RD+K +N+LL + + L DFGL++
Sbjct: 159 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERA 217
Query: 139 XX--XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQ 194
+MAP++ +R G+ H + VD +S G++++ELLT PF +G N Q
Sbjct: 218 YDFCGTIEYMAPDI-----VRGGDSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 271
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
A + + P P+++S ++Q ++DP R
Sbjct: 272 AEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 80/183 (43%), Gaps = 33/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
R +RE+ ++ KHDN++ A KD I+ +P + V L + DLH ++
Sbjct: 99 RTLRELKILKHFKHDNII----AIKD----ILRPTVPYGEFKSVYVVLDLMESDLHQIIH 150
Query: 84 ------------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--- 128
F + R + +H+ +IHRDLKP NLL+ + LK+ DFG+AR
Sbjct: 151 SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLC 209
Query: 129 -XXXXXXXXXXXXXXYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
RW APEL ++ Y +D++S G + E+L R
Sbjct: 210 TSPAEHQYFMTEYVATRWYRAPELMLSL-------HEYTQAIDLWSVGCIFGEMLARRQL 262
Query: 187 FEG 189
F G
Sbjct: 263 FPG 265
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 65.5 bits (158), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 56/182 (30%), Positives = 82/182 (45%), Gaps = 26/182 (14%)
Query: 24 RFIREVNMMSRVKHDNLVKF--------LGACKDPLMVIVTELLPGMSLRKYLVSLRPNK 75
R +RE+ ++ R +H+N++ L A +D V + + L L K L S +
Sbjct: 87 RTLREIQILLRFRHENVIGIRDILRASTLEAMRD---VYIVQDLMETDLYKLLKS---QQ 140
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
L F I R + +H+ ++HRDLKP NLL+ LK+ DFGLAR
Sbjct: 141 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLIN-TTCDLKICDFGLARIADPEHD 199
Query: 136 XX---XXXXXYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 191
RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 200 HTGFLTEXVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252
Query: 192 NL 193
L
Sbjct: 253 YL 254
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 65.5 bits (158), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 10/167 (5%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ +KH N+VK +V+V E L L+K L+ + L+ A +F
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKK-LLDVCEGGLESVTAKSF 105
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
L + + H ++HRDLKP NLL+ + LK+ADFGLAR
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEVVTL 164
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 191
W Y + G KK Y+ +D++S G + E++ F G+S
Sbjct: 165 W-----YRAPDVLMGSKK-YSTTIDIWSVGCIFAEMVNGTPLFPGVS 205
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 65.5 bits (158), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 10/167 (5%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ +KH N+VK +V+V E L L+K L+ + L+ A +F
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKK-LLDVCEGGLESVTAKSF 105
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
L + + H ++HRDLKP NLL+ + LK+ADFGLAR
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTL 164
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 191
W Y + G KK Y+ +D++S G + E++ F G+S
Sbjct: 165 W-----YRAPDVLMGSKK-YSTTIDIWSVGCIFAEMVNGTPLFPGVS 205
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 65.5 bits (158), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 16/167 (9%)
Query: 27 REVNMMSRV-KHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
E+ ++ R +H N++ D V +VTEL+ G L + LR A
Sbjct: 64 EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREASAV 121
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---KSLKLADFGLARXXXXXXXXXXX-X 140
I + ++ LHA G++HRDLKP N+L + +S+++ DFG A+
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++APE V RQG Y+ D++S G++L+ +LT PF
Sbjct: 182 YTANFVAPE----VLERQG----YDAACDIWSLGVLLYTMLTGYTPF 220
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 21/184 (11%)
Query: 13 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSL-RKYLVS 70
+TS+ ALL+ EV ++ ++ H N++K +D +V E+ G L + ++
Sbjct: 44 TTSNSGALLD-----EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILR 98
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLAR 128
+ +++D V + L LH + I+HRDLKP+NLLL + +K+ DFGL+
Sbjct: 99 QKFSEVDAAVIMKQVL---SGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA 155
Query: 129 XXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
++APE+ +K Y+ K DV+S G++L+ LL PF
Sbjct: 156 HFEVGGKMKERLGTAYYIAPEVL---------RKKYDEKCDVWSCGVILYILLCGYPPFG 206
Query: 189 GMSN 192
G ++
Sbjct: 207 GQTD 210
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 10/167 (5%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ +KH N+VK +V+V E L L+K L+ + L+ A +F
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKK-LLDVCEGGLESVTAKSF 105
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYR 144
L + + H ++HRDLKP NLL+ + LK+ADFGLAR
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEVVTL 164
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 191
W Y + G KK Y+ +D++S G + E++ F G+S
Sbjct: 165 W-----YRAPDVLMGSKK-YSTTIDIWSVGCIFAEMVNGAPLFPGVS 205
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 127
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---XXXXX 135
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 186
Query: 136 XXXXXXXYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 187 FLXEXVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 234
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 20/175 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + + L L K L + L
Sbjct: 72 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL---KTQHLSN 128
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---XXXXX 135
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR
Sbjct: 129 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTG 187
Query: 136 XXXXXXXYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 188 FLXEXVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG 235
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 65.1 bits (157), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 67/243 (27%), Positives = 102/243 (41%), Gaps = 28/243 (11%)
Query: 9 LNRGS-TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSL 64
L+ GS T E+ +L + EVN++ +KH N+V++ D + IV E G L
Sbjct: 39 LDYGSMTEAEKQML----VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL 94
Query: 65 RKYLVSLRPNK--LDLHVALNFALDIARAMDCLH-----ANGIIHRDLKPDNLLLTPDQK 117
+ + LD L + A+ H + ++HRDLKP N+ L Q
Sbjct: 95 ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ- 153
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXY-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176
++KL DFGLAR +M+PE Q + YN K D++S G +
Sbjct: 154 NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE--------QMNRMSYNEKSDIWSLGCL 205
Query: 177 LWELLTNRLPFEGMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
L+EL PF S Q A + + +P S +L I+ RPS
Sbjct: 206 LYELCALMPPFTAFS--QKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVE 263
Query: 236 QII 238
+I+
Sbjct: 264 EIL 266
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 65.1 bits (157), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 6/143 (4%)
Query: 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLR 157
+G+IHRD+KP N+LL ++ +KL DFG++ +MAPE +
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPE---RIDPP 199
Query: 158 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI--SPD 215
K Y+ + DV+S GI L EL T + P++ + P LP + S D
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259
Query: 216 LAFIVQSCWVEDPNLRPSFSQII 238
V+ C +D RP +++++
Sbjct: 260 FQSFVKDCLTKDHRKRPKYNKLL 282
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 67/243 (27%), Positives = 102/243 (41%), Gaps = 28/243 (11%)
Query: 9 LNRGS-TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSL 64
L+ GS T E+ +L + EVN++ +KH N+V++ D + IV E G L
Sbjct: 39 LDYGSMTEAEKQML----VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL 94
Query: 65 RKYLVSLRPNK--LDLHVALNFALDIARAMDCLH-----ANGIIHRDLKPDNLLLTPDQK 117
+ + LD L + A+ H + ++HRDLKP N+ L Q
Sbjct: 95 ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ- 153
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXY-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176
++KL DFGLAR +M+PE Q + YN K D++S G +
Sbjct: 154 NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE--------QMNRMSYNEKSDIWSLGCL 205
Query: 177 LWELLTNRLPFEGMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
L+EL PF S Q A + + +P S +L I+ RPS
Sbjct: 206 LYELCALMPPFTAFS--QKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVE 263
Query: 236 QII 238
+I+
Sbjct: 264 EIL 266
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
E+ ++ ++KH+N+V + +V +L+ G L ++ R + +L
Sbjct: 56 EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQ- 113
Query: 87 DIARAMDCLHANGIIHRDLKPDNLL-LTPDQKS-LKLADFGLARXXXXXXXXXXXXXXYR 144
+ A+ LH NGI+HRDLKP+NLL LTP++ S + + DFGL++
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTP-G 172
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFK 202
++APE+ + +K Y+ VD +S G++ + LL PF E S L +
Sbjct: 173 YVAPEVLA--------QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY 224
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+DIS + +DPN R
Sbjct: 225 EFESPFWDDISESAKDFICHLLEKDPNER 253
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 21/220 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E+ MS ++H LV A +D MV++ E + G L + V+ NK+ A+ +
Sbjct: 97 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE-KVADEHNKMSEDEAVEYM 155
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + +H N +H DLKP+N++ T + + LKL DFGL
Sbjct: 156 RQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 215
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG------MSNLQAAYA 198
+ APE+ E K D++S G++ + LL+ PF G + N+++
Sbjct: 216 FAAPEV--------AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 267
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
A G IS D ++ + DPN R + Q +
Sbjct: 268 NMDDSAFSG----ISEDGKDFIRKLLLADPNTRMTIHQAL 303
>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g
pdb|2HW7|A Chain A, Crystal Structure Of Mnk2-D228g In Complex With
Staurosporine
Length = 316
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 54/190 (28%), Positives = 91/190 (47%), Gaps = 19/190 (10%)
Query: 21 LEGRFIREVNMMSRVK-HDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRP-NKLD 77
+ R REV M+ + + H N+++ + ++ +V E + G S+ ++ R N+L+
Sbjct: 53 IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE 112
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT-PDQKS-LKLADFGLARXXXXXXX 135
V + D+A A+D LH GI HRDLKP+N+L P+Q S +K+ DFGL
Sbjct: 113 ASVVVQ---DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGD 169
Query: 136 XXXXXX--------XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+MAPE+ + E Y+ + D++S G++L+ LL+ PF
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFS---EEASIYDKRCDLWSLGVILYILLSGYPPF 226
Query: 188 EGMSNLQAAY 197
G +
Sbjct: 227 VGRCGSDCGW 236
>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase-Activated Protein Kinase 3
(Mk3)-Inhibitor Complex
pdb|3FXW|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase- Activated Protein Kinase 3INHIBITOR 2
COMPLEX
Length = 336
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 21/197 (10%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++I+ E + G L + A DI A+ LH++ I HRD+KP+NLL
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T +K LKL DFG A+ Y ++APE+ G +K Y+ D
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVL-------GPEK-YDKSCD 211
Query: 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH----ARPGLP----EDISPDLAFIVQ 221
++S G++++ LL PF SN A + K + G P ++S D +++
Sbjct: 212 MWSLGVIMYILLCGFPPF--YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIR 269
Query: 222 SCWVEDPNLRPSFSQII 238
DP R + +Q +
Sbjct: 270 LLLKTDPTERLTITQFM 286
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 21/220 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E+ MS ++H LV A +D MV++ E + G L + V+ NK+ A+ +
Sbjct: 203 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE-KVADEHNKMSEDEAVEYM 261
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLARXXXXXXXXXXXXXXYR 144
+ + + +H N +H DLKP+N++ T + + LKL DFGL
Sbjct: 262 RQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 321
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG------MSNLQAAYA 198
+ APE+ E K D++S G++ + LL+ PF G + N+++
Sbjct: 322 FAAPEV--------AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
A G IS D ++ + DPN R + Q +
Sbjct: 374 NMDDSAFSG----ISEDGKDFIRKLLLADPNTRMTIHQAL 409
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVK---HDNLVKFLGAC------KDPLM 52
G+F+ R T +E L IREV ++ ++ H N+V+ C ++ +
Sbjct: 37 GRFVALKRVRVQTGEEGMPLST--IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 94
Query: 53 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
+V E + L YL + + + + R +D LH++ ++HRDLKP N+L+
Sbjct: 95 TLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV 153
Query: 113 TPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172
T + +KLADFGLAR + APE+ + Y VD++S
Sbjct: 154 TSSGQ-IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL--------QSSYATPVDLWS 204
Query: 173 FGIVLWELLTNRLPFEGMSNL 193
G + E+ + F G S++
Sbjct: 205 VGCIFAEMFRRKPLFRGSSDV 225
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVK---HDNLVKFLGAC------KDPLM 52
G+F+ R T +E L IREV ++ ++ H N+V+ C ++ +
Sbjct: 37 GRFVALKRVRVQTGEEGMPLST--IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 94
Query: 53 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
+V E + L YL + + + + R +D LH++ ++HRDLKP N+L+
Sbjct: 95 TLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV 153
Query: 113 TPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172
T + +KLADFGLAR + APE+ + Y VD++S
Sbjct: 154 TSSGQ-IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL--------QSSYATPVDLWS 204
Query: 173 FGIVLWELLTNRLPFEGMSNL 193
G + E+ + F G S++
Sbjct: 205 VGCIFAEMFRRKPLFRGSSDV 225
>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b
pdb|3SHE|A Chain A, Novel Atp-Competitive Mk2 Inhibitors With Potent
Biochemical And Cell- Based Activity Throughout The
Series
Length = 317
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 21/197 (10%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++I+ E + G L + A DI A+ LH++ I HRD+KP+NLL
Sbjct: 82 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T +K LKL DFG A+ Y ++APE+ G +K Y+ D
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVL-------GPEK-YDKSCD 192
Query: 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH----ARPGLP----EDISPDLAFIVQ 221
++S G++++ LL PF SN A + K + G P ++S D +++
Sbjct: 193 MWSLGVIMYILLCGFPPF--YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIR 250
Query: 222 SCWVEDPNLRPSFSQII 238
DP R + +Q +
Sbjct: 251 LLLKTDPTERLTITQFM 267
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 67/243 (27%), Positives = 102/243 (41%), Gaps = 28/243 (11%)
Query: 9 LNRGS-TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSL 64
L+ GS T E+ +L + EVN++ +KH N+V++ D + IV E G L
Sbjct: 39 LDYGSMTEAEKQML----VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL 94
Query: 65 RKYLVSLRPNK--LDLHVALNFALDIARAMDCLH-----ANGIIHRDLKPDNLLLTPDQK 117
+ + LD L + A+ H + ++HRDLKP N+ L Q
Sbjct: 95 ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ- 153
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXY-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176
++KL DFGLAR +M+PE Q + YN K D++S G +
Sbjct: 154 NVKLGDFGLARILNHDEDFAKEFVGTPYYMSPE--------QMNRMSYNEKSDIWSLGCL 205
Query: 177 LWELLTNRLPFEGMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
L+EL PF S Q A + + +P S +L I+ RPS
Sbjct: 206 LYELCALMPPFTAFS--QKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVE 263
Query: 236 QII 238
+I+
Sbjct: 264 EIL 266
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 64.3 bits (155), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVK---HDNLVKFLGAC------KDPLM 52
G+F+ R T +E L IREV ++ ++ H N+V+ C ++ +
Sbjct: 37 GRFVALKRVRVQTGEEGMPLST--IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 94
Query: 53 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
+V E + L YL + + + + R +D LH++ ++HRDLKP N+L+
Sbjct: 95 TLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV 153
Query: 113 TPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172
T + +KLADFGLAR + APE+ + Y VD++S
Sbjct: 154 TSSGQ-IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL--------QSSYATPVDLWS 204
Query: 173 FGIVLWELLTNRLPFEGMSNL 193
G + E+ + F G S++
Sbjct: 205 VGCIFAEMFRRKPLFRGSSDV 225
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 85/180 (47%), Gaps = 19/180 (10%)
Query: 20 LLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTE---LLP--GMSLRKYLVSLRP 73
L R RE+ ++ ++H+N++ L D + T+ ++P G L K + +
Sbjct: 66 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM---KH 122
Query: 74 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXX 133
KL + + + +HA GIIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQADSE 181
Query: 134 XXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
YR APE+ Y VD++S G ++ E++T + F+G +L
Sbjct: 182 MXGXVVTRWYR--APEVILNWM-------RYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 232
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 50/188 (26%), Positives = 83/188 (44%), Gaps = 21/188 (11%)
Query: 24 RFIREVNMMSRVKHD----NLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH 79
R REV + + + + L++F D +V E L G S+ ++ + +
Sbjct: 56 RVFREVETLYQCQGNKNILELIEFFE--DDTRFYLVFEKLQGGSILAHI--QKQKHFNER 111
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLARXXXXXXXXX 137
A D+A A+D LH GI HRDLKP+N+L +P++ S +K+ DF L
Sbjct: 112 EASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCT 171
Query: 138 XXXX--------XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+MAPE+ T + Y+ + D++S G+VL+ +L+ PF G
Sbjct: 172 PITTPELTTPCGSAEYMAPEVVEVFT---DQATFYDKRCDLWSLGVVLYIMLSGYPPFVG 228
Query: 190 MSNLQAAY 197
+
Sbjct: 229 HCGADCGW 236
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 26/172 (15%)
Query: 27 REVNMMSRV-KHDNLVKFLGACKDPLMV-IVTELLPGMSL-----RKYLVSLRPNKLDLH 79
E+ ++ R +H N++ D V +VTEL+ G L R+ S R LH
Sbjct: 69 EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH 128
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---KSLKLADFGLARXXXXXXXX 136
I + ++ LH+ G++HRDLKP N+L + + L++ DFG A+
Sbjct: 129 T-------IGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGL 181
Query: 137 XXX-XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++APE V RQG Y+ D++S GI+L+ +L PF
Sbjct: 182 LMTPCYTANFVAPE----VLKRQG----YDEGCDIWSLGILLYTMLAGYTPF 225
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 47/180 (26%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E+ +E + RE+ + S ++H N+++ D + ++ E P L K L + +
Sbjct: 54 EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGR 111
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + F ++A A+ H +IHRD+KP+NLL+ + LK+ADFG +
Sbjct: 112 FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLR 169
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E K ++ KVD++ G++ +E L PF+ S+ +
Sbjct: 170 RRXMCGTLDYLPPEMI--------EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET 221
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 47/180 (26%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E+ +E + RE+ + S ++H N+++ D + ++ E P L K L + +
Sbjct: 53 EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGR 110
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + F ++A A+ H +IHRD+KP+NLL+ + LK+ADFG +
Sbjct: 111 FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLR 168
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E K ++ KVD++ G++ +E L PF+ S+ +
Sbjct: 169 RRXMCGTLDYLPPEMI--------EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET 220
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 14/175 (8%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKY 67
L R D+ + +RE+ ++ +KH N+V+ D + +V E L+KY
Sbjct: 32 LKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKY 90
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
S LD + +F + + + H+ ++HRDLKP NLL+ + + LKLADFGLA
Sbjct: 91 FDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLADFGLA 148
Query: 128 RXXXXXXXXXXXXXXYRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
R W P L+ K Y+ +D++S G + EL
Sbjct: 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGA--------KLYSTSIDMWSAGCIFAEL 195
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 15/220 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
I+E+++M + ++VK+ G+ K+ + IV E S+ ++ LR L
Sbjct: 70 EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIA 128
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXX 141
+ ++ LH IHRD+K N+LL + + KLADFG+A +
Sbjct: 129 TILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHA-KLADFGVAGQLTDXMAKRNXVIG 187
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
WMAPE+ + YN D++S GI E+ + P+ + ++A +
Sbjct: 188 TPFWMAPEVIQEIG--------YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP- 238
Query: 202 KHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ P PE S + V+ C V+ P R + +Q+++
Sbjct: 239 TNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 47/180 (26%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E+ +E + RE+ + S ++H N+++ D + ++ E P L K L + +
Sbjct: 53 EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGR 110
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D + F ++A A+ H +IHRD+KP+NLL+ + LK+ADFG +
Sbjct: 111 FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLR 168
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ PE+ E K ++ KVD++ G++ +E L PF+ S+ +
Sbjct: 169 RRXMCGTLDYLPPEMI--------EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET 220
>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2: Se-Met Derivative
Length = 342
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 16/166 (9%)
Query: 28 EVNMMSRV-KHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
E+ ++ R +H N++ D V +VTEL G L + LR A
Sbjct: 65 EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKI--LRQKFFSEREASAVL 122
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---KSLKLADFGLARXXXXXXXXXXX-XX 141
I + ++ LHA G++HRDLKP N+L + +S+++ DFG A+
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY 182
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++APE V RQG Y+ D++S G++L+ LT PF
Sbjct: 183 TANFVAPE----VLERQG----YDAACDIWSLGVLLYTXLTGYTPF 220
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 26/172 (15%)
Query: 27 REVNMMSRV-KHDNLVKFLGACKDPLMV-IVTELLPGMSL-----RKYLVSLRPNKLDLH 79
E+ ++ R +H N++ D V +VTEL+ G L R+ S R LH
Sbjct: 69 EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH 128
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---KSLKLADFGLARXXXXXXXX 136
I + ++ LH+ G++HRDLKP N+L + + L++ DFG A+
Sbjct: 129 T-------IGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGL 181
Query: 137 XXX-XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++APE V RQG Y+ D++S GI+L+ +L PF
Sbjct: 182 LMTPCYTANFVAPE----VLKRQG----YDEGCDIWSLGILLYTMLAGYTPF 225
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 50/183 (27%), Positives = 78/183 (42%), Gaps = 33/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 69 RAYRELVLMKVVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLSQ 117
Query: 81 ALNFALDIAR----------AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R + LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 VIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTA 176
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+ APE V L G Y VD++S G+++ E++ + F G
Sbjct: 177 GTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGVIMGEMIKGGVLFPGT 228
Query: 191 SNL 193
++
Sbjct: 229 DHI 231
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 50/183 (27%), Positives = 78/183 (42%), Gaps = 33/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 69 RAYRELVLMKVVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLSQ 117
Query: 81 ALNFALDIAR----------AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R + LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 VIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTA 176
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+ APE V L G Y VD++S G+++ E++ + F G
Sbjct: 177 GTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGVIMGEMIKGGVLFPGT 228
Query: 191 SNL 193
++
Sbjct: 229 DHI 231
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 43 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 103 DD-----EKLYFGLSYAKNGCLLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 155
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 156 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT------- 207
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K + D+++ G ++++L+ PF
Sbjct: 208 -EKSASKSSDLWALGCIIYQLVAGLPPF 234
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 7/159 (4%)
Query: 83 NFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
A+ I +A++ LH+ +IHRD+KP N+L+ +K+ DFG++
Sbjct: 157 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDSVAKTIDAG 215
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
+MAPE + ++G Y+ K D++S GI + EL R P++
Sbjct: 216 CKPYMAPERINPELNQKG----YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 271
Query: 202 KHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ P LP D S + C ++ RP++ ++++
Sbjct: 272 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 310
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 42/194 (21%)
Query: 18 RALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYL-----VSLR 72
R L + +REV +++++H +V++ A L TE L S + YL + +
Sbjct: 43 RELAREKVMREVKALAKLEHPGIVRYFNAW---LEKNTTEKLQPSSPKVYLYIQMQLCRK 99
Query: 73 PNKLDL------------HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 120
N D V L+ L IA A++ LH+ G++HRDLKP N+ T D +K
Sbjct: 100 ENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVK 158
Query: 121 LADFGLARXXXXXXXXXXXXX-------------XYRWMAPELYSTVTLRQGEKKHYNNK 167
+ DFGL +M+PE Q Y++K
Sbjct: 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE--------QIHGNSYSHK 210
Query: 168 VDVYSFGIVLWELL 181
VD++S G++L+ELL
Sbjct: 211 VDIFSLGLILFELL 224
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 27/238 (11%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKY 67
+ RG+ DE RE+ ++H N+V+F P + I+ E G L +
Sbjct: 53 IERGAAIDENVQ------REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYER 106
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL--TPDQKSLKLADFG 125
+ + + A F + + H+ I HRDLK +N LL +P + LK+ DFG
Sbjct: 107 ICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPR-LKICDFG 163
Query: 126 LARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV-DVYSFGIVLWELLTNR 184
++ ++APE V LRQ Y+ K+ DV+S G+ L+ +L
Sbjct: 164 YSKSSVLHSQPKSTVGTPAYIAPE----VLLRQ----EYDGKIADVWSCGVTLYVMLVGA 215
Query: 185 LPFEGMSNLQAAYAAAFKH---ARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQI 237
PFE + Y + + +P+D ISP+ ++ +V DP R S +I
Sbjct: 216 YPFEDPEEPR-DYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 33/179 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 69 RAYRELVLMKCVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLCQ 117
Query: 81 ALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA 176
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 177 GTSFMMEPEVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVCHKILFPG 227
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P +L + YLV + +L
Sbjct: 69 RAYRELVLMKXVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLX 116
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDX-TLKILDFGLART 175
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 227
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 41 GSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 101 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 153
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 154 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 205
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 206 -EKSACKSSDLWALGCIIYQLVAGLPPF 232
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 70/252 (27%), Positives = 107/252 (42%), Gaps = 40/252 (15%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 43 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 103 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 155
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 156 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 207
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 219
+K D+++ G ++++L+ PF N +A K PE P +
Sbjct: 208 -EKSAXKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIK-LEYDFPEKFFPKARDL 264
Query: 220 VQSCWVEDPNLR 231
V+ V D R
Sbjct: 265 VEKLLVLDATKR 276
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 33/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 69 RAYRELVLMKVVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLSQ 117
Query: 81 ALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTA 176
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+ APE V L G Y VD++S G ++ E++ + F G
Sbjct: 177 GTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 191 SNL 193
++
Sbjct: 229 DHI 231
>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain
Length = 316
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 53/190 (27%), Positives = 90/190 (47%), Gaps = 19/190 (10%)
Query: 21 LEGRFIREVNMMSRVK-HDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRP-NKLD 77
+ R REV M+ + + H N+++ + ++ +V E + G S+ ++ R N+L+
Sbjct: 53 IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE 112
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT-PDQKS-LKLADFGLARXXXXXXX 135
V + D+A A+D LH GI HRDLKP+N+L P+Q S +K+ DF L
Sbjct: 113 ASVVVQ---DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 136 XXXXXX--------XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+MAPE+ + E Y+ + D++S G++L+ LL+ PF
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFS---EEASIYDKRCDLWSLGVILYILLSGYPPF 226
Query: 188 EGMSNLQAAY 197
G +
Sbjct: 227 VGRCGSDCGW 236
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 61.6 bits (148), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 33/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 69 RAYRELVLMKCVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLSQ 117
Query: 81 ALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTA 176
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+ APE V L G Y VD++S G ++ E++ + F G
Sbjct: 177 GTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 191 SNL 193
++
Sbjct: 229 DHI 231
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 46 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 105
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 106 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 158
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX---XXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 159 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 210
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 211 -EKSACKSSDLWALGCIIYQLVAGLPPF 237
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 12/185 (6%)
Query: 15 SDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRP 73
S++ +++ +RE+ M+ ++KH NLV L + + +V E L + +
Sbjct: 39 SEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHE--LDRYQ 96
Query: 74 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXX 133
+ H+ + +A++ H + IHRD+KP+N+L+T +KL DFG AR
Sbjct: 97 RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT-KHSVIKLCDFGFARLLTGP 155
Query: 134 XXXXXXXXXYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
RW +PEL T Y VDV++ G V ELL+ + G S+
Sbjct: 156 SDYYDDEVATRWYRSPELLVGDT-------QYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208
Query: 193 LQAAY 197
+ Y
Sbjct: 209 VDQLY 213
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 54/184 (29%), Positives = 81/184 (44%), Gaps = 35/184 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ ++ V H N++ L P +L + YLV + +L
Sbjct: 67 RAYRELVLLKCVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLC 114
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
++ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 115 QVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 173
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ EL+ + F+G
Sbjct: 174 ASTNFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGELVKGSVIFQG 225
Query: 190 MSNL 193
++
Sbjct: 226 TDHI 229
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P +L + YLV + +L
Sbjct: 69 RAYRELVLMKXVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLC 116
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDX-TLKILDFGLART 175
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 227
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 41 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 101 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 153
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 154 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT------- 205
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 206 -EKSACKSSDLWALGCIIYQLVAGLPPF 232
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 44 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 103
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 104 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 156
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 157 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT------- 208
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 209 -EKSACKSSDLWALGCIIYQLVAGLPPF 235
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 70/252 (27%), Positives = 107/252 (42%), Gaps = 40/252 (15%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 43 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 103 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 155
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 156 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 207
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 219
+K D+++ G ++++L+ PF N +A K PE P +
Sbjct: 208 -EKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIK-LEYDFPEKFFPKARDL 264
Query: 220 VQSCWVEDPNLR 231
V+ V D R
Sbjct: 265 VEKLLVLDATKR 276
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 44 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 103
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 104 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 156
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX---XXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 157 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 208
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 209 -EKSACKSSDLWALGCIIYQLVAGLPPF 235
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 7/159 (4%)
Query: 83 NFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
A+ I +A++ LH+ +IHRD+KP N+L+ +K+ DFG++
Sbjct: 113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAG 171
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
+MAPE + + +K Y+ K D++S GI + EL R P++
Sbjct: 172 CKPYMAPERINP----ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227
Query: 202 KHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ P LP D S + C ++ RP++ ++++
Sbjct: 228 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 41 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 101 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 153
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 154 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 205
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 206 -EKSACKSSDLWALGCIIYQLVAGLPPF 232
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 43 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 103 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 155
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 156 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 207
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 208 -EKSACKSSDLWALGCIIYQLVAGLPPF 234
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 43 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 103 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 155
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 156 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 207
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 208 -EKSACKSSDLWALGCIIYQLVAGLPPF 234
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 23/174 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPL-------MVIVTELLPGMSLRKYLVSLRPNKL 76
R RE+ +M V H N++ L + +V EL+ L + +L
Sbjct: 69 RAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMEL 123
Query: 77 DLHVALNFAL-DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D H +++ L + + LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 124 D-HERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFM 181
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 182 MTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 227
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 21 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 80
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 81 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 133
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX---XXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 134 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 185
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 186 -EKSACKSSDLWALGCIIYQLVAGLPPF 212
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 41 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 101 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 153
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 154 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 205
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 206 -EKSACKSSDLWALGCIIYQLVAGLPPF 232
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 33/179 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 74 RAYRELVLMKCVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLCQ 122
Query: 81 ALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 123 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA 181
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 182 GTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDLWSVGCIMGEMVCHKILFPG 232
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 43 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 103 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 155
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 156 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 207
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 208 -EKSACKSSDLWALGCIIYQLVAGLPPF 234
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 12 GSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA----CKDPLMVIVTELLPGMSLRKY 67
G S+ + + +RE+ ++ + H N++ L A L+ E + ++
Sbjct: 46 GHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN 105
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+ L P+ + ++ + + ++ LH + I+HRDLKP+NLLL + LKLADFGLA
Sbjct: 106 SLVLTPSHIKAYMLMTL-----QGLEYLHQHWILHRDLKPNNLLLD-ENGVLKLADFGLA 159
Query: 128 RXXXXXXXXXXXXXXYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
+ RW APEL + Y VD+++ G +L ELL R+P
Sbjct: 160 KSFGSPNRAYXHQVVTRWYRAPELLFGARM-------YGVGVDMWAVGCILAELLL-RVP 211
Query: 187 F 187
F
Sbjct: 212 F 212
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 33/179 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 63 RAYRELVLMKCVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLCQ 111
Query: 81 ALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 112 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA 170
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 171 GTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDLWSVGCIMGEMVCHKILFPG 221
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 48 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQ 107
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 108 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 160
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 161 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 212
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 213 -EKSACKSSDLWALGCIIYQLVAGLPPF 239
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 14/175 (8%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKY 67
L R D+ + +RE+ ++ +KH N+V+ D + +V E L+KY
Sbjct: 32 LKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKY 90
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
S LD + +F + + + H+ ++HRDLKP NLL+ + + LKLA+FGLA
Sbjct: 91 FDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLA 148
Query: 128 RXXXXXXXXXXXXXXYRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
R W P L+ K Y+ +D++S G + EL
Sbjct: 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGA--------KLYSTSIDMWSAGCIFAEL 195
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 33/179 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 69 RAYRELVLMKCVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLCQ 117
Query: 81 ALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA 176
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 177 GTSFMMEPEVVTRYYRAPE----VILGMG----YKENVDLWSVGCIMGEMVCHKILFPG 227
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 33/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 69 RAYRELVLMKVVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLSQ 117
Query: 81 ALNFALDIAR----------AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R + LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 VIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTA 176
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+ APE V L G Y VD++S G ++ E++ + F G
Sbjct: 177 GTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 191 SNL 193
++
Sbjct: 229 DHI 231
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 20 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 79
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 80 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 132
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX---XXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 133 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 184
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 185 -EKSACKSSDLWALGCIIYQLVAGLPPF 211
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 19 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 79 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 131
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 132 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 183
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 184 -EKSACKSSDLWALGCIIYQLVAGLPPF 210
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P +L + YLV + +L
Sbjct: 107 RAYRELVLMKCVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLC 154
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 155 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART 213
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 214 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 265
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 40 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 99
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 100 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 152
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 153 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT------- 204
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 205 -EKSACKSSDLWALGCIIYQLVAGLPPF 231
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 18 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 77
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 78 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 130
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 131 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 182
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 183 -EKSACKSSDLWALGCIIYQLVAGLPPF 209
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 33/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 69 RAYRELVLMKCVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLSQ 117
Query: 81 ALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA 176
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+ APE V L G Y VD++S G ++ E++ + F G
Sbjct: 177 GTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 191 SNL 193
++
Sbjct: 229 DHI 231
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 25 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 84
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 85 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 137
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 138 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 189
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 190 -EKSACKSSDLWALGCIIYQLVAGLPPF 216
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 60.8 bits (146), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 33/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 69 RAYRELVLMKCVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLCQ 117
Query: 81 ALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA 176
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+ APE V L G Y VD++S G ++ E++ + F G
Sbjct: 177 GTSFMMTPEVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 191 SNL 193
++
Sbjct: 229 DHI 231
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 60.8 bits (146), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 2 GKFMKEVLNRG-STSDERAL--LEGRFI----------REVNMMSRVKHDNLVKFLGACK 48
G F VL R +TS E A+ LE R I RE ++MSR+ H VK +
Sbjct: 40 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 99
Query: 49 DPLMVIVTELLPGMS------LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102
D +L G+S L KY+ + D + +I A++ LH GIIH
Sbjct: 100 DD-----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIH 152
Query: 103 RDLKPDNLLLTPDQKSLKLADFGLARX---XXXXXXXXXXXXXYRWMAPELYSTVTLRQG 159
RDLKP+N+LL D +++ DFG A+ ++++PEL +
Sbjct: 153 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT------- 204
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+K D+++ G ++++L+ PF
Sbjct: 205 -EKSACKSSDLWALGCIIYQLVAGLPPF 231
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 60.8 bits (146), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 33/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 70 RAYRELVLMKCVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLCQ 118
Query: 81 ALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 119 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA 177
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+ APE V L G Y VD++S G ++ E++ + F G
Sbjct: 178 GTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGT 229
Query: 191 SNL 193
++
Sbjct: 230 DHI 232
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 37 HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR----A 91
H N+VK D L +V ELL G L + + K H + A I R A
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERI------KKKKHFSETEASYIMRKLVSA 118
Query: 92 MDCLHANGIIHRDLKPDNLLLTPDQKSL--KLADFGLARXX-XXXXXXXXXXXXYRWMAP 148
+ +H G++HRDLKP+NLL T + +L K+ DFG AR + AP
Sbjct: 119 VSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 149 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA--FKHARP 206
EL + + Y+ D++S G++L+ +L+ ++PF+ +A K +
Sbjct: 179 ELLN--------QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK 230
Query: 207 G-------LPEDISPDLAFIVQSCWVEDPNLRPSFS 235
G +++S + ++Q DPN R S
Sbjct: 231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 16/170 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH---VAL 82
RE ++ +KH ++V+ L D ++ +V E + G L +V R + ++ VA
Sbjct: 77 REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVAS 135
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLA-RXXXXXXXXXXX 139
++ I A+ H N IIHRD+KP +LL + S +KL FG+A +
Sbjct: 136 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 195
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+MAPE+ +++ Y VDV+ G++L+ LL+ LPF G
Sbjct: 196 VGTPHFMAPEVV--------KREPYGKPVDVWGCGVILFILLSGCLPFYG 237
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P +L + YLV + +L
Sbjct: 107 RAYRELVLMKCVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLC 154
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 155 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART 213
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 214 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 265
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P +L + YLV + +L
Sbjct: 69 RAYRELVLMKCVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLX 116
Query: 80 VALNFALDIAR----------AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ LD R + LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 117 QVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDX-TLKILDFGLART 175
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 227
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
E+++M+++ H NL++ A + +V+V E + G L ++ N +L L F
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL-FMK 194
Query: 87 DIARAMDCLHANGIIHRDLKPDNLL-LTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRW 145
I + +H I+H DLKP+N+L + D K +K+ DFGLAR +
Sbjct: 195 QICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEF 254
Query: 146 MAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+APE+ Y V+ D++S G++ + LL+ PF G
Sbjct: 255 LAPEVVNYDFVSF----------PTDMWSVGVIAYMLLSGLSPFLG 290
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 33/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 69 RAYRELVLMKCVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLCQ 117
Query: 81 ALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA 176
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+ APE V L G Y VD++S G ++ E++ + F G
Sbjct: 177 GTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 191 SNL 193
++
Sbjct: 229 DHI 231
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 33/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 69 RAYRELVLMKCVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLCQ 117
Query: 81 ALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA 176
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+ APE V L G Y VD++S G ++ E++ + F G
Sbjct: 177 GTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 191 SNL 193
++
Sbjct: 229 DHI 231
>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And
Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1)
Length = 311
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 29/225 (12%)
Query: 24 RFIREVNMMSRV-KHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
R + EV +V +H V+ A ++ ++ + L G SL+++ + + + V
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQV-W 160
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
+ D A+ LH+ G++H D+KP N+ L P + KL DFGL
Sbjct: 161 GYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRC-KLGDFGLLVELGTAGAGEVQEGD 219
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPF--EGMSNLQAAYAA 199
R+MAPEL + Y DV+S G+ + E+ N LP EG L+ Y
Sbjct: 220 PRYMAPELL---------QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY-- 268
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWV----EDPNLRPSFSQIIRM 240
LP + + L+ ++S V DP LR + ++ +
Sbjct: 269 --------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 22/184 (11%)
Query: 26 IREVNMMSRVKHDNLVK---FLGACKDPLMVIV---TELLPGMSLRKYLVSLRPNKLDLH 79
+RE+ ++ R+ HDN+VK LG L V TEL +++Y+ + N L+
Sbjct: 56 LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG 115
Query: 80 VALN-----FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---X 131
L F + R + +H+ ++HRDLKP NL + + LK+ DFGLAR
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 132 XXXXXXXXXXXYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+W +P L + +Y +D+++ G + E+LT + F G
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228
Query: 191 SNLQ 194
L+
Sbjct: 229 HELE 232
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 33/183 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 71 RAYRELVLMKCVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLCQ 119
Query: 81 ALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 120 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA 178
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+ APE V L G Y VD++S G ++ E++ + F G
Sbjct: 179 GTSFMMVPFVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGT 230
Query: 191 SNL 193
++
Sbjct: 231 DHI 233
>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform
Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo
Sapiens
Length = 350
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 39 NLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95
N++K + KDP+ +V E + ++ L D + + ++ +A+D
Sbjct: 94 NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQIL----TDFDIRF-YMYELLKALDYC 148
Query: 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVT 155
H+ GI+HRD+KP N+++ QK L+L D+GLA + PEL
Sbjct: 149 HSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQ 208
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSN 192
+ Y+ +D++S G +L ++ R P F G N
Sbjct: 209 M-------YDYSLDMWSLGCMLASMIFRREPFFHGQDN 239
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 26/199 (13%)
Query: 32 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDI 88
+S +H +LV +G C + M+++ + + +L+++L L + L +
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 89 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSL-KLADFGLARXXXXXXXXX---XXXXXYR 144
AR + LH IIHRD+K N+LL D+ + K+ DFG+++
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILL--DENFVPKITDFGISKKGTELGQTHLXXVVKGTLG 206
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR------LPFEGMSNLQAAYA 198
++ PE + K K DVYSFG+VL+E+L R LP E M NL A
Sbjct: 207 YIDPEYFI--------KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNL--AEW 255
Query: 199 AAFKHARPGLPEDISPDLA 217
A H L + + P+LA
Sbjct: 256 AVESHNNGQLEQIVDPNLA 274
>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein
Kinase Ck2alpha Prime With A Potent Indazole-Derivative
Inhibitor
Length = 339
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 39 NLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95
N++K + KDP+ +V E + ++ L D + + ++ +A+D
Sbjct: 99 NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQIL----TDFDIRF-YMYELLKALDYC 153
Query: 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVT 155
H+ GI+HRD+KP N+++ QK L+L D+GLA + PEL
Sbjct: 154 HSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQ 213
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSN 192
+ Y+ +D++S G +L ++ R P F G N
Sbjct: 214 M-------YDYSLDMWSLGCMLASMIFRREPFFHGQDN 244
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 23/174 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPL-------MVIVTELLPGMSLRKYLVSLRPNKL 76
R RE+ +M V H N++ L + +V EL+ L + +L
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMEL 116
Query: 77 DLHVALNFAL-DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D H +++ L + + LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 117 D-HERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFM 174
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 175 MTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 220
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 26/199 (13%)
Query: 32 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDI 88
+S +H +LV +G C + M+++ + + +L+++L L + L +
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 89 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSL-KLADFGLARXXX---XXXXXXXXXXXYR 144
AR + LH IIHRD+K N+LL D+ + K+ DFG+++
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILL--DENFVPKITDFGISKKGTELDQTHLXXVVKGTLG 206
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR------LPFEGMSNLQAAYA 198
++ PE + K K DVYSFG+VL+E+L R LP E M NL A
Sbjct: 207 YIDPEYFI--------KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNL--AEW 255
Query: 199 AAFKHARPGLPEDISPDLA 217
A H L + + P+LA
Sbjct: 256 AVESHNNGQLEQIVDPNLA 274
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P +L + YLV + +L
Sbjct: 69 RAYRELVLMKCVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLC 116
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART 175
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 227
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P +L + YLV + +L
Sbjct: 70 RAYRELVLMKCVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLC 117
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART 176
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 177 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 228
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P +L + YLV + +L
Sbjct: 70 RAYRELVLMKCVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLC 117
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART 176
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 177 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 228
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P +L + YLV + +L
Sbjct: 69 RAYRELVLMKCVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLC 116
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART 175
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 227
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 16/170 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH---VAL 82
RE ++ +KH ++V+ L D ++ +V E + G L +V R + ++ VA
Sbjct: 75 REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVAS 133
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLA-RXXXXXXXXXXX 139
++ I A+ H N IIHRD+KP +LL + S +KL FG+A +
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+MAPE+ +++ Y VDV+ G++L+ LL+ LPF G
Sbjct: 194 VGTPHFMAPEVV--------KREPYGKPVDVWGCGVILFILLSGCLPFYG 235
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 15/183 (8%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPL-----MVIVTELLPGMSLRKYLVS 70
++ L R +RE+ ++ KH+N++ + D + I+ EL+ L + + +
Sbjct: 48 DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST 106
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ D H+ F RA+ LH + +IHRDLKP NLL+ + LK+ DFGLAR
Sbjct: 107 QMLS--DDHIQY-FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARII 162
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGE----KKHYNNKVDVYSFGIVLWELLTNRLP 186
+ E +T R E Y+ +DV+S G +L EL R
Sbjct: 163 DESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222
Query: 187 FEG 189
F G
Sbjct: 223 FPG 225
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P +L + YLV + +L
Sbjct: 68 RAYRELVLMKCVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLC 115
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 116 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART 174
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 175 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 226
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 15/183 (8%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPL-----MVIVTELLPGMSLRKYLVS 70
++ L R +RE+ ++ KH+N++ + D + I+ EL+ L + + +
Sbjct: 48 DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST 106
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ D H+ F RA+ LH + +IHRDLKP NLL+ + LK+ DFGLAR
Sbjct: 107 QMLS--DDHIQY-FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARII 162
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGE----KKHYNNKVDVYSFGIVLWELLTNRLP 186
+ E +T R E Y+ +DV+S G +L EL R
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222
Query: 187 FEG 189
F G
Sbjct: 223 FPG 225
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNF 84
RE + +KH N+V+ + ++ +V +L+ G L + +V+ ++ D A +
Sbjct: 52 REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHC 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXXXX 142
I +++ H NGI+HRDLKP+NLLL K ++KLADFGLA
Sbjct: 109 IQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--------IEVQGDQ 160
Query: 143 YRWMA----PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNL-QA 195
W P S LR K Y VD+++ G++L+ LL PF E L Q
Sbjct: 161 QAWFGFAGTPGYLSPEVLR---KDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQ 217
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A A+ P + ++P+ ++ +P R + S+ ++
Sbjct: 218 IKAGAYDFPSPEW-DTVTPEAKDLINKMLTINPAKRITASEALK 260
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 15/183 (8%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPL-----MVIVTELLPGMSLRKYLVS 70
++ L R +RE+ ++ KH+N++ + D + I+ EL+ L + + +
Sbjct: 48 DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST 106
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX 130
+ D H+ F RA+ LH + +IHRDLKP NLL+ + LK+ DFGLAR
Sbjct: 107 QMLS--DDHIQY-FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARII 162
Query: 131 XXXXXXXXXXXXYRWMAPELYSTVTLRQGE----KKHYNNKVDVYSFGIVLWELLTNRLP 186
+ E +T R E Y+ +DV+S G +L EL R
Sbjct: 163 DESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222
Query: 187 FEG 189
F G
Sbjct: 223 FPG 225
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P +L + YLV + +L
Sbjct: 63 RAYRELVLMKCVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLC 110
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 111 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART 169
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 170 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 221
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 21/194 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLP 60
KF+K+ R S + R + REV+++ +V H N++ ++ +V++ EL+
Sbjct: 42 AKFIKK---RQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVS 98
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---K 117
G L +L + L A +F I ++ LH I H DLKP+N++L
Sbjct: 99 GGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+KL DFGLA ++APE+ Y + L + D++S G+
Sbjct: 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 206
Query: 176 VLWELLTNRLPFEG 189
+ + LL+ PF G
Sbjct: 207 ITYILLSGASPFLG 220
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P +L + YLV + +L
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLC 109
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 110 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 168
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 169 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 220
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/246 (24%), Positives = 108/246 (43%), Gaps = 31/246 (12%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPG 61
KF+K+ R +S R + REVN++ ++H N++ ++ +V++ EL+ G
Sbjct: 36 KFIKK---RRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSG 92
Query: 62 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL----TPDQK 117
L +L L A F I + LH+ I H DLKP+N++L P+ +
Sbjct: 93 GELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 150
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+KL DFG+A ++APE+ Y + L + D++S G+
Sbjct: 151 -IKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 199
Query: 176 VLWELLTNRLPFEGMSNLQ-----AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 230
+ + LL+ PF G + + +A F +++ D ++ V+DP
Sbjct: 200 ITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDF---IRRLLVKDPKR 256
Query: 231 RPSFSQ 236
R + +Q
Sbjct: 257 RMTIAQ 262
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P +L + YLV + +L
Sbjct: 63 RAYRELVLMKCVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLC 110
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 111 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 169
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 170 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 221
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 21/194 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLP 60
KF+K+ R S + R + REV+++ +V H N++ ++ +V++ EL+
Sbjct: 42 AKFIKK---RQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---K 117
G L +L + L A +F I ++ LH I H DLKP+N++L
Sbjct: 99 GGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+KL DFGLA ++APE+ Y + L + D++S G+
Sbjct: 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 206
Query: 176 VLWELLTNRLPFEG 189
+ + LL+ PF G
Sbjct: 207 ITYILLSGASPFLG 220
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 68/258 (26%), Positives = 102/258 (39%), Gaps = 57/258 (22%)
Query: 25 FIREVNM--MSRVKHDNLVKFLGA----CKDPLM--VIVTELLPGMSLRKYLVSLRPNKL 76
FI E N+ + ++HDN+ +F+ D M ++V E P SL KYL SL +
Sbjct: 52 FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTS-- 108
Query: 77 DLHVALNFALDIARAMDCLHAN---------GIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
D + A + R + LH I HRDL N+L+ D + ++DFGL+
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV-ISDFGLS 167
Query: 128 ---------RXXXXXXXXXXXXXXYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
R R+MAPE L V LR E +VD+Y+ G++
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESAL--KQVDMYALGLIY 225
Query: 178 WELL---TNRLPFEGMSNLQAAYAAAF---------------KHARPGLPEDISPD---- 215
WE+ T+ P E + Q A+ + RP PE +
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV 285
Query: 216 --LAFIVQSCWVEDPNLR 231
L ++ CW +D R
Sbjct: 286 RSLKETIEDCWDQDAEAR 303
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 21/194 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLP 60
KF+K+ R S + R + REV+++ +V H N++ ++ +V++ EL+
Sbjct: 42 AKFIKK---RQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---K 117
G L +L + L A +F I ++ LH I H DLKP+N++L
Sbjct: 99 GGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+KL DFGLA ++APE+ Y + L + D++S G+
Sbjct: 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 206
Query: 176 VLWELLTNRLPFEG 189
+ + LL+ PF G
Sbjct: 207 ITYILLSGASPFLG 220
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNF 84
RE + +KH N+V+ + ++ +V +L+ G L + +V+ ++ D A +
Sbjct: 52 REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHC 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXXXX 142
I +++ H NGI+HRDLKP+NLLL K ++KLADFGLA
Sbjct: 109 IQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--------IEVQGDQ 160
Query: 143 YRWMA----PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNL-QA 195
W P S LR K Y VD+++ G++L+ LL PF E L Q
Sbjct: 161 QAWFGFAGTPGYLSPEVLR---KDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQ 217
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A A+ P + ++P+ ++ +P R + S+ ++
Sbjct: 218 IKAGAYDFPSPEW-DTVTPEAKDLINKMLTINPAKRITASEALK 260
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/192 (26%), Positives = 87/192 (45%), Gaps = 17/192 (8%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLP 60
KF+K+ R S + R + REV+++ +V H N++ ++ +V++ EL+
Sbjct: 42 AKFIKK---RQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---K 117
G L +L + L A +F I ++ LH I H DLKP+N++L
Sbjct: 99 GGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
+KL DFGLA ++APE+ + L + D++S G++
Sbjct: 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL--------GLEADMWSIGVIT 208
Query: 178 WELLTNRLPFEG 189
+ LL+ PF G
Sbjct: 209 YILLSGASPFLG 220
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 21/194 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLP 60
KF+K+ R S + R + REV+++ +V H N++ ++ +V++ EL+
Sbjct: 42 AKFIKK---RQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---K 117
G L +L + L A +F I ++ LH I H DLKP+N++L
Sbjct: 99 GGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+KL DFGLA ++APE+ Y + L + D++S G+
Sbjct: 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 206
Query: 176 VLWELLTNRLPFEG 189
+ + LL+ PF G
Sbjct: 207 ITYILLSGASPFLG 220
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 21/194 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLP 60
KF+K+ R S + R + REV+++ +V H N++ ++ +V++ EL+
Sbjct: 42 AKFIKK---RQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---K 117
G L +L + L A +F I ++ LH I H DLKP+N++L
Sbjct: 99 GGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+KL DFGLA ++APE+ Y + L + D++S G+
Sbjct: 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 206
Query: 176 VLWELLTNRLPFEG 189
+ + LL+ PF G
Sbjct: 207 ITYILLSGASPFLG 220
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 54/184 (29%), Positives = 81/184 (44%), Gaps = 35/184 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ ++ V H N++ L P +L + YLV + +L
Sbjct: 69 RAYRELVLLKCVNHKNIISLLNV-----------FTPQKTLEEFQDVYLV-MELMDANLC 116
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARX 129
++ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 117 QVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 175
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APE V L G Y VD++S G ++ EL+ + F+G
Sbjct: 176 ACTNFMMTPYVVTRYYRAPE----VILGMG----YAANVDIWSVGCIMGELVKGCVIFQG 227
Query: 190 MSNL 193
++
Sbjct: 228 TDHI 231
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/195 (26%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLP 60
KF+K+ R +S R + REVN++ ++H N++ ++ +V++ EL+
Sbjct: 42 AKFIKK---RRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVS 98
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL----TPDQ 116
G L +L L A F I + LH+ I H DLKP+N++L P+
Sbjct: 99 GGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNP 156
Query: 117 KSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFG 174
+ +KL DFG+A ++APE+ Y + L + D++S G
Sbjct: 157 R-IKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIG 205
Query: 175 IVLWELLTNRLPFEG 189
++ + LL+ PF G
Sbjct: 206 VITYILLSGASPFLG 220
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 53 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 169 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 59.3 bits (142), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 54 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 170 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 59.3 bits (142), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 12/152 (7%)
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
A+ +A +IA + L + GII+RDLK DN++L + +K+ADFG+ +
Sbjct: 123 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKXF 181
Query: 141 XXY-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
++APE+ + + Y VD ++FG++L+E+L + PFEG + + +
Sbjct: 182 CGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQS 232
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+H P+ +S + I + + P R
Sbjct: 233 IMEH-NVAYPKSMSKEAVAICKGLMTKHPGKR 263
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 59.3 bits (142), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 53 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 169 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYS 218
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 25/237 (10%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKY 67
+ RG DE RE+ ++H N+V+F P + IV E G L +
Sbjct: 52 IERGEKIDENVK------REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 105
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL--TPDQKSLKLADFG 125
+ + + A F + + HA + HRDLK +N LL +P + LK+ADFG
Sbjct: 106 ICNA--GRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPR-LKIADFG 162
Query: 126 LARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV-DVYSFGIVLWELLTNR 184
++ ++APE+ KK Y+ KV DV+S G+ L+ +L
Sbjct: 163 YSKASVLHSQPKSAVGTPAYIAPEVLL--------KKEYDGKVADVWSCGVTLYVMLVGA 214
Query: 185 LPFEGMSNLQAAYAAAFK--HARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQI 237
PFE + + + + +P+ ISP+ ++ +V DP R S +I
Sbjct: 215 YPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 12/152 (7%)
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
A+ +A +IA + L + GII+RDLK DN++L + +K+ADFG+ +
Sbjct: 444 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKXF 502
Query: 141 XXY-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
++APE+ + + Y VD ++FG++L+E+L + PFEG + + +
Sbjct: 503 CGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQS 553
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+H P+ +S + I + + P R
Sbjct: 554 IMEH-NVAYPKSMSKEAVAICKGLMTKHPGKR 584
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 15/209 (7%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYL 68
+ R E + G IREV+++ ++H N+++ + + L+KY+
Sbjct: 64 IKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM 123
Query: 69 VSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS----LKLADF 124
P+ + + V +F + ++ H+ +HRDLKP NLLL+ S LK+ DF
Sbjct: 124 -DKNPD-VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181
Query: 125 GLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
GLAR W P + L +HY+ VD++S + E+L
Sbjct: 182 GLARAFGIPIRQFTHEIITLWYRP---PEILLGS---RHYSTSVDIWSIACIWAEMLMKT 235
Query: 185 LPFEGMSNLQAAYAAAFKHARPGLPEDIS 213
F G S + + GLP+D +
Sbjct: 236 PLFPGDSEIDQLFKI---FEVLGLPDDTT 261
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 53 KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 169 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 54 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 170 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 54 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 170 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 54 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 170 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYMPGGDMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +K+ADFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIKVADFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 53 KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 169 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYMPGGDMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +K+ADFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIKVADFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 54 KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXG 169
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 170 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 53 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 169 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +K+ADFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIKVADFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 52 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 109 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 167
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 168 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 54 KEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 170 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 20/228 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ IRE+ ++ +V F GA D + I E + G SL + L + ++ +
Sbjct: 69 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILG 126
Query: 83 NFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
++ + + + L + I+HRD+KP N+L+ + +KL DFG++
Sbjct: 127 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGT 185
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--- 198
+M+PE + HY+ + D++S G+ L E+ R P S A +
Sbjct: 186 R-SYMSPERL--------QGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLD 236
Query: 199 AAFKHARPGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
P LP + S + V C +++P R Q+ M++AF+
Sbjct: 237 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL--MVHAFI 282
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 53 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 169 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 53 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 169 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 23/194 (11%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPG 61
KF+K+ R S R + REVN++ ++H N++ ++ +V++ EL+ G
Sbjct: 57 KFIKK---RRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSG 113
Query: 62 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL----TPDQK 117
L +L L A F I + LH+ I H DLKP+N++L P+ +
Sbjct: 114 GELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 171
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+KL DFG+A ++APE+ Y + L + D++S G+
Sbjct: 172 -IKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 220
Query: 176 VLWELLTNRLPFEG 189
+ + LL+ PF G
Sbjct: 221 ITYILLSGASPFLG 234
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 50/183 (27%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 12 GSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---LMVIVTELL---PGMSLR 65
G R +E + +E+ ++ ++ H N+VK + DP + +V EL+ P M +
Sbjct: 71 GGCIQPRGPIE-QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP 129
Query: 66 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
+L+P L A + D+ + ++ LH IIHRD+KP NLL+ D +K+ADFG
Sbjct: 130 ----TLKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED-GHIKIADFG 182
Query: 126 LARXXXXXXXXXXXXXXY-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
++ +MAPE +L + K +DV++ G+ L+ + +
Sbjct: 183 VSNEFKGSDALLSNTVGTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
Query: 185 LPF 187
PF
Sbjct: 238 CPF 240
>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum
In Complex With Indirubin E804
pdb|3EB0|C Chain C, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum
In Complex With Indirubin E804
Length = 383
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 35/110 (31%), Positives = 53/110 (48%), Gaps = 7/110 (6%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ + RA+ +H+ GI HRD+KP NLL+ +LKL DFG A+
Sbjct: 146 YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSR 205
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
+ APEL T Y +D++S G V EL+ + F G +++
Sbjct: 206 FYRAPELMLGAT-------EYTPSIDLWSIGCVFGELILGKPLFSGETSI 248
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 54 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 170 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 53 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 169 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 55/244 (22%), Positives = 103/244 (42%), Gaps = 29/244 (11%)
Query: 28 EVNMMSRVK----HDNLVKFLG--ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
EV ++ +V H +++ L ++ M+++ LP L Y+ P L +
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPS 141
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
F + A+ H+ G++HRD+K +N+L+ + KL DFG
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGT 201
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
+ PE S +++ V+S GI+L++++ +PFE + A
Sbjct: 202 RV-YSPPEWIS-------RHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELH-- 251
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTN 261
P +SPD +++ C P+ RPS +I +L+ ++ T P+ VP + +
Sbjct: 252 ------FPAHVSPDCCALIRRCLAPKPSSRPSLEEI--LLDPWMQT---PAEDVPLNPSK 300
Query: 262 EAAA 265
A
Sbjct: 301 GGPA 304
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 53 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 169 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 53 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 169 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 58.2 bits (139), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 53 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 169 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 58.2 bits (139), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 37/149 (24%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ +I A++ LH+ +++RD+K +NL+L D +K+ DFGL +
Sbjct: 113 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGT 171
Query: 144 -RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
++APE+ E Y VD + G+V++E++ RLPF + + +
Sbjct: 172 PEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 223
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
R P +SP+ ++ +DP R
Sbjct: 224 EIR--FPRTLSPEAKSLLAGLLKKDPKQR 250
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 58.2 bits (139), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 54 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 110
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 170 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 58.2 bits (139), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNF 84
+E+ + + H+N+VKF G ++ + + E G L + P+ + A F
Sbjct: 53 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXX 141
+ + LH GI HRD+KP+NLLL ++ +LK++DFGLA R
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 169 TLPYVAPELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 58.2 bits (139), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 37/149 (24%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ +I A++ LH+ +++RD+K +NL+L D +K+ DFGL +
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGT 168
Query: 144 -RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
++APE+ E Y VD + G+V++E++ RLPF + + +
Sbjct: 169 PEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
R P +SP+ ++ +DP R
Sbjct: 221 EIR--FPRTLSPEAKSLLAGLLKKDPKQR 247
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 58.2 bits (139), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 25/237 (10%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKY 67
+ RG DE RE+ ++H N+V+F P + IV E G L +
Sbjct: 51 IERGEKIDENVK------REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 104
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL--TPDQKSLKLADFG 125
+ + + A F + + HA + HRDLK +N LL +P + LK+ DFG
Sbjct: 105 ICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR-LKICDFG 161
Query: 126 LARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV-DVYSFGIVLWELLTNR 184
++ ++APE+ KK Y+ KV DV+S G+ L+ +L
Sbjct: 162 YSKSSVLHSQPKSTVGTPAYIAPEVLL--------KKEYDGKVADVWSCGVTLYVMLVGA 213
Query: 185 LPFEGMSNLQAAYAAAFK--HARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQI 237
PFE + + + + +P+ ISP+ ++ +V DP R S +I
Sbjct: 214 YPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEI 270
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 58.2 bits (139), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 40/170 (23%), Positives = 79/170 (46%), Gaps = 11/170 (6%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
E+++M+++ H L+ A +D MV++ E L G L ++ K+ +N+
Sbjct: 98 EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD-RIAAEDYKMSEAEVINYMR 156
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARXXXXXXXXXXXXXXYRW 145
+ +H + I+H D+KP+N++ T S+K+ DFGLA +
Sbjct: 157 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 216
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
APE+ +++ D+++ G++ + LL+ PF G +L+
Sbjct: 217 AAPEIV--------DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 258
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 37/149 (24%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ +I A++ LH+ +++RD+K +NL+L D +K+ DFGL +
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGT 168
Query: 144 -RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
++APE+ E Y VD + G+V++E++ RLPF + + +
Sbjct: 169 PEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
R P +SP+ ++ +DP R
Sbjct: 221 EIR--FPRTLSPEAKSLLAGLLKKDPKQR 247
>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From
Mycobacterium Tuberculosis In Complex With
Tetrahydrobenzothiophene Ax20017
pdb|2PZI|B Chain B, Crystal Structure Of Protein Kinase Pkng From
Mycobacterium Tuberculosis In Complex With
Tetrahydrobenzothiophene Ax20017
Length = 681
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+F+ EV S V+ N V+ DP+ IV E + G SL++ + KL + A+
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRS----KGQKLPVAEAIA 186
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
+ L+I A+ LH+ G+++ DLKP+N++LT +Q LKL D G
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ--LKLIDLG 226
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 37/141 (26%), Positives = 69/141 (48%), Gaps = 10/141 (7%)
Query: 48 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 107
KD L +++T L+ G L+ ++ + A+ +A +I ++ LH I++RDLKP
Sbjct: 256 KDALCLVLT-LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314
Query: 108 DNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNK 167
+N+LL D ++++D GLA +MAPE+ + Y
Sbjct: 315 ENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN--------ERYTFS 365
Query: 168 VDVYSFGIVLWELLTNRLPFE 188
D ++ G +L+E++ + PF+
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQ 386
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 37/141 (26%), Positives = 69/141 (48%), Gaps = 10/141 (7%)
Query: 48 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 107
KD L +++T L+ G L+ ++ + A+ +A +I ++ LH I++RDLKP
Sbjct: 256 KDALCLVLT-LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314
Query: 108 DNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNK 167
+N+LL D ++++D GLA +MAPE+ + Y
Sbjct: 315 ENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN--------ERYTFS 365
Query: 168 VDVYSFGIVLWELLTNRLPFE 188
D ++ G +L+E++ + PF+
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQ 386
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 10/109 (9%)
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX 139
V L+ + IA A++ LH+ G++HRDLKP N+ T D +K+ DFGL
Sbjct: 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTV 223
Query: 140 -------XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
+ +LY ++ Q +Y++KVD++S G++L+ELL
Sbjct: 224 LTPMPAYATHXGQVGTKLY--MSPEQIHGNNYSHKVDIFSLGLILFELL 270
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 12/149 (8%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ +I A++ LH+ +++RD+K +NL+L D +K+ DFGL +
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKXFCGT 168
Query: 144 -RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
++APE+ E Y VD + G+V++E++ RLPF + + +
Sbjct: 169 PEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
R P +SP+ ++ +DP R
Sbjct: 221 EIR--FPRTLSPEAKSLLAGLLKKDPKQR 247
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 12/149 (8%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ +I A++ LH+ +++RD+K +NL+L D +K+ DFGL +
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKXFCGT 168
Query: 144 -RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
++APE+ E Y VD + G+V++E++ RLPF + + +
Sbjct: 169 PEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
R P +SP+ ++ +DP R
Sbjct: 221 EIR--FPRTLSPEAKSLLAGLLKKDPKQR 247
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 48/179 (26%), Positives = 88/179 (49%), Gaps = 16/179 (8%)
Query: 16 DERALLEGRFIR----EVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVS 70
D++A+ + ++ EV + ++KH ++++ +D V +V E+ + +YL +
Sbjct: 45 DKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN 104
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-RX 129
R + A +F I M LH++GI+HRDL NLLLT + ++K+ADFGLA +
Sbjct: 105 -RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQL 162
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+++PE+ + + + DV+S G + + LL R PF+
Sbjct: 163 KMPHEKHYTLCGTPNYISPEI--------ATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 57.4 bits (137), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 20/168 (11%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
RE + +KH N+V+ + ++ +V +L+ G L + +V+ R + +
Sbjct: 52 REARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA-REYYSEADASHCIQ 110
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXXXXY 143
+ + C H G++HRDLKP+NLLL K ++KLADFGLA
Sbjct: 111 QILEAVLHC-HQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQA------- 162
Query: 144 RWMA----PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
W P S LR K+ Y VD+++ G++L+ LL PF
Sbjct: 163 -WFGFAGTPGYLSPEVLR---KEAYGKPVDIWACGVILYILLVGYPPF 206
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 57.4 bits (137), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 12/149 (8%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ +I A++ LH+ +++RD+K +NL+L D +K+ DFGL +
Sbjct: 115 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKXFCGT 173
Query: 144 -RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
++APE+ E Y VD + G+V++E++ RLPF + + +
Sbjct: 174 PEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 225
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
R P +SP+ ++ +DP R
Sbjct: 226 EIR--FPRTLSPEAKSLLAGLLKKDPKQR 252
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 57.4 bits (137), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 12/149 (8%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ +I A++ LH+ +++RD+K +NL+L D +K+ DFGL +
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKXFCGT 168
Query: 144 -RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
++APE+ E Y VD + G+V++E++ RLPF + + +
Sbjct: 169 PEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
R P +SP+ ++ +DP R
Sbjct: 221 EIR--FPRTLSPEAKSLLAGLLKKDPKQR 247
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 19/219 (8%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
RE+ ++H N+V+F P + IV E G L + + + + A F
Sbjct: 64 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFF 121
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLL--TPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ + HA + HRDLK +N LL +P + LK+ DFG ++
Sbjct: 122 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTP 180
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKV-DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
++APE+ KK Y+ KV DV+S G+ L+ +L PFE + +
Sbjct: 181 AYIAPEVLL--------KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232
Query: 203 --HARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQI 237
+ + +P+ ISP+ ++ +V DP R S +I
Sbjct: 233 ILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 19/225 (8%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
EG E+ ++ ++KH N+V + + ++ +L+ G L +V
Sbjct: 60 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERD 117
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLL---LTPDQKSLKLADFGLARXXXXXXXXX 137
A + A+ LH GI+HRDLKP+NLL L D K + ++DFGL++
Sbjct: 118 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK-IMISDFGLSKMEDPGSVLS 176
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQ 194
++APE+ + +K Y+ VD +S G++ + LL PF ++ +
Sbjct: 177 TACGTPGYVAPEVLA--------QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 228
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A ++ P +DIS ++ +DP R + Q ++
Sbjct: 229 QILKAEYEFDSP-YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 60/110 (54%), Gaps = 10/110 (9%)
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXX 140
A+ +A +I+ + LH GII+RDLK DN++L + +K+ADFG+ +
Sbjct: 122 AVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMMDGVTTREF 180
Query: 141 XXY-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
++APE+ + + Y VD +++G++L+E+L + PF+G
Sbjct: 181 CGTPDYIAPEIIAY--------QPYGKSVDWWAYGVLLYEMLAGQPPFDG 222
>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands
pdb|3GOK|B Chain B, Binding Site Mapping Of Protein Ligands
pdb|3GOK|C Chain C, Binding Site Mapping Of Protein Ligands
pdb|3GOK|D Chain D, Binding Site Mapping Of Protein Ligands
pdb|3GOK|E Chain E, Binding Site Mapping Of Protein Ligands
pdb|3GOK|F Chain F, Binding Site Mapping Of Protein Ligands
pdb|3GOK|G Chain G, Binding Site Mapping Of Protein Ligands
pdb|3GOK|H Chain H, Binding Site Mapping Of Protein Ligands
pdb|3GOK|I Chain I, Binding Site Mapping Of Protein Ligands
pdb|3GOK|J Chain J, Binding Site Mapping Of Protein Ligands
pdb|3GOK|K Chain K, Binding Site Mapping Of Protein Ligands
pdb|3GOK|L Chain L, Binding Site Mapping Of Protein Ligands
Length = 334
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 41/138 (29%), Positives = 62/138 (44%), Gaps = 10/138 (7%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++IV E L G L + A I A+ LH+ I HRD+KP+NLL
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 163
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T + + LKL DFG A+ ++APE+ G +K Y+ D
Sbjct: 164 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-------GPEK-YDKSCD 215
Query: 170 VYSFGIVLWELLTNRLPF 187
++S G++++ LL PF
Sbjct: 216 MWSLGVIMYILLCGYPPF 233
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 91 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL 150
A+ LHAN I+HRDLKP+N+LL D ++L+DFG + ++APE+
Sbjct: 212 AVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 151 YSTVTLRQGEKKH--YNNKVDVYSFGIVLWELLTNRLPF 187
++ H Y +VD+++ G++L+ LL PF
Sbjct: 271 LKCSM----DETHPGYGKEVDLWACGVILFTLLAGSPPF 305
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 19/225 (8%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
EG E+ ++ ++KH N+V + + ++ +L+ G L +V
Sbjct: 60 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERD 117
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLL---LTPDQKSLKLADFGLARXXXXXXXXX 137
A + A+ LH GI+HRDLKP+NLL L D K + ++DFGL++
Sbjct: 118 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK-IMISDFGLSKMEDPGSVLS 176
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQ 194
++APE+ + +K Y+ VD +S G++ + LL PF ++ +
Sbjct: 177 TACGTPGYVAPEVLA--------QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 228
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A ++ P +DIS ++ +DP R + Q ++
Sbjct: 229 QILKAEYEFDSP-YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272
>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
Length = 406
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 20/212 (9%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++IV E L G L + A I A+ LH+ I HRD+KP+NLL
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 199
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T + + LKL DFG A+ ++APE+ G +K Y+ D
Sbjct: 200 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-------GPEK-YDKSCD 251
Query: 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPE-------DISPDLAFIVQ 221
++S G++++ LL PF SN A + K R G E ++S ++ +++
Sbjct: 252 MWSLGVIMYILLCGYPPF--YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 309
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
+ +P R + ++ + T P +P
Sbjct: 310 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 341
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 19/225 (8%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
EG E+ ++ ++KH N+V + + ++ +L+ G L +V
Sbjct: 60 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERD 117
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLL---LTPDQKSLKLADFGLARXXXXXXXXX 137
A + A+ LH GI+HRDLKP+NLL L D K + ++DFGL++
Sbjct: 118 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK-IMISDFGLSKMEDPGSVLS 176
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQ 194
++APE+ + +K Y+ VD +S G++ + LL PF ++ +
Sbjct: 177 TACGTPGYVAPEVLA--------QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 228
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A ++ P +DIS ++ +DP R + Q ++
Sbjct: 229 QILKAEYEFDSP-YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272
>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal
Form-1, Soaking)
pdb|2JBP|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|B Chain B, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|C Chain C, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|D Chain D, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|E Chain E, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|F Chain F, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|G Chain G, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|H Chain H, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|I Chain I, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|J Chain J, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|K Chain K, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|L Chain L, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
Length = 326
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 41/138 (29%), Positives = 62/138 (44%), Gaps = 10/138 (7%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++IV E L G L + A I A+ LH+ I HRD+KP+NLL
Sbjct: 96 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 155
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T + + LKL DFG A+ ++APE+ G +K Y+ D
Sbjct: 156 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-------GPEK-YDKSCD 207
Query: 170 VYSFGIVLWELLTNRLPF 187
++S G++++ LL PF
Sbjct: 208 MWSLGVIMYILLCGYPPF 225
>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|B Chain B, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|C Chain C, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|D Chain D, Structure Of Mk2 Complexed With Compound 76
pdb|3KC3|A Chain A, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|B Chain B, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|C Chain C, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|D Chain D, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|E Chain E, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|F Chain F, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|G Chain G, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|H Chain H, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|I Chain I, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|J Chain J, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|K Chain K, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|L Chain L, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3A2C|A Chain A, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|B Chain B, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|C Chain C, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|D Chain D, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|E Chain E, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|F Chain F, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|G Chain G, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|H Chain H, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|I Chain I, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|J Chain J, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|K Chain K, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|L Chain L, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
Length = 324
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 41/138 (29%), Positives = 62/138 (44%), Gaps = 10/138 (7%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++IV E L G L + A I A+ LH+ I HRD+KP+NLL
Sbjct: 94 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 153
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T + + LKL DFG A+ ++APE+ G +K Y+ D
Sbjct: 154 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-------GPEK-YDKSCD 205
Query: 170 VYSFGIVLWELLTNRLPF 187
++S G++++ LL PF
Sbjct: 206 MWSLGVIMYILLCGYPPF 223
>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2
pdb|1KWP|B Chain B, Crystal Structure Of Mapkap2
pdb|1NY3|A Chain A, Crystal Structure Of Adp Bound To Map Kap Kinase 2
Length = 400
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 20/212 (9%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++IV E L G L + A I A+ LH+ I HRD+KP+NLL
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T + + LKL DFG A+ ++APE+ G +K Y+ D
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-------GPEK-YDKSCD 245
Query: 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPE-------DISPDLAFIVQ 221
++S G++++ LL PF SN A + K R G E ++S ++ +++
Sbjct: 246 MWSLGVIMYILLCGYPPF--YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 303
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
+ +P R + ++ + T P +P
Sbjct: 304 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 19/225 (8%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
EG E+ ++ ++KH N+V + + ++ +L+ G L +V
Sbjct: 60 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERD 117
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLL---LTPDQKSLKLADFGLARXXXXXXXXX 137
A + A+ LH GI+HRDLKP+NLL L D K + ++DFGL++
Sbjct: 118 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK-IMISDFGLSKMEDPGSVLS 176
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQ 194
++APE+ + +K Y+ VD +S G++ + LL PF ++ +
Sbjct: 177 TACGTPGYVAPEVLA--------QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 228
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A ++ P +DIS ++ +DP R + Q ++
Sbjct: 229 QILKAEYEFDSP-YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272
>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap
Kinase-2
Length = 325
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 41/138 (29%), Positives = 62/138 (44%), Gaps = 10/138 (7%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++IV E L G L + A I A+ LH+ I HRD+KP+NLL
Sbjct: 95 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 154
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T + + LKL DFG A+ ++APE+ G +K Y+ D
Sbjct: 155 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-------GPEK-YDKSCD 206
Query: 170 VYSFGIVLWELLTNRLPF 187
++S G++++ LL PF
Sbjct: 207 MWSLGVIMYILLCGYPPF 224
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 26/224 (11%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNF 84
RE + +KH N+V+ + ++ +V +L+ G L + +V+ ++ D ++
Sbjct: 79 REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH- 137
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXXXX 142
I +++ +H + I+HRDLKP+NLLL K ++KLADFGLA
Sbjct: 138 --QILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQA------ 189
Query: 143 YRWMA----PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNL-QA 195
W P S LR K Y VD+++ G++L+ LL PF E L Q
Sbjct: 190 --WFGFAGTPGYLSPEVLR---KDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQ 244
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A A+ P + ++P+ ++ +P R + Q ++
Sbjct: 245 IKAGAYDFPSPEW-DTVTPEAKNLINQMLTINPAKRITADQALK 287
>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1
pdb|3R30|A Chain A, Mk2 Kinase Bound To Compound 2
Length = 319
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 20/212 (9%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++IV E L G L + A I A+ LH+ I HRD+KP+NLL
Sbjct: 89 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 148
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T + + LKL DFG A+ ++APE+ G +K Y+ D
Sbjct: 149 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-------GPEK-YDKSCD 200
Query: 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPE-------DISPDLAFIVQ 221
++S G++++ LL PF SN A + K R G E ++S ++ +++
Sbjct: 201 MWSLGVIMYILLCGYPPF--YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 258
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
+ +P R + ++ + T P +P
Sbjct: 259 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 290
>pdb|2OZA|A Chain A, Structure Of P38alpha Complex
Length = 356
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 20/212 (9%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++IV E L G L + A I A+ LH+ I HRD+KP+NLL
Sbjct: 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T + + LKL DFG A+ ++APE+ G +K Y+ D
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-------GPEK-YDKSCD 201
Query: 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPE-------DISPDLAFIVQ 221
++S G++++ LL PF SN A + K R G E ++S ++ +++
Sbjct: 202 MWSLGVIMYILLCGYPPF--YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 259
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
+ +P R + ++ + T P +P
Sbjct: 260 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 291
>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|B Chain B, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|C Chain C, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|D Chain D, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|E Chain E, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|F Chain F, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|G Chain G, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|H Chain H, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|I Chain I, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|J Chain J, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|K Chain K, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|L Chain L, Mk2 Kinase Bound To Compound 5b
Length = 318
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 20/212 (9%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++IV E L G L + A I A+ LH+ I HRD+KP+NLL
Sbjct: 88 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T + + LKL DFG A+ ++APE+ G +K Y+ D
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-------GPEK-YDKSCD 199
Query: 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPE-------DISPDLAFIVQ 221
++S G++++ LL PF SN A + K R G E ++S ++ +++
Sbjct: 200 MWSLGVIMYILLCGYPPF--YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 257
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
+ +P R + ++ + T P +P
Sbjct: 258 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 289
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 32/108 (29%), Positives = 49/108 (45%), Gaps = 9/108 (8%)
Query: 84 FALDIARAMDCLH--ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
F + R++ CLH + + HRD+KP N+L+ +LKL DFG A+
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ APEL +HY VD++S G + E++ F G
Sbjct: 194 SRYYRAPELIFG-------NQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NL++ Q +K+ DFGLA+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGLAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To
Mapkap Kinase-2
pdb|3FYJ|X Chain X, Crystal Structure Of An Optimzied Benzothiophene Inhibitor
Bound To Mapkap Kinase-2 (Mk-2)
pdb|3FYK|X Chain X, Crystal Structure Of A Benzthiophene Lead Bound To Mapkap
Kinase-2 (Mk-2)
Length = 327
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 20/212 (9%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++IV E L G L + A I A+ LH+ I HRD+KP+NLL
Sbjct: 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T + + LKL DFG A+ ++APE+ G +K Y+ D
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-------GPEK-YDKSCD 201
Query: 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPE-------DISPDLAFIVQ 221
++S G++++ LL PF SN A + K R G E ++S ++ +++
Sbjct: 202 MWSLGVIMYILLCGYPPF--YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 259
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
+ +P R + ++ + T P +P
Sbjct: 260 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 291
>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor
6-(5-(2-Aminopyrimidin-4-Ylamino)-2-
Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide
Length = 320
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 20/212 (9%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++IV E L G L + A I A+ LH+ I HRD+KP+NLL
Sbjct: 88 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T + + LKL DFG A+ ++APE+ G +K Y+ D
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVL-------GPEK-YDKSCD 199
Query: 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPE-------DISPDLAFIVQ 221
++S G++++ LL PF SN A + K R G E ++S ++ +++
Sbjct: 200 MWSLGVIMYILLCGYPPF--YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 257
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
+ +P R + ++ + T P +P
Sbjct: 258 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 289
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 40 LVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98
LVK + KD + +V E PG + +L R + A +A I + LH+
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQ 158
+I+RDLKP+NLL+ Q +K+ADFG A+ Y +APE + L +
Sbjct: 162 DLIYRDLKPENLLID-QQGYIKVADFGFAKRVKGRTWXLCGTPEY--LAPE----IILSK 214
Query: 159 GEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
G YN VD ++ G++++E+ PF
Sbjct: 215 G----YNKAVDWWALGVLIYEMAAGYPPF 239
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 87 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 138
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 197
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 198 TLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 239
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 107 EHTLNEKRILQAVNF------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 158
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 159 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 217
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 218 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 259
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 87 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 138
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 197
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 198 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 239
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 87 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 138
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 197
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 198 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 239
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 87 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 138
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 197
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 198 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 239
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 87 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 138
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 197
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 198 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 239
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 20/237 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ IRE+ ++ +V F GA D + I E + G SL + L + ++ +
Sbjct: 60 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILG 117
Query: 83 NFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
++ + R + L + I+HRD+KP N+L+ + +KL DFG++
Sbjct: 118 KVSIAVLRGLAYLREKHQIMHRDVKPSNILVN-SRGEIKLCDFGVS-GQLIDSMANSFVG 175
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAA 199
+MAPE QG HY+ + D++S G+ L EL R P L+A +
Sbjct: 176 TRSYMAPERL------QG--THYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGR 227
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
G P ISP + + RP+ + I +L+ + + P P +P
Sbjct: 228 PVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMA-IFELLD---YIVNEPPPKLP 280
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 11/103 (10%)
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX----- 142
I A+ +H+ GIIHRDLKP N+ + + +++K+ DFGLA+
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFI-DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 143 ----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
+ +Y + G HYN K+D+YS GI+ +E++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMI 225
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 11/103 (10%)
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX----- 142
I A+ +H+ GIIHRDLKP N+ + + +++K+ DFGLA+
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFI-DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 143 ----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
+ +Y + G HYN K+D+YS GI+ +E++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMI 225
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 67/248 (27%), Positives = 103/248 (41%), Gaps = 36/248 (14%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNK---LD 77
E +F EV M+S H NL++ G C P ++V + S+ L RP LD
Sbjct: 79 ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLD 137
Query: 78 LHVALNFALDIARAMDCLHAN---GIIHRDLKPDNLLLTPDQKSLKLADFGLARXX--XX 132
AL AR + LH + IIHRD+K N+LL + +++ + DFGLA+
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKD 196
Query: 133 XXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE---- 188
+APE ST + K DV+ +G++L EL+T + F+
Sbjct: 197 XHVXXAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELITGQRAFDLARL 248
Query: 189 -------------GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
G+ + A + ++ L + C P RP S
Sbjct: 249 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 308
Query: 236 QIIRMLNA 243
+++RML
Sbjct: 309 EVVRMLEG 316
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 52/195 (26%), Positives = 87/195 (44%), Gaps = 23/195 (11%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLP 60
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+
Sbjct: 41 AKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVA 97
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL----TPDQ 116
G L +L L A F I + LH+ I H DLKP+N++L P
Sbjct: 98 GGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155
Query: 117 KSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFG 174
+ +K+ DFGLA ++APE+ Y + L + D++S G
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIG 204
Query: 175 IVLWELLTNRLPFEG 189
++ + LL+ PF G
Sbjct: 205 VITYILLSGASPFLG 219
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 68/248 (27%), Positives = 104/248 (41%), Gaps = 36/248 (14%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNK---LD 77
E +F EV M+S H NL++ G C P ++V + S+ L RP LD
Sbjct: 71 ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLD 129
Query: 78 LHVALNFALDIARAMDCLHAN---GIIHRDLKPDNLLLTPDQKSLKLADFGLARXX--XX 132
AL AR + LH + IIHRD+K N+LL + +++ + DFGLA+
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKD 188
Query: 133 XXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE---- 188
+APE ST + K DV+ +G++L EL+T + F+
Sbjct: 189 XHVXXAVRGXIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 189 -------------GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
G+ + A + ++ L + C P RP S
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 236 QIIRMLNA 243
+++RML
Sbjct: 301 EVVRMLEG 308
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 79 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 130
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 131 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 189
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 190 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 231
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+ V E + G L ++ R + D A +A +I A+ LH GII+RDLK DN+L
Sbjct: 99 LFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVL 156
Query: 112 LTPDQKSLKLADFGLARXXXXXXXXXXXXXXY-RWMAPELYSTVTLRQGEKKHYNNKVDV 170
L + KLADFG+ + ++APE+ + Y VD
Sbjct: 157 LD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML--------YGPAVDW 207
Query: 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 230
++ G++L+E+L PFE + + A + P + D I++S ++P +
Sbjct: 208 WAMGVLLYEMLCGHAPFEAEN--EDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTM 265
Query: 231 R 231
R
Sbjct: 266 R 266
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 52/195 (26%), Positives = 87/195 (44%), Gaps = 23/195 (11%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLP 60
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+
Sbjct: 41 AKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL----TPDQ 116
G L +L L A F I + LH+ I H DLKP+N++L P
Sbjct: 98 GGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155
Query: 117 KSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFG 174
+ +K+ DFGLA ++APE+ Y + L + D++S G
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIG 204
Query: 175 IVLWELLTNRLPFEG 189
++ + LL+ PF G
Sbjct: 205 VITYILLSGASPFLG 219
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 72 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 123
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 124 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 182
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 183 TLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 224
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLP 60
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+
Sbjct: 41 AKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQK 117
G L +L L A F I + LH+ I H DLKP+N++L +
Sbjct: 98 GGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+K+ DFGLA ++APE+ Y + L + D++S G+
Sbjct: 156 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 205
Query: 176 VLWELLTNRLPFEG 189
+ + LL+ PF G
Sbjct: 206 ITYILLSGASPFLG 219
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLP 60
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+
Sbjct: 40 AKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQK 117
G L +L L A F I + LH+ I H DLKP+N++L +
Sbjct: 97 GGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 154
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+K+ DFGLA ++APE+ Y + L + D++S G+
Sbjct: 155 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 204
Query: 176 VLWELLTNRLPFEG 189
+ + LL+ PF G
Sbjct: 205 ITYILLSGASPFLG 218
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 52/195 (26%), Positives = 87/195 (44%), Gaps = 23/195 (11%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLP 60
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+
Sbjct: 40 AKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL----TPDQ 116
G L +L L A F I + LH+ I H DLKP+N++L P
Sbjct: 97 GGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 154
Query: 117 KSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFG 174
+ +K+ DFGLA ++APE+ Y + L + D++S G
Sbjct: 155 R-IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIG 203
Query: 175 IVLWELLTNRLPFEG 189
++ + LL+ PF G
Sbjct: 204 VITYILLSGASPFLG 218
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 52/195 (26%), Positives = 87/195 (44%), Gaps = 23/195 (11%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLP 60
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+
Sbjct: 41 AKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL----TPDQ 116
G L +L L A F I + LH+ I H DLKP+N++L P
Sbjct: 98 GGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155
Query: 117 KSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFG 174
+ +K+ DFGLA ++APE+ Y + L + D++S G
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIG 204
Query: 175 IVLWELLTNRLPFEG 189
++ + LL+ PF G
Sbjct: 205 VITYILLSGASPFLG 219
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLP 60
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+
Sbjct: 41 AKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQK 117
G L +L L A F I + LH+ I H DLKP+N++L +
Sbjct: 98 GGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+K+ DFGLA ++APE+ Y + L + D++S G+
Sbjct: 156 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 205
Query: 176 VLWELLTNRLPFEG 189
+ + LL+ PF G
Sbjct: 206 ITYILLSGASPFLG 219
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 7/158 (4%)
Query: 84 FALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
A+ I +A++ LH+ +IHRD+KP N+L+ +K DFG++
Sbjct: 141 IAVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDIDAGC 199
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+ APE + ++G Y+ K D++S GI EL R P++ +
Sbjct: 200 KPYXAPERINPELNQKG----YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVE 255
Query: 203 HARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P LP D S + C ++ RP++ ++ +
Sbjct: 256 EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQ 293
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 31/201 (15%)
Query: 5 MKEVLNRGSTSDER-------ALLEGRFIREVNMMSRVKHDNLV---KFLGACKDPLM-- 52
+K V N + SD R + L R +RE+ +++ H N++ ++P M
Sbjct: 51 IKRVFN--TVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK 108
Query: 53 -VIVTELLP---GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 108
+VTEL+ + + + P + F I + LH G++HRDL P
Sbjct: 109 LYLVTELMRTDLAQVIHDQRIVISPQHIQY-----FMYHILLGLHVLHEAGVVHRDLHPG 163
Query: 109 NLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV 168
N+LL D + + DF LAR + APEL + K + V
Sbjct: 164 NILLA-DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM-------QFKGFTKLV 215
Query: 169 DVYSFGIVLWELLTNRLPFEG 189
D++S G V+ E+ + F G
Sbjct: 216 DMWSAGCVMAEMFNRKALFRG 236
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ IRE+ ++ +V F GA D + I E + G SL + L + ++ +
Sbjct: 53 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILG 110
Query: 83 NFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
++ + + + L + I+HRD+KP N+L+ + +KL DFG++
Sbjct: 111 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDE-------- 161
Query: 142 XYRWMAPELYSTVTLRQGEK---KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
MA E T + E+ HY+ + D++S G+ L E+ R P M+ +
Sbjct: 162 ----MANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFE-LLD 216
Query: 199 AAFKHARPGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
P LP + S + V C +++P R Q+ M++AF+
Sbjct: 217 YIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQL--MVHAFI 262
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 38/150 (25%), Positives = 67/150 (44%), Gaps = 13/150 (8%)
Query: 84 FALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
+ +I A+D LH+ +++RDLK +NL+L D +K+ DFGL +
Sbjct: 256 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCG 314
Query: 143 Y-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 315 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 366
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ R P + P+ ++ +DP R
Sbjct: 367 EEIR--FPRTLGPEAKSLLSGLLKKDPKQR 394
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 66/249 (26%), Positives = 102/249 (40%), Gaps = 51/249 (20%)
Query: 27 REVNMMSRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
RE+ +KH+NL++F+ A K + + ++T SL YL + N + +
Sbjct: 58 REIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYL---KGNIITWNEL 114
Query: 82 LNFALDIARAMDCLHAN-----------GIIHRDLKPDNLLLTPDQKSLKLADFGLA--- 127
+ A ++R + LH + I HRD K N+LL D ++ LADFGLA
Sbjct: 115 CHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAV-LADFGLAVRF 173
Query: 128 RXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN---- 183
R+MAPE+ Q + ++D+Y+ G+VLWEL++
Sbjct: 174 EPGKPPGDTHGQVGTRRYMAPEVLEGAINFQ---RDAFLRIDMYAMGLVLWELVSRCKAA 230
Query: 184 -------RLPFE-------GMSNLQAAYAAAFKHARPGLPEDI--SPDLA---FIVQSCW 224
LPFE + LQ K RP + + P LA ++ CW
Sbjct: 231 DGPVDEYMLPFEEEIGQHPSLEELQE--VVVHKKMRPTIKDHWLKHPGLAQLCVTIEECW 288
Query: 225 VEDPNLRPS 233
D R S
Sbjct: 289 DHDAEARLS 297
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 31/201 (15%)
Query: 5 MKEVLNRGSTSDER-------ALLEGRFIREVNMMSRVKHDNLV---KFLGACKDPLM-- 52
+K V N + SD R + L R +RE+ +++ H N++ ++P M
Sbjct: 51 IKRVFN--TVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK 108
Query: 53 -VIVTELLP---GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 108
+VTEL+ + + + P + F I + LH G++HRDL P
Sbjct: 109 LYLVTELMRTDLAQVIHDQRIVISPQHIQY-----FMYHILLGLHVLHEAGVVHRDLHPG 163
Query: 109 NLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV 168
N+LL D + + DF LAR + APEL + K + V
Sbjct: 164 NILLA-DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM-------QFKGFTKLV 215
Query: 169 DVYSFGIVLWELLTNRLPFEG 189
D++S G V+ E+ + F G
Sbjct: 216 DMWSAGCVMAEMFNRKALFRG 236
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E PG + +L R +
Sbjct: 87 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGR 138
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NL++ Q +K+ DFG A+
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW 197
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 198 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 239
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 38/150 (25%), Positives = 67/150 (44%), Gaps = 13/150 (8%)
Query: 84 FALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
+ +I A+D LH+ +++RDLK +NL+L D +K+ DFGL +
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCG 311
Query: 143 Y-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 312 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ R P + P+ ++ +DP R
Sbjct: 364 EEIR--FPRTLGPEAKSLLSGLLKKDPKQR 391
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLP 60
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+
Sbjct: 41 AKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQK 117
G L +L L A F I + LH+ I H DLKP+N++L +
Sbjct: 98 GGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+K+ DFGLA ++APE+ Y + L + D++S G+
Sbjct: 156 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 205
Query: 176 VLWELLTNRLPFEG 189
+ + LL+ PF G
Sbjct: 206 ITYILLSGASPFLG 219
>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|B Chain B, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|C Chain C, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|D Chain D, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
Length = 400
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 41/138 (29%), Positives = 60/138 (43%), Gaps = 10/138 (7%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++IV E L G L + A I A+ LH+ I HRD+KP+NLL
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T + + LKL DFG A+ ++APE+ G +K Y+ D
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-------GPEK-YDKSCD 245
Query: 170 VYSFGIVLWELLTNRLPF 187
+S G++ + LL PF
Sbjct: 246 XWSLGVIXYILLCGYPPF 263
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/193 (26%), Positives = 86/193 (44%), Gaps = 21/193 (10%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLPG 61
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+ G
Sbjct: 42 KFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 62 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQKS 118
L +L L A F I + LH+ I H DLKP+N++L +
Sbjct: 99 GELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 119 LKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIV 176
+K+ DFGLA ++APE+ Y + L + D++S G++
Sbjct: 157 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGVI 206
Query: 177 LWELLTNRLPFEG 189
+ LL+ PF G
Sbjct: 207 TYILLSGASPFLG 219
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 38/139 (27%), Positives = 69/139 (49%), Gaps = 12/139 (8%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHV--ALNFALDIARAMDCLHANGIIHRDLKPDN 109
+ +V ++ G +R ++ ++ + A+ + I ++ LH II+RDLKP+N
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPEN 319
Query: 110 LLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV 168
+LL D +++++D GLA +MAPEL GE+ Y+ V
Sbjct: 320 VLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL------GEE--YDFSV 370
Query: 169 DVYSFGIVLWELLTNRLPF 187
D ++ G+ L+E++ R PF
Sbjct: 371 DYFALGVTLYEMIAARGPF 389
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NL++ Q +++ DFGLA+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIQVTDFGLAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NL++ Q +K+ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 87 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 138
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 139 FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 197
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 198 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 239
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 39/150 (26%), Positives = 68/150 (45%), Gaps = 13/150 (8%)
Query: 84 FALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
+ +I A+D LH+ +++RDLK +NL+L D +K+ DFGL +
Sbjct: 114 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXFCG 172
Query: 143 Y-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 173 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 224
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ R P + P+ ++ +DP R
Sbjct: 225 EEIR--FPRTLGPEAKSLLSGLLKKDPKQR 252
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 35/116 (30%), Positives = 57/116 (49%), Gaps = 12/116 (10%)
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARXXXXXXXXXXXXX 141
N I A+ LH GI HRD+KP+N L + ++ +KL DFGL++
Sbjct: 172 NIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM 231
Query: 142 XYR-----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
+ ++APE+ +T + Y K D +S G++L LL +PF G+++
Sbjct: 232 TTKAGTPYFVAPEVLNTTN------ESYGPKCDAWSAGVLLHLLLMGAVPFPGVND 281
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E +PG + +L R +
Sbjct: 79 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGR 130
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 131 FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 189
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 190 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 231
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 38/139 (27%), Positives = 69/139 (49%), Gaps = 12/139 (8%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHV--ALNFALDIARAMDCLHANGIIHRDLKPDN 109
+ +V ++ G +R ++ ++ + A+ + I ++ LH II+RDLKP+N
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPEN 319
Query: 110 LLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV 168
+LL D +++++D GLA +MAPEL GE+ Y+ V
Sbjct: 320 VLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL------GEE--YDFSV 370
Query: 169 DVYSFGIVLWELLTNRLPF 187
D ++ G+ L+E++ R PF
Sbjct: 371 DYFALGVTLYEMIAARGPF 389
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 39/150 (26%), Positives = 68/150 (45%), Gaps = 13/150 (8%)
Query: 84 FALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
+ +I A+D LH+ +++RDLK +NL+L D +K+ DFGL +
Sbjct: 113 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXFCG 171
Query: 143 Y-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 172 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 223
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ R P + P+ ++ +DP R
Sbjct: 224 EEIR--FPRTLGPEAKSLLSGLLKKDPKQR 251
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLP 60
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+
Sbjct: 41 AKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQK 117
G L +L L A F I + LH+ I H DLKP+N++L +
Sbjct: 98 GGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+K+ DFGLA ++APE+ Y + L + D++S G+
Sbjct: 156 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 205
Query: 176 VLWELLTNRLPFEG 189
+ + LL+ PF G
Sbjct: 206 ITYILLSGASPFLG 219
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 38/139 (27%), Positives = 69/139 (49%), Gaps = 12/139 (8%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHV--ALNFALDIARAMDCLHANGIIHRDLKPDN 109
+ +V ++ G +R ++ ++ + A+ + I ++ LH II+RDLKP+N
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPEN 319
Query: 110 LLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV 168
+LL D +++++D GLA +MAPEL GE+ Y+ V
Sbjct: 320 VLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL------GEE--YDFSV 370
Query: 169 DVYSFGIVLWELLTNRLPF 187
D ++ G+ L+E++ R PF
Sbjct: 371 DYFALGVTLYEMIAARGPF 389
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 52/195 (26%), Positives = 87/195 (44%), Gaps = 23/195 (11%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLP 60
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+
Sbjct: 41 AKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL----TPDQ 116
G L +L L A F I + LH+ I H DLKP+N++L P
Sbjct: 98 GGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155
Query: 117 KSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFG 174
+ +K+ DFGLA ++APE+ Y + L + D++S G
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIG 204
Query: 175 IVLWELLTNRLPFEG 189
++ + LL+ PF G
Sbjct: 205 VITYILLSGASPFLG 219
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 39/150 (26%), Positives = 68/150 (45%), Gaps = 13/150 (8%)
Query: 84 FALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
+ +I A+D LH+ +++RDLK +NL+L D +K+ DFGL +
Sbjct: 115 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXFCG 173
Query: 143 Y-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 174 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 225
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ R P + P+ ++ +DP R
Sbjct: 226 EEIR--FPRTLGPEAKSLLSGLLKKDPKQR 253
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLP 60
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+
Sbjct: 41 AKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQK 117
G L +L L A F I + LH+ I H DLKP+N++L +
Sbjct: 98 GGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+K+ DFGLA ++APE+ Y + L + D++S G+
Sbjct: 156 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 205
Query: 176 VLWELLTNRLPFEG 189
+ + LL+ PF G
Sbjct: 206 ITYILLSGASPFLG 219
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 38/139 (27%), Positives = 69/139 (49%), Gaps = 12/139 (8%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHV--ALNFALDIARAMDCLHANGIIHRDLKPDN 109
+ +V ++ G +R ++ ++ + A+ + I ++ LH II+RDLKP+N
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPEN 319
Query: 110 LLLTPDQKSLKLADFGLA-RXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV 168
+LL D +++++D GLA +MAPEL GE+ Y+ V
Sbjct: 320 VLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL------GEE--YDFSV 370
Query: 169 DVYSFGIVLWELLTNRLPF 187
D ++ G+ L+E++ R PF
Sbjct: 371 DYFALGVTLYEMIAARGPF 389
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
RF +E+ +M + H N+++ +D + +V EL G L + +V R + A
Sbjct: 69 RFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES--DAA 126
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLARXXXXXXXXXXXX 140
D+ A+ H + HRDLKP+N L D LKL DFGLA
Sbjct: 127 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 186
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
+++P++ + Y + D +S G++++ LL PF ++ +
Sbjct: 187 GTPYYVSPQVLEGL---------YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEV 232
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLP 60
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+
Sbjct: 41 AKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQK 117
G L +L L A F I + LH+ I H DLKP+N++L +
Sbjct: 98 GGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155
Query: 118 SLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGI 175
+K+ DFGLA ++APE+ Y + L + D++S G+
Sbjct: 156 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL----------EADMWSIGV 205
Query: 176 VLWELLTNRLPFEG 189
+ + LL+ PF G
Sbjct: 206 ITYILLSGASPFLG 219
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 25/237 (10%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKY 67
+ RG DE RE+ ++H N+V+F P + IV E G L +
Sbjct: 52 IERGEKIDENVK------REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 105
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL--TPDQKSLKLADFG 125
+ + + A F + + HA + HRDLK +N LL +P + LK+ FG
Sbjct: 106 ICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR-LKICAFG 162
Query: 126 LARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV-DVYSFGIVLWELLTNR 184
++ ++APE+ KK Y+ KV DV+S G+ L+ +L
Sbjct: 163 YSKSSVLHSQPKSTVGTPAYIAPEVLL--------KKEYDGKVADVWSCGVTLYVMLVGA 214
Query: 185 LPFEGMSNLQAAYAAAFK--HARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQI 237
PFE + + + + +P+ ISP+ ++ +V DP R S +I
Sbjct: 215 YPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
RF +E+ +M + H N+++ +D + +V EL G L + +V R + A
Sbjct: 52 RFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES--DAA 109
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLARXXXXXXXXXXXX 140
D+ A+ H + HRDLKP+N L D LKL DFGLA
Sbjct: 110 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169
Query: 141 XXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
+++P++ + Y + D +S G++++ LL PF ++ +
Sbjct: 170 GTPYYVSPQVLEGL---------YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEV 215
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NL++ Q +K+ DFG A+
Sbjct: 138 FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 25/237 (10%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKY 67
+ RG DE RE+ ++H N+V+F P + IV E G L +
Sbjct: 52 IERGEKIDENVK------REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 105
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL--TPDQKSLKLADFG 125
+ + + A F + + HA + HRDLK +N LL +P + LK+ FG
Sbjct: 106 ICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR-LKICAFG 162
Query: 126 LARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV-DVYSFGIVLWELLTNR 184
++ ++APE+ KK Y+ KV DV+S G+ L+ +L
Sbjct: 163 YSKSSVLHSQPKDTVGTPAYIAPEVLL--------KKEYDGKVADVWSCGVTLYVMLVGA 214
Query: 185 LPFEGMSNLQAAYAAAFK--HARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQI 237
PFE + + + + +P+ ISP+ ++ +V DP R S +I
Sbjct: 215 YPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 10/105 (9%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+A +IA A+ LH+ I++RDLKP+N+LL Q + L DFGL +
Sbjct: 144 YAAEIASALGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCGT 202
Query: 144 -RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++APE+ K+ Y+ VD + G VL+E+L PF
Sbjct: 203 PEYLAPEVL--------HKQPYDRTVDWWCLGAVLYEMLYGLPPF 239
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 27/183 (14%)
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL----------ARXXXXXXX 135
L I R ++ +HA G HRDLKP N+LL D+ L D G +R
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKH--YNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
+ APEL+S + H + + DV+S G VL+ ++ P++ +
Sbjct: 200 WAAQRCTISYRAPELFSV-------QSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 194 QAAYAAAFKH--ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251
+ A A ++ + P P S L ++ S DP+ RP ++ L A L+PP
Sbjct: 253 GDSVALAVQNQLSIPQSPRH-SSALWQLLNSMMTVDPHQRPHIPLLLSQLEA----LQPP 307
Query: 252 SPS 254
+P
Sbjct: 308 APG 310
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 52/195 (26%), Positives = 87/195 (44%), Gaps = 23/195 (11%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLP 60
KF+K+ R + S R + REV+++ ++H N++ ++ VI + EL+
Sbjct: 41 AKFIKK---RRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL----TPDQ 116
G L +L L A F I + LH+ I H DLKP+N++L P
Sbjct: 98 GGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155
Query: 117 KSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFG 174
+ +K+ DFGLA ++APE+ Y + L + D++S G
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPLGL----------EADMWSIG 204
Query: 175 IVLWELLTNRLPFEG 189
++ + LL+ PF G
Sbjct: 205 VITYILLSGASPFLG 219
>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme
pdb|4DGL|D Chain D, Crystal Structure Of The Ck2 Tetrameric Holoenzyme
Length = 335
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/152 (24%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 39 NLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95
N++ KDP+ +V E + ++ LR D + + +I +A+D
Sbjct: 93 NIITLADIVKDPVSRTPALVFEHVNNTDFKQ----LRQTLTDYDIRF-YMYEILKALDYC 147
Query: 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVT 155
H+ GI+HRD+KP N+++ + + L+L D+GLA + PEL
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ Y+ +D++S G +L ++ + PF
Sbjct: 208 M-------YDYSLDMWSLGCMLASMIFRKEPF 232
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 54.3 bits (129), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 66/263 (25%), Positives = 107/263 (40%), Gaps = 57/263 (21%)
Query: 28 EVNMMSRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
EV + +KH+N+++F+GA K D + ++T SL +L + N + +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELC 124
Query: 83 NFALDIARAMDCLHAN----------GIIHRDLKPDNLLLTPDQKSLKLADFGLA---RX 129
+ A +AR + LH + I HRD+K N+LL + + +ADFGLA
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC-IADFGLALKFEA 183
Query: 130 XXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN------ 183
R+MAPE+ Q + ++D+Y+ G+VLWEL +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQ---RDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 184 -----RLPFE-------GMSNLQAAYAAAFKHARPGLPEDISPD-----LAFIVQSCWVE 226
LPFE + ++Q K RP L + L ++ CW
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQE--VVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 227 DPNLRPS-------FSQIIRMLN 242
D R S +Q+ R+ N
Sbjct: 299 DAEARLSAGCVGERITQMQRLTN 321
>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine
Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex
With An Indirubin Ligand
Length = 429
Score = 54.3 bits (129), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 42/132 (31%), Positives = 62/132 (46%), Gaps = 11/132 (8%)
Query: 53 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
+ +T L M+L + + + L + FA I + +D LH N IIH DLKP+N+LL
Sbjct: 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL 233
Query: 113 TPDQKS-LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171
+S +K+ DFG + YR APE+ Y +D++
Sbjct: 234 KQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR--APEVILGA--------RYGMPIDMW 283
Query: 172 SFGIVLWELLTN 183
S G +L ELLT
Sbjct: 284 SLGCILAELLTG 295
>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41
Length = 417
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 42/132 (31%), Positives = 62/132 (46%), Gaps = 11/132 (8%)
Query: 53 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
+ +T L M+L + + + L + FA I + +D LH N IIH DLKP+N+LL
Sbjct: 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL 233
Query: 113 TPDQKS-LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171
+S +K+ DFG + YR APE+ Y +D++
Sbjct: 234 KQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR--APEVILGA--------RYGMPIDMW 283
Query: 172 SFGIVLWELLTN 183
S G +L ELLT
Sbjct: 284 SLGCILAELLTG 295
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E PG + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NL++ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase
Ck2alpha With Altered Cosubstrate Specificity
pdb|3JUH|B Chain B, Crystal Structure Of A Mutant Of Human Protein Kinase
Ck2alpha With Altered Cosubstrate Specificity
Length = 335
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ +I +A+D H+ GI+HRD+KP N+L+ + + L+L D+GLA
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 195
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ PEL + Y+ +D++S G +L ++ + PF
Sbjct: 196 YFKGPELLVDYQM-------YDYSLDMWSLGCMLASMIFRKEPF 232
>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine
Phosphorylation Regulated Kinase 2 (Dyrk2)
Length = 429
Score = 53.9 bits (128), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 53 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
+ +T L M+L + + + L + FA I + +D LH N IIH DLKP+N+LL
Sbjct: 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL 233
Query: 113 TPDQKS-LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171
+S +K+ DFG + YR APE+ Y +D++
Sbjct: 234 KQQGRSGIKVIDFGSSCYEHQRVYXXIQSRFYR--APEVILGA--------RYGMPIDMW 283
Query: 172 SFGIVLWELLTN 183
S G +L ELLT
Sbjct: 284 SLGCILAELLTG 295
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 40/138 (28%), Positives = 70/138 (50%), Gaps = 12/138 (8%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+ V E + G L ++ R KL A ++ +I+ A++ LH GII+RDLK DN+L
Sbjct: 128 LFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 185
Query: 112 LTPDQKSLKLADFGLARXXXXXXXXXXXXXXY-RWMAPELYSTVTLRQGEKKHYNNKVDV 170
L + +KL D+G+ + ++APE+ +GE Y VD
Sbjct: 186 LDS-EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL------RGED--YGFSVDW 236
Query: 171 YSFGIVLWELLTNRLPFE 188
++ G++++E++ R PF+
Sbjct: 237 WALGVLMFEMMAGRSPFD 254
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN L K + KD + +V E PG + +L R +
Sbjct: 87 EHTLNEKRILQAVNFPF------LTKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGR 138
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NL++ Q +K+ DFG A+
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW 197
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 198 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 239
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 63/266 (23%), Positives = 103/266 (38%), Gaps = 56/266 (21%)
Query: 22 EGRFIREVNMMSRV--KHDNLVKFLGA-----CKDPLMVIVTELLPGMSLRKYLVSLRPN 74
E + RE + + V +H+N++ F+ + + ++T SL YL +
Sbjct: 44 EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLT 100
Query: 75 KLDLHVALNFALDIARAMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLADFGL 126
LD L L IA + LH I HRDLK N+L+ + + +AD GL
Sbjct: 101 TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC-IADLGL 159
Query: 127 ARXXXXXXXXXXX-----XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE-- 179
A R+MAPE+ Q + +VD+++FG+VLWE
Sbjct: 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI--QVDCFDSYKRVDIWAFGLVLWEVA 217
Query: 180 ------------------LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD-----L 216
++ N FE M + RP +P D L
Sbjct: 218 RRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV-----VCVDQQRPNIPNRWFSDPTLTSL 272
Query: 217 AFIVQSCWVEDPNLRPSFSQIIRMLN 242
A +++ CW ++P+ R + +I + L
Sbjct: 273 AKLMKECWYQNPSARLTALRIKKTLT 298
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 65/147 (44%), Gaps = 20/147 (13%)
Query: 95 LHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL-- 150
LH N I+H DLKP N+LL+ +K+ DFG++R ++APE+
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 151 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 210
Y +T D+++ GI+ + LLT+ PF G N Q Y E
Sbjct: 207 YDPIT----------TATDMWNIGIIAYMLLTHTSPFVGEDN-QETY-LNISQVNVDYSE 254
Query: 211 D----ISPDLAFIVQSCWVEDPNLRPS 233
+ +S +QS V++P RP+
Sbjct: 255 ETFSSVSQLATDFIQSLLVKNPEKRPT 281
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN L K + KD + +V E PG + +L R +
Sbjct: 87 EHTLNEKRILQAVNFPF------LTKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGR 138
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NL++ Q +K+ DFG A+
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW 197
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 198 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 239
>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And
Human Ck2alpha' In Complex With A Non-hydrolysable
Atp-analogue
pdb|3U87|B Chain B, Structure Of A Chimeric Construct Of Human Ck2alpha And
Human Ck2alpha' In Complex With A Non-hydrolysable
Atp-analogue
Length = 349
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ +I +A+D H+ GI+HRD+KP N+++ + + L+L D+GLA
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 195
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ PEL + Y+ +D++S G +L ++ + PF
Sbjct: 196 YFKGPELLVDYQM-------YDYSLDMWSLGCMLASMIFRKEPF 232
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 63/266 (23%), Positives = 103/266 (38%), Gaps = 56/266 (21%)
Query: 22 EGRFIREVNMMSRV--KHDNLVKFLGA-----CKDPLMVIVTELLPGMSLRKYLVSLRPN 74
E + RE + + V +H+N++ F+ + + ++T SL YL +
Sbjct: 44 EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLT 100
Query: 75 KLDLHVALNFALDIARAMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLADFGL 126
LD L L IA + LH I HRDLK N+L+ + + +AD GL
Sbjct: 101 TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC-IADLGL 159
Query: 127 ARXXXXXXXXXXX-----XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE-- 179
A R+MAPE+ Q + +VD+++FG+VLWE
Sbjct: 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI--QVDCFDSYKRVDIWAFGLVLWEVA 217
Query: 180 ------------------LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD-----L 216
++ N FE M + RP +P D L
Sbjct: 218 RRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV-----VCVDQQRPNIPNRWFSDPTLTSL 272
Query: 217 AFIVQSCWVEDPNLRPSFSQIIRMLN 242
A +++ CW ++P+ R + +I + L
Sbjct: 273 AKLMKECWYQNPSARLTALRIKKTLT 298
>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2
Length = 329
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 37/165 (22%), Positives = 75/165 (45%), Gaps = 16/165 (9%)
Query: 27 REVNMMSRVKHD-NLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
RE+ ++ ++ N++ KDP+ +V E + ++ +L +
Sbjct: 80 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF---- 135
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
+ +I +A+D H+ GI+HRD+KP N+++ + + L+L D+GLA
Sbjct: 136 -YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 194
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ PEL + Y+ +D++S G +L ++ + PF
Sbjct: 195 RYFKGPELLVDYQM-------YDYSLDMWSLGCMLASMIFRKEPF 232
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 63/266 (23%), Positives = 103/266 (38%), Gaps = 56/266 (21%)
Query: 22 EGRFIREVNMMSRV--KHDNLVKFLGA-----CKDPLMVIVTELLPGMSLRKYLVSLRPN 74
E + RE + + V +H+N++ F+ + + ++T SL YL +
Sbjct: 73 EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLT 129
Query: 75 KLDLHVALNFALDIARAMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLADFGL 126
LD L L IA + LH I HRDLK N+L+ + + +AD GL
Sbjct: 130 TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC-IADLGL 188
Query: 127 ARXXXXXXXXXXX-----XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE-- 179
A R+MAPE+ Q + +VD+++FG+VLWE
Sbjct: 189 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI--QVDCFDSYKRVDIWAFGLVLWEVA 246
Query: 180 ------------------LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD-----L 216
++ N FE M + RP +P D L
Sbjct: 247 RRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV-----VCVDQQRPNIPNRWFSDPTLTSL 301
Query: 217 AFIVQSCWVEDPNLRPSFSQIIRMLN 242
A +++ CW ++P+ R + +I + L
Sbjct: 302 AKLMKECWYQNPSARLTALRIKKTLT 327
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 41/138 (29%), Positives = 71/138 (51%), Gaps = 12/138 (8%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+ V E + G L ++ R KL A ++ +I+ A++ LH GII+RDLK DN+L
Sbjct: 96 LFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 153
Query: 112 LTPDQKSLKLADFGLARXXXXXXXXXXXXXXY-RWMAPELYSTVTLRQGEKKHYNNKVDV 170
L + +KL D+G+ + ++APE+ +GE Y VD
Sbjct: 154 LDS-EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL------RGED--YGFSVDW 204
Query: 171 YSFGIVLWELLTNRLPFE 188
++ G++++E++ R PF+
Sbjct: 205 WALGVLMFEMMAGRSPFD 222
>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With
Ellagic Acid
pdb|3AMY|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With
Apigenin
pdb|3AT2|A Chain A, Crystal Structure Of Ck2alpha
pdb|3AT3|A Chain A, Crystal Structure Of Ck2alpha With Pyradine Derivative
pdb|3AT4|A Chain A, Crystal Structure Of Ck2alpha With Pyradine Derivertive
pdb|3AXW|A Chain A, Crystal Structure Of Human Ck2alpha Complexed With A
Potent Inhibitor
Length = 340
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ +I +A+D H+ GI+HRD+KP N+++ + + L+L D+GLA
Sbjct: 141 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 200
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ PEL + Y+ +D++S G +L ++ + PF
Sbjct: 201 YFKGPELLVDYQM-------YDYSLDMWSLGCMLASMIFRKEPF 237
>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Emodin At Ph 8.5
pdb|3Q9X|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Emodin At Ph 6.5
pdb|3Q9X|B Chain B, Crystal Structure Of Human Ck2 Alpha In Complex With
Emodin At Ph 6.5
pdb|3Q9Y|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Quinalizarin At Ph 8.5
pdb|3Q9Z|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Quinalizarin At Ph 6.5
pdb|3Q9Z|B Chain B, Crystal Structure Of Human Ck2 Alpha In Complex With
Quinalizarin At Ph 6.5
pdb|3QA0|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph
6.5
pdb|3QA0|B Chain B, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph
6.5
Length = 336
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 39 NLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95
N++ KDP+ +V E + ++ +L + + +I +A+D
Sbjct: 93 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-----YMYEILKALDYC 147
Query: 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVT 155
H+ GI+HRD+KP N+++ + + L+L D+GLA + PEL
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ Y+ +D++S G +L ++ + PF
Sbjct: 208 M-------YDYSLDMWSLGCMLASMIFRKEPF 232
>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
pdb|2R7I|B Chain B, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
pdb|2R7I|C Chain C, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
pdb|2R7I|D Chain D, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
Length = 335
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 39 NLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95
N++ KDP+ +V E + ++ +L + + +I +A+D
Sbjct: 93 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-----YMYEILKALDYC 147
Query: 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVT 155
H+ GI+HRD+KP N+++ + + L+L D+GLA + PEL
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ Y+ +D++S G +L ++ + PF
Sbjct: 208 M-------YDYSLDMWSLGCMLASMIFRKEPF 232
>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme
pdb|1JWH|B Chain B, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme
pdb|3PE1|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Alpha
Subunit In Complex With The Inhibitor Cx-4945
pdb|3PE2|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 In Complex
With The Inhibitor Cx-5011
pdb|3R0T|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Alpha
Subunit In Complex With The Inhibitor Cx-5279
Length = 337
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 39 NLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95
N++ KDP+ +V E + ++ +L + + +I +A+D
Sbjct: 93 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-----YMYEILKALDYC 147
Query: 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVT 155
H+ GI+HRD+KP N+++ + + L+L D+GLA + PEL
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ Y+ +D++S G +L ++ + PF
Sbjct: 208 M-------YDYSLDMWSLGCMLASMIFRKEPF 232
>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With
The Catalytic Subunit Of Protein Kinase Ck2
pdb|3C13|A Chain A, Low Ph-Value Crystal Structure Of Emodin In Complex With
The Catalytic Subunit Of Protein Kinase Ck2
pdb|3FWQ|A Chain A, Inactive Conformation Of Human Protein Kinase Ck2
Catalytic Subunit
pdb|3FWQ|B Chain B, Inactive Conformation Of Human Protein Kinase Ck2
Catalytic Subunit
pdb|3RPS|A Chain A, Structure Of Human Ck2alpha In Complex With The
Atp-Competitive Inhibitor
3-(4,5,6,7-Tetrabromo-1h-Benzotriazol-1-Yl)propan-1-Ol
pdb|3RPS|B Chain B, Structure Of Human Ck2alpha In Complex With The
Atp-Competitive Inhibitor
3-(4,5,6,7-Tetrabromo-1h-Benzotriazol-1-Yl)propan-1-Ol
pdb|3U9C|A Chain A, Structure Of A C-terminal Deletion Mutant Of Human Protein
Kinase Ck2 Catalytic Subunit With The Atp-competitive
Inhibitor Resorufin
pdb|3U9C|B Chain B, Structure Of A C-terminal Deletion Mutant Of Human Protein
Kinase Ck2 Catalytic Subunit With The Atp-competitive
Inhibitor Resorufin
pdb|4FBX|A Chain A, Complex Structure Of Human Protein Kinase Ck2 Catalytic
Subunit Crystallized In The Presence Of A Bisubstrate
Inhibitor
Length = 335
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 39 NLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95
N++ KDP+ +V E + ++ +L + + +I +A+D
Sbjct: 93 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-----YMYEILKALDYC 147
Query: 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVT 155
H+ GI+HRD+KP N+++ + + L+L D+GLA + PEL
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ Y+ +D++S G +L ++ + PF
Sbjct: 208 M-------YDYSLDMWSLGCMLASMIFRKEPF 232
>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D-
Ribofuranosylbenzimidazole
pdb|3H30|B Chain B, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D-
Ribofuranosylbenzimidazole
Length = 334
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 39 NLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95
N++ KDP+ +V E + ++ +L + + +I +A+D
Sbjct: 93 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-----YMYEILKALDYC 147
Query: 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVT 155
H+ GI+HRD+KP N+++ + + L+L D+GLA + PEL
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ Y+ +D++S G +L ++ + PF
Sbjct: 208 M-------YDYSLDMWSLGCMLASMIFRKEPF 232
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 37/138 (26%), Positives = 65/138 (47%), Gaps = 7/138 (5%)
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG-- 125
L+S ++L +A + ++ A+D +H +HRD+KPDN+L+ + ++LADFG
Sbjct: 164 LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSC 222
Query: 126 LARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
L +++PE+ + +G K Y + D +S G+ ++E+L
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAM---EGGKGRYGPECDWWSLGVCMYEMLYGET 279
Query: 186 PFEGMSNLQAAYAAAFKH 203
PF S L Y H
Sbjct: 280 PFYAES-LVETYGKIMNH 296
>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945
pdb|3NGA|B Chain B, Human Ck2 Catalytic Domain In Complex With Cx-4945
pdb|3U4U|A Chain A, Casein Kinase 2 In Complex With Az-Inhibitor
Length = 333
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 39 NLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95
N++ KDP+ +V E + ++ +L + + +I +A+D
Sbjct: 93 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-----YMYEILKALDYC 147
Query: 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVT 155
H+ GI+HRD+KP N+++ + + L+L D+GLA + PEL
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ Y+ +D++S G +L ++ + PF
Sbjct: 208 M-------YDYSLDMWSLGCMLASMIFRKEPF 232
>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human
Protein Kinase Ck2 Catalytic Subunit
pdb|2PVR|A Chain A, Crystal Structure Of The Catalytic Subunit Of Protein
Kinase Ck2 (c- Terminal Deletion Mutant 1-335) In
Complex With Two Sulfate Ions
Length = 334
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 39 NLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95
N++ KDP+ +V E + ++ +L + + +I +A+D
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-----YMYEILKALDYC 146
Query: 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVT 155
H+ GI+HRD+KP N+++ + + L+L D+GLA + PEL
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ Y+ +D++S G +L ++ + PF
Sbjct: 207 M-------YDYSLDMWSLGCMLASMIFRKEPF 231
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN L K + KD + +V E PG + +L R +
Sbjct: 87 EHTLNEKRILQAVNFPF------LTKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGR 138
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NL++ Q +K+ DFG A+
Sbjct: 139 FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW 197
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 198 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 239
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/185 (25%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 7 EVLNRGS-TSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMS 63
+V GS +++E L ++EV+++ +V H N+++ + + +V +L+
Sbjct: 51 DVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 110
Query: 64 LRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
L YL + ++ + + L++ A LH I+HRDLKP+N+LL D ++KL
Sbjct: 111 LFDYLTEKVTLSEKETRKIMRALLEVICA---LHKLNIVHRDLKPENILLD-DDMNIKLT 166
Query: 123 DFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
DFG + ++APE+ Y +VD++S G++++ LL
Sbjct: 167 DFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSM--NDNHPGYGKEVDMWSTGVIMYTLLA 224
Query: 183 NRLPF 187
PF
Sbjct: 225 GSPPF 229
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
RE + +KH N+V+ + ++ ++ +L+ G L + +V+ R + +
Sbjct: 70 REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQ 128
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXXXXY 143
+ + C H G++HRDLKP+NLLL K ++KLADFGLA
Sbjct: 129 QILEAVLHC-HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA------- 180
Query: 144 RWMA----PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
W P S LR K Y VD+++ G++L+ LL PF
Sbjct: 181 -WFGFAGTPGYLSPEVLR---KDPYGKPVDLWACGVILYILLVGYPPF 224
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/185 (25%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 7 EVLNRGS-TSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMS 63
+V GS +++E L ++EV+++ +V H N+++ + + +V +L+
Sbjct: 38 DVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 97
Query: 64 LRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
L YL + ++ + + L++ A LH I+HRDLKP+N+LL D ++KL
Sbjct: 98 LFDYLTEKVTLSEKETRKIMRALLEVICA---LHKLNIVHRDLKPENILLD-DDMNIKLT 153
Query: 123 DFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
DFG + ++APE+ Y +VD++S G++++ LL
Sbjct: 154 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM--NDNHPGYGKEVDMWSTGVIMYTLLA 211
Query: 183 NRLPF 187
PF
Sbjct: 212 GSPPF 216
>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane
Derivative Inhibitor (Cpa)
pdb|3MB7|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane
Derivative Inhibitor (Amr)
pdb|3OWJ|A Chain A, Human Ck2 Catalytic Domain In Complex With A
Pyridocarbazole Derivative Inhibitor
pdb|3OWK|A Chain A, Human Ck2 Catalytic Domain In Complex With A
Benzopyridoindole Derivative Inhibitor
pdb|3OWL|A Chain A, Human Ck2 Catalytic Domain In Complex With A
Benzopyridoindole Derivative Inhibitor
Length = 331
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 39 NLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95
N++ KDP+ +V E + ++ +L + + +I +A+D
Sbjct: 93 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-----YMYEILKALDYC 147
Query: 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVT 155
H+ GI+HRD+KP N+++ + + L+L D+GLA + PEL
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ Y+ +D++S G +L ++ + PF
Sbjct: 208 M-------YDYSLDMWSLGCMLASMIFRKEPF 232
>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn
Length = 330
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 39 NLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95
N++ KDP+ +V E + ++ +L + + +I +A+D
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-----YMYEILKALDYC 146
Query: 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVT 155
H+ GI+HRD+KP N+++ + + L+L D+GLA + PEL
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ Y+ +D++S G +L ++ + PF
Sbjct: 207 M-------YDYSLDMWSLGCMLASMIFRKEPF 231
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 73 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 124
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ +Q +++ DFG A+
Sbjct: 125 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-EQGYIQVTDFGFAKRVKGRTW 183
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 184 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 225
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/185 (25%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 7 EVLNRGS-TSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMS 63
+V GS +++E L ++EV+++ +V H N+++ + + +V +L+
Sbjct: 51 DVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 110
Query: 64 LRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
L YL + ++ + + L++ A LH I+HRDLKP+N+LL D ++KL
Sbjct: 111 LFDYLTEKVTLSEKETRKIMRALLEVICA---LHKLNIVHRDLKPENILLD-DDMNIKLT 166
Query: 123 DFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
DFG + ++APE+ Y +VD++S G++++ LL
Sbjct: 167 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM--NDNHPGYGKEVDMWSTGVIMYTLLA 224
Query: 183 NRLPF 187
PF
Sbjct: 225 GSPPF 229
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 13/177 (7%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK 75
E+ +E + RE+ + + + H N+++ D + ++ E P L K L +
Sbjct: 62 EKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL--QKSCT 119
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
D ++A A+ H +IHRD+KP+NLLL + LK+ADFG +
Sbjct: 120 FDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLR 177
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
++ PE+ E + +N KVD++ G++ +ELL PFE S+
Sbjct: 178 RKTMCGTLDYLPPEMI--------EGRMHNEKVDLWCIGVLCYELLVGNPPFESASH 226
>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And
Regulatory (Ri{alpha}) Subunits Of Pka
Length = 350
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLAGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph
8.5
Length = 328
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ +I +A+D H+ GI+HRD+KP N+++ + + L+L D+GLA
Sbjct: 134 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 193
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ PEL + Y+ +D++S G +L ++ + PF
Sbjct: 194 YFKGPELLVDYQM-------YDYSLDMWSLGCMLASMIFRKEPF 230
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 49/172 (28%), Positives = 79/172 (45%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 107 EHTLNEKRILQAVNF------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 158
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 159 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGATW 217
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 218 TLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 259
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 41/138 (29%), Positives = 71/138 (51%), Gaps = 12/138 (8%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+ V E + G L ++ R KL A ++ +I+ A++ LH GII+RDLK DN+L
Sbjct: 81 LFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 138
Query: 112 LTPDQKSLKLADFGLARXXXXXXXXXXXXXXY-RWMAPELYSTVTLRQGEKKHYNNKVDV 170
L + +KL D+G+ + ++APE+ +GE Y VD
Sbjct: 139 LDS-EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL------RGED--YGFSVDW 189
Query: 171 YSFGIVLWELLTNRLPFE 188
++ G++++E++ R PF+
Sbjct: 190 WALGVLMFEMMAGRSPFD 207
>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
pdb|1J3H|B Chain B, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
Length = 350
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLXGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 41/138 (29%), Positives = 71/138 (51%), Gaps = 12/138 (8%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+ V E + G L ++ R KL A ++ +I+ A++ LH GII+RDLK DN+L
Sbjct: 85 LFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 142
Query: 112 LTPDQKSLKLADFGLARXXXXXXXXXXXXXXY-RWMAPELYSTVTLRQGEKKHYNNKVDV 170
L + +KL D+G+ + ++APE+ +GE Y VD
Sbjct: 143 LDS-EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL------RGED--YGFSVDW 193
Query: 171 YSFGIVLWELLTNRLPFE 188
++ G++++E++ R PF+
Sbjct: 194 WALGVLMFEMMAGRSPFD 211
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 60/252 (23%), Positives = 94/252 (37%), Gaps = 50/252 (19%)
Query: 22 EGRFIREVNMMSRV--KHDNLVKFL-----GACKDPLMVIVTELLPGMSLRKYLVSLRPN 74
E + RE + V +H+N++ F+ G + ++T+ SL YL S
Sbjct: 73 EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---T 129
Query: 75 KLDLHVALNFALDIARAMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLADFGL 126
LD L A + LH I HRDLK N+L+ + + +AD GL
Sbjct: 130 TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGL 188
Query: 127 ARXXXXXXXXX-----XXXXXYRWMAPELYSTVTLRQGEKKHYNNKV--DVYSFGIVLWE 179
A R+M PE+ R H+ + + D+YSFG++LWE
Sbjct: 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN----HFQSYIMADMYSFGLILWE 244
Query: 180 LLTN----------RLPFEGMSNLQAAYA-----AAFKHARPGLPEDISPD-----LAFI 219
+ +LP+ + +Y K RP P S D + +
Sbjct: 245 VARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKL 304
Query: 220 VQSCWVEDPNLR 231
+ CW +P R
Sbjct: 305 MTECWAHNPASR 316
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 87 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 138
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 197
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 198 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 239
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil
pdb|3TKU|B Chain B, Mrck Beta In Complex With Fasudil
Length = 433
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG-- 125
L+S +KL +A + ++ A+D +H +HRD+KPDN+LL + ++LADFG
Sbjct: 180 LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVN-GHIRLADFGSC 238
Query: 126 LARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
L +++PE+ + G+ Y + D +S G+ ++E+L
Sbjct: 239 LKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGK---YGPECDWWSLGVCMYEMLYGET 295
Query: 186 PFEGMSNLQAAYAAAFKHAR----PGLPEDISPDLAFIVQ 221
PF S L Y H P D+S + ++Q
Sbjct: 296 PFYAES-LVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQ 334
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 107 EHTLNEKRILQAVNF------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 158
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 159 FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 217
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 218 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 259
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1
pdb|3QFV|B Chain B, Mrck Beta In Complex With Tpca-1
Length = 415
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG-- 125
L+S +KL +A + ++ A+D +H +HRD+KPDN+LL + ++LADFG
Sbjct: 164 LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVN-GHIRLADFGSC 222
Query: 126 LARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
L +++PE+ + G+ Y + D +S G+ ++E+L
Sbjct: 223 LKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGK---YGPECDWWSLGVCMYEMLYGET 279
Query: 186 PFEGMSNLQAAYAAAFKHAR----PGLPEDISPDLAFIVQ 221
PF S L Y H P D+S + ++Q
Sbjct: 280 PFYAES-LVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQ 318
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 81 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 132
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 133 FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 191
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 192 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 233
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1
Catalytic Domain Apo Form
Length = 390
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 90 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---XXXXXXXXXXXXYRWM 146
A+ +H +GI+H DLKP N L+ LKL DFG+A +M
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 147 APELYSTVTLRQ---GEKKHYNNKVDVYSFGIVLWELLTNRLPFE----GMSNLQAAYAA 199
PE ++ + K + K DV+S G +L+ + + PF+ +S L A
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P +PE DL +++ C DP R S +++
Sbjct: 284 NHEIEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELL 319
>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With Atp
pdb|3HMO|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With The Inhibitor Staurosporine
pdb|3HMP|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With A Quinazolin Ligand Compound 4
Length = 342
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 90 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---RXXXXXXXXXXXXXXYRWM 146
A+ +H +GI+H DLKP N L+ LKL DFG+A + +M
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 147 APELYSTVTLRQGE---KKHYNNKVDVYSFGIVLWELLTNRLPFE----GMSNLQAAYAA 199
PE ++ + K + K DV+S G +L+ + + PF+ +S L A
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P +PE DL +++ C DP R S +++
Sbjct: 284 NHEIEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELL 319
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NL++ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE+ + K YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAPEIIIS--------KGYNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain
Length = 343
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 15/162 (9%)
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---XXXXXXXXXXXXY 143
++ A+ +H +GI+H DLKP N L+ LKL DFG+A
Sbjct: 116 NMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 144 RWMAPELYSTVTLRQGE---KKHYNNKVDVYSFGIVLWELLTNRLPFE----GMSNLQAA 196
+M PE ++ + K + K DV+S G +L+ + + PF+ +S L A
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P +PE DL +++ C DP R S +++
Sbjct: 234 IDPNHEIEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELL 272
>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a
Mutant In Complex With Sp600125 Inhibitor
Length = 390
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 90 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---XXXXXXXXXXXXYRWM 146
A+ +H +GI+H DLKP N L+ LKL DFG+A +M
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 147 APELYSTVTLRQ---GEKKHYNNKVDVYSFGIVLWELLTNRLPFE----GMSNLQAAYAA 199
PE ++ + K + K DV+S G +L+ + + PF+ +S L A
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P +PE DL +++ C DP R S +++
Sbjct: 284 NHEIEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELL 319
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 51.6 bits (122), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 8/165 (4%)
Query: 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
G+ E+ ++SRV+H N++K L ++ + G L + R +LD +A
Sbjct: 74 GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX 142
+ A+ L IIHRD+K +N+++ D ++KL DFG A
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKLFYTFCGT 192
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ APE+ R E ++++S G+ L+ L+ PF
Sbjct: 193 IEYCAPEVLMGNPYRGPE-------LEMWSLGVTLYTLVFEENPF 230
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 51.6 bits (122), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 11/103 (10%)
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXX----- 142
I A+ +H+ GIIHR+LKP N+ + + +++K+ DFGLA+
Sbjct: 125 ILEALSYIHSQGIIHRNLKPXNIFI-DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 143 ----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
+ Y + G HYN K+D YS GI+ +E +
Sbjct: 184 SDNLTSAIGTAXYVATEVLDG-TGHYNEKIDXYSLGIIFFEXI 225
>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(ttk)
pdb|3GFW|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrolo-Pyridin Ligand
Length = 313
Score = 51.6 bits (122), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 90 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---XXXXXXXXXXXXYRWM 146
A+ +H +GI+H DLKP N L+ LKL DFG+A +M
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 147 APELYSTVTLRQGE---KKHYNNKVDVYSFGIVLWELLTNRLPFE----GMSNLQAAYAA 199
PE ++ + K + K DV+S G +L+ + + PF+ +S L A
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P +PE DL +++ C DP R S +++
Sbjct: 256 NHEIEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELL 291
>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715
Length = 317
Score = 51.6 bits (122), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 15/162 (9%)
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---XXXXXXXXXXXXY 143
++ A+ +H +GI+H DLKP N L+ LKL DFG+A
Sbjct: 119 NMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 176
Query: 144 RWMAPELYSTVTLRQGE---KKHYNNKVDVYSFGIVLWELLTNRLPFE----GMSNLQAA 196
+M PE ++ + K + K DV+S G +L+ + + PF+ +S L A
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 236
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P +PE DL +++ C DP R S +++
Sbjct: 237 IDPNHEIEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELL 275
>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2-
Yl)amino]benzamide
Length = 320
Score = 51.6 bits (122), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 15/162 (9%)
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXX---XXXXXXXXXXXXY 143
++ A+ +H +GI+H DLKP N L+ LKL DFG+A
Sbjct: 115 NMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDSQVGTV 172
Query: 144 RWMAPELYSTVTLRQGE---KKHYNNKVDVYSFGIVLWELLTNRLPFE----GMSNLQAA 196
+M PE ++ + K + K DV+S G +L+ + + PF+ +S L A
Sbjct: 173 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 232
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P +PE DL +++ C DP R S +++
Sbjct: 233 IDPNHEIEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELL 271
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +APE + L +G YN VD ++ G++++++ PF
Sbjct: 197 XLCGTPEY--LAPE----IILSKG----YNKAVDWWALGVLIYQMAAGYPPF 238
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
RE + +KH N+V+ + ++ ++ +L+ G L + +V+ R + +
Sbjct: 59 REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQ 117
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLARXXXXXXXXXXXXXXY 143
+ + C H G++HR+LKP+NLLL K ++KLADFGLA
Sbjct: 118 QILEAVLHC-HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA------- 169
Query: 144 RWMA----PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
W P S LR K Y VD+++ G++L+ LL PF
Sbjct: 170 -WFGFAGTPGYLSPEVLR---KDPYGKPVDLWACGVILYILLVGYPPF 213
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 51.2 bits (121), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 55/237 (23%), Positives = 102/237 (43%), Gaps = 26/237 (10%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH 79
+ + IRE+ ++ +V F GA D + I E + G SL + L + ++
Sbjct: 47 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQ 104
Query: 80 VALNFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 138
+ ++ + + + L + I+HRD+KP N+L+ + +KL DFG++
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSF 163
Query: 139 XXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF---EGMSNLQA 195
+M+PE QG HY+ + D++S G+ L E+ R P + + +
Sbjct: 164 VGTR-SYMSPERL------QG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRP 214
Query: 196 AYAA------AFKHARPGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A P LP + S + V C +++P R Q+ M++AF+
Sbjct: 215 PMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL--MVHAFI 269
>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrimido-Diazepin Ligand
Length = 313
Score = 51.2 bits (121), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 90 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXX---XXXXXXXXXXXYRWM 146
A+ +H +GI+H DLKP N L+ LKL DFG+A +M
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 147 APELYSTVTLRQGE---KKHYNNKVDVYSFGIVLWELLTNRLPFE----GMSNLQAAYAA 199
PE ++ + K + K DV+S G +L+ + + PF+ +S L A
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ P +PE DL +++ C DP R S +++
Sbjct: 256 NHEIEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELL 291
>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC
Length = 405
Score = 50.8 bits (120), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 35/124 (28%), Positives = 57/124 (45%), Gaps = 14/124 (11%)
Query: 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAR 128
+P +L + + I + LHAN ++HRDLKP N+L+ P++ +K+AD G AR
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 129 XXXX----XXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
+ + APEL +HY +D+++ G + ELLT+
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSE 233
Query: 185 LPFE 188
F
Sbjct: 234 PIFH 237
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 50.8 bits (120), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 42/172 (24%), Positives = 78/172 (45%), Gaps = 14/172 (8%)
Query: 18 RALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKL 76
+ + + IRE+ ++ +V F GA D + I E + G SL + L + ++
Sbjct: 106 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRI 163
Query: 77 DLHVALNFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
+ ++ + + + L + I+HRD+KP N+L+ + +KL DFG++
Sbjct: 164 PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVS-GQLIDSM 221
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+M+PE QG HY+ + D++S G+ L E+ R P
Sbjct: 222 ANSFVGTRSYMSPERL------QG--THYSVQSDIWSMGLSLVEMAVGRYPI 265
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 50.8 bits (120), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 42/189 (22%), Positives = 80/189 (42%), Gaps = 18/189 (9%)
Query: 49 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 108
D ++I+ + P L ++ L +A +F + A+ H G++HRD+K +
Sbjct: 86 DSFVLILERMEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 143
Query: 109 NLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKV 168
N+L+ ++ LKL DFG +YS + + H
Sbjct: 144 NILIDLNRGELKLIDFGSGALLKDTVYTDFD-------GTRVYSPPEWIRYHRYH-GRSA 195
Query: 169 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDP 228
V+S GI+L++++ +PFE + + F R +S + +++ C P
Sbjct: 196 AVWSLGILLYDMVCGDIPFE--HDEEIIRGQVFFRQR------VSSECQHLIRWCLALRP 247
Query: 229 NLRPSFSQI 237
+ RP+F +I
Sbjct: 248 SDRPTFEEI 256
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 50.8 bits (120), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 70/264 (26%), Positives = 110/264 (41%), Gaps = 53/264 (20%)
Query: 25 FIREVNMMSRVK-HDNLVKFLGACK---------DPLMVIVTELLPG--MSLRKYLVSLR 72
I+EV M ++ H N+V+F A +++TEL G + K + S
Sbjct: 72 IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131
Query: 73 PNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLA--- 127
P L L RA+ +H IIHRDLK +NLLL+ +Q ++KL DFG A
Sbjct: 132 P--LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTI 188
Query: 128 ------------RXXXXXXXXXXXXXXYRWMAPE---LYSTVTLRQGEKKHYNNKVDVYS 172
R YR PE LYS + GEK+ D+++
Sbjct: 189 SHYPDYSWSAQRRALVEEEITRNTTPMYR--TPEIIDLYSNFPI--GEKQ------DIWA 238
Query: 173 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF-IVQSCWVEDPNLR 231
G +L+ L + PFE + L+ K++ P P D + ++++ +P R
Sbjct: 239 LGCILYLLCFRQHPFEDGAKLRIVNG---KYSIP--PHDTQYTVFHSLIRAMLQVNPEER 293
Query: 232 PSFSQIIRMLN--AFLFTLRPPSP 253
S ++++ L A + P SP
Sbjct: 294 LSIAEVVHQLQEIAAARNVNPKSP 317
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 50.8 bits (120), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 49/172 (28%), Positives = 79/172 (45%), Gaps = 20/172 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK 75
E L E R ++ VN LVK + KD + +V E + G + +L R +
Sbjct: 86 EHTLNEKRILQAVNFPF------LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGR 137
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
A +A I + LH+ +I+RDLKP+NLL+ Q +++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
Y +AP + L +G YN VD ++ G++++E+ PF
Sbjct: 197 XLCGTPEY--LAP----AIILSKG----YNKAVDWWALGVLIYEMAAGYPPF 238
>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With
A Potent 3-Aminopyrazole Atp Site Inhibitor
pdb|3M2W|A Chain A, Crystal Structure Of Mapkak Kinase 2 (Mk2) Complexed With
A Spiroazetidine-Tetracyclic Atp Site Inhibitor
pdb|3M42|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With
A Tetracyclic Atp Site Inhibitor
Length = 299
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 84/212 (39%), Gaps = 41/212 (19%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
++IV E L G L + A I A+ LH+ I HRD+KP+NLL
Sbjct: 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 112 LTPDQKS--LKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVD 169
T + + LKL DFG A+ GEK Y+ D
Sbjct: 150 YTSKRPNAILKLTDFGFAKETT---------------------------GEK--YDKSCD 180
Query: 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPE-------DISPDLAFIVQ 221
++S G++++ LL PF SN A + K R G E ++S ++ +++
Sbjct: 181 MWSLGVIMYILLCGYPPF--YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 238
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
+ +P R + ++ + T P +P
Sbjct: 239 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 14/166 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ IRE+ ++ +V F GA D + I E + G SL + L + ++ +
Sbjct: 77 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILG 134
Query: 83 NFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
++ + + + L + I+HRD+KP N+L+ + +KL DFG++
Sbjct: 135 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVS-GQLIDSMANSFVG 192
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+M+PE QG HY+ + D++S G+ L E+ R P
Sbjct: 193 TRSYMSPERL------QG--THYSVQSDIWSMGLSLVEMAVGRYPI 230
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 14/166 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ IRE+ ++ +V F GA D + I E + G SL + L + ++ +
Sbjct: 50 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILG 107
Query: 83 NFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
++ + + + L + I+HRD+KP N+L+ + +KL DFG++
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+M+PE QG HY+ + D++S G+ L E+ R P
Sbjct: 167 R-SYMSPERL------QG--THYSVQSDIWSMGLSLVEMAVGRYPI 203
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 75/166 (45%), Gaps = 14/166 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ IRE+ ++ +V F GA D + I E + G SL + L + ++ +
Sbjct: 50 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILG 107
Query: 83 NFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
++ + + + L + I+HRD+KP N+L+ + +KL DFG++
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+M+PE + HY+ + D++S G+ L E+ R P
Sbjct: 167 R-SYMSPERL--------QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203
>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVJ|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVK|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVL|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVM|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVN|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|3BE9|A Chain A, Structure-Based Design And Synthesis Of Novel Macrocyclic
Pyrazolo[1,5-A] [1,3,5]triazine Compounds As Potent
Inhibitors Of Protein Kinase Ck2 And Their Anticancer
Activities
Length = 352
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 53/104 (50%), Gaps = 7/104 (6%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ ++ +A+D H+ GI+HRD+KP N+++ + + L+L D+GLA
Sbjct: 151 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 210
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ PEL V L+ Y+ +D++S G + ++ + PF
Sbjct: 211 YFKGPEL--LVDLQD-----YDYSLDMWSLGCMFAGMIFRKEPF 247
>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147
pdb|3NIE|B Chain B, Crystal Structure Of Pf11_0147
Length = 429
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 87/211 (41%), Gaps = 54/211 (25%)
Query: 24 RFIREVNMMSRVKHDNLVKF--LGACKDPL----MVIVTELLPGMSLRKYLVSLRPNKLD 77
R +RE+ +++R+K D +++ L +D L + IV E+ L+K + P L
Sbjct: 73 RILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADS-DLKKLFKT--PIFLT 129
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXX----- 132
++ +H +GIIHRDLKP N LL D S+K+ DFGLAR
Sbjct: 130 EQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDC-SVKICDFGLARTINSDKDIH 188
Query: 133 --------------------XXXXXXXXXXYRWM-APELYSTVTLRQGEKKHYNNKVDVY 171
RW APEL + L++ Y N +D++
Sbjct: 189 IVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL---ILLQEN----YTNSIDIW 241
Query: 172 SFGIVLWELL----------TNRLP-FEGMS 191
S G + ELL TNR P F G S
Sbjct: 242 STGCIFAELLNMMKSHINNPTNRFPLFPGSS 272
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 37/158 (23%), Positives = 69/158 (43%), Gaps = 16/158 (10%)
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX 139
+A +F + A+ H G++HRD+K +N+L+ ++ LKL DFG
Sbjct: 111 LARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 170
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
+YS + + H V+S GI+L++++ +PFE + +
Sbjct: 171 -------GTRVYSPPEWIRYHRYH-GRSAAVWSLGILLYDMVCGDIPFE--HDEEIIRGQ 220
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
F R +S + +++ C P+ RP+F +I
Sbjct: 221 VFFRQR------VSXECQHLIRWCLALRPSDRPTFEEI 252
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 14/166 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ IRE+ ++ +V F GA D + I E + G SL + L + ++ +
Sbjct: 50 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILG 107
Query: 83 NFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
++ + + + L + I+HRD+KP N+L+ + +KL DFG++
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+M+PE QG HY+ + D++S G+ L E+ R P
Sbjct: 167 R-SYMSPERL------QG--THYSVQSDIWSMGLSLVEMAVGRYPI 203
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 14/166 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ IRE+ ++ +V F GA D + I E + G SL + L + ++ +
Sbjct: 50 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILG 107
Query: 83 NFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXX 141
++ + + + L + I+HRD+KP N+L+ + +KL DFG++
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 142 XYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+M+PE QG HY+ + D++S G+ L E+ R P
Sbjct: 167 R-SYMSPERL------QG--THYSVQSDIWSMGLSLVEMAVGRYPI 203
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 37/158 (23%), Positives = 69/158 (43%), Gaps = 16/158 (10%)
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX 139
+A +F + A+ H G++HRD+K +N+L+ ++ LKL DFG
Sbjct: 114 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 173
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
+YS + + H V+S GI+L++++ +PFE + +
Sbjct: 174 -------GTRVYSPPEWIRYHRYH-GRSAAVWSLGILLYDMVCGDIPFE--HDEEIIRGQ 223
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
F R +S + +++ C P+ RP+F +I
Sbjct: 224 VFFRQR------VSSECQHLIRWCLALRPSDRPTFEEI 255
>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor
Length = 335
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 53/104 (50%), Gaps = 7/104 (6%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
+ ++ +A+D H+ GI+HRD+KP N+++ + + L+L D+GLA
Sbjct: 132 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 191
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ PEL V L+ Y+ +D++S G + ++ + PF
Sbjct: 192 YFKGPEL--LVDLQD-----YDYSLDMWSLGCMFAGMIFRKEPF 228
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 16/162 (9%)
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
L +A +F + A+ H G++HRD+K +N+L+ ++ LKL DFG
Sbjct: 112 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 171
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
+YS + + H V+S GI+L++++ +PFE + +
Sbjct: 172 TDFD-------GTRVYSPPEWIRYHRYH-GRSAAVWSLGILLYDMVCGDIPFE--HDEEI 221
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
F R +S + +++ C P+ RP+F +I
Sbjct: 222 IRGQVFFRQR------VSSECQHLIRWCLALRPSDRPTFEEI 257
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 10/111 (9%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC------KDPLMVIVTELLPGMSLRKYLVSLRPNKLD 77
R +RE+ +++R+ HD++VK L K + +V E+ S K L +
Sbjct: 98 RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI--ADSDFKKLFRTPVYLTE 155
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
LH+ ++ + +H+ GI+HRDLKP N L+ D S+K+ DFGLAR
Sbjct: 156 LHIK-TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLAR 204
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 16/162 (9%)
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXX 135
L +A +F + A+ H G++HRD+K +N+L+ ++ LKL DFG
Sbjct: 112 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 171
Query: 136 XXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
+YS + + H V+S GI+L++++ +PFE + +
Sbjct: 172 TDFD-------GTRVYSPPEWIRYHRYH-GRSAAVWSLGILLYDMVCGDIPFE--HDEEI 221
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
F R +S + +++ C P+ RP+F +I
Sbjct: 222 IRGQVFFRQR------VSSECQHLIRWCLALRPSDRPTFEEI 257
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.323 0.136 0.404
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 8,063,360
Number of Sequences: 62578
Number of extensions: 304270
Number of successful extensions: 3805
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 1022
Number of HSP's successfully gapped in prelim test: 91
Number of HSP's that attempted gapping in prelim test: 629
Number of HSP's gapped (non-prelim): 1154
length of query: 298
length of database: 14,973,337
effective HSP length: 98
effective length of query: 200
effective length of database: 8,840,693
effective search space: 1768138600
effective search space used: 1768138600
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (22.0 bits)
S2: 51 (24.3 bits)